
<html lang="en"     class="pb-page"  data-request-id="a2635b7d-f110-477c-a137-a274d000f95d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm401431x;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Prostanoid Receptor EP2 as a Therapeutic Target" /></meta><meta name="dc.Creator" content="Thota  Ganesh" /></meta><meta name="dc.Description" content="Cycoloxygenase-2 (COX-2) induction is prevalent in a variety of (brain and peripheral) injury models where COX-2 levels correlate with disease progression. Thus, COX-2 has been widely explored for ..." /></meta><meta name="Description" content="Cycoloxygenase-2 (COX-2) induction is prevalent in a variety of (brain and peripheral) injury models where COX-2 levels correlate with disease progression. Thus, COX-2 has been widely explored for ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 4, 2013" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401431x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401431x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401431x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401431x" /></link>
        
    
    

<title>Prostanoid Receptor EP2 as a Therapeutic Target | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401431x" /></meta><meta property="og:title" content="Prostanoid Receptor EP2 as a Therapeutic Target" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0008.jpeg" /></meta><meta property="og:description" content="Cycoloxygenase-2 (COX-2) induction is prevalent in a variety of (brain and peripheral) injury models where COX-2 levels correlate with disease progression. Thus, COX-2 has been widely explored for anti-inflammatory therapy with COX-2 inhibitors, which proved to be effective in reducing the pain and inflammation in patients with arthritis and menstrual cramps, but they have not provided any benefit to patients with chronic inflammatory neurodegenerative disease. Recently, two COX-2 drugs, rofecoxib and valdecoxib, were withdrawn from the United States market due to cardiovascular side effects. Thus, future anti-inflammatory therapy could be targeted through a specific prostanoid receptor downstream of COX-2. The PGE2 receptor EP2 is emerging as a pro-inflammatory target in a variety of CNS and peripheral diseases. Here we highlight the latest developments on the role of EP2 in diseases, mechanism of activation, and small molecule discovery targeted either to enhance or to block the function of this receptor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401431x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401431x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401431x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401431x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401431x&amp;href=/doi/10.1021/jm401431x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4454-4465</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401427c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm4014746" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Prostanoid Receptor EP2 as a Therapeutic Target</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thota++Ganesh">Thota Ganesh</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Pharmacology, Emory University School of Medicine, 1510 Clifton Road, Atlanta, Georgia, 30322, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-404-727-7393. Fax: +1-404-727-0365. E-mail: <a href="/cdn-cgi/l/email-protection#94e0f3f5faf1e7fcd4f1f9fbe6edbaf1f0e1"><span class="__cf_email__" data-cfemail="4a3e2d2b242f39220a2f27253833642f2e3f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401431x&amp;href=/doi/10.1021%2Fjm401431x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4454–4465</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 26, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 September 2013</li><li><span class="item_label"><b>Published</b> online</span>4 December 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 June 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401431x" title="DOI URL">https://doi.org/10.1021/jm401431x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4454%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThota%2BGanesh%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D11%26contentID%3Djm401431x%26title%3DProstanoid%2BReceptor%2BEP2%2Bas%2Ba%2BTherapeutic%2BTarget%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4465%26publicationDate%3DJune%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401431x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2708</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401431x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Prostanoid Receptor EP2 as a Therapeutic Target&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thota&quot;,&quot;last_name&quot;:&quot;Ganesh&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;4454-4465&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401431x&quot;},&quot;abstract&quot;:&quot;Cycoloxygenase-2 (COX-2) induction is prevalent in a variety of (brain and peripheral) injury models where COX-2 levels correlate with disease progression. Thus, COX-2 has been widely explored for anti-inflammatory therapy with COX-2 inhibitors, which proved to be effective in reducing the pain and inflammation in patients with arthritis and menstrual cramps, but they have not provided any benefit to patients with chronic inflammatory neurodegenerative disease. Recently, two COX-2 drugs, rofecoxib and valdecoxib, were withdrawn from the United States market due to cardiovascular side effects. Thus, future anti-inflammatory therapy could be targeted through a specific prostanoid receptor downstream of COX-2. The PGE2 receptor EP2 is emerging as a pro-inflammatory target in a variety of CNS and peripheral diseases. Here we highlight the latest developments on the role of EP2 in diseases, mechanism of activation, and small molecule discovery targeted either to enhance or to block the function of this receptor.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401431x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401431x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401431x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401431x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401431x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401431x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401431x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401431x&amp;href=/doi/10.1021/jm401431x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401431x" /></input><a href="/doi/pdf/10.1021/jm401431x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (995 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401431x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401431x%26sid%3Dliteratum%253Aachs%26pmid%3D24279689%26genre%3Darticle%26aulast%3DGanesh%26date%3D2014%26atitle%3DProstanoid%2BReceptor%2BEP2%2Bas%2Ba%2BTherapeutic%2BTarget%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D11%26spage%3D4454%26epage%3D4465%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jmcmar.2014.57.issue-11/production/jmcmar.2014.57.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0008.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cycoloxygenase-2 (COX-2) induction is prevalent in a variety of (brain and peripheral) injury models where COX-2 levels correlate with disease progression. Thus, COX-2 has been widely explored for anti-inflammatory therapy with COX-2 inhibitors, which proved to be effective in reducing the pain and inflammation in patients with arthritis and menstrual cramps, but they have not provided any benefit to patients with chronic inflammatory neurodegenerative disease. Recently, two COX-2 drugs, rofecoxib and valdecoxib, were withdrawn from the United States market due to cardiovascular side effects. Thus, future anti-inflammatory therapy could be targeted through a specific prostanoid receptor downstream of COX-2. The PGE<sub>2</sub> receptor EP2 is emerging as a pro-inflammatory target in a variety of CNS and peripheral diseases. Here we highlight the latest developments on the role of EP2 in diseases, mechanism of activation, and small molecule discovery targeted either to enhance or to block the function of this receptor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Inflammation plays a vital role in the pathogenesis of many chronic neurodegenerative<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> and peripheral diseases.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3-6)</a> An acute injury to the brain or to the body induces inflammatory pathways as an immune response. Common features of inflammation include upregulation of cytokines and chemokines, activation of microglia (in the central nervous system) or macrophages (in the periphery), induction of cyclooxygenase-2 (COX-2) and nitric oxide synthase (iNOS), and oxidative stress.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> All of these features are manifested in patients as well as animal models of chronic neurodegenerative diseases such as Alzheimer’s disease (AD),<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Parkinson’s disease (PD),<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> epilepsy,<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> amyotrophic lateral sclerosis (ALS),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and traumatic brain injury (TBI).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> The inflammatory features are also evident in patients with other diseases such as rheumatoid arthritis (RA),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> chronic obstructive pulmonary disease (COPD),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and inflammatory bowel diseases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Prolonged activation of these inflammatory pathways results in a secondary damage to the neighboring neurons in the brain and to the cells and tissues in the body, exacerbating the disease pathology. Thus, inhibition of inflammatory pathways with small molecule inhibitors should provide benefit to patients by reducing the severity of the diseases. It is important to note that the inflammatory responses are critical for survival and homeostasis. However, more than one inflammatory pathway or mediator is activated simultaneously during and after an injury to maintain homeostasis and aid in repair. There is also cross-talk among some of these inflammatory mediators (cytokines, iNOS, and COX-2). An important issue that is often difficult to address is whether these inflammatory mediators act independently or in concert to fight against potential pathogens or clearing the debris from the tissue. As a result, it will be ambitious to comprehend an anti-inflammatory therapeutic agent that blocks a single inflammatory target or pathway resulting in alleviation of an entire inflammatory cascade without interfering with compensatory mechanisms. However, such a therapeutic agent might mitigate the severity of the inflammation and disease progression to some extent. Nonetheless, small molecular agents that block a single biological target such as COX-2, iNOS, cytokines, and glia are currently being pursued by investigators for anti-inflammatory therapy.</div><div class="NLM_p">The cyclooxygenase enzymes (COX-1 and COX-2) have been widely explored for anti-inflammatory therapy.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> COX-1 is constitutively expressed throughout the body and is involved in a range of physiological functions including cellular homeostasis and protection of gastrointestinal integrity.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> COX-2 is rapidly induced or upregulated after a variety of stimuli or injuries and remains upregulated in chronic inflammatory diseases. Both COX-1 and COX-2 isoforms activate prostaglandin signaling (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Several COX-1 selective inhibitors (aka nonsteroidal anti-inflammatory drugs (NSAIDs)) have been shown to produce on-target mediated side effects, mainly gastrointestinal tract and renal toxicity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> It has been hypothesized that selective inhibition of COX-2 by small molecules could potentially eliminate COX-1 mediated toxicities because COX-2 is induced only upon an insult or injury in inflamed joints and tissues.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Thus, several selective COX-2 inhibitors were discovered.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> For example, celecoxib (Celebrex), rofecoxib (Vioxx), and valdecoxib (Bextra) have been clinically proven as anti-inflammatory and pain relievers for chronic indications such as osteoarthritis and rheumatoid arthritis.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> Surprisingly, although elevated levels of COX-2 were observed in AD patients and COX-2 levels were correlated with progression of AD,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> COX-2 inhibitors and NSAIDs have not shown any cognitive benefits to patients with AD. The data suggest that COX-2 inhibitors could have an adverse effect on AD pathogenesis.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Moreover, chronic use of COX-2 drugs like rofecoxib and valdecoxib for arthritis and other diseases also resulted in adverse cardiovascular side effects including myocardial infarction and stroke in a significant number of patients.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Consequently, rofecoxib and valdecoxib were withdrawn from the USA market. These side effects could impose severe restrictions on the future use of COX-2 drugs, particularly for elderly patients with AD, who are already at increased risk for heart disease. It was demonstrated that inhibition of the prostanoid receptor IP, which is activated by COX-2 derived prostaglandin PGI<sub>2</sub> (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), is responsible for myocardial infarction, stroke, and atherosclerosis.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Thus, future generations of anti-inflammatory therapy should be directed to target specific prostaglandin synthases or prostanoid receptors downstream of COX-2 rather than the generic block of the entire COX-2 signaling cascade (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. COX/prostaglandin signaling cascade. Arachidonic acid is converted to PGG<sub>2</sub> and then to PGH<sub>2</sub> by both COX-1 and COX-2 enzymes. Cell specific synthases convert the intermediate PGH<sub>2</sub> into prostaglandin ligands, which activate one or more G coupled-prostanoid receptors. There are four receptors, DP1, EP2, EP4, and IP, which promote cAMP production. cAMP then activates PKA- and Epac-signaling. COX-2 inhibitor (red) would block every prostanoid receptor type, but an EP2 antagonist (blue) could block only one out of 11 prostanoid receptors and may avoid COX-2 inhibition mediated side effects.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">COX/Prostanoid Signaling Cascade</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Both COX-1 and COX-2 catalyze the conversion of arachidonic acid into endoperoxide intermediate prostaglandin-H<sub>2</sub> (PGH<sub>2</sub>), which is then transformed by a variety of cell specific prostaglandin synthases to produce five prostaglandins (PGD<sub>2</sub>, PGE<sub>2</sub>, PGF<sub>2</sub>, PGI<sub>2</sub>, and TXA<sub>2</sub>). These natural ligands activate 11 different G protein-coupled prostanoid receptors (DP1, DP2, EP1, EP2, EP3, EP4, FPα,β, IP, and TPα,β).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> These prostanoid receptors are differentially expressed in various cells and tissues and show a physiological and pathological role in a variety of conditions.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> On the basis of structural and functional properties, these prostanoid receptors are classified into three major groups. The first group, called relaxant receptors, consists of DP1, EP2, EP4, and IP receptors because they mediate smooth muscle relaxation through cyclic AMP (cAMP) production. The second group, known as contractile receptors, consists of EP1, FP, and TP receptors because they induce smooth muscle contraction by intracellular Ca<sup>2+</sup> mobilization. The third group, known as inhibitory receptors, has only two members (EP3 and DP2) that inhibit the production of cAMP. Activation of the DP2 receptor has been shown to increase intracellular Ca<sup>2+</sup> levels as well (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Additional articles regarding the detailed description of prostanoid receptor properties and function have been published recently.<a onclick="showRef(event, 'ref34 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref34 ref36 ref37 ref38">(34, 36-38)</a> Thus, in this perspective article, we focus specifically on the EP2 receptor and the binding of the natural ligand prostaglandin-E<sub>2</sub> (PGE<sub>2</sub>)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (<b>1</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) and synthetic analogues. Both a beneficial and deleterious role of EP2 has been suggested in central nervous system (CNS) and peripheral diseases by making use of EP2 knockout mouse models and selective small molecular agonists and antagonists developed for EP2 (see below).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">EP2 Receptor Is a Target for a Variety of CNS and Peripheral Diseases: An Overview</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The EP2 receptor is widely distributed in the body.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In the brain, EP2 is expressed in the cerebral cortex, thalamus, hypothalamus, spinal cord, hippocampus, and striatum.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> At the cellular level, EP2 is expressed in neurons, astrocytes, and microglia.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> A significant body of evidence shows that the EP2 receptor plays both protective and deleterious role in brain injury models. EP2 activation by butaprost (aka TR4979<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>) (<b>2</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) (a relatively selective EP2 agonist) protects neurons from glutamate- and NMDA-induced excitotoxicity in rat hippocampal cultures in vitro.<a onclick="showRef(event, 'ref42 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref44">(42, 44)</a> EP2 activation by <b>2</b> reduces 6-hydroxydopamine (6-OHDA)-mediated neurotoxicity in primary neuronal cultures prepared from rat midbrain.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> An EP2 selective allosteric potentiator TG3-95-1<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (<b>10</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) also displays a neuroprotective effect in vitro against NMDA-induced excitotoxicity in rat cultures,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> indicating that EP2 is involved in neuroprotection (see next section for neuroprotection in EP2 knockout models).</div><div class="NLM_p">In contrast to the above results, several studies indicate that EP2 activation promotes inflammation and neurotoxicity in chronic neurodegenerative disease models. For example, deletion of EP2 receptors reduces the oxidative damage and amyloid burden in a model of AD,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> attenuates neurotoxicity by α-synuclein aggregation in a mouse model of PD,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and improves motor strength while extending the survival of ALS mice (G93ASOD model).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Mice lacking the EP2 receptor are less prone to cerebral oxidative damage produced by the activation of innate immunity.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Microglia cultures from mice lacking EP2 are less sensitive to neurotoxicity, indicating that microglial EP2 is involved in paracrine neurotoxicity.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Microglia lacking EP2 also show enhanced phagocytosis of amyloid-β (Aβ) peptides, which are hallmarks of AD, and initiate AD progression. Microglia lacking EP2 are also less sensitive to neurotoxicity when activated by Aβ-peptides,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> suggesting that EP2 plays a key role in AD pathology. PGE<sub>2</sub> (<b>1</b>) acting on EP2 and EP4 receptors mediates the production of Aβ-peptides as EP2 knockout mice show reduced amounts of Aβ peptides in the brain.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Taken together, these data suggest that EP2 exacerbates AD by maintaining high levels of Aβ peptides. Furthermore, EP2 receptor activation increases expression of iNOS, an enzyme that produces nitric oxide (NO), which is converted into reactive nitrates and nitrites in cytokine activated astrocytes,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> creating an environment for oxidative stress that has been shown to damage the brain tissue.</div><div class="NLM_p">EP2 receptors are also widely distributed in the periphery. For example, EP2 is highly expressed in retinal tissue, dendritic cells, endometriotic cells, skin epidermis, and in a variety of cancer cells.<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54-56)</a> Studies also indicate that EP2 plays protective and deleterious roles in the peripheral disease models. EP2 activation by a selective agonist ONO-AE1-259-01<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (<b>5</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) in a rat model of retinal degeneration increases the retinal arteriolar diameter and fundus blood flow and also prevents NMDA induced exitotoxic injuries to rat retina, suggesting that EP2 plays a role in the regulation of ocular hemodynamics.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58, 59)</a> An EP2 agonist CP-533536<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> (<b>7</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) has been shown to accelerate bone healing in a preclinical canine model of bone fracture.<a onclick="showRef(event, 'ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62">(60-62)</a> EP2 activation by <b>1</b> also improves renal function in an HgCl<sub>2</sub> model of renal failure<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and survival of epithelial cells after radiation injury.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p">EP2 activation exacerbates symptoms of experimental inflammatory bowel disease (colitis) by increasing IL-23 expression and reducing both IL-12 and IL-27, causing T-cells to differentiate to Th17 effectors (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref55 ref65'); return false;" href="javascript:void(0);" class="ref ref55 ref65">(55, 65)</a> Activation of EP2 also mediates joint inflammation in a mouse model of collagen induced arthritis.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> EP2 has been suggested to function in UV-induced skin inflammation, where loss of EP2 significantly reduces inflammatory cell infiltration into the local skin and local blood flow after UV exposure.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> EP2 has also been shown to promote tumor angiogenesis by enhancing endothelial cell motility and opposing apoptosis<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> and mediating epidermal growth and tumor formation in response to UV radiation<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> or chemical carcinogenesis.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> PGE<sub>2</sub> promotes survival of human endometriotic cells through EP2 and EP4 receptors by activating multiple cell survival signaling pathways. Selective or combined inhibition of EP2 and EP4 receptors impairs these survival pathways and activates intrinsic apoptotic pathways, thereby promoting apoptosis of human endometriotic cells, indicating the potential of nonestrogenic therapy for the treatment of endometriosis in women using an EP2 inhibition strategy.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PGE<sub>2</sub> via EP2 receptor stimulates the differentiation of Th0 to Th17, which exacerbates the disease progression and severity in peripheral diseases such as arthritis and IBD. Additional EP2 signaling is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">EP2 Agonism and Antagonism for Drug Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15423" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15423" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The above overview of results indicates the pleotrophic nature of the EP2 receptor in the CNS and periphery, thus rendering it as a potential target for medicinal chemistry approaches to discover treatments for a variety of disease indications (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The results also suggest that EP2 receptors play a context dependent protective and deleterious role. Thus, both EP2 agonistic and antagonistic strategies may be applied for therapeutic intervention, depending upon the disease and the role played by EP2 in that setting. So far, there is no small molecule agent that either activates or inhibits this G protein-coupled receptor that is approved for clinical use in patients. However, recent preclinical data using a selective EP2 agonist in ischemic stroke and glaucoma models, an EP2 antagonist in seizure and status epilepticus models, suggests that EP2 modulators (agonists and antagonists) should be explored aggressively in the clinical setting.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. EP2 receptors are involved in a variety of CNS and peripheral diseases. EP2 receptors shown to play a protective role in models of stroke, bone fracture, and glaucoma, but mouse models of cancer, endometriosis, AD, PD, ALS, arthritis, and IBD suggest EP2 promotes inflammatory cascade or exacerbates disease pathology. Thus EP2 may be targeted for discovery of therapeutics for these diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> EP2 Agonism for Stroke</h3><div class="NLM_p">Stroke affects about 800000 Americans each year. Treatment and disability for ischemic cerebral injury is estimated to cost about 73 billion/year ( <cite>Heart Disease and Stroke Statistics</cite>; American Heart Association, <span class="NLM_year">2013</span>, Update). So far, a significant number of neuroprotective agents, which have been shown to be effective in preclinical models, failed to show efficacy in patients in clinical studies.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Thus activation of the EP2 receptor may provide neuroprotective benefits to stroke patients. McCullough et al.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and Liu et al.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> have demonstrated that mice lacking EP2 show a significantly larger infarct size and larger stroke volumes compared to wild-type control mice in models of both transient and permanent focal ischemia, with middle cerebral artery occlusion (MCAO). However, both EP2 knockout and wild-type mice show similar physiological parameters and vascular anatomy.<a onclick="showRef(event, 'ref42 ref72'); return false;" href="javascript:void(0);" class="ref ref42 ref72">(42, 72)</a> Independently, Ahmad et al.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> also demonstrated that mice lacking EP2 show higher neurologic deficit scores and larger infarct sizes than those of wild-type controls after MCAO (transient- and permanent-middle cerebral artery occlusion, <i>t</i>MCAO and <i>p</i>MCAO). Importantly, an injection of a selective EP2 agonist <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) (1–2 nM) into the right lateral ventricle of mice prior to <i>t</i>MCAO displayed fewer neurologic deficits and smaller hemispheric infarct volumes in the brain compared to mice injected with only vehicle.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Moreover, Serrano et al.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> have shown that a single injection of butaprost free acid<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> (<b>3</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) immediately after termination of status epilepticus shows about 50% neuroprotection in the hippocampal CA1. These groups have chosen to administer EP2 agonists, either <b>3</b> or <b>5</b>, directly into the lateral ventricle. Although this is not the method of choice for the dosing of a drug to patients, given the poor brain penetration properties of these carboxylic acids, this method of administration may be justified. Thus, it is also possible that bolus dosing of an EP2 agonist early on could potentially saturate and desensitize the EP2 receptors by internalization, as described before for other receptors<a onclick="showRef(event, 'ref76 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref76 ref77 ref78">(76-78)</a> and negatively regulate the deleterious functions of the receptor, leading to a net neuroprotective effect. However, Desai et al.,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> showed that 1 μM <b>1</b> (about 500-fold higher concentration than its EC<sub>50</sub> for EP2) for 0–60 min does not internalize EP2 receptors expressed on 293-EBNA cell line, but in comparison, the same dose of <b>1</b> internalizes EP4 receptors by 40%. In the study involving an ischemic stroke model,<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> the EP2 agonist <b>5</b> was dosed to produce cerebrospinal fluid (CSF) concentrations of only 1–2 nM, a concentration at its EC<sub>50</sub> for the EP2 receptor (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). It is less likely that EP2 receptors are desensitized in this situation. However, in a mouse model of status epilepticus, Serrano et al., used butaprost free acid <b>3</b> at concentration about 3-fold higher than its EC<sub>50</sub> for EP2.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> In this case, there is a possibility of receptor desensitization. Overall, the very weak internalization tendency of EP2 receptors in vitro,<a onclick="showRef(event, 'ref77 ref79'); return false;" href="javascript:void(0);" class="ref ref77 ref79">(77, 79)</a> in conjunction with results from mice lacking EP2 receptors,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> rule out the possibility of receptor desensitization is the cause of beneficial effects in the stoke models<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73, 74)</a> and provide a rationale for using EP2 activation as an attractive strategy for a neuroprotection therapy in ischemic stroke patients by using a highly selective, orally available, brain penetrant EP2 agonist. Whether the animal models of <i>t</i>MCAO and <i>p</i>MCAO, as well as pilocarpine induced status epilepticus discussed here,<a onclick="showRef(event, 'ref42 ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref42 ref72 ref73 ref74">(42, 72-74)</a> are relevant to the human disease or whether they will translate into the clinical setting is beyond the scope of this review.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of EP2 agonists, EP2 allosteric potentiator, and EP2 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pharmacological Properties of Selected EP2 Agonists</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">EC<sub>50</sub>/IC<sub>50</sub> (nM)</th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">binding <i>K</i><sub>i</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd name/ID</th><th class="colsep0 rowsep0" align="center">EP2</th><th class="colsep0 rowsep0" align="center">IP</th><th class="colsep0 rowsep0" align="center" char=".">EP2</th><th class="colsep0 rowsep0" align="center">EP1</th><th class="colsep0 rowsep0" align="center">EP3</th><th class="colsep0 rowsep0" align="center">EP4</th><th class="colsep0 rowsep0" align="center">IP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">PGE<sub>2</sub></td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="center">260</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">3.1</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">Butaprost</td><td class="colsep0 rowsep0" align="center">33</td><td class="colsep0 rowsep0" align="center">37</td><td class="colsep0 rowsep0" align="char" char=".">2400</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">Butaprost</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">870</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">free acid<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">3.8</td><td class="colsep0 rowsep0" align="center">NA<a class="ref internalNav" href="#tbl1-fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">ONO-AE1-259-01</td><td class="colsep0 rowsep0" align="center">1.8</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="center">1300</td><td class="colsep0 rowsep0" align="center">2700</td><td class="colsep0 rowsep0" align="center">2300</td><td class="colsep0 rowsep0" align="center">10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">AH-13205</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char=".">240</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">82</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="center">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">CP-533536</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="center">>2800</td><td class="colsep0 rowsep0" align="center">>2800</td><td class="colsep0 rowsep0" align="center">>3200</td><td class="colsep0 rowsep0" align="center">>3200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">CP-544326</td><td class="colsep0 rowsep0" align="center">2.8</td><td class="colsep0 rowsep0" align="center">NA</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="center">>3200</td><td class="colsep0 rowsep0" align="center">>3200</td><td class="colsep0 rowsep0" align="center">>3200</td><td class="colsep0 rowsep0" align="center">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">An independent study indicates butaprost free acid (<b>3</b>) is only 17-fold selective to EP2 over EP3 receptors.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></p></div><div class="footnote" id="tbl1-fn1"><sup>b</sup><p class="last">NA = data not available.</p></div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> EP2 Agonism for Ocular Disease</h3><div class="NLM_p last">Treatments for lowering intraocular pressure with hypotensive agents that antagonize β2-adrenergic receptors, or agonize α2-adrenergic receptors and prostanoid receptor FP are currently marketed.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a> Recent studies from Pfizer, using an EP2 agonist taprenepag isopropyl (PF-04217329)<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> (<b>9</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), suggest EP2 as an attractive target for open-angle glaucoma and ocular hypertension therapy. Compound <b>9</b> (a prodrug of CP-544326<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> (<b>8</b>)) has been shown to control intraocular pressure in preclinical models of rabbit, dog, and monkey.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Moreover, this compound has been investigated in a phase 2 clinical trial of 28 days of monotherapy, where it significantly reduced intraocular pressure in patients with open-angle glaucoma and ocular hypertension.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83, 84)</a> Because of the poor aqueous solubility of <b>9</b>, it was formulated with a surface active ingredient (1% Tween-80, 5% Cremophor-L, and 0.02% benzalkonium chloride in 100 mM phosphate buffer pH 5.5) as an ophthalmic solution. This compound, at a concentration of 0.0025–0.03%, produced benefits comparable to a 0.005% latanoprost solution (a current standard of care) in reducing intraocular pressure in patients.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83, 84)</a> A point to note is that topical administration of an EP2 agonist, like <b>9</b>, is unlikely to be efficacious in treating other CNS and peripheral diseases. Although it is unknown whether systemic administration of an EP2 agonist will cause hypotension, EP2 knockout mice and mice injected with an EP2 agonist (by intracerebroventricular route) after MCAO have shown no differences in mean arterial cerebral blood flow in comparison to control mice.<a onclick="showRef(event, 'ref42 ref73'); return false;" href="javascript:void(0);" class="ref ref42 ref73">(42, 73)</a> Nonetheless, long-term oral treatment with an EP2 agonist may cause hypotension as a side effect.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> EP2 Antagonism for Neurodegenerative Disease</h3><div class="NLM_p last">Chronic inflammatory neurodegenerative diseases such as epilepsy, AD, PD, and ALS contribute to the mortality and morbidity of a significant fraction of the population in the USA. AD and PD are particularly associated with dementia symptoms in the elderly. However, all of these diseases share a common feature of overactivated inflammatory pathways.<a onclick="showRef(event, 'ref1 ref2 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref7">(1, 2, 7)</a> Interestingly, PGE<sub>2</sub> is a major prostaglandin produced during the progression of these diseases and has been shown to mediate proinflammatory functions via EP2 (and to a lesser extent by EP4) receptors. Recently, Jiang et al.,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> have shown that administration of a potent and selective EP2 antagonist, TG4-155<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> (<b>12</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), substantially blocks neuronal damage in the hippocampus (>60% in the hilus, 80% in the CA3, and >90% in the CA1 region) in a pilocarpine model of status epilepticus. Jiang et al.,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> also showed that another potent EP2 antagonist, TG6-10-1<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> (<b>13</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), suppresses neurodegeneration, upregulation of inflammatory cytokines and chemokines, and activation of glia in mice following status epilepticus, suggesting a potential therapeutic benefit for an EP2 antagonist to block epileptogenesis. On the basis of beneficial effects observed in EP2-knockout mouse models of AD, PD, and ALS (vide supra),<a onclick="showRef(event, 'ref41 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref41 ref47 ref48">(41, 47, 48)</a> a potent and highly selective EP2 receptor antagonist may show utility as an adjunct therapeutic agent for chronic inflammatory neurodegenerative diseases including epilepsy, AD, PD, and ALS.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Effects of EP2 Deletion in Animal Models</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50335" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50335" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Creation and use of EP2 genetic knockout models provided a wealth of information regarding the function of EP2 receptor in physiological and pathophysiological conditions. However, it is important to note that EP2 knockout mice exhibited significant cognitive and social memory deficits, impaired spatial learning and prepulse inhibition, and heightened anxiety, suggesting an association between the EP2 receptor and long-term hippocampal depression and learning and memory.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87, 88)</a> The loss of EP2 also has functional ramifications for reproduction, as EP2-lacking mice have decreased ovulation number and fertilization rate compared to wild-type mice, and EP2 null females produce lower than normal litter sizes.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Other functional roles of EP2 identified by genetic manipulation studies in pregnant EP2 mice include arterial dilatation, salt-sensitive hypertension during pregnancy, and reduced female fertility.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Reports such as these may have contributed to the paucity in antagonistic drug discovery approaches for this receptor. However, it is unlikely that these developmental compromises will be observed with small molecule inhibitors. Thus, use of a highly specific EP2 receptor antagonist for longer periods of time may provide a definitive answer to whether EP2 antagonism has a therapeutic advantage in comparison to genetically manipulated mice.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">EP2-Downstream Mechanisms of Action</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A significant body of evidence suggests that EP2 activates downstream signaling either by a G protein-coupled or by G protein-independent mechanism.<a onclick="showRef(event, 'ref91 ref92 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref91 ref92 ref93 ref94 ref95">(91-95)</a> As shown briefly in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, activation of EP2 by PGE<sub>2</sub> stimulates adenylate cyclase (via Gαs) resulting in cAMP, which mediates events either through protein kinase A (PKA)<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> or exchange protein activated (Epac).<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96, 97)</a> PKA activates transcription factors such as cAMP-responsive element binding protein (CREB), which is involved in neuronal survival and neurogenesis.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98, 99)</a> Epac initiates downstream effectors Rap1/2 to regulate neuronal differentiation, neuronal excitability, learning, memory, and social interactions.<a onclick="showRef(event, 'ref100 ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref100 ref101 ref102">(100-102)</a> It has been shown that there is cross-talk between PKA and Epac and that PKA and Epac work synergistically to activate CREB. However, more often they work antagonistically. Generally, it is believed that PKA activation is associated with neuronal survival, whereas Epac activation leads to neuronal injury. EP2 also regulates other downstream effectors independent of G protein-coupling via β-arrestin to promote or exacerbate disease conditions including cancer proliferation and metastasis (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Thus, EP2 is a complex target displaying pleotrophic roles depending on the circumstances. For simplicity, only a few downstream pathways are described here. However, it is important to remember that some of the downstream effectors shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> are also influenced by other G protein-coupled receptors, like EP4.<a onclick="showRef(event, 'ref91 ref92 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref91 ref92 ref93 ref94 ref95">(91-95)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. EP2 mediates both beneficial and deleterious effects by G protein-coupled and G protein-independent downstream mechanisms. Upon PGE<sub>2</sub> binding, EP2 activates and dissociates Gas protein. Then Gas regulates activities of various effectors. Abbreviations used: PKA = protein kinase A, CREB = cAMP responsive binding element protein, PI3K = phosphatidylinositol-3-kinase, ERK = extracellular signal regulated kinase, JNK = c-Jun N-terminal kinase, EGFR = epidermal growth factor receptor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">EP2 Structure and Binding Site</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The EP2 receptor belongs to the seven-transmembrane G protein-coupled receptor family. Human EP2 encodes a protein of 488 amino acids with a molecular mass of 53 kDa. The amino acid sequence identity between human and mouse EP2 is 88%. The difference between these receptors is the presence of an extra 25 amino acids at the NH<sub>2</sub> terminus of the mouse EP2 protein and a difference of six consecutive amino acids in the third extracellular loop. Despite these differences, the pharmacological properties of human EP2 receptors are similar to those of mouse EP2 receptors.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Within the family of prostanoid receptors, the amino acid identity is limited. The identity of EP2 amino acids to EP1, EP3, and EP4 is in the range of 20–30%. However, EP2 is more homologous to DP1, with a structural identity of 44%, and then to the IP receptor with 40% identity.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> No 3D structure of the EP2 receptor or any other prostanoid receptor has yet been solved which might provide details for the binding of small molecule (natural and synthetic) EP2 modulators. However, the second extracellular loop region has shown a highly conserved amino acid sequence and it is presumed that the ligand-recognition site is located in this region.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> So far, small molecule discovery (vide infra) has been carried out only on the basis of intuitive ligand-based design strategy.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">In Vitro Bioactivities of EP2 Agonists and Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71578" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71578" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In comparison to other prostanoid receptors, relatively fewer efforts have appeared toward discovery and development of small molecule modulators of EP2.<a onclick="showRef(event, 'ref34 ref38'); return false;" href="javascript:void(0);" class="ref ref34 ref38">(34, 38)</a> There are only two classes of agonists currently available. Representative members of these classes that are widely used and chemically optimized are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. The first class of agonists is composed of molecules that are structurally related to the endogenous ligand <b>1</b>, a nonselective EP2 agonist with EP2 <i>K</i><sub>i</sub> = 38 nM determined by a competitive binding assay.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The synthetic agonist <b>2</b> (butaprost) is about 63-fold less potent than <b>1</b>, with an EP2 <i>K</i><sub>i</sub> = 2400 nM. The agonist <b>2</b> is selective for EP2 over other prostanoid receptors in receptor binding assays but was equally effective in activating IP receptors in a functional assay (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> In a separate study, <b>2</b> was shown to be only 3–4-fold selective for EP2 over EP3 and EP4 receptors but very selective against the IP receptor in binding assays.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The ester group of <b>2</b> is unstable and is expected to be cleaved metabolically to produce acid <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The acid <b>3</b> is more potent than <b>2</b>, with an EP2 <i>K</i><sub>i</sub> of 73 nM. By comparison, <b>3</b> is only 2-fold less potent than <b>1</b>, however, the free acid <b>3</b> has lost selectivity to EP2 binding over IP receptor binding (IP <i>K</i><sub>i</sub> = 870 nM). In a potency assay, <b>3</b> showed nearly the same activity for EP2 and IP receptors, with an EC<sub>50</sub> of 32 and 25 nM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The other agonist in the same class represented as compound <b>4</b><a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) appears very selective for the EP2 receptor over other prostanoid receptors. The affinity of <b>4</b> to EP2 is nearly 10-fold higher than that of <b>1</b> and 20-fold higher than that of <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, in functional assays, it has nearly the same potency as <b>1</b> and roughly a 10-fold higher potency than <b>3</b>.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Compound <b>4</b> is found to be unstable as the free acid, but its stability is markedly improved when it is converted to the lysine salt.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Compound <b>5</b> shows a higher binding affinity for EP2 (<i>K</i><sub>i</sub> = 1.7 nM), a 22-fold higher affinity than <b>1</b> and 42-fold higher affinity than <b>3</b>. Compound <b>5</b> also shows ∼700–1500-fold selectivity for EP2 over other prostanoid receptors such as EP1, EP3, EP4, and IP.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In a functional assay, it has about an 18-fold higher potency than <b>2</b> and <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The nonselective EP2 agonist AH-13205<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105, 106)</a> (<b>6</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) is also a member of this class, but because of its low potency it has not received much attention.</div><div class="NLM_p">The second class of EP2 agonists are pyridyl-sulfonamides. Compound <b>7</b> is the initial lead compound in the class and has high binding affinity to EP2 (<i>K</i><sub>i</sub> = 50 nM) with high selectivity for EP2 over other prostanoid receptors (16-fold selectivity against DP1 and 50–60-fold selectivity against EP1, EP3, EP4, and IP receptors).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> A related compound in this class, <b>8</b>, also displays high binding affinity to EP2 and at least a 270-fold selectivity against EP1, EP3, and EP4 receptors. The potency of <b>8</b> is equal to <b>1</b> in a cAMP determination assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Importantly, a prodrug of <b>8</b>, taprenepag isopropyl (<b>9</b>) has been developed as a clinical candidate (vide supra).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The only class of EP2-allosteric potentiators reported, represented by <b>10</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), was developed recently at Emory University. Compound <b>10</b> potentiates EP2 receptors with EC<sub>50</sub> = 7.8 μM in a cAMP assay and also displays selective potentiation of EP2 receptors versus EP4 and β2-AR receptors.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Allosteric potentiators are designed to function in the presence of high PGE<sub>2</sub> concentrations that are expected to be present during tissue injury. Two drawbacks of these potentiators are that they are weakly active and poorly water soluble for dosing into animal models. However, <b>10</b> may be useful for in vitro studies.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p">The only EP2 antagonist widely used for probing the roles of EP2 is AH-6809<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> (<b>11</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). <b>11</b> is commercially available, but it shows weak antagonistic activity (EP2 <i>K</i><sub>i</sub> = 1150 nM) and very poor selectivity against other prostanoid receptors such as EP1, EP3, and DP1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Recently, Pfizer revealed the azetidine-carboxylic acid derivative PF-04418948<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> (<b>15</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) as the first of a new class of selective EP2 antagonists, with an IC<sub>50</sub> of 16 nM and Schild <i>K</i><sub>B</sub> of 1.8 nM (a concentration required to cause a 2-fold increase of the EC<sub>50</sub> of PGE<sub>2</sub>).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> This antagonist exhibits >10000-fold selectivity for the EP2 receptor over other prostanoid receptors (i.e., EP1, EP3, EP4, DP1, and IP) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and does not show significant effects on a diverse panel of other GPCRs.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> However, brain penetration of this antagonist has not been disclosed and thus it is unclear whether this compound could be useful for in vivo evaluation in mouse models of CNS disease. Nonetheless, <b>15</b> has been shown to attenuate butaprost-induced vasodilatory blood flow in rats, demonstrating that it has the requisite plasma pharmacokinetics and tissue penetration to be useful as an in vivo probe for a variety of peripheral diseases.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacological Properties of EP2 Antagonists<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">functional cAMP assays, Schild <i>K</i><sub>B</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">compd ID</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> EP2 (nM)</th><th class="colsep0 rowsep0" align="center">EP2</th><th class="colsep0 rowsep0" align="center">EP1</th><th class="colsep0 rowsep0" align="center">EP3</th><th class="colsep0 rowsep0" align="center" char=".">EP4</th><th class="colsep0 rowsep0" align="center" char=".">DP1</th><th class="colsep0 rowsep0" align="center" char=".">IP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">AH-6809</td><td class="colsep0 rowsep0" align="center">1150</td><td class="colsep0 rowsep0" align="center">1150</td><td class="colsep0 rowsep0" align="center">1200</td><td class="colsep0 rowsep0" align="center">1600</td><td class="colsep0 rowsep0" align="char" char=".">>100000</td><td class="colsep0 rowsep0" align="char" char=".">1400</td><td class="colsep0 rowsep0" align="char" char=".">>100000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">TG4-155</td><td class="colsep0 rowsep0" align="center">9.9</td><td class="colsep0 rowsep0" align="center">2.4</td><td class="colsep0 rowsep0" align="center">2100</td><td class="colsep0 rowsep0" align="center">10000</td><td class="colsep0 rowsep0" align="char" char=".">>11400</td><td class="colsep0 rowsep0" align="char" char=".">34.5</td><td class="colsep0 rowsep0" align="char" char=".">1320</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">TG6-10-1</td><td class="colsep0 rowsep0" align="center">210</td><td class="colsep0 rowsep0" align="center">17.8</td><td class="colsep0 rowsep0" align="center">1700</td><td class="colsep0 rowsep0" align="center">5300</td><td class="colsep0 rowsep0" align="char" char=".">17200</td><td class="colsep0 rowsep0" align="char" char=".">167</td><td class="colsep0 rowsep0" align="char" char=".">8120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">TG6-129</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">8.8</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char=".">3900</td><td class="colsep0 rowsep0" align="char" char=".">14600</td><td class="colsep0 rowsep0" align="char" char=".">199</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">PF-04418948</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">1.8</td><td class="colsep0 rowsep0" align="center">>100000</td><td class="colsep0 rowsep0" align="center">>100000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values are taken from binding assay. Schild <i>K</i><sub>B</sub>S are derived from a cAMP functional assay. For compound AH-6809, Schild <i>K</i><sub>B</sub> values are not available, so <i>K</i><sub>i</sub> values are presented in the table to show the nonselectivity and poor EP2 activity</p></div></div></div><div class="NLM_p last">Independently from Pfizer, Emory University identified a novel cinnamic acid amide class of EP2 antagonists and has investigated them for proof of concept in mouse models of status epilepticus.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a> These compounds are unique in structure and do not belong to any other class of agonists or antagonists previously reported. Importantly, the Emory EP2 antagonists do not possess a carboxylic acid, which is intrinsic to the majority of the EP2 agonists and antagonists discovered thus far (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Two representatives in this class of EP2 antagonists are <b>12</b> and <b>13</b>, whose structures are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> The prototype compound <b>12</b> has an EP2 Schild <i>K</i><sub>B</sub> of 2.4 nM and displays 550–4750-fold selectivity for EP2 over EP1, EP3, EP4, and IP but only 14-fold selectivity against the DP1 receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Another lead compound in this class of EP2 receptor antagonists is <b>13</b>, which has an EP2 Schild <i>K</i><sub>B</sub> of 17.8 nM and displays greater than 300-fold selectivity against EP3, EP4, and IP receptors. Compound <b>13</b> shows a 100-fold selectivity against EP1, FP, and TP receptors but only 10-fold selectivity against the DP1 receptor.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Moreover, <b>13</b> shows a plasma half-life (<i>t</i><sub>1/2</sub>) of 1.6 h and brain to plasma ratio of 1.6 in mice. These two Emory compounds (<b>12</b> and <b>13</b>) did not show significant off-target activity against a diverse panel of 47 enzymes and receptors including COX, NOS, PDE, adrenergic receptors, serotonin receptors, and cytochrome P450 enzymes. So far, <b>12</b> and <b>13</b> have only shown significant off-target activity at the serotonin 5-HT2B receptor with an IC<sub>50</sub> 2.6 and 7.5 μM, respectively.<a onclick="showRef(event, 'ref86 ref109'); return false;" href="javascript:void(0);" class="ref ref86 ref109">(86, 109)</a> These IC<sub>50</sub> values far exceed their respective EP2 Schild K<sub>B</sub> values (1080-fold higher for <b>12</b>, 420-fold higher for <b>13</b>). The data obtained thus far on these novel EP2 receptor antagonists suggest that <b>13</b> may serve as a valuable probe for proof of concept studies in CNS and other neurodegenerative animal models where EP2 receptors may mediate deleterious effects. Very recently, Emory university group discovered a second class of antagonists that are carbamothioylacrylamides.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> A lead compound, TG6-129<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> (<b>14</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), displayed EP2 potency at low nanomolar concentrations (EP2 Schild <i>K</i><sub>B</sub> = 8.8 nM). Unlike <b>12</b> and <b>13</b>, compound <b>14</b> has shown high selectivity against DP1 (1660-fold) and EP4 (440-fold) receptors but only 22-fold selectivity against the IP receptor. This compound did not cross the blood–brain barrier, and thus it might be useful as a probe for a variety of peripheral disease models shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">EP2 Antagonists Reported in Patent Literature</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50240" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50240" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although very little bioactivity or biology is included in the patent literature, a brief summary on patented EP2 antagonists is presented due to the relatively limited number of chemical scaffolds available so far. Two pharmaceutical companies, Pfizer and Bayer Schering Pharma, have identified small molecule antagonists for the EP2 receptor. Representative structures <b>16</b>–<b>22</b> are illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>. Pfizer has created 3-azetidine carboxylic acids and 3-azetidine carboxamides (<b>16</b>–<b>17</b>) with potent EP2 inhibition activity.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Compound <b>15</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) emerged as a lead compound from the general structure <b>16</b>. Bayer Schering Pharma has also developed four distinct classes of antagonists represented by <b>18</b>–<b>21</b>,<a onclick="showRef(event, 'ref112 ref113 ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114 ref115">(112-115)</a> but in vivo data is not available for any lead structure from these scaffolds <b>18</b>–<b>22</b>. Emory University also created a class of compounds represented by <b>22</b>, which display potent EP2 antagonist activity<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> from which <b>13</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) has emerged as a lead compound. Several compounds from each class (<b>16</b>–<b>22</b>) show EP2 potency in the range of low nanomolar to low micromolar level (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) and are available as backups for development into therapeutically useful compounds. Because of the large number of EP2 agonists published in the patent literature and scholarly articles, they are not highlighted here.<a onclick="showRef(event, 'ref122 ref123 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref122 ref123 ref124 ref125">(122-125)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. General structural scaffolds of EP2 antagonists reported in the patent literature. EP2 inhibition activity range from nanomolar to micromolar among the members in each class is shown here for comparison purposes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions and Prospects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PGE<sub>2</sub> is a major product of increased COX-2 activity in the brain of rodents and human patients following various insults. It activates four G protein-coupled receptors (EP1, EP2, EP3, and EP4). EP2 receptor is expressed in various parts of the body and brain and plays context-dependent, beneficial, and deleterious roles. Thus, concerns are inevitable about whether EP2 receptor is druggable with small molecules, and if so, whether activation or inhibition is a better therapeutic strategy. Recent studies with mouse models of ischemic stroke and inflammatory neurodegenerative disease model of status epilepticus (vide supra) suggest both agonism and antagonism strategies may be explored for therapeutic development. Studies also suggest that the cell type from which EP2 receptors originate may affect the role of the receptor. For example, in the brain, EP2 receptors are expressed in neurons and glia. Thus, it is also possible that EP2 of neuronal origin may act, mainly through PKA activation, in an autocrine fashion to protect neurons from acute brain injury (as in stroke, or just after status epilepticus). The signaling from dying neurons, in conjunction with several other proinflammatory mediators produced during acute brain injury, may activate EP2 receptors in microglia and astrocytes, which, predominantly via the Epac activation pathway, may exacerbate paracrine toxicity, leading to neurodegeneration. Thus, as illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, an appropriate therapeutic approach may be to use an EP2 agonist or an allosteric potentiator immediately after brain injury to maximize the beneficial effects. An alternative therapeutic strategy would be to use an EP2 antagonist, starting several hours to days after brain insult to break the glia-induced vicious inflammatory cycle, as a first line or adjunct therapeutic agent in patients with neurodegenerative diseases such as epilepsy, AD, PD, TBI, and ALS.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Two potential therapeutic strategies that may be useful for EP2 receptor mediated effects in the brain for neuroprotection and for blocking the neurodegeneration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As recently described by Weiss et al.,<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> it is not always true that the phenotype of small molecular inhibitors of a target mimics the phenotype of genetic knockout animals lacking the same target. There are several receptors and enzymes including a few kinases (e.g., Aurora B) known to show divergence. EP2 knockout mice were created many years ago and have been used extensively to explore the role of EP2 in a variety of disease models. However, EP2 receptor antagonists have been reported recently and have been explored in limited neurodegenerative disease models. Thus they should be examined for on-target mediated effects on healthy mice during chronic dosing (2–3 months) in order to characterize memory deficits, fertility complications, formation, and loss of synapses in the hippocampus (vide supra). This experiment would yield valuable information to rule in or out whether an antagonism of EP2 is therapeutically beneficial.</div><div class="NLM_p">There are several highly characterized EP2 specific agonists now available (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) but a limited number of selective antagonists (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) that are useful for CNS and other disease models. Other than steroids, NSAIDs, and COX-2 inhibitors, currently, there is no other FDA approved anti-inflammatory therapeutic agent available which works through a specific inflammatory target. However, selective inhibitors of microsomal prostaglandin-E-synthase (mPGES)<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> and antagonists of prostanoid receptor EP4<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> are currently under preclinical evaluation. These agents (mPGSE-1 and EP4 inhibitors) may also alleviate some of the adverse side effects caused by COX-2 inhibitors. However, experiments designed to reduce inflammation or neurodegeneration (or both) in chronic inflammatory or neurodegenerative disease models (examples: arthritis, AD, epilepsy) using COX-2, and EP2 or EP4 or mPEGS-1 selective inhibitors head-to-head, is worth pursuing.</div><div class="NLM_p last">Although the available EP2 agonists and antagonists are selective for EP2 in binding and in vitro functional assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), in vivo target-engagement studies<a onclick="showRef(event, 'ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref120 ref121">(120, 121)</a> are lacking to ascertain whether the observed efficacy is mediated through the binding of EP2 modulators to the receptor in vivo. Demonstration of target engagement is a formidable task for EP2 receptor and is complicated by the fact that there is no specific biomarker produced solely by the EP2 receptor and lack of available radiolabeled agonists or antagonists that specifically bind to EP2 in vivo. Nonetheless, this study is very important, and if target engagement can be demonstrated, it will strengthen the published results and advance the EP2 receptor as a target for drug discovery.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm401431x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thota Ganesh</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Emory University School
of Medicine, 1510 Clifton
Road, Atlanta, Georgia, 30322, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b1c5d6d0dfd4c2d9f1d4dcdec3c89fd4d5c4"><span class="__cf_email__" data-cfemail="8efae9efe0ebfde6ceebe3e1fcf7a0ebeafb">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Thota Ganesh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=BIO-d1759e7365-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Thota Ganesh</b> obtained his M.Sc. and Ph.D. degrees from Osmania University, Hyderabad, India. After his postdoctoral studies at IIT-Bombay (India), University of Durham (UK), and Virginia Tech (USA), he began working as an Assistant Professor at the Department of Pharmacology, Emory University. Dr. Ganesh’s current research focuses on developing small molecule agents to mitigate the inflammatory pathologies in neurodegenerative diseases, including epilepsy and Alzheimer’s disease. His past research includes, total synthesis, medicinal chemistry of Taxol, epothilones and other bioactive molecules, and development of small molecules inhibitors for HSP90 and histone methyltransferase enzymes. Dr. Ganesh is grateful to his past mentors Drs. Sambasivarao Kotha (IIT-Bombay, India), Patrick G. Steel (University Durham, UK), David G. I. Kingston (Virginia Tech, USA), and Dennis Liotta (Emory University).</p></figure></div><div class="ack" id="ACK-d1759e1752-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">T.G. thanks lab members Dr. Asheebo Rojas, Dr. Jianxiong Jiang, Dr. Ray Dingledine, and Nadia Lelutiu for reading the proof of the manuscript and comments. Dr. Ganesh is supported by NIH/NINDS grant U01NS058158 (P. I. Ray Dingledine)</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i20" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i20"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i21" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i21"> Abbreviations Used</h2><tr><td class="NLM_term">PGE<sub>2</sub></td><td class="NLM_def"><p class="first last">prostaglandin-E<sub>2</sub></p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">ALS</td><td class="NLM_def"><p class="first last">amyotrophic lateral sclerosis</p></td></tr><tr><td class="NLM_term">SE</td><td class="NLM_def"><p class="first last">status epilepticus</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">IBD</td><td class="NLM_def"><p class="first last">inflammatory bowel disease</p></td></tr><tr><td class="NLM_term">DC</td><td class="NLM_def"><p class="first last">dendritic cells</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">OGD</td><td class="NLM_def"><p class="first last">oxygen-glucose deprivation</p></td></tr><tr><td class="NLM_term">MCAO</td><td class="NLM_def"><p class="first last">middle cerebral artery occlusion</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 125 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lucas, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothwell, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R. M.</span><span> </span><span class="NLM_article-title">The role of inflammation in CNS injury and disease</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S232</span><span class="NLM_x">–</span> <span class="NLM_lpage">S240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S232-S240&issue=Suppl+1&author=S.+M.+Lucasauthor=N.+J.+Rothwellauthor=R.+M.+Gibson&title=The+role+of+inflammation+in+CNS+injury+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%2BM.%26aulast%3DRothwell%26aufirst%3DN.%2BJ.%26aulast%3DGibson%26aufirst%3DR.%2BM.%26atitle%3DThe%2520role%2520of%2520inflammation%2520in%2520CNS%2520injury%2520and%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26issue%3DSuppl%25201%26spage%3DS232%26epage%3DS240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Minghetti, L.</span><span> </span><span class="NLM_article-title">Role of inflammation in neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1097%2F01.wco.0000169752.54191.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=15891419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslWht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=315-321&author=L.+Minghetti&title=Role+of+inflammation+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Role of inflammation in neurodegenerative diseases</span></div><div class="casAuthors">Minghetti, Luisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Although significant advances have been made in the knowledge of degenerative diseases, there remains controversy regarding whether neuroinflammation and microglial activation are beneficial or detrimental.  Strategies aimed at both preventing and boosting microglial activation are presently under investigation, and these studies might reveal new potentially effective treatments for these neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFq64evVEgCLVg90H21EOLACvtfcHk0lgoFplFq8jJyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslWht7Y%253D&md5=6cbc4795a09f1014e26eb0b0f8ad2100</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2F01.wco.0000169752.54191.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wco.0000169752.54191.97%26sid%3Dliteratum%253Aachs%26aulast%3DMinghetti%26aufirst%3DL.%26atitle%3DRole%2520of%2520inflammation%2520in%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2005%26volume%3D18%26spage%3D315%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Baumgart, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carding, S. R.</span><span> </span><span class="NLM_article-title">Gastroenterology 1—Inflammatory bowel disease: cause and immunobiology</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=1627-1640&author=D.+C.+Baumgartauthor=S.+R.+Carding&title=Gastroenterology+1%E2%80%94Inflammatory+bowel+disease%3A+cause+and+immunobiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgart%26aufirst%3DD.%2BC.%26aulast%3DCarding%26aufirst%3DS.%2BR.%26atitle%3DGastroenterology%25201%25E2%2580%2594Inflammatory%2520bowel%2520disease%253A%2520cause%2520and%2520immunobiology%26jtitle%3DLancet%26date%3D2007%26volume%3D369%26spage%3D1627%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schett, G.</span><span> </span><span class="NLM_article-title">The pathogenesis of rheumatoid arthritis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">2205</span><span class="NLM_x">–</span> <span class="NLM_lpage">2219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1056%2FNEJMra1004965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=22150039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ajsrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=2205-2219&author=I.+B.+McInnesauthor=G.+Schett&title=The+pathogenesis+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The pathogenesis of rheumatoid arthritis</span></div><div class="casAuthors">McInnes, Lain B.; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2205-2219</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses key pathogenic advances in rheumatoid arthritis, genetics, environmental factors, immunol. processes, inflammation, and structural damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJslDVaG7MxbVg90H21EOLACvtfcHk0lhoWLMtGMsfiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ajsrrM&md5=31a79ccb05bca03f207b15f934b2d52d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1004965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1004965%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DThe%2520pathogenesis%2520of%2520rheumatoid%2520arthritis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D2205%26epage%3D2219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sethi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahler, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yawn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S.</span><span> </span><span class="NLM_article-title">Inflammation in COPD: implications for management</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.amjmed.2012.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3s7ks1aruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=1162-1170&author=S.+Sethiauthor=D.+A.+Mahlerauthor=P.+Marcusauthor=C.+A.+Owenauthor=B.+Yawnauthor=S.+Rennard&title=Inflammation+in+COPD%3A+implications+for+management"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in COPD: implications for management</span></div><div class="casAuthors">Sethi Sanjay; Mahler Donald A; Marcus Philip; Owen Caroline A; Yawn Barbara; Rennard Stephen</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1162-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) is recognized by the Global Initiative for Chronic Obstructive Lung Disease guidelines as an inflammatory disease state, and treatment rationales are provided accordingly.  However, not all physicians follow or are even aware of these guidelines.  Research has shown that COPD inflammation involves multiple inflammatory cells and mediators and the underlying pathology differs from asthma inflammation.  For these reasons, therapeutic agents that are effective in asthma patients may not be optimal in COPD patients.  COPD exacerbations are intensified inflammatory events compared with stable COPD.  The clinical and systemic consequences believed to result from the chronic inflammation observed in COPD suggest that inflammation intensity is a key factor in COPD and exacerbation severity and frequency.  Although inhaled corticosteroids are commonly used and are essential in asthma management, their efficacy in COPD is limited, with only a modest effect at reducing exacerbations.  The importance of inflammation in COPD needs to be better understood by clinicians, and the differences in inflammation in COPD versus asthma should be considered carefully to optimize the use of anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzQskOX44WUjEwO064Z95rfW6udTcc2ebA9uf5kf8777ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7ks1aruw%253D%253D&md5=3cc2174d2b8a69585346c756f3ca3d39</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2012.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2012.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DSethi%26aufirst%3DS.%26aulast%3DMahler%26aufirst%3DD.%2BA.%26aulast%3DMarcus%26aufirst%3DP.%26aulast%3DOwen%26aufirst%3DC.%2BA.%26aulast%3DYawn%26aufirst%3DB.%26aulast%3DRennard%26aufirst%3DS.%26atitle%3DInflammation%2520in%2520COPD%253A%2520implications%2520for%2520management%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2012%26volume%3D125%26spage%3D1162%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Tabas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, C. K.</span><span> </span><span class="NLM_article-title">Anti-inflammatory therapy in chronic disease: challenges and opportunities</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1126%2Fscience.1230720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23307734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=166-172&author=I.+Tabasauthor=C.+K.+Glass&title=Anti-inflammatory+therapy+in+chronic+disease%3A+challenges+and+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities</span></div><div class="casAuthors">Tabas, Ira; Glass, Christopher K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6116</span>),
    <span class="NLM_cas:pages">166-172</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  A no. of widespread and devastating chronic diseases, including atherosclerosis, type 2 diabetes, and Alzheimer's disease, have a pathophysiol. important inflammatory component.  In these diseases, the precise identity of the inflammatory stimulus is often unknown and, if known, is difficult to remove.  Thus, there is interest in therapeutically targeting the inflammatory response.  Although there has been success with anti-inflammatory therapy in chronic diseases triggered by primary inflammation dysregulation or autoimmunity, there are considerable limitations.  In particular, the inflammatory response is crit. for survival.  As a result, redundancy, compensatory pathways, and necessity narrow the risk:benefit ratio of anti-inflammatory drugs.  However, new advances in understanding inflammatory signaling and its links to resoln. pathways, together with new drug development, offer promise in this area of translational biomedical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru6vCXZUnqN7Vg90H21EOLACvtfcHk0lhoWLMtGMsfiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVCnuw%253D%253D&md5=7f05ebe4e34eb363f11bdc891350e7f2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1230720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1230720%26sid%3Dliteratum%253Aachs%26aulast%3DTabas%26aufirst%3DI.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26atitle%3DAnti-inflammatory%2520therapy%2520in%2520chronic%2520disease%253A%2520challenges%2520and%2520opportunities%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D166%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, N. R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Inflammation and Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2FS0197-4580%2800%2900124-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=10858586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVSmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=383-421&author=H.+Akiyamaauthor=S.+Bargerauthor=S.+Barnumauthor=B.+Bradtauthor=J.+Bauerauthor=G.+M.+Coleauthor=N.+R.+Cooper&title=Inflammation+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and Alzheimer's disease</span></div><div class="casAuthors">Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G. M.; Cooper, N. R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B. L.; Finch, C. E.; Frautschy, S.; Griffin, W. S. T.; Hampel, H.; Hull, M.; Landreth, G.; Lue, L.-F.; Mrak, R.; Mackenzie, I. R.; McGeer, P. L.; O'Banion, M. K.; Pachter, J.; Pasinetti, G.; Plata-Salaman, C.; Rogers, J.; Rydel, R.; Shen, Y.; Streit, W.; Strohmeyer, R.; Tooyoma, I.; Van Muiswinkel, F. L.; Veerhuis, R.; Walker, D.; Webster, S.; Wegrzyniak, B.; Wenk, G.; Wyss-Coray, T.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-421</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 636 refs.  Inflammation clearly occurs in pathol. vulnerable regions of the Alzheimer's disease (AD) brain, and it does so with the full complexity of local peripheral inflammatory responses.  In the periphery, degenerating tissue and the deposition of highly insol. abnormal materials are classical stimulants of inflammation.  Likewise, in the AD brain damaged neurons and neurites and highly insol. amyloid β peptide deposits and neurofibrillary tangles provide obvious stimuli for inflammation.  Because these stimuli are discrete, microlocalized, and present from early preclin. to terminal stages of AD, local upregulation of complement, cytokines, acute-phase reactants, and other inflammatory mediators is also discrete, microlocalized, and chronic.  Cumulated over many years, direct and bystander damage from AD inflammatory mechanisms is likely to exacerbate the very pathogenic processes that gave rise to it.  Thus, animal models and clin. studies, although still in their infancy, strongly suggest that AD inflammation contributes to AD pathogenesis.  By better understanding AD inflammatory and immunoregulatory processes, it should be possible to develop anti-inflammatory approaches that may not cure AD but will likely help slow the progression or delay the onset of this devastating disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr72c3W8HExubVg90H21EOLACvtfcHk0lhSx6vN_guoGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVSmt74%253D&md5=409a0ca2920ef2cba12474cb7d05f4aa</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2800%2900124-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252800%252900124-X%26sid%3Dliteratum%253Aachs%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DBarger%26aufirst%3DS.%26aulast%3DBarnum%26aufirst%3DS.%26aulast%3DBradt%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DG.%2BM.%26aulast%3DCooper%26aufirst%3DN.%2BR.%26atitle%3DInflammation%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2000%26volume%3D21%26spage%3D383%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Heneka, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Banion, M. K.</span><span> </span><span class="NLM_article-title">Inflammatory processes in Alzheimer’s disease</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.jneuroim.2006.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=17222916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislejtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2007&pages=69-91&author=M.+T.+Henekaauthor=M.+K.+O%E2%80%99Banion&title=Inflammatory+processes+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory processes in Alzheimer's disease</span></div><div class="casAuthors">Heneka, Michael T.; O'Banion, M. Kerry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">69-91</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Generation and deposition of amyloid beta peptides and neurofibrillary tangle formation are key mechanisms involved in AD pathogenesis.  Recent evidence suggests that inflammatory mechanisms represent a third component which, once initiated by degeneration, may significantly contribute to disease progression and chronicity.  Various neuroinflammatory mediators including complement activators and inhibitors, chemokines, cytokines, radical oxygen species and inflammatory enzymes are generated and released by microglia, astrocytes and neurons.  Degeneration of aminergic brain stem nuclei such as the locus ceruleus and the nucleus baslis of Meynert may facilitate the occurrence of inflammation in their resp. projection areas given the antiinflammatory and neuroprotective action of their key products norepinephrine and acetylcholine.  While inflammation has been thought to arise secondary to degeneration, recent expts. demonstrated that inflammatory mediators may stimulate APP processing by upregulation of beta secretase 1 and therefore are able to establish a vicious cycle.  Despite the fact that some aspects of inflammation may even exert protective effects to bystander neurons, antiinflammatory treatment strategies should therefore be considered.  Non-steroidal antiinflammatory drugs have been shown to reduce the risk and delay the onset to develop AD.  However, the precise mol. mechanism underlying this effect is still being debated.  Several mechanisms including inhibition of cyclooxygenase 2, gamma secretase or activation of the peroxisome proliferator activated receptor gamma may alone or, more likely, in concert account for the epidemiol. obsd. protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUnTmvRLIgtrVg90H21EOLACvtfcHk0lhSx6vN_guoGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislejtLo%253D&md5=d06c7d14ee09331a8a1432d0f3740264</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2006.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2006.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DO%25E2%2580%2599Banion%26aufirst%3DM.%2BK.%26atitle%3DInflammatory%2520processes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2007%26volume%3D184%26spage%3D69%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ferrari, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarelli, R.</span><span> </span><span class="NLM_article-title">Parkinson’s disease and systemic inflammation</span> <span class="citation_source-journal">Parkinsons Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">436813</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><div class="note"><p class="first last">9 pp.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436813&publication_year=2011&pages=9&author=C.+C.+Ferrariauthor=R.+Tarelli&title=Parkinson%E2%80%99s+disease+and+systemic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DC.%2BC.%26aulast%3DTarelli%26aufirst%3DR.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520and%2520systemic%2520inflammation%26jtitle%3DParkinsons%2520Dis.%26date%3D2011%26volume%3D436813%26spage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Inflammation and Parkinson’s disease pathogenesis</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S55</span><span class="NLM_x">–</span> <span class="NLM_lpage">S57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=S55-S57&issue=Suppl+1&author=S.+Przedborski&title=Inflammation+and+Parkinson%E2%80%99s+disease+pathogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DInflammation%2520and%2520Parkinson%25E2%2580%2599s%2520disease%2520pathogenesis%26jtitle%3DMov.%2520Disord.%26date%3D2010%26volume%3D25%26issue%3DSuppl%25201%26spage%3DS55%26epage%3DS57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Vezzani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronica, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittman, Q. J.</span><span> </span><span class="NLM_article-title">Epilepsy and brain inflammation</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.expneurol.2011.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21985866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntV2gu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2013&pages=11-21&author=A.+Vezzaniauthor=E.+Aronicaauthor=A.+Mazaratiauthor=Q.+J.+Pittman&title=Epilepsy+and+brain+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Epilepsy and brain inflammation</span></div><div class="casAuthors">Vezzani, Annamaria; Aronica, Eleonora; Mazarati, Andrey; Pittman, Quentin J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-21</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  During the last decade, exptl. research has demonstrated a prominent role of glial cells, activated in brain by various injuries, in the mechanisms of seizure pptn. and recurrence.  In particular, alterations in the phenotype and function of activated astrocytes and microglial cells have been described in exptl. and human epileptic tissue, including modifications in potassium and water channels, alterations of glutamine/glutamate cycle, changes in glutamate receptor expression and transporters, release of neuromodulatory mols. (e.g. gliotransmitters, neurotrophic factors), and induction of mols. involved in inflammatory processes (e.g. cytokines, chemokines, prostaglandins, complement factors, cell adhesion mols.) (Seifert et al., 2006; Vezzani et al., 2011; Wetherington et al., 2008).  In particular, brain injury or proconvulsant events can activate microglia and astrocytes to release a no. of proinflammatory mediators, thus initiating a cascade of inflammatory processes in brain tissue.  Proinflammatory mols. can alter neuronal excitability and affect the physiol. functions of glia by paracrine or autocrine actions, thus perturbing the glioneuronal communications.  In exptl. models, these changes contribute to decreasing the threshold to seizures and may compromise neuronal survival (Riazi et al., 2010; Vezzani et al., 2008).  In this context, understanding which are the sol. mediators and the mol. mechanisms crucially involved in glio-neuronal interactions is instrumental to shed light on how brain inflammation may contribute to neuronal hyperexcitability in epilepsy.  This review will report the clin. observations in drug-resistant human epilepsies and the exptl. findings in adult and immature rodents linking brain inflammation to the epileptic process in a causal and reciprocal manner.  By confronting the clin. evidence with the exptl. findings, we will discuss the role of specific sol. inflammatory mediators in the etiopathogenesis of seizures, reporting evidence for both their acute and long term effects on seizure threshold.  The possible contribution of these mediators to co-morbidities often described in epilepsy patients will be also discussed.  Finally, we will report on the anti-inflammatory treatments with anticonvulsant actions in exptl. models highlighting possible therapeutic options for treating drug-resistant seizures and for prevention of epileptogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3phEZ4D9TULVg90H21EOLACvtfcHk0lhSx6vN_guoGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntV2gu7g%253D&md5=21506046fc3ff021e246cdb511b4e358</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2011.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2011.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DVezzani%26aufirst%3DA.%26aulast%3DAronica%26aufirst%3DE.%26aulast%3DMazarati%26aufirst%3DA.%26aulast%3DPittman%26aufirst%3DQ.%2BJ.%26atitle%3DEpilepsy%2520and%2520brain%2520inflammation%26jtitle%3DExp.%2520Neurol.%26date%3D2013%26volume%3D244%26spage%3D11%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Vezzani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balosso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravizza, T.</span><span> </span><span class="NLM_article-title">Inflammation and epilepsy</span> <span class="citation_source-journal">Handb. Clin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2FB978-0-444-52898-8.00010-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC38bjsFelsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=163-175&author=A.+Vezzaniauthor=S.+Balossoauthor=T.+Ravizza&title=Inflammation+and+epilepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and epilepsy</span></div><div class="casAuthors">Vezzani Annamaria; Balosso Silvia; Ravizza Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of clinical neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">163-75</span>
        ISSN:<span class="NLM_cas:issn">0072-9752</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQox4gD7Gi_p5dYoSR9eyvsfW6udTcc2eab3xS4R3pRF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bjsFelsw%253D%253D&md5=807caa42771e3af01b8acc6a3d67bb68</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-52898-8.00010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-52898-8.00010-0%26sid%3Dliteratum%253Aachs%26aulast%3DVezzani%26aufirst%3DA.%26aulast%3DBalosso%26aufirst%3DS.%26aulast%3DRavizza%26aufirst%3DT.%26atitle%3DInflammation%2520and%2520epilepsy%26jtitle%3DHandb.%2520Clin.%2520Neurol.%26date%3D2012%26volume%3D107%26spage%3D163%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Vezzani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartfai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baram, T. Z.</span><span> </span><span class="NLM_article-title">The role of inflammation in epilepsy</span> <span class="citation_source-journal">Nature Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnrneurol.2010.178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1OmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=31-40&author=A.+Vezzaniauthor=J.+Frenchauthor=T.+Bartfaiauthor=T.+Z.+Baram&title=The+role+of+inflammation+in+epilepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The role of inflammation in epilepsy</span></div><div class="casAuthors">Vezzani, Annamaria; French, Jacqueline; Bartfai, Tamas; Baram, Tallie Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Relatively little is known about the mechanisms and processes that lead to the generation of seizures in patients with epilepsy, and this lack of knowledge hampers the development of treatments and cures.  In this article, Vezzani et al. provide an overview of the involvement of inflammatory mediators in epileptic seizures.  Gaining insights into the role of inflammation should yield new mol. targets for the design of antiepileptic drugs.  Epilepsy is the third most common chronic brain disorder, and is characterized by an enduring predisposition to generate seizures.  Despite progress in pharmacol. and surgical treatments of epilepsy, relatively little is known about the processes leading to the generation of individual seizures, and about the mechanisms whereby a healthy brain is rendered epileptic.  These gaps in our knowledge hamper the development of better preventive treatments and cures for the ≈30% of epilepsy cases that prove resistant to current therapies.  Here, we focus on the rapidly growing body of evidence that supports the involvement of inflammatory mediators-released by brain cells and peripheral immune cells-in both the origin of individual seizures and the epileptogenic process.  We first describe aspects of brain inflammation and immunity, before exploring the evidence from clin. and exptl. studies for a relationship between inflammation and epilepsy.  Subsequently, we discuss how seizures cause inflammation, and whether such inflammation, in turn, influences the occurrence and severity of seizures, and seizure-related neuronal death.  Further insight into the complex role of inflammation in the generation and exacerbation of epilepsy should yield new mol. targets for the design of antiepileptic drugs, which might not only inhibit the symptoms of this disorder, but also prevent or abrogate disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZXR_EQsILxbVg90H21EOLACvtfcHk0liEOS8DXE_0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1OmtA%253D%253D&md5=08b7773b0139313e77d4a233c55167fc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2010.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2010.178%26sid%3Dliteratum%253Aachs%26aulast%3DVezzani%26aufirst%3DA.%26aulast%3DFrench%26aufirst%3DJ.%26aulast%3DBartfai%26aufirst%3DT.%26aulast%3DBaram%26aufirst%3DT.%2BZ.%26atitle%3DThe%2520role%2520of%2520inflammation%2520in%2520epilepsy%26jtitle%3DNature%2520Rev.%2520Neurol.%26date%3D2011%26volume%3D7%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Vezzani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R. J.</span><span> </span><span class="NLM_article-title">The role of inflammation in epileptogenesis</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=16-24&author=A.+Vezzaniauthor=A.+Friedmanauthor=R.+J.+Dingledine&title=The+role+of+inflammation+in+epileptogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVezzani%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DA.%26aulast%3DDingledine%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520role%2520of%2520inflammation%2520in%2520epileptogenesis%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D69%26spage%3D16%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">McGeer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeer, E. G.</span><span> </span><span class="NLM_article-title">Inflammatory processes in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Muscle Nerve</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2002&pages=459-470&author=P.+L.+McGeerauthor=E.+G.+McGeer&title=Inflammatory+processes+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGeer%26aufirst%3DP.%2BL.%26aulast%3DMcGeer%26aufirst%3DE.%2BG.%26atitle%3DInflammatory%2520processes%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DMuscle%2520Nerve%26date%3D2002%26volume%3D26%26spage%3D459%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Nagamoto-Combs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeal, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morecraft, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, C. K.</span><span> </span><span class="NLM_article-title">Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury</span> <span class="citation_source-journal">J. Neurotrauma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1742</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1089%2Fneu.2007.0377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=18001202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BD2snnslKksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=1719-1742&author=K.+Nagamoto-Combsauthor=D.+W.+McNealauthor=R.+J.+Morecraftauthor=C.+K.+Combs&title=Prolonged+microgliosis+in+the+rhesus+monkey+central+nervous+system+after+traumatic+brain+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury</span></div><div class="casAuthors">Nagamoto-Combs Kumi; McNeal David W; Morecraft Robert J; Combs Colin K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1719-42</span>
        ISSN:<span class="NLM_cas:issn">0897-7151</span>.
    </div><div class="casAbstract">Impaired fine motor functions after traumatic brain injury (TBI) in humans and non-human primates often continue to improve months after injury.  To initiate a series of studies in the primate model designed to investigate possible involvement of microglia/macrophage in the long-term recovery processes, changes in these cells were studied in the rhesus monkey central nervous system at 1, 6, and 12 months after a combined unilateral lesion of the arm area of the primary motor cortex and arm area of the lateral premotor cortex.  Immunohistological studies showed profound CD68 immunoreactivity in the lesion area and the contralateral lateral corticospinal tract in the spinal cord at all time points, demonstrating that microglia/macrophage remain reactive at the sites of injury and axonal degeneration/survival for at least 12 months.  We also observed marked increases in brain-derived neurotrophic factor (BDNF) and its receptor subtypes, TrkB[gp145] and TrkB[TK-], around the cortical lesion site after 6-month survival.  Similar increases were also observed in the spinal cord, although it was less apparent for TrkB[gp145].  Double-labeling revealed that a subpopulation of CD68-immunoreacitve microglia/macrophage co-expressed BDNF in the cortex and spinal cord, and also TrkB[gp145] or TrkB[TK-] in the spinal cord.  In contrast, cytokine expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interleukin-6 (IL-6) at these time intervals was less prominent, suggesting that immediate inflammatory responses had subsided.  These results demonstrate that microglia/macrophage undergo prolonged activation after TBI in the non-human primate brain and express BDNF and its receptors, suggesting their tropic/trophic roles in the long-term recovery processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpwL6y37wYDBgd2Wuil24tfW6udTcc2eab3xS4R3pRF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snnslKksQ%253D%253D&md5=15bc8f12575575f81c0271daf090478c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1089%2Fneu.2007.0377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2007.0377%26sid%3Dliteratum%253Aachs%26aulast%3DNagamoto-Combs%26aufirst%3DK.%26aulast%3DMcNeal%26aufirst%3DD.%2BW.%26aulast%3DMorecraft%26aufirst%3DR.%2BJ.%26aulast%3DCombs%26aufirst%3DC.%2BK.%26atitle%3DProlonged%2520microgliosis%2520in%2520the%2520rhesus%2520monkey%2520central%2520nervous%2520system%2520after%2520traumatic%2520brain%2520injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2007%26volume%3D24%26spage%3D1719%26epage%3D1742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ramlackhansingh, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkheimer, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnunen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentleman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckemann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunanayagam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, D. J.</span><span> </span><span class="NLM_article-title">Inflammation after trauma: microglial activation and traumatic brain injury</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2Fana.22455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21710619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3MfitFCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=374-383&author=A.+F.+Ramlackhansinghauthor=D.+J.+Brooksauthor=R.+J.+Greenwoodauthor=S.+K.+Boseauthor=F.+E.+Turkheimerauthor=K.+M.+Kinnunenauthor=S.+Gentlemanauthor=R.+A.+Heckemannauthor=K.+Gunanayagamauthor=G.+Gelosaauthor=D.+J.+Sharp&title=Inflammation+after+trauma%3A+microglial+activation+and+traumatic+brain+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation after trauma: microglial activation and traumatic brain injury</span></div><div class="casAuthors">Ramlackhansingh Anil F; Brooks David J; Greenwood Richard J; Bose Subrata K; Turkheimer Federico E; Kinnunen Kirsi M; Gentleman Steve; Heckemann Rolf A; Gunanayagam Karen; Gelosa Giorgio; Sharp David J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">374-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Patient outcome after traumatic brain injury (TBI) is highly variable.  The underlying pathophysiology of this is poorly understood, but inflammation is potentially an important factor.  Microglia orchestrate many aspects of this response.  Their activation can be studied in vivo using the positron emission tomography (PET) ligand [11C](R)PK11195 (PK).  In this study, we investigate whether an inflammatory response to TBI persists, and whether this response relates to structural brain abnormalities and cognitive function.  METHODS:  Ten patients, studied at least 11 months after moderate to severe TBI, underwent PK PET and structural magnetic resonance imaging (including diffusion tensor imaging).  PK binding potentials were calculated in and around the site of focal brain damage, and in selected distant and subcortical brain regions.  Standardized neuropsychological tests were administered.  RESULTS:  PK binding was significantly raised in the thalami, putamen, occipital cortices, and posterior limb of the internal capsules after TBI.  There was no increase in PK binding at the original site of focal brain injury.  High PK binding in the thalamus was associated with more severe cognitive impairment, although binding was not correlated with either the time since the injury or the extent of structural brain damage.  INTERPRETATION:  We demonstrate that increased microglial activation can be present up to 17 years after TBI.  This suggests that TBI triggers a chronic inflammatory response particularly in subcortical regions.  This highlights the importance of considering the response to TBI as evolving over time and suggests interventions may be beneficial for longer intervals after trauma than previously assumed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuaFbXMB7kxJagfuraLLzSfW6udTcc2ebp7eirSblqI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MfitFCnuw%253D%253D&md5=6471bbc334c28ee0f03d4e39d4d70192</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fana.22455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22455%26sid%3Dliteratum%253Aachs%26aulast%3DRamlackhansingh%26aufirst%3DA.%2BF.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DGreenwood%26aufirst%3DR.%2BJ.%26aulast%3DBose%26aufirst%3DS.%2BK.%26aulast%3DTurkheimer%26aufirst%3DF.%2BE.%26aulast%3DKinnunen%26aufirst%3DK.%2BM.%26aulast%3DGentleman%26aufirst%3DS.%26aulast%3DHeckemann%26aufirst%3DR.%2BA.%26aulast%3DGunanayagam%26aufirst%3DK.%26aulast%3DGelosa%26aufirst%3DG.%26aulast%3DSharp%26aufirst%3DD.%2BJ.%26atitle%3DInflammation%2520after%2520trauma%253A%2520microglial%2520activation%2520and%2520traumatic%2520brain%2520injury%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D70%26spage%3D374%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Turini, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, R. N.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2: a therapeutic target</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=35-57&author=M.+E.+Turiniauthor=R.+N.+DuBois&title=Cyclooxygenase-2%3A+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurini%26aufirst%3DM.%2BE.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26atitle%3DCyclooxygenase-2%253A%2520a%2520therapeutic%2520target%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2002%26volume%3D53%26spage%3D35%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Davies, N. M.</span><span> </span><span class="NLM_article-title">Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1007%2FBF02049158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=7497845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADyaK287gtFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1311-1121&author=N.+M.+Davies&title=Toxicity+of+nonsteroidal+anti-inflammatory+drugs+in+the+large+intestine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine</span></div><div class="casAuthors">Davies N M</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1311-21</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  Adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDS) on the upper gastrointestinal (GI) tract and small intestine are well described.  Evidence is also accumulating that implicate NSAIDS in inducing and exacerbating damage in the distal GI tract.  The purpose of this review is to identify possible adverse effects of NSAIDS on the large intestine and increase the clinical awareness of these toxicologic effects.  METHODS:  A literature review identified the diversity of toxicologic effects induced by NSAIDS in the large intestine.  The epidemiology, pathogenesis, and clinical implications of these adverse effects are described.  RESULTS:  NSAID use has been associated with colonic bleeding, iron deficiency anemia, strictures, ulcerations, perforations, diarrhea, and death.  In addition, NSAIDS can exacerbate inflammatory bowel disease and ulcerative colitis.  The prevalence of NSAID-induced large intestinal damage is unknown.  Diagnosis can be made by colonoscopy and barium scans.  Although the clinical presentation of NSAID-induced gastropathy and enteropathy, bleeding or perforation, may be more dramatic than colonopathy, the overall clinical significance of these adverse effects of NSAIDS on the large intestine has not been fully characterized.  CONCLUSIONS:  This review illustrates that NSAID-induced large bowel toxicity can cause significant morbidity in some patients, ranging from profuse diarrhea, chronic blood loss, and iron deficiency anemia to fatality.  The pathogenesis is likely multifactorial and is thought to be related to inhibition of prostaglandin synthesis.  Because NSAIDS are widely prescribed and some are available without a prescription, heightened awareness of these toxicologic manifestations throughout the GI tract may reduce morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4iCgcs9PWFxfKb6ELK8t0fW6udTcc2ebp7eirSblqI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287gtFGlsQ%253D%253D&md5=dad5beb858de832f17cc3cf09868bb38</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2FBF02049158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02049158%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DN.%2BM.%26atitle%3DToxicity%2520of%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520in%2520the%2520large%2520intestine%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1995%26volume%3D38%26spage%3D1311%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Murray, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brater, D. C.</span><span> </span><span class="NLM_article-title">Renal toxicity of the nonsteroidal anti-inflammatory drugs</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1993&pages=435-465&author=M.+D.+Murrayauthor=D.+C.+Brater&title=Renal+toxicity+of+the+nonsteroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DM.%2BD.%26aulast%3DBrater%26aufirst%3DD.%2BC.%26atitle%3DRenal%2520toxicity%2520of%2520the%2520nonsteroidal%2520anti-inflammatory%2520drugs%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1993%26volume%3D33%26spage%3D435%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Knights, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangoni, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miners, J. O.</span><span> </span><span class="NLM_article-title">Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity</span> <span class="citation_source-journal">Expert Rev. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1586%2Fecp.10.120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVCjsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=769-776&author=K.+M.+Knightsauthor=A.+A.+Mangoniauthor=J.+O.+Miners&title=Defining+the+COX+inhibitor+selectivity+of+NSAIDs%3A+implications+for+understanding+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity</span></div><div class="casAuthors">Knights, Kathleen M.; Mangoni, Arduino A.; Miners, John O.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">769-776</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The hypothesis that the anti-inflammatory activity of NSAIDs derives from COX inhibition is well established.  It also underpins the accepted mechanism of the gastrointestinal and renal toxicity of NSAIDs.  However, in terms of NSAID-induced cardiovascular toxicity, is COX inhibition then guilty by assocn. Multiple exptl. models of COX-1/COX-2 inhibition have enabled ranking of the relative inhibitory activity of NSAIDs.  Inhibition is expressed as an IC50 value and the index of COX selectivity as the ratio of the IC50 value for COX-2 and COX-1.  These data informed the imbalance hypothesis' that the cardiovascular risk of NSAIDs results from an imbalance in the detrimental actions of COX-1-derived thromboxane A2 and the beneficial actions of COX-2-derived prostacyclin (PGI2).  Data derived from in vitro models used to generate NSAID IC50 values are discussed in the context of the difficulties in defining COX selectivity and hence understanding the toxicity of NSAIDs in current clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzdgl8xodkfrVg90H21EOLACvtfcHk0ljjLs-H6g_glA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVCjsbnN&md5=e7af1b58553876d622732e19403fc5ca</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1586%2Fecp.10.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fecp.10.120%26sid%3Dliteratum%253Aachs%26aulast%3DKnights%26aufirst%3DK.%2BM.%26aulast%3DMangoni%26aufirst%3DA.%2BA.%26aulast%3DMiners%26aufirst%3DJ.%2BO.%26atitle%3DDefining%2520the%2520COX%2520inhibitor%2520selectivity%2520of%2520NSAIDs%253A%2520implications%2520for%2520understanding%2520toxicity%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D3%26spage%3D769%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Anderson, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarity, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, S. A.</span><span> </span><span class="NLM_article-title">Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2672</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1996&pages=2672-2679&author=G.+D.+Andersonauthor=S.+D.+Hauserauthor=K.+L.+McGarityauthor=M.+E.+Bremerauthor=P.+C.+Isaksonauthor=S.+A.+Gregory&title=Selective+inhibition+of+cyclooxygenase+%28COX%29-2+reverses+inflammation+and+expression+of+COX-2+and+interleukin+6+in+rat+adjuvant+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DG.%2BD.%26aulast%3DHauser%26aufirst%3DS.%2BD.%26aulast%3DMcGarity%26aufirst%3DK.%2BL.%26aulast%3DBremer%26aufirst%3DM.%2BE.%26aulast%3DIsakson%26aufirst%3DP.%2BC.%26aulast%3DGregory%26aufirst%3DS.%2BA.%26atitle%3DSelective%2520inhibition%2520of%2520cyclooxygenase%2520%2528COX%2529-2%2520reverses%2520inflammation%2520and%2520expression%2520of%2520COX-2%2520and%2520interleukin%25206%2520in%2520rat%2520adjuvant%2520arthritis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1996%26volume%3D97%26spage%3D2672%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kang, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire-Moar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigal, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. Q.</span><span> </span><span class="NLM_article-title">Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis</span> <span class="citation_source-journal">Br. J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1093%2Frheumatology%2F35.8.711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=8761181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaK28XmsFWlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=711-718&author=R.+Y.+Kangauthor=J.+Freire-Moarauthor=E.+Sigalauthor=C.+Q.+Chu&title=Expression+of+cyclooxygenase-2+in+human+and+an+animal+model+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis</span></div><div class="casAuthors">Kang, R. Y.; Freire-Moar, J.; Sigal, E.; Chu, C. -Q.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Rheumatology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-718</span>CODEN:
                <span class="NLM_cas:coden">BJRHDF</span>;
        ISSN:<span class="NLM_cas:issn">0263-7103</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">An inducible form of cyclooxygenase-2 (COX-2) has been shown to be upregulated in vitro by various pro-inflammatory agents, such as lipopolysaccharide, IL-1 and TNF.  COX-2 appears to be responsible for the increase in prostaglandin synthesis at the site of inflammation.  To examine the involvement of COX-2 in inflammation, we analyzed the expression of this gene in human rheumatoid arthritis (RA) and in rat adjuvant-induced arthritis.  Immunocytochem. studies of synovial membrane biopsies from human RA, osteoarthritic (OA) and normal joints using a COX-2 specific antibody showed pos. staining in RA, but not in normal synovial membranes.  Specifically, expression of COX-2 was detected in synovial lining cells, lymphoid aggregates and endothelial cells of blood vessels.  Although some pos. staining was obsd. in the OA joints, the no. of stained cells was dramatically lower and the staining of the cells was less intense than in the rheumatoid tissue.  By reverse transcription and polymerase chain reaction anal., COX-2 mRNA was detected in the rat adjuvant arthritic limb, whereas no COX-2 mRNA was detectable in the normal limb.  These observations indicate that COX-2 expression is upregulated in inflammatory joint disease and that COX-2 is a potential therapeutic target for specific inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCj8czAXbB9LVg90H21EOLACvtfcHk0lgvbHntzSl8qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFWlu7o%253D&md5=8f0e3915319601eb98d9b36b603b1964</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2F35.8.711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252F35.8.711%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DR.%2BY.%26aulast%3DFreire-Moar%26aufirst%3DJ.%26aulast%3DSigal%26aufirst%3DE.%26aulast%3DChu%26aufirst%3DC.%2BQ.%26atitle%3DExpression%2520of%2520cyclooxygenase-2%2520in%2520human%2520and%2520an%2520animal%2520model%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBr.%2520J.%2520Rheumatol.%26date%3D1996%26volume%3D35%26spage%3D711%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">DeWitt, D. L.</span><span> </span><span class="NLM_article-title">Cox-2-selective inhibitors: the new super aspirins</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">631</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=10101019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaK1MXisVCgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=625-631&author=D.+L.+DeWitt&title=Cox-2-selective+inhibitors%3A+the+new+super+aspirins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cox-2-selective inhibitors: the new super aspirins</span></div><div class="casAuthors">DeWitt, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">625-631</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review, with 35 refs. describing a new family of cyclooxygenase-2 isoenzyme inhibitors.  The author discusses the rationale for Cox-2-selective drugs, development of Cox-2-selective inhibitors, and mechanism of nonsteroidal anti-inflammatory drug inhibition of Cox-1 and Cox-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cLRNAKHt4rVg90H21EOLACvtfcHk0lgvbHntzSl8qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVCgs70%253D&md5=afbe2a13a17d8f9a3793535e344daf58</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeWitt%26aufirst%3DD.%2BL.%26atitle%3DCox-2-selective%2520inhibitors%253A%2520the%2520new%2520super%2520aspirins%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D55%26spage%3D625%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Tacconelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capone, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciulli, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricciotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrignani, P.</span><span> </span><span class="NLM_article-title">The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1185%2F030079902125001335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=12564662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Wku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=503-511&author=S.+Tacconelliauthor=M.+L.+Caponeauthor=M.+G.+Sciulliauthor=E.+Ricciottiauthor=P.+Patrignani&title=The+biochemical+selectivity+of+novel+COX-2+inhibitors+in+whole+blood+assays+of+COX-isozyme+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity</span></div><div class="casAuthors">Tacconelli, Stefania; Capone, Marta L.; Sciulli, Maria G.; Ricciotti, Emanuela; Patrignani, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">503-511</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">We have evaluated the biochem. selectivity of novel cyclo-oxygenase (COX)-2 inhibitors, etoricoxib, valdecoxib/, DFU and DFP, vs. rofecoxib and celecoxib, using the human whole blood assays of COX-isoenzyme activity, in vitro.  Compds. were incubated with human whole blood samples, allowed to clot for 1 h at 37°, or stimulated with lipopolysaccharide (10 μg/mL) for 24 h at 37°.  Serum thromboxane (TX) B2 and plasma prostaglandin (PG) E2 levels were measured by specific RIAs as indexes of platelet COX-1 and monocyte COX-2 activity, resp.  Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, resp.  The ref. compds., celecoxib and rofecoxib had corresponding values of 29.6 and 272.  In conclusion, a second wave of COX-2 inhibitors with higher biochem. selectivity than the existing coxibs has been developed.  Whether their administration will be assocd. with improved clin. efficacy and/or safety visa-vis celecoxib and rofecoxib remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXp52P5XevwrVg90H21EOLACvtfcHk0lgvbHntzSl8qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Wku7c%253D&md5=6adbff0cb04b5f79618387d63efef8d5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1185%2F030079902125001335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079902125001335%26sid%3Dliteratum%253Aachs%26aulast%3DTacconelli%26aufirst%3DS.%26aulast%3DCapone%26aufirst%3DM.%2BL.%26aulast%3DSciulli%26aufirst%3DM.%2BG.%26aulast%3DRicciotti%26aufirst%3DE.%26aulast%3DPatrignani%26aufirst%3DP.%26atitle%3DThe%2520biochemical%2520selectivity%2520of%2520novel%2520COX-2%2520inhibitors%2520in%2520whole%2520blood%2520assays%2520of%2520COX-isozyme%2520activity%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2002%26volume%3D18%26spage%3D503%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Cannon, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, B.</span><span> </span><span class="NLM_article-title">Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">978</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2F1529-0131%28200005%2943%3A5%3C978%3A%3AAID-ANR4%3E3.0.CO%3B2-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=10817549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvVeitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=978-987&author=G.+W.+Cannonauthor=J.+R.+Caldwellauthor=P.+Holtauthor=B.+McLeanauthor=B.+Seidenbergauthor=J.+Bologneseauthor=E.+Ehrichauthor=S.+Mukhopadhyayauthor=B.+Daniels&title=Rofecoxib%2C+a+specific+inhibitor+of+cyclooxygenase+2%2C+with+clinical+efficacy+comparable+with+that+of+diclofenac+sodium%3A+results+of+a+one-year%2C+randomized%2C+clinical+trial+in+patients+with+osteoarthritis+of+the+knee+and+hip.+Rofecoxib+Phase+III+Protocol+035+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip</span></div><div class="casAuthors">Cannon, Grant W.; Caldwell, Jacques R.; Holt, Peter; McLean, Barry; Seidenberg, Beth; Bolognese, James; Ehrich, Elliot; Mukhopadhyay, Suarabh; Daniels, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">978-987</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective. To compare the clin. efficacy of rofecoxib, a specific inhibitor of cyclooxygenase 2 (COX-2), with that of diclofenac in patients with osteoarthritis (OA) and to evaluate the safety and tolerability of rofecoxib.  Methods. We performed a randomized, double-blind, active comparator-controlled trial in 784 adults with OA of the knee or hip.  Patients were randomized to 1 of 3 treatment groups: 12.5 mg of rofecoxib once daily, 25 mg of rofecoxib once daily, and 50 mg of diclofenac 3 times daily.  Clin. efficacy and safety were evaluated over a 1-yr continuous treatment period.  Results. Rofecoxib at dosages of 12.5 and 25 mg demonstrated efficacy that was clin. comparable to that of diclofenac, as assessed by all 3 primary end points according to predefined comparability criteria.  Results from secondary end points were consistent with those of the primary end points.  There were small statistical differences favoring diclofenac for 2 of the end points.  All treatments were well tolerated.  Conclusion. Rofecoxib was well tolerated and provided efficacy that was clin. comparable, according to predefined statistical criteria, to that of 150 mg of diclofenac per day in this 1-yr study.  Specific inhibition of COX-2 provided therapeutic efficacy in OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6_K36-J_gVLVg90H21EOLACvtfcHk0lh_gjzd4Gn09A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvVeitbs%253D&md5=432390eacb31d325bfa052443bd5bf34</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28200005%2943%3A5%3C978%3A%3AAID-ANR4%3E3.0.CO%3B2-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528200005%252943%253A5%253C978%253A%253AAID-ANR4%253E3.0.CO%253B2-0%26sid%3Dliteratum%253Aachs%26aulast%3DCannon%26aufirst%3DG.%2BW.%26aulast%3DCaldwell%26aufirst%3DJ.%2BR.%26aulast%3DHolt%26aufirst%3DP.%26aulast%3DMcLean%26aufirst%3DB.%26aulast%3DSeidenberg%26aufirst%3DB.%26aulast%3DBolognese%26aufirst%3DJ.%26aulast%3DEhrich%26aufirst%3DE.%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DDaniels%26aufirst%3DB.%26atitle%3DRofecoxib%252C%2520a%2520specific%2520inhibitor%2520of%2520cyclooxygenase%25202%252C%2520with%2520clinical%2520efficacy%2520comparable%2520with%2520that%2520of%2520diclofenac%2520sodium%253A%2520results%2520of%2520a%2520one-year%252C%2520randomized%252C%2520clinical%2520trial%2520in%2520patients%2520with%2520osteoarthritis%2520of%2520the%2520knee%2520and%2520hip.%2520Rofecoxib%2520Phase%2520III%2520Protocol%2520035%2520Study%2520Group%26jtitle%3DArthritis%2520Rheum.%26date%3D2000%26volume%3D43%26spage%3D978%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Clemett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goa, K. L.</span><span> </span><span class="NLM_article-title">Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2000&pages=957-980&author=D.+Clemettauthor=K.+L.+Goa&title=Celecoxib%3A+a+review+of+its+use+in+osteoarthritis%2C+rheumatoid+arthritis+and+acute+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClemett%26aufirst%3DD.%26aulast%3DGoa%26aufirst%3DK.%2BL.%26atitle%3DCelecoxib%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520osteoarthritis%252C%2520rheumatoid%2520arthritis%2520and%2520acute%2520pain%26jtitle%3DDrugs%26date%3D2000%26volume%3D59%26spage%3D957%26epage%3D980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer’s disease brain</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1998&pages=319-324&author=G.+M.+Pasinettiauthor=P.+S.+Aisen&title=Cyclooxygenase-2+expression+is+increased+in+frontal+cortex+of+Alzheimer%E2%80%99s+disease+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26atitle%3DCyclooxygenase-2%2520expression%2520is%2520increased%2520in%2520frontal%2520cortex%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%26jtitle%3DNeuroscience%26date%3D1998%26volume%3D87%26spage%3D319%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span> </span><span class="NLM_article-title">Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">2819</span><span class="NLM_x">–</span> <span class="NLM_lpage">2826</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=2819-2826&author=P.+S.+Aisenauthor=K.+A.+Schaferauthor=M.+Grundmanauthor=E.+Pfeifferauthor=M.+Sanoauthor=K.+L.+Davisauthor=M.+R.+Farlowauthor=S.+Jinauthor=R.+G.+Thomasauthor=L.+J.+Thal&title=Effects+of+rofecoxib+or+naproxen+vs+placebo+on+Alzheimer+disease+progression%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSchafer%26aufirst%3DK.%2BA.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DPfeiffer%26aufirst%3DE.%26aulast%3DSano%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DK.%2BL.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26atitle%3DEffects%2520of%2520rofecoxib%2520or%2520naproxen%2520vs%2520placebo%2520on%2520Alzheimer%2520disease%2520progression%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D2819%26epage%3D2826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Breitner, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinert, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyketsos, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashe, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismail, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P. N.</span><span> </span><span class="NLM_article-title">Extended results of the Alzheimer’s disease anti-inflammatory prevention trial</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.jalz.2010.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21784351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3MjgslemtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=402-411&author=J.+C.+Breitnerauthor=L.+D.+Bakerauthor=T.+J.+Montineauthor=C.+L.+Meinertauthor=C.+G.+Lyketsosauthor=K.+H.+Asheauthor=J.+Brandtauthor=S.+Craftauthor=D.+E.+Evansauthor=R.+C.+Greenauthor=M.+S.+Ismailauthor=B.+K.+Martinauthor=M.+J.+Mullanauthor=M.+Sabbaghauthor=P.+N.+Tariot&title=Extended+results+of+the+Alzheimer%E2%80%99s+disease+anti-inflammatory+prevention+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Extended results of the Alzheimer's disease anti-inflammatory prevention trial</span></div><div class="casAuthors">Breitner John C; Baker Laura D; Montine Thomas J; Meinert Curtis L; Lyketsos Constantine G; Ashe Karen H; Brandt Jason; Craft Suzanne; Evans Denis E; Green Robert C; Ismail M Saleem; Martin Barbara K; Mullan Michael J; Sabbagh Marwan; Tariot Pierre N</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Epidemiologic evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) delay onset of Alzheimer's dementia (AD), but randomized trials show no benefit from NSAIDs in patients with symptomatic AD.  The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) randomized 2,528 elderly persons to naproxen or celecoxib versus placebo for 2 years (standard deviation = 11 months) before treatments were terminated.  During the treatment interval, 32 cases of AD revealed increased rates in both NSAID-assigned groups.  METHODS:  We continued the double-masked ADAPT protocol for 2 additional years to investigate incidence of AD (primary outcome).  We then collected cerebrospinal fluid (CSF) from 117 volunteer participants to assess their ratio of CSF tau to Aβ(1-42.)  RESULTS:  Including 40 new events observed during follow-up of 2,071 randomized individuals (92% of participants at treatment cessation), there were 72 AD cases.  Overall, NSAID-related harm was no longer evident, but secondary analyses showed that increased risk remained notable in the first 2.5 years of observations, especially in 54 persons enrolled with cognitive impairment--no dementia (CIND).  These same analyses showed later reduction in AD incidence among asymptomatic enrollees who were given naproxen.  CSF biomarker assays suggested that the latter result reflected reduced Alzheimer-type neurodegeneration.  CONCLUSIONS:  These data suggest a revision of the original ADAPT hypothesis that NSAIDs reduce AD risk, as follows: NSAIDs have an adverse effect in later stages of AD pathogenesis, whereas asymptomatic individuals treated with conventional NSAIDs such as naproxen experience reduced AD incidence, but only after 2 to 3 years.  Thus, treatment effects differ at various stages of disease.  This hypothesis is consistent with data from both trials and epidemiological studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRp1vb8yEF2ZtenUz0lpNqnfW6udTcc2eYn4CjejPKznrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjgslemtQ%253D%253D&md5=72baff395a1e0c2ead0e181d7d82a0f8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26aulast%3DBaker%26aufirst%3DL.%2BD.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMeinert%26aufirst%3DC.%2BL.%26aulast%3DLyketsos%26aufirst%3DC.%2BG.%26aulast%3DAshe%26aufirst%3DK.%2BH.%26aulast%3DBrandt%26aufirst%3DJ.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DD.%2BE.%26aulast%3DGreen%26aufirst%3DR.%2BC.%26aulast%3DIsmail%26aufirst%3DM.%2BS.%26aulast%3DMartin%26aufirst%3DB.%2BK.%26aulast%3DMullan%26aufirst%3DM.%2BJ.%26aulast%3DSabbagh%26aufirst%3DM.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26atitle%3DExtended%2520results%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520anti-inflammatory%2520prevention%2520trial%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D402%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Grosser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, G. A.</span><span> </span><span class="NLM_article-title">Emotion recollected in tranquility: lessons learned from the COX-2 saga</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1146%2Fannurev-med-011209-153129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=20059330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFyls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2010&pages=17-33&author=T.+Grosserauthor=Y.+Yuauthor=G.+A.+Fitzgerald&title=Emotion+recollected+in+tranquility%3A+lessons+learned+from+the+COX-2+saga"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Emotion recollected in tranquility: lessons learned from the COX-2 saga</span></div><div class="casAuthors">Grosser, Tilo; Yu, Ying; FitzGerald, Garret A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-33</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">Nonsteroidal antinflammatory drugs (NSAIDs) inhibit prostaglandin formation by cyclooxygenases (COX) 1 and 2.  NSAIDs selective for inhibition of COX-2 are less likely than traditional drugs to cause serious gastrointestinal adverse effects, but predispose to adverse cardiovascular events, such as heart failure, myocardial infarction, and stroke.  Evidence from human pharmacol. and genetics, genetically manipulated rodents, and other animal models and randomized trials indicates that this is consequent to suppression of COX-2-dependent cardioprotective prostagladins, particularly prostacyclin.  Lessons drawn from how this saga unfolded are relevant to how we approach drug surveillance and regulation, integrate diversifed forms of information and might pursue a more personalized approach to drug efficacy and risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7InShCVYT_bVg90H21EOLACvtfcHk0liK65cyOUAVNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFyls7s%253D&md5=4706ede28ada88f53acde7c31b1189ef</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-011209-153129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-011209-153129%26sid%3Dliteratum%253Aachs%26aulast%3DGrosser%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DFitzgerald%26aufirst%3DG.%2BA.%26atitle%3DEmotion%2520recollected%2520in%2520tranquility%253A%2520lessons%2520learned%2520from%2520the%2520COX-2%2520saga%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2010%26volume%3D61%26spage%3D17%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Egan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rader, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FitzGerald, G. A.</span><span> </span><span class="NLM_article-title">COX-2-derived prostacyclin confers atheroprotection on female mice</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">1954</span><span class="NLM_x">–</span> <span class="NLM_lpage">1957</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2004&pages=1954-1957&author=K.+M.+Eganauthor=J.+A.+Lawsonauthor=S.+Friesauthor=B.+Kollerauthor=D.+J.+Raderauthor=E.+M.+Smythauthor=G.+A.+FitzGerald&title=COX-2-derived+prostacyclin+confers+atheroprotection+on+female+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DK.%2BM.%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26aulast%3DFries%26aufirst%3DS.%26aulast%3DKoller%26aufirst%3DB.%26aulast%3DRader%26aufirst%3DD.%2BJ.%26aulast%3DSmyth%26aufirst%3DE.%2BM.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26atitle%3DCOX-2-derived%2520prostacyclin%2520confers%2520atheroprotection%2520on%2520female%2520mice%26jtitle%3DScience%26date%3D2004%26volume%3D306%26spage%3D1954%26epage%3D1957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Grosser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FitzGerald, G. A.</span><span> </span><span class="NLM_article-title">Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=4-15&author=T.+Grosserauthor=S.+Friesauthor=G.+A.+FitzGerald&title=Biological+basis+for+the+cardiovascular+consequences+of+COX-2+inhibition%3A+therapeutic+challenges+and+opportunities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrosser%26aufirst%3DT.%26aulast%3DFries%26aufirst%3DS.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26atitle%3DBiological%2520basis%2520for%2520the%2520cardiovascular%2520consequences%2520of%2520COX-2%2520inhibition%253A%2520therapeutic%2520challenges%2520and%2520opportunities%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D4%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hirata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostanoid receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">6209</span><span class="NLM_x">–</span> <span class="NLM_lpage">6230</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr200010h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVWltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6209-6230&author=T.+Hirataauthor=S.+Narumiya&title=Prostanoid+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Prostanoid Receptors</span></div><div class="casAuthors">Hirata, Takako; Narumiya, Shuh</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6209-6230</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, on prostanoid receptors features and role as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGfWgwLJd47Vg90H21EOLACvtfcHk0liK65cyOUAVNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWltro%253D&md5=6132b351c7983ef2618149991c0166b6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcr200010h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200010h%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DT.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstanoid%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6209%26epage%3D6230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Narumiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushikubi, F.</span><span> </span><span class="NLM_article-title">Prostanoid receptors: structures, properties, and functions</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1152%2Fphysrev.1999.79.4.1193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=10508233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVymtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1999&pages=1193-1226&author=S.+Narumiyaauthor=Y.+Sugimotoauthor=F.+Ushikubi&title=Prostanoid+receptors%3A+structures%2C+properties%2C+and+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Prostanoid receptors: structures, properties, and functions</span></div><div class="casAuthors">Narumiya, Shuh; Sugimoto, Yukihiko; Ushikubi, Fumitaka</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1193-1226</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 254 refs.  Prostanoids are the cyclooxygenase metabolites of arachidonic acid and include prostaglandin (PG) D2, PGE2, PGF2α, PGI2, and thromboxane A2.  They are synthesized and released upon cell stimulation and act on cells in the vicinity of their synthesis to exert their actions.  Receptors mediating the actions of prostanoids were recently identified and cloned.  They are G protein-coupled receptors with seven transmembrane domains.  There are eight types and subtypes of prostanoid receptors that are encoded by different genes but as a whole constitute a subfamily in the superfamily of the rhodopsin-type receptors.  Each of the receptors was expressed in cultured cells, and its ligand-binding properties and signal transduction pathways were characterized.  Moreover, domains and amino acid residues conferring the specificities of ligand binding and signal transduction are being clarified.  Information also is accumulating as to the distribution of these receptors in the body.  It is also becoming clear for some types of receptors how expression of their genes is regulated.  Furthermore, the gene for each of the eight types of prostanoid receptor has been disrupted, and mice deficient in each type of receptor are being examd. to identify and assess the roles played by each receptor under various physiol. and pathophysiol. conditions.  In this article, we summarize these findings and attempt to give an overview of the current status of research on the prostanoid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryyKYnqFDGUbVg90H21EOLACvtfcHk0lgxttY_RFbDfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVymtL0%253D&md5=868b556bb0e6b8628efbc5bdc630025d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1999.79.4.1193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1999.79.4.1193%26sid%3Dliteratum%253Aachs%26aulast%3DNarumiya%26aufirst%3DS.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DUshikubi%26aufirst%3DF.%26atitle%3DProstanoid%2520receptors%253A%2520structures%252C%2520properties%252C%2520and%2520functions%26jtitle%3DPhysiol.%2520Rev.%26date%3D1999%26volume%3D79%26spage%3D1193%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Emerging roles of PGE2 receptors in models of neurological disease</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.prostaglandins.2009.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19808012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=104-112&author=K.+Andreasson&title=Emerging+roles+of+PGE2+receptors+in+models+of+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of PGE2 receptors in models of neurological disease</span></div><div class="casAuthors">Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">104-112</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This review presents an overview of the emerging field of prostaglandin signaling in neurol. diseases, focusing on PGE2 signaling through its four E-prostanoid (EP) receptors.  A large no. of studies have demonstrated a neurotoxic function of the inducible cyclooxygenase COX-2 in a broad spectrum of neurol. disease models in the central nervous system (CNS), from models of cerebral ischemia to models of neurodegeneration and inflammation.  Since COX-1 and COX-2 catalyze the first committed step in prostaglandin synthesis, an effort is underway to identify the downstream prostaglandin signaling pathways that mediate the toxic effect of COX-2.  Recent epidemiol. studies demonstrate that chronic COX-2 inhibition can produce adverse cerebrovascular and cardiovascular effects, indicating that some prostaglandin signaling pathways are beneficial.  Consistent with this concept, recent studies demonstrate that in the CNS, specific prostaglandin receptor signaling pathways mediate toxic effects in brain but a larger no. appear to mediate paradoxically protective effects.  Further complexity is emerging, as exemplified by the PGE2 EP2 receptor, where cerebroprotective or toxic effects of a particular prostaglandin signaling pathway can differ depending on the context of cerebral injury, for example, in excitotoxicity/hypoxia paradigms vs. inflammatory-mediated secondary neurotoxicity.  The divergent effects of prostaglandin receptor signaling will likely depend on distinct patterns and dynamics of receptor expression in neurons, endothelial cells, and glia and the specific ways in which these cell types participate in particular models of neurol. injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3_8vqPcrborVg90H21EOLACvtfcHk0lgxttY_RFbDfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu78%253D&md5=a4c75c03cd679c5316d515ff72515567</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DEmerging%2520roles%2520of%2520PGE2%2520receptors%2520in%2520models%2520of%2520neurological%2520disease%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26spage%3D104%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hata, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span> </span><span class="NLM_article-title">Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.pharmthera.2004.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=15369681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFSqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=147-166&author=A.+N.+Hataauthor=R.+M.+Breyer&title=Pharmacology+and+signaling+of+prostaglandin+receptors%3A+multiple+roles+in+inflammation+and+immune+modulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation</span></div><div class="casAuthors">Hata, Aaron N.; Breyer, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-166</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Prostaglandins are lipid-derived autacoids that modulate many physiol. systems including the CNS, cardiovascular, gastrointestinal, genitourinary, endocrine, respiratory, and immune systems.  In addn., prostaglandins were implicated in a broad array of diseases including cancer, inflammation, cardiovascular disease, and hypertension.  Prostaglandins exert their effects by activating rhodopsin-like 7 transmembrane spanning G protein-coupled receptors (GPCRs).  The prostanoid receptor subfamily is comprised of 8 members (DP, EP1-4, FP, IP, and TP), and recently, a ninth prostaglandin receptor was identified-the chemoattractant receptor homologous mol. expressed on Th2 cells (CRTH2).  The precise roles prostaglandin receptors play in physiol. and pathol. settings are detd. by multiple factors including cellular context, receptor expression profile, ligand affinity, and differential coupling to signal transduction pathways.  This complexity is highlighted by the diverse and often opposing effects of prostaglandins within the immune system.  In certain settings, prostaglandins function as pro-inflammatory mediators, but in others, they appear to have anti-inflammatory properties.  In this review, the authors will discuss the pharmacol. and signaling of the 9 known prostaglandin GPCRs and highlight the specific roles that these receptors play in inflammation and immune modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUuiw0S9UeQ7Vg90H21EOLACvtfcHk0lgxttY_RFbDfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFSqtL8%253D&md5=98c2a06cdfcc3c2e02d7b856a052201c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DHata%26aufirst%3DA.%2BN.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26atitle%3DPharmacology%2520and%2520signaling%2520of%2520prostaglandin%2520receptors%253A%2520multiple%2520roles%2520in%2520inflammation%2520and%2520immune%2520modulation%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D103%26spage%3D147%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Jones, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giembycz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, D. F.</span><span> </span><span class="NLM_article-title">Prostanoid receptor antagonists: development strategies and therapeutic applications</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1476-5381.2009.00317.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19624532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKmu7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=104-145&author=R.+L.+Jonesauthor=M.+A.+Giembyczauthor=D.+F.+Woodward&title=Prostanoid+receptor+antagonists%3A+development+strategies+and+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Prostanoid Receptor Antagonists: Development Strategies and Therapeutic Applications</span></div><div class="casAuthors">Jones, R. L.; Giembycz, M. A.; Woodward, D. F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-145</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Identification of the primary products of cyclo-oxygenase (COX)/prostaglandin synthase(s), which occurred between 1958 and 1976, was followed by a classification system for prostanoid receptors (DP, EP1, EP2...) based mainly on the pharmacol. actions of natural and synthetic agonists and a few antagonists.  The design of potent selective antagonists was rapid for certain prostanoid receptors (EP1, TP), slow for others (FP, IP) and has yet to be achieved in certain cases (EP2).  While some antagonists are structurally related to the natural agonist, most recent compds. are 'non-prostanoid' (often acyl-sulfonamides) and have emerged from high-throughput screening of compd. libraries, made possible by the development of (functional) assays involving single recombinant prostanoid receptors.  Selective antagonists have been crucial to defining the roles of PGD2 (acting on DP1 and DP2 receptors) and PGE2 (on EP1 and EP4 receptors) in various inflammatory conditions; there are clear opportunities for therapeutic intervention.  The vast endeavour on TP (thromboxane) antagonists is considered in relation to their limited pharmaceutical success in the cardiovascular area.  Correspondingly, the clin. utility of IP (prostacyclin) antagonists is assessed in relation to the cloud hanging over the long-term safety of selective COX-2 inhibitors.  Aspirin apart, COX inhibitors broadly suppress all prostanoid pathways, while high selectivity has been a major goal in receptor antagonist development; more targeted therapy may require an intermediate position with defined antagonist selectivity profiles.  This review is intended to provide overviews of each antagonist class (including prostamide antagonists), covering major development strategies and current and potential clin. usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyqQqvML3herVg90H21EOLACvtfcHk0lgxttY_RFbDfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKmu7bJ&md5=cc9dda6d0296b60531ba6484fb8d318a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00317.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00317.x%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BL.%26aulast%3DGiembycz%26aufirst%3DM.%2BA.%26aulast%3DWoodward%26aufirst%3DD.%2BF.%26atitle%3DProstanoid%2520receptor%2520antagonists%253A%2520development%2520strategies%2520and%2520therapeutic%2520applications%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D104%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Dong, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, N. H.</span><span> </span><span class="NLM_article-title">Prostaglandin-E Receptor Subtypes in Smooth-Muscle-Agonist Activities of Stable Prostacyclin Analogs</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1476-5381.1986.tb10161.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=2420404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaL28XhtVeis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1986&pages=97-107&author=Y.+J.+Dongauthor=R.+L.+Jonesauthor=N.+H.+Wilson&title=Prostaglandin-E+Receptor+Subtypes+in+Smooth-Muscle-Agonist+Activities+of+Stable+Prostacyclin+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E receptor subtypes in smooth muscle:  agonist activities of stable prostacyclin analogs</span></div><div class="casAuthors">Dong, Y. J.; Jones, R. L.; Wilson, N. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-107</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The agonist activities of a range of prostaglandin (PG) analogs on smooth muscle prepns. sensitive to PGE2  [363-24-6] were investigated.  When necessary, thromboxane-like activity was eliminated by using the thromboxane receptor antagonists EP 045 and EP 092.  On the bullock iris sphincter, rat stomach fundus, and guinea pig trachea, (±)-ω-tetranor-16-p-chlorophenoxy PGE2  [75024-02-1] and 16,16-dimethyl PGE2  [39746-25-3] were more active contractile agents than PGE2; for relaxant activity on the cat trachea, guinea pig trachea, and dog hind limb arterial vessels in vivo, the order of potency was reversed.  11-Deoxy PGE1  [37786-00-8] exhibited greater relaxant than contractile activity when compared with PGE2.  Iloprost  [78919-13-8] and 6a-carba-Δ6,6a-PGI1  [88911-35-7] (potent mimetics of PGI2) showed high contractile activity on the PGE-sensitive prepns.  PGI2  [35121-78-9] was less active, and another potent PGI2 mimetic, ZK96480  [94079-80-8], showed only very weak activity.  When tested, the dibenzoxazepines SC 19220 and SC 25191 blocked the contractile actions of iloprost and 6a-carba-Δ6,6a-PGI1 and those of PGE2 and 16,16-dimethyl PGE2 to similar extents.  Each of the PGI2 analogs showed weak activity on the relaxant systems.  On the proximal portion of the ascending colon of the rat, PGI2, iloprost, 6a-carba-Δ6,6a-PGI1 and ZK 96480 always inhibited spontaneous activity at nanomolar concns.  PGE2 and PGE1 showed weak contractile activity.  The distal portion of the ascending colon was more responsive to the contractile action of PGE analogs: both iloprost and 6a-carba-Δ6,6a-PGI1 showed evidence of contractile activity, whereas PGI2 and ZK 96480 always inhibited spontaneous activity.  Evidence was obtained that the rat stomach fundus also contains a PGF receptor; (±)-ω-tetranor-16-m-trifluoromethylphenoxy PGF2α (ICI 81008)  [55028-71-2] acted as a specific agonist.  PGF2α  [551-11-1] and ω-tetranor-16-p-fluorophenoxy PGF2α  [96443-56-0] produced a higher max. response than ICI 81008, probably due to their addnl. agonist action at the PGE receptor.  Apparently, there are 2 subtypes of the PGE receptor.  ZK 96480 has minimal activity on both receptor subtypes and appears to be a highly specific PGI2 mimetic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc0SPuJS3XkrVg90H21EOLACvtfcHk0lgfmceJiFW1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhtVeis7c%253D&md5=4d745e0cb7ff1337a3658f5ad0ba5cfd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1986.tb10161.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1986.tb10161.x%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BL.%26aulast%3DWilson%26aufirst%3DN.%2BH.%26atitle%3DProstaglandin-E%2520Receptor%2520Subtypes%2520in%2520Smooth-Muscle-Agonist%2520Activities%2520of%2520Stable%2520Prostacyclin%2520Analogs%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1986%26volume%3D87%26spage%3D97%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Bastien, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygorczyk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, M.</span><span> </span><span class="NLM_article-title">Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">11873</span><span class="NLM_x">–</span> <span class="NLM_lpage">11877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=11873-11877&author=L.+Bastienauthor=N.+Sawyerauthor=R.+Grygorczykauthor=K.+M.+Mettersauthor=M.+Adam&title=Cloning%2C+functional+expression%2C+and+characterization+of+the+human+prostaglandin+E2+receptor+EP2+subtype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBastien%26aufirst%3DL.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DGrygorczyk%26aufirst%3DR.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DAdam%26aufirst%3DM.%26atitle%3DCloning%252C%2520functional%2520expression%252C%2520and%2520characterization%2520of%2520the%2520human%2520prostaglandin%2520E2%2520receptor%2520EP2%2520subtype%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D11873%26epage%3D11877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokteva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2Fana.21437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=18825663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yisr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=304-314&author=X.+Liangauthor=Q.+Wangauthor=J.+Shiauthor=L.+Loktevaauthor=R.+M.+Breyerauthor=T.+J.+Montineauthor=K.+Andreasson&title=The+prostaglandin+E2+EP2+receptor+accelerates+disease+progression+and+inflammation+in+a+model+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Liang, Xibin; Wang, Qian; Shi, Ju; Lokteva, Ludmila; Breyer, Richard M.; Montine, Thomas J.; Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-314</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Inflammation has emerged as an important factor in disease progression in human and transgenic models of amyotrophic lateral sclerosis (ALS).  Recent studies demonstrate that the prostaglandin E2 EP2 receptor is a major regulator of inflammatory oxidative injury in innate immunity.  We tested whether EP2 signaling participated in disease pathogenesis in the G93A superoxide dismutase (SOD) model of familial ALS.  We examd. the phenotype of G93A SOD mice lacking the EP2 receptor and performed immunocytochem., quant. reverse transcriptase polymerase chain reaction, and Western analyses to det. the mechanism of EP2 toxicity in this model.  EP2 receptor is significantly induced in G93A SOD mice in astrocytes and microglia in parallel with increases in expression of proinflammatory enzymes and lipid peroxidn.  In human ALS, EP2 receptor immunoreactivity was upregulated in astrocytes in ventral spinal cord.  In aging G93A SOD mice, genetic deletion of the prostaglandin E2 EP2 receptor improved motor strength and extended survival.  Deletion of the EP2 receptor in G93A SOD mice resulted in significant redns. in levels of proinflammatory effectors, including cyclooxygenase-1, cyclooxygenase-2, inducible nitric oxide synthase, and components of the NADPH oxidase complex.  In alternate models of inflammation, including the lipopolysaccharide model of innate immunity and the APPSwe-PS1ΔE9 model of amyloidosis, deletion of EP2 also reduced expression of proinflammatory genes.  These data suggest that prostaglandin E2 signaling via the EP2 receptor functions in the mutant SOD model and more broadly in inflammatory neurodegeneration to regulate expression of a cassette of proinflammatory genes.  Inhibition of EP2 signaling may represent a novel strategy to downregulate the inflammatory response in neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruLggt1bC9dbVg90H21EOLACvtfcHk0lgfmceJiFW1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yisr3O&md5=fe6acc1bb4b3be25e4d9d7474a5b2b3a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fana.21437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21437%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLokteva%26aufirst%3DL.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DThe%2520prostaglandin%2520E2%2520EP2%2520receptor%2520accelerates%2520disease%2520progression%2520and%2520inflammation%2520in%2520a%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D2008%26volume%3D64%26spage%3D304%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">McCullough, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haughey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1523%2FJNEUROSCI.4485-03.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=14715958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotF2ltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=257-268&author=L.+McCulloughauthor=L.+Wuauthor=N.+Haugheyauthor=X.+Liangauthor=T.+Handauthor=Q.+Wangauthor=R.+M.+Breyerauthor=K.+Andreasson&title=Neuroprotective+function+of+the+PGE2+EP2+receptor+in+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia</span></div><div class="casAuthors">McCullough, Louise; Wu, Liejun; Haughey, Norman; Liang, Xibin; Hand, Tracey; Wang, Qian; Breyer, Richard M.; Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">257-268</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The cyclooxygenases COX-1 and COX-2 catalyze the first committed step of prostaglandin synthesis from arachidonic acid.  Previous studies in rodent stroke models have shown that the inducible COX-2 isoform promotes neuronal injury, and the administration of COX-2 inhibitors reduces infarct vol.  We investigated the function of PGE2, a principal prostaglandin product of COX-2 enzymic activity, in neuronal survival in cerebral ischemia.  PGE2 exerts its downstream effects by signaling through a class of four distinct G-protein-coupled EP receptors (for E-prostanoid: EP1, EP2, EP3, and EP4) that have divergent effects on cAMP and phosphoinositol turnover and different anatomical distributions in brain.  The EP2 receptor subtype is abundantly expressed in cerebral cortex, striatum, and hippocampus, and is pos. coupled to cAMP prodn.  In vitro studies of dispersed neurons and organotypic hippocampal cultures demonstrated that activation of the EP2 receptor was neuroprotective in paradigms of NMDA toxicity and oxygen glucose deprivation.  Pharmacol. blockade of EP2 signaling by inhibition of protein kinase A activation reversed this protective effect, suggesting that EP2-mediated neuroprotection is dependent on cAMP signaling.  In the middle cerebral artery occlusion-reperfusion model of transient forebrain ischemia, genetic deletion of the EP2 receptor significantly increased cerebral infarction in cerebral cortex and subcortical structures.  These studies indicate that activation of the PGE2 EP2 receptor can protect against excitotoxic and anoxic injury in a cAMP-dependent manner.  Taken together, these data suggest a novel mechanism of neuroprotection mediated by a dominant PGE2 receptor subtype in brain that may provide a target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjazLQgIyS47Vg90H21EOLACvtfcHk0licZ-l2b9e2VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotF2ltQ%253D%253D&md5=73a862c6c9372fccb711bfacd07ff6d6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4485-03.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4485-03.2004%26sid%3Dliteratum%253Aachs%26aulast%3DMcCullough%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DHaughey%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DHand%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DNeuroprotective%2520function%2520of%2520the%2520PGE2%2520EP2%2520receptor%2520in%2520cerebral%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D257%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Gardiner, P. J.</span><span> </span><span class="NLM_article-title">Characterization of Prostanoid Relaxant Inhibitory Receptors (Psi) Using a Highly Selective Agonist, TR4979</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1476-5381.1986.tb10155.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaL28Xht1ektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1986&pages=45-56&author=P.+J.+Gardiner&title=Characterization+of+Prostanoid+Relaxant+Inhibitory+Receptors+%28Psi%29+Using+a+Highly+Selective+Agonist%2C+TR4979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979</span></div><div class="casAuthors">Gardiner, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-56</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">TR 4979 (I) [69648-38-0], an analog of PGE1 [745-65-3], was evaluated on respiratory and nonrespiratory isolated tissues known to contain heterogeneous or homogeneous populations of the 2 classes of prostanoid (prostaglandins and thromboxanes) receptors.  These receptors are classified as χ the contractant/stimulant receptor with χ1,2,3 being 3 subdivisions and ψ the relaxant/inhibitory receptor(s).  On a respiratory tissue (cat trachea) contg. predominantly ψ receptors, I was 26 times less potent than PGE1 or PGE2 [363-24-6].  On other respiratory tissues known to contain mixts. of the χ1,2,3- and ψ-receptors (guinea-pig trachea and lung strip, cat lung strip, and human bronchial muscle), I consistently acted as a potent relaxant whereas PGE2 and to a lesser extent PGE1 had contractant activities.  Human pregnant uterus, guinea-pig and rat pseudopregnant uteri, rat colon and fundic strips, and chick ileum are known to contain 1 or more of the 3 subclasses of the χ-receptor.  I (10-9-10-5 M) was inactive on all these tissues whereas all of the ref. prostanoids were contractants of varying potencies.  PGE1 and histamine [51-45-6]-induced contractions of the guinea-pig isolated ileum were both noncompetitively antagonized by increasing concns. of I suggesting that ψ-receptors also exist on this tissue.  I is a highly selective agonist of prostanoid ψ (relaxant/inhibitory)-receptors which exist mainly in the lung.  This prostaglandin analog is a useful new selective pharmacol. tool for revealing as yet unidentified prostanoid ψ-receptors and actions in a wide range of nonrespiratory tissues/organs such as the guinea-pige ileum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcKdpcICdVLVg90H21EOLACvtfcHk0licZ-l2b9e2VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1ektb4%253D&md5=13cd55eed4f220c8cf2739a5fc539aad</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1986.tb10155.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1986.tb10155.x%26sid%3Dliteratum%253Aachs%26aulast%3DGardiner%26aufirst%3DP.%2BJ.%26atitle%3DCharacterization%2520of%2520Prostanoid%2520Relaxant%2520Inhibitory%2520Receptors%2520%2528Psi%2529%2520Using%2520a%2520Highly%2520Selective%2520Agonist%252C%2520TR4979%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1986%26volume%3D87%26spage%3D45%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Ahmad, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echeverria, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, S.</span><span> </span><span class="NLM_article-title">Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity</span> <span class="citation_source-journal">J. Neurotrauma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1089%2Fneu.2006.23.1895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BD28jkslagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=1895-1903&author=A.+S.+Ahmadauthor=H.+A.+Zhuangauthor=V.+Echeverriaauthor=S.+Dore&title=Stimulation+of+prostaglandin+EP2+receptors+prevents+NMDA-induced+excitotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity</span></div><div class="casAuthors">Ahmad Abdullah Shafique; Zhuang Hean; Echeverria Valentina; Dore Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1895-903</span>
        ISSN:<span class="NLM_cas:issn">0897-7151</span>.
    </div><div class="casAbstract">Prostaglandin E(2) (PGE(2)) plays an important role in inflammation and neurologic disorders.  The neuromodulatory effects of PGE(2) are mediated through regulation of four G-protein-coupled receptors known as EP1, EP2, EP3, and EP4.  The goal of the current study was to determine whether EP2 receptor activation protects neurons from acute NMDA-mediated excitotoxicity.  To examine the effects of EP2 activation, mice were given an injection of the EP2 receptor-selective agonist butaprost (K (i) = 110 nM for EP2 receptor; K (i) > 10,000 for other prostaglandin receptors) in the cerebral ventricle and then an injection of NMDA in the right striatum.  After 48 h, a significant reduction in NMDA-induced lesion volume was observed in groups pretreated with butaprost (1-300 nmol/L), with maximal protection at 100 nmol/L (p < 0.001).  To determine if EP2-activated protection was specific to neurons, mouse neuronal cultures were treated with butaprost, and cell viability was analyzed after 24 h of NMDA excitotoxicity.  The results showed that butaprost significantly increased neuron survival in a dose-dependent fashion.  Furthermore, treatment of primary neurons with butaprost significantly increased cAMP levels (p < 0.001).  Together, these data reveal that EP2 receptor stimulation mediates neuroprotection against NMDA excitotoxicity both in vivo and in vitro and that butaprost can limit acute brain damage.  Development and testing of specific PGE(2) receptor mimetics could lead to a decrease in side effects associated with anti-inflammatory drugs and could help to fight acute and/or chronic neurologic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0CGBldOxMXt-cVm4E2RlLfW6udTcc2eYqrlfXcPT-cLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jkslagsA%253D%253D&md5=bec86d4155fa57c6af14ca0c4ccd7b6f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1089%2Fneu.2006.23.1895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2006.23.1895%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DA.%2BS.%26aulast%3DZhuang%26aufirst%3DH.%2BA.%26aulast%3DEcheverria%26aufirst%3DV.%26aulast%3DDore%26aufirst%3DS.%26atitle%3DStimulation%2520of%2520prostaglandin%2520EP2%2520receptors%2520prevents%2520NMDA-induced%2520excitotoxicity%26jtitle%3DJ.%2520Neurotrauma%26date%3D2006%26volume%3D23%26spage%3D1895%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Carrasco, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casper, D.</span><span> </span><span class="NLM_article-title">Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2008&pages=44-49&author=E.+Carrascoauthor=P.+Wernerauthor=D.+Casper&title=Prostaglandin+receptor+EP2+protects+dopaminergic+neurons+against+6-OHDA-mediated+low+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarrasco%26aufirst%3DE.%26aulast%3DWerner%26aufirst%3DP.%26aulast%3DCasper%26aufirst%3DD.%26atitle%3DProstaglandin%2520receptor%2520EP2%2520protects%2520dopaminergic%2520neurons%2520against%25206-OHDA-mediated%2520low%2520oxidative%2520stress%26jtitle%3DNeurosci.%2520Lett.%26date%3D2008%26volume%3D441%26spage%3D44%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thepchatri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2307</span><span class="NLM_x">–</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1073%2Fpnas.0909310107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=20080612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFChsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2307-2312&author=J.+Jiangauthor=T.+Ganeshauthor=Y.+Duauthor=P.+Thepchatriauthor=A.+Rojasauthor=I.+Lewisauthor=S.+Kurtkayaauthor=L.+Liauthor=M.+Quiauthor=G.+Serranoauthor=R.+Shawauthor=A.+Sunauthor=R.+Dingledine&title=Neuroprotection+by+selective+allosteric+potentiators+of+the+EP2+prostaglandin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor</span></div><div class="casAuthors">Jiang, Jianxiong; Ganesh, Thota; Du, Yuhong; Thepchatri, Pahk; Rojas, Asheebo; Lewis, Lestyn; Kurtkaya, Serdar; Li, Lian; Qui, Min; Serrano, Geidy; Shaw, Renee; Sun, Aiming; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2307-2312, S2307/1-S2307/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activation of the Gαs-coupled EP2 receptor for prostaglandin E2 (PGE2) promotes cell survival in several models of tissue damage.  To advance understanding of EP2 functions, we designed expts. to develop allosteric potentiators of this key prostaglandin receptor.  Screens of 292,000 compds. identified 93 that at 20 μM (i) potentiated the cAMP response to a low concn. of PGE2 by >50%; (ii) had no effect on EP4 or β2 adrenergic receptors, the cAMP assay itself, or the parent cell line; and (iii) increased the potency of PGE2 on EP2 receptors at least 3-fold.  In aq. soln., the active compds. are largely present as nanoparticles that appear to serve as active reservoirs for bioactive monomer.  From 94 compds. synthesized or purchased, based on the modification of one hit compd., the most active increased the potency of PGE2 on EP2 receptors 4- to 5-fold at 10 to 20 μM and showed substantial neuroprotection in an excitotoxicity model.  These small mols. represent previously undescribed allosteric modulators of a PGE2 receptor.  Our results strongly reinforce the notion that activation of EP2 receptors by endogenous PGE2 released in a cell-injury setting is neuroprotective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreVs-Pts4UO7Vg90H21EOLACvtfcHk0licZ-l2b9e2VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFChsrw%253D&md5=46aabca1d636956d252e2b9114650b69</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0909310107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0909310107%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DThepchatri%26aufirst%3DP.%26aulast%3DRojas%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DI.%26aulast%3DKurtkaya%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DQui%26aufirst%3DM.%26aulast%3DSerrano%26aufirst%3DG.%26aulast%3DShaw%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DNeuroprotection%2520by%2520selective%2520allosteric%2520potentiators%2520of%2520the%2520EP2%2520prostaglandin%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D2307%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10180</span><span class="NLM_x">–</span> <span class="NLM_lpage">10187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1523%2FJNEUROSCI.3591-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=16267225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wqt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10180-10187&author=X.+Liangauthor=Q.+Wangauthor=T.+Handauthor=L.+Wuauthor=R.+M.+Breyerauthor=T.+J.+Montineauthor=K.+Andreasson&title=Deletion+of+the+prostaglandin+E2+EP2+receptor+reduces+oxidative+damage+and+amyloid+burden+in+a+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease</span></div><div class="casAuthors">Liang, Xibin; Wang, Qian; Hand, Tracey; Wu, Liejun; Breyer, Richard M.; Montine, Thomas J.; Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">10180-10187</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Epidemiol. studies demonstrate that chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) in normal aging populations reduces the risk of developing Alzheimer's disease (AD).  NSAIDs inhibit the enzymic activity of cyclooxygenase-1 (COX-1) and inducible COX-2, which catalyze the first committed step in the synthesis of prostaglandins.  These studies implicate COX-mediated inflammation as an early and potentially reversible preclin. event; however, the mechanism by which COX activity promotes development of AD has not been detd.  Recent studies implicate the prostaglandin E2 (PGE2) E prostanoid subtype 2 (EP2) receptor in the development of the innate immune response in brain.  Here, we report that deletion of the PGE2 EP2 receptor in the APPSwe-PS1ΔE9 model of familial AD results in marked redns. in lipid peroxidn. in aging mice.  This redn. in oxidative stress is assocd. with significant decreases in levels of amyloid-β (Aβ) 40 and 42 peptides and amyloid deposition.  Aged APPSwe-PS1ΔE9 mice lacking the EP2 receptor harbor lower levels of β C-terminal fragments, the product of β-site APP cleaving enzyme (BACE1) processing of amyloid precursor protein.  Increases in BACE1 processing have been demonstrated in models of aging and AD and after oxidative stress.  Our results indicate that PGE2 signaling via the EP2 receptor promotes age-dependent oxidative damage and increased Aβ peptide burden in this model of AD, possibly via effects on BACE1 activity.  Our findings identify EP2 receptor signaling as a novel proinflammatory and proamyloidogenic pathway in this model of AD, and suggest a rationale for development of therapeutics targeting the EP2 receptor in neuroinflammatory diseases such as AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvQcRSqBUHdrVg90H21EOLACvtfcHk0li9-jKb--bllA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wqt77I&md5=fadd58f101e78d983b0be1832c5bbb10</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3591-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3591-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHand%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DDeletion%2520of%2520the%2520prostaglandin%2520E2%2520EP2%2520receptor%2520reduces%2520oxidative%2520damage%2520and%2520amyloid%2520burden%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10180%26epage%3D10187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shie, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schantz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1186%2F1742-2094-4-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=17204153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FhvFOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=2&author=J.+Jinauthor=F.+S.+Shieauthor=J.+Liuauthor=Y.+Wangauthor=J.+Davisauthor=A.+M.+Schantzauthor=K.+S.+Montineauthor=T.+J.+Montineauthor=J.+Zhang&title=Prostaglandin+E2+receptor+subtype+2+%28EP2%29+regulates+microglial+activation+and+associated+neurotoxicity+induced+by+aggregated+alpha-synuclein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein</span></div><div class="casAuthors">Jin Jinghua; Shie Feng-Shiun; Liu Jun; Wang Yan; Davis Jeanne; Schantz Aimee M; Montine Kathleen S; Montine Thomas J; Zhang Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The pathogenesis of idiopathic Parkinson's disease (PD) remains elusive, although evidence has suggested that neuroinflammation characterized by activation of resident microglia in the brain may contribute significantly to neurodegeneration in PD.  It has been demonstrated that aggregated alpha-synuclein potently activates microglia and causes neurotoxicity.  However, the mechanisms by which aggregated alpha-synuclein activates microglia are not understood fully.  METHODS:  We investigated the role of prostaglandin E2 receptor subtype 2 (EP2) in alpha-synuclein aggregation-induced microglial activation using ex vivo, in vivo and in vitro experimental systems.  RESULTS:  Results demonstrated that ablation of EP2(EP2-/-) significantly enhanced microglia-mediated ex vivo clearance of alpha-synuclein aggregates (from mesocortex of Lewy body disease patients) while significantly attenuating neurotoxicity and extent of alpha-synuclein aggregation in mice treated with a parkinsonian toxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.  Furthermore, we report that reduced neurotoxicity by EP2-/- microglia could be attributed to suppressed translocation of a critical cytoplasmic subunit (p47-phox) of NADPH oxidase (PHOX) to the membranous compartment after exposure to aggregated alpha-synuclein.  CONCLUSION:  Thus, it appears that microglial EP2 plays a critical role in alpha-synuclein-mediated neurotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRG7pnC3ErmPJdYoSR9eyvsfW6udTcc2eY1ELdsg1-rsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FhvFOisQ%253D%253D&md5=e37cc154dc6e92d9a1e3ccc9ebcfcfcd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-4-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-4-2%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DShie%26aufirst%3DF.%2BS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DSchantz%26aufirst%3DA.%2BM.%26aulast%3DMontine%26aufirst%3DK.%2BS.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DProstaglandin%2520E2%2520receptor%2520subtype%25202%2520%2528EP2%2529%2520regulates%2520microglial%2520activation%2520and%2520associated%2520neurotoxicity%2520induced%2520by%2520aggregated%2520alpha-synuclein%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2007%26volume%3D4%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milatovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valyi-Nagy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span> </span><span class="NLM_article-title">Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent</span> <span class="citation_source-journal">J. Neurochem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1046%2Fj.1471-4159.2002.01157.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=12423256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFylur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2002&pages=463-70&author=T.+J.+Montineauthor=D.+Milatovicauthor=R.+C.+Guptaauthor=T.+Valyi-Nagyauthor=J.+D.+Morrowauthor=R.+M.+Breyer&title=Neuronal+oxidative+damage+from+activated+innate+immunity+is+EP2+receptor-dependent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent</span></div><div class="casAuthors">Montine, Thomas J.; Milatovic, Dejan; Gupta, Ramesh C.; Valyi-Nagy, Tibor; Morrow, Jason D.; Breyer, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">463-470</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Increase in prostaglandin (PG) E2 levels and oxidative damage are assocd. with diseases of brain that involve activation of innate immunity.  We tested the hypothesis that cerebral oxidative damage resulting from activation of innate immunity with intracerebroventricular (icv) lipopolysaccharide (LPS) is dependent on PGE2-mediated signaling.  We measured two quant. in vivo biomarkers of lipid peroxidn.: F2-isoprostanes (IsoPs) that derive from arachidonic acid (AA) that is uniformly distributed in all cell types in brain, and F4-neuroprostanes (NeuroPs) that derive from docosahexaenoic acid (DHA) that is highly concd. in neuronal membranes.  LPS stimulated delayed elevations in cerebral F2-IsoPs and F4-NeuroPs that were completely suppressed by indomethacin or ibuprofen pre-treatment.  LPS-induced cerebral oxidative damage was abolished by disruption of subtype 2 receptor for PGE2 (EP2).  In contrast, initial oxidative damage from icv kainic acid (KA) was more rapid than with LPS also was completely suppressed by indomethacin or ibuprofen pre-treatment but was independent of EP2 receptor activation.  The protective effect of deleting the EP2 receptor was not assocd. with changes in cerebral eicosaniod prodn., but was partially related to reduced induction of nitric oxide synthase (NOS) activity.  These results suggest the EP2 receptor as a therapeutic target to limit oxidative damage from activation of innate immunity in cerebrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxTvNydACwmrVg90H21EOLACvtfcHk0li9-jKb--bllA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFylur0%253D&md5=95f5b6706a9fc10c2410cadf8cd471d4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01157.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01157.x%26sid%3Dliteratum%253Aachs%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMilatovic%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DR.%2BC.%26aulast%3DValyi-Nagy%26aufirst%3DT.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26atitle%3DNeuronal%2520oxidative%2520damage%2520from%2520activated%2520innate%2520immunity%2520is%2520EP2%2520receptor-dependent%26jtitle%3DJ.%2520Neurochem%26date%3D2002%26volume%3D83%26spage%3D463%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Shie, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span> </span><span class="NLM_article-title">Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=70-77&author=F.+S.+Shieauthor=K.+S.+Montineauthor=R.+M.+Breyerauthor=T.+J.+Montine&title=Microglial+EP2+is+critical+to+neurotoxicity+from+activated+cerebral+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShie%26aufirst%3DF.%2BS.%26aulast%3DMontine%26aufirst%3DK.%2BS.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26atitle%3DMicroglial%2520EP2%2520is%2520critical%2520to%2520neurotoxicity%2520from%2520activated%2520cerebral%2520innate%2520immunity%26jtitle%3DGlia%26date%3D2005%26volume%3D52%26spage%3D70%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Shie, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span> </span><span class="NLM_article-title">Microglia lacking E prostanoid receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2FS0002-9440%2810%2962336-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=15793296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFaksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2005&pages=1163-1172&author=F.+S.+Shieauthor=R.+M.+Breyerauthor=T.+J.+Montine&title=Microglia+lacking+E+prostanoid+receptor+subtype+2+have+enhanced+Abeta+phagocytosis+yet+lack+Abeta-activated+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia lacking E prostanoid receptor subtype 2 have enhanced Aβ phagocytosis yet lack Aβ-activated neurotoxicity</span></div><div class="casAuthors">Shie, Feng-Shiun; Breyer, Richard M.; Montine, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1163-1172</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Exptl. therapies for Alzheimer's disease (AD) are focused on enhanced clearance of neurotoxic Aβ peptides from brain.  Microglia can be neuroprotective by phagocytosing Aβ; however, this comes at the cost of activated innate immunity that causes paracrine damage to neurons.  Here, we show that ablation of E prostanoid receptor subtype 2 (EP2) significantly increased microglial-mediated clearance of Aβ peptides from AD brain sections-and enhanced microglial Aβ phagocytosis in cell culture.  The enhanced phagocytosis was PKC-dependent and was assocd. with elevated microglial secretion of the chemoattractant chemokines, macrophage inflammatory protein-1α and macrophage chemoattractant protein-1.  This suggested that microglial activation is neg. regulated by EP2 signaling through suppression of prophagocytic cytokine secretion.  However, despite this enhancement of Aβ phagocytosis, lack of EP2 completely suppressed Aβ-activated microglia-mediated paracrine neurotoxicity.  These data demonstrate that blockade of microglial EP2 is a highly desirable mechanism for AD therapy that can maximize neuroprotective actions while minimizing bystander damage to neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7BtF6wH0_LVg90H21EOLACvtfcHk0lhZgvSDgmoSPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFaksLc%253D&md5=2724ce1927452f9b018cb2ba78bfd4da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2962336-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252962336-X%26sid%3Dliteratum%253Aachs%26aulast%3DShie%26aufirst%3DF.%2BS.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26atitle%3DMicroglia%2520lacking%2520E%2520prostanoid%2520receptor%2520subtype%25202%2520have%2520enhanced%2520Abeta%2520phagocytosis%2520yet%2520lack%2520Abeta-activated%2520neurotoxicity%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2005%26volume%3D166%26spage%3D1163%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Hoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizushima, T.</span><span> </span><span class="NLM_article-title">Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">32676</span><span class="NLM_x">–</span> <span class="NLM_lpage">32688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=32676-32688&author=T.+Hoshinoauthor=T.+Nakayaauthor=T.+Homanauthor=K.+Tanakaauthor=Y.+Sugimotoauthor=W.+Arakiauthor=M.+Naritaauthor=S.+Narumiyaauthor=T.+Suzukiauthor=T.+Mizushima&title=Involvement+of+prostaglandin+E2+in+production+of+amyloid-beta+peptides+both+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoshino%26aufirst%3DT.%26aulast%3DNakaya%26aufirst%3DT.%26aulast%3DHoman%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DW.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DNarumiya%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMizushima%26aufirst%3DT.%26atitle%3DInvolvement%2520of%2520prostaglandin%2520E2%2520in%2520production%2520of%2520amyloid-beta%2520peptides%2520both%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D32676%26epage%3D32688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Hsiao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, S. F.</span><span> </span><span class="NLM_article-title">TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=214-223&author=H.+Y.+Hsiaoauthor=O.+T.+Makauthor=C.+S.+Yangauthor=Y.+P.+Liuauthor=K.+M.+Fangauthor=S.+F.+Tzeng&title=TNF-alpha%2FIFN-gamma-induced+iNOS+expression+increased+by+prostaglandin+E2+in+rat+primary+astrocytes+via+EP2-evoked+cAMP%2FPKA+and+intracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DH.%2BY.%26aulast%3DMak%26aufirst%3DO.%2BT.%26aulast%3DYang%26aufirst%3DC.%2BS.%26aulast%3DLiu%26aufirst%3DY.%2BP.%26aulast%3DFang%26aufirst%3DK.%2BM.%26aulast%3DTzeng%26aufirst%3DS.%2BF.%26atitle%3DTNF-alpha%252FIFN-gamma-induced%2520iNOS%2520expression%2520increased%2520by%2520prostaglandin%2520E2%2520in%2520rat%2520primary%2520astrocytes%2520via%2520EP2-evoked%2520cAMP%252FPKA%2520and%2520intracellular%2520calcium%2520signaling%26jtitle%3DGlia%26date%3D2007%26volume%3D55%26spage%3D214%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Banu, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speights, V. O.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starzinski-Powitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arosh, J. A.</span><span> </span><span class="NLM_article-title">Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1210%2Fme.2009-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19407222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFOnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1291-1305&author=S.+K.+Banuauthor=J.+Leeauthor=V.+O.+Speightsauthor=A.+Starzinski-Powitzauthor=J.+A.+Arosh&title=Selective+inhibition+of+prostaglandin+E2+receptors+EP2+and+EP4+induces+apoptosis+of+human+endometriotic+cells+through+suppression+of+ERK1%2F2%2C+AKT%2C+NFkappaB%2C+and+beta-catenin+pathways+and+activation+of+intrinsic+apoptotic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFκB, and β-catenin pathways and activation of intrinsic apoptotic mechanisms</span></div><div class="casAuthors">Banu, Sakhila K.; Lee, Je Hoon; Speights, V. O., Jr.; Starzinski-Powitz, Anna; Arosh, Joe A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1291-1305</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Endometriosis is a benign chronic gynecol. disease of reproductive-age women characterized by the presence of functional endometrial tissues outside the uterine cavity.  It is an estrogen-dependent disease.  Current treatment modalities to inhibit biosynthesis and actions of estrogen compromise menstruation, pregnancy, and the reproductive health of women and fail to prevent reoccurrence of disease.  There is a crit. need to identify new specific signaling modules for non-estrogen-targeted therapies for endometriosis.  In our previous study, we reported that selective inhibition of cyclooxygenase-2 prevented survival, migration, and invasion of human endometriotic epithelial and stromal cells, which was due to decreased prostaglandin E2 (PGE2) prodn.  In this study, we detd. mechanisms through which PGE2 promoted survival of human endometriotic cells.  Results of the present study indicate that (1) PGE2 promotes survival of human endometriotic cells through EP2 and EP4 receptors by activating ERK1/2, AKT, nuclear factor-κB, and β-catenin signaling pathways; (2) selective inhibition of EP2 and EP4 suppresses these cell survival pathways and augments interactions between proapoptotic proteins (Bax and Bad) and antiapoptotic proteins (Bcl-2/Bcl-XL), facilitates the release of cytochrome c, and thus activates caspase-3/poly (ADP-ribose) polymerase-mediated intrinsic apoptotic pathways; and (3) these PGE2 signaling components are more abundantly expressed in ectopic endometriosis tissues compared with eutopic endometrial tissues during the menstrual cycle in women.  These novel findings may provide an important mol. framework for further evaluation of selective inhibition of EP2 and EP4 as potential therapy, including nonestrogen target, to expand the spectrum of currently available treatment options for endometriosis in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT-eMJGdcvIbVg90H21EOLACvtfcHk0lhZgvSDgmoSPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFOnurk%253D&md5=a94631d71a249410f9be5b5612ed8ed1</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0017%26sid%3Dliteratum%253Aachs%26aulast%3DBanu%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSpeights%26aufirst%3DV.%2BO.%26aulast%3DStarzinski-Powitz%26aufirst%3DA.%26aulast%3DArosh%26aufirst%3DJ.%2BA.%26atitle%3DSelective%2520inhibition%2520of%2520prostaglandin%2520E2%2520receptors%2520EP2%2520and%2520EP4%2520induces%2520apoptosis%2520of%2520human%2520endometriotic%2520cells%2520through%2520suppression%2520of%2520ERK1%252F2%252C%2520AKT%252C%2520NFkappaB%252C%2520and%2520beta-catenin%2520pathways%2520and%2520activation%2520of%2520intrinsic%2520apoptotic%2520mechanisms%26jtitle%3DMol.%2520Endocrinol.%26date%3D2009%26volume%3D23%26spage%3D1291%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Sheibanie, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khayrullina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emig, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganea, D.</span><span> </span><span class="NLM_article-title">The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">8138</span><span class="NLM_x">–</span> <span class="NLM_lpage">8147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=8138-8147&author=A.+F.+Sheibanieauthor=J.+H.+Yenauthor=T.+Khayrullinaauthor=F.+Emigauthor=M.+Zhangauthor=R.+Tumaauthor=D.+Ganea&title=The+proinflammatory+effect+of+prostaglandin+E2+in+experimental+inflammatory+bowel+disease+is+mediated+through+the+IL-23%E2%86%92IL-17+axis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheibanie%26aufirst%3DA.%2BF.%26aulast%3DYen%26aufirst%3DJ.%2BH.%26aulast%3DKhayrullina%26aufirst%3DT.%26aulast%3DEmig%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DTuma%26aufirst%3DR.%26aulast%3DGanea%26aufirst%3DD.%26atitle%3DThe%2520proinflammatory%2520effect%2520of%2520prostaglandin%2520E2%2520in%2520experimental%2520inflammatory%2520bowel%2520disease%2520is%2520mediated%2520through%2520the%2520IL-23%25E2%2586%2592IL-17%2520axis%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D8138%26epage%3D8147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Sung, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S. M.</span><span> </span><span class="NLM_article-title">Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5507</span><span class="NLM_x">–</span> <span class="NLM_lpage">5516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5507-5516&author=Y.+M.+Sungauthor=G.+Heauthor=D.+H.+Hwangauthor=S.+M.+Fischer&title=Overexpression+of+the+prostaglandin+E2+receptor+EP2+results+in+enhanced+skin+tumor+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSung%26aufirst%3DY.%2BM.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHwang%26aufirst%3DD.%2BH.%26aulast%3DFischer%26aufirst%3DS.%2BM.%26atitle%3DOverexpression%2520of%2520the%2520prostaglandin%2520E2%2520receptor%2520EP2%2520results%2520in%2520enhanced%2520skin%2520tumor%2520development%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5507%26epage%3D5516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Tani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egashira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Development of a highly selective EP2-receptor agonist. Part 2: Identification of 16-hydroxy-17,17-trimethylene 9beta-chloro PGF derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=1107-1114&author=K.+Taniauthor=A.+Naganawaauthor=A.+Ishidaauthor=H.+Egashiraauthor=K.+Sagawaauthor=H.+Haradaauthor=M.+Ogawaauthor=T.+Maruyamaauthor=S.+Ohuchidaauthor=H.+Nakaiauthor=K.+Kondoauthor=M.+Toda&title=Development+of+a+highly+selective+EP2-receptor+agonist.+Part+2%3A+Identification+of+16-hydroxy-17%2C17-trimethylene+9beta-chloro+PGF+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTani%26aufirst%3DK.%26aulast%3DNaganawa%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DA.%26aulast%3DEgashira%26aufirst%3DH.%26aulast%3DSagawa%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520highly%2520selective%2520EP2-receptor%2520agonist.%2520Part%25202%253A%2520Identification%2520of%252016-hydroxy-17%252C17-trimethylene%25209beta-chloro%2520PGF%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D1107%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">The prostanoid EP(2) receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">616</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.ejphar.2009.04.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlant70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=616&publication_year=2009&pages=64-67&author=A.+Moriauthor=T.+Ishiiauthor=T.+Kurokiauthor=N.+Shigetaauthor=K.+Sakamotoauthor=T.+Nakaharaauthor=K.+Ishii&title=The+prostanoid+EP%282%29+receptor+agonist+ONO-AE1-259-01+protects+against+glutamate-induced+neurotoxicity+in+rat+retina"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The prostanoid EP2 receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina</span></div><div class="casAuthors">Mori, Asami; Ishii, Takayuki; Kuroki, Taiyo; Shigeta, Naoki; Sakamoto, Kenji; Nakahara, Tsutomu; Ishii, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">616</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">64-67</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prostaglandin E2 (PGE2) plays an important role in promoting inflammation and neurol. disorders.  The actions of PGE2 are mediated by four different G-protein-coupled receptors (EP1, EP2, EP3, and EP4).  The purpose of this study was to det. whether stimulation of prostanoid EP2 receptors has the potential to prevent the excitotoxic injuries in the retina.  For this purpose, we examd. the effect of 11,15-O-dimethyl prostaglandin E2 (ONO-AE1-259-01), a selective prostanoid EP2 receptor agonist, on N-methyl-D-aspartate (NMDA)-induced neurotoxicity in the rat retina.  ONO-AE1-259-01 (2 or 20 nmol) together with NMDA (200 nmol) was given intravitreally, and histol. evaluation was performed at 1 wk after the injection.  ONO-AE1-259-01 concn.-dependently prevented NMDA-induced cell loss in ganglion cell layer and redn. in thickness of inner plexiform layer.  These results indicate that ONO-AE1-259-01 protects the excitotoxic injuries in the rat retina, and that the prostanoid EP2 receptor may be a target for neuroprotective intervention in the retinal diseases assocd. with glutamate-induced excitotoxicity, such as glaucoma and diabetic retinopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAIBBrBH0PZLVg90H21EOLACvtfcHk0lh7fKgfNVO2Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlant70%253D&md5=565912dd747bc8504e0c7ec0b6db7996</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.04.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.04.051%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DA.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DKuroki%26aufirst%3DT.%26aulast%3DShigeta%26aufirst%3DN.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNakahara%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DThe%2520prostanoid%2520EP%25282%2529%2520receptor%2520agonist%2520ONO-AE1-259-01%2520protects%2520against%2520glutamate-induced%2520neurotoxicity%2520in%2520rat%2520retina%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D616%26spage%3D64%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">570</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.ejphar.2007.05.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Sjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2007&pages=135-141&author=A.+Moriauthor=M.+Saitoauthor=K.+Sakamotoauthor=M.+Naritaauthor=T.+Nakaharaauthor=K.+Ishii&title=Stimulation+of+prostanoid+IP+and+EP%282%29+receptors+dilates+retinal+arterioles+and+increases+retinal+and+choroidal+blood+flow+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of prostanoid IP and EP2 receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats</span></div><div class="casAuthors">Mori, Asami; Saito, Maki; Sakamoto, Kenji; Narita, Masami; Nakahara, Tsutomu; Ishii, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">135-141</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the effects of vasodilatory prostaglandins (prostacyclin and prostaglandin E2) and selective agonists for prostanoid EP2 and EP4 receptor on the diams. of retinal blood vessels and fundus (retinal/choroidal) blood flow in rats.  Male Wistar rats (8- to 10-wk-old) were treated with tetrodotoxin (50 μg/kg, i.v.) to eliminate any nerve activity and prevent movement of the eye and infused with a mixt. soln. of norepinephrine and epinephrine (1:9) to maintain adequate systemic circulation under artificial ventilation.  Fundus images were captured with a digital camera that was equipped with the special objective lens for small animals, and the diams. of retinal arterioles and venules were measured on a personal computer.  Fundus blood flow was estd. using a laser Doppler flowmetry.  I.v. infusions of prostacyclin and prostaglandin E2 dilated retinal blood vessels, increased fundus blood flow and decreased systemic blood pressure in a dose-dependent manner.  The effects of vasodilatory prostaglandins on retinal arterioles were greater than those on retinal venules.  Similarly, a prostanoid EP2 receptor agonist (ONO-AE1-259-01) dilated retinal blood vessels, and increased fundus blood flow and decreased systemic blood pressure.  However, a prostanoid EP4 receptor agonist (ONO-AE1-329) failed to increase fundus blood flow, despite its comparable depressor response with those to vasodilatory prostaglandins and the prostanoid EP2 receptor agonist.  The responses to forskolin, an activator of adenylyl cyclase, were very similar to those to prostacyclin and the prostanoid EP2 receptor agonist.  These results suggest that prostacyclin and prostaglandin E2 act as vasodilators in retinal and choroidal circulation, and prostanoid IP and EP2 receptors play an important role in the regulation of ocular hemodynamics in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3ecv4TYhZj7Vg90H21EOLACvtfcHk0lh7fKgfNVO2Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Sjsbs%253D&md5=597f83e4cdb74b38f7232ce8363294ba</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.05.052%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DA.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DNakahara%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DStimulation%2520of%2520prostanoid%2520IP%2520and%2520EP%25282%2529%2520receptors%2520dilates%2520retinal%2520arterioles%2520and%2520increases%2520retinal%2520and%2520choroidal%2520blood%2520flow%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D570%26spage%3D135%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borovecki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowchalk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vukicevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">An EP2 receptor-selective prostaglandin E2 agonist induces bone healing</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">6736</span><span class="NLM_x">–</span> <span class="NLM_lpage">6740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=6736-6740&author=V.+M.+Paralkarauthor=F.+Boroveckiauthor=H.+Z.+Keauthor=K.+O.+Cameronauthor=B.+Lefkerauthor=W.+A.+Grasserauthor=T.+A.+Owenauthor=M.+Liauthor=P.+DaSilva-Jardineauthor=M.+Zhouauthor=R.+L.+Dunnauthor=F.+Dumontauthor=R.+Korsmeyerauthor=P.+Krasneyauthor=T.+A.+Brownauthor=D.+Plowchalkauthor=S.+Vukicevicauthor=D.+D.+Thompson&title=An+EP2+receptor-selective+prostaglandin+E2+agonist+induces+bone+healing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DBorovecki%26aufirst%3DF.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DR.%2BL.%26aulast%3DDumont%26aufirst%3DF.%26aulast%3DKorsmeyer%26aufirst%3DR.%26aulast%3DKrasney%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DPlowchalk%26aufirst%3DD.%26aulast%3DVukicevic%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DAn%2520EP2%2520receptor-selective%2520prostaglandin%2520E2%2520agonist%2520induces%2520bone%2520healing%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D6736%26epage%3D6740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawistoski, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjoa, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2075</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2075-2078&author=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=H.+Z.+Keauthor=M.+Liauthor=M.+P.+Zawistoskiauthor=C.+M.+Tjoaauthor=A.+S.+Wrightauthor=S.+L.+DeNinnoauthor=V.+M.+Paralkarauthor=T.+A.+Owenauthor=L.+Yuauthor=D.+D.+Thompson&title=Discovery+of+CP-533536%3A+an+EP2+receptor+selective+prostaglandin+E2+%28PGE2%29+agonist+that+induces+local+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DTjoa%26aufirst%3DC.%2BM.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520of%2520CP-533536%253A%2520an%2520EP2%2520receptor%2520selective%2520prostaglandin%2520E2%2520%2528PGE2%2529%2520agonist%2520that%2520induces%2520local%2520bone%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2075%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing</span> <span class="citation_source-journal">J. Bone. Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1359%2Fjbmr.2003.18.11.2033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=14606517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVyiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=2033-2042&author=M.+Liauthor=H.+Z.+Keauthor=H.+Qiauthor=D.+R.+Healyauthor=Y.+Liauthor=D.+T.+Crawfordauthor=V.+M.+Paralkarauthor=T.+A.+Owenauthor=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=T.+A.+Brownauthor=D.+D.+Thompson&title=A+novel%2C+non-prostanoid+EP2+receptor-selective+prostaglandin+E2+agonist+stimulates+local+bone+formation+and+enhances+fracture+healing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing</span></div><div class="casAuthors">Li, Mei; Ke, Hua Zhu; Qi, Hong; Healy, David R.; Li, Yan; Crawford, D. Todd; Paralkar, Vishwas M.; Owen, Thomas A.; Cameron, Kimberly O.; Lefker, Bruce A.; Brown, Thomas A.; Thompson, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2033-2042</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">CP-533,536, a newly discovered, non-prostanoid EP2 receptor-selective PGE2 agonist, stimulates local bone formation and enhances fracture healing in rat models.  There is a significant medical need for agents that can stimulate local bone formation and enhance fracture healing.  The authors tested the effects of CP-533,536, a newly discovered, non-prostanoid EP2 receptor-selective PGE2 agonist, in stimulating local bone formation and enhancing fracture healing in rat models.  In the first model, a single injection of CP-533,536 at doses of 0.3, 1, or 3 mg/kg to the proximal tibial metaphysis of 6-wk-old male rats was given on day 1, and the local bone anabolic effect was detd. on day 7.  The authors then tested the effects of this compd. in inducing bone formation on rat periosteum of the femur.  A single dose of 0.3 mg of CP-533,536 incorporated in a poly-(DL-lactide-co-glycolide) (PLGH) matrix was injected onto the periosteum of the femur in 3-wk-old male rats, and local bone formation was detd. on day 14.  Finally, the ability of CP-533,536 in PLGH matrix in enhancing fracture healing was tested using the rat femoral fracture model.  CP-533,536 in PLGH matrix at doses of 0.05, 0.5, or 5 mg was delivered to the local fracture site on the same day of fracture, and its efficacy was evaluated on day 21.  A single injection of CP-533,536 at doses of 0.3, 1, or 3 mg/kg to the proximal tibial metaphysis dose-dependently stimulated local lamellar bone formation on trabecular, endocortical, and periosteal surfaces, and thus increased bone mineral content and bone strength at the injected site.  Similarly, a single injection of 0.3 mg of CP-533,536 incorporated in PLGH matrix onto the periosteum of the femur induced significantly local bone formation.  In the rat femoral fracture model, CP-533,536 in PLGH matrix at doses of 0.05, 0.5, and 5 mg dose-dependently increased callus size, d., and strength compared with PLGH matrix alone.  These results show that CP-533,536 stimulates new bone formation on trabecular, endocortical, and periosteal surfaces and enhances fracture healing.  These data reveal that EP2 receptor-selective agonists provide therapeutic potential for local bone augmentation, bone repair, and bone healing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eB8GOoJsErVg90H21EOLACvtfcHk0lgstwzuiolb4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVyiu7o%253D&md5=96d5d5fca5c87a121edda85af9cdbb9b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.11.2033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.11.2033%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DHealy%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DA%2520novel%252C%2520non-prostanoid%2520EP2%2520receptor-selective%2520prostaglandin%2520E2%2520agonist%2520stimulates%2520local%2520bone%2520formation%2520and%2520enhances%2520fracture%2520healing%26jtitle%3DJ.%2520Bone.%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26spage%3D2033%26epage%3D2042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Vukicevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simic, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borovecki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grgurevic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span> </span><span class="NLM_article-title">Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1099</span><span class="NLM_x">–</span> <span class="NLM_lpage">1106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fsj.ki.5001715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFCls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1099-1106&author=S.+Vukicevicauthor=P.+Simicauthor=F.+Boroveckiauthor=L.+Grgurevicauthor=D.+Rogicauthor=I.+Orlicauthor=W.+A.+Grasserauthor=D.+D.+Thompsonauthor=V.+M.+Paralkar&title=Role+of+EP2+and+EP4+receptor-selective+agonists+of+prostaglandin+E%282%29+in+acute+and+chronic+kidney+failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Role of EP2 and EP4 receptor-selective agonists of prostaglandin E2 in acute and chronic kidney failure</span></div><div class="casAuthors">Vukicevic, S.; Simic, P.; Borovecki, F.; Grgurevic, L.; Rogic, D.; Orlic, I.; Grasser, W. A.; Thompson, D. D.; Paralkar, V. M.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1099-1106</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the efficacy of three selective agonists of prostaglandin E2 (PGE2) receptor, EP2 (CP-536,745-01), EP2/4 (CP-043,305-02), and EP4 (CP-044,519-02), in two models of acute and chronic kidney failure.  In the nephrotoxic mercury chloride (HgCl2) rat model of acute kidney failure systemically administered EP4 agonist reduced the serum creatinine values and increased the survival rate.  Although the EP2 or the EP2/4 agonist did not change the serum creatinine values, the EP2 receptor agonist increased the survival rate.  Histol. evaluation of kidneys from EP4-treated rats indicated less proximal tubular necrosis and less apoptotic cells.  In a rat model of chronic renal failure, the three receptor agonists decreased the serum creatinine and increased the glomerular filtration rate at 9 wk following therapy.  Kidneys treated with the EP4 agonist had less glomerular sclerosis, better preservation of proximal and distal tubules and blood vessels, increased convoluted epithelium proliferation and less apoptotic cells.  Nephrectomy had no influence on the expression of the EP4 receptor, whereas EP2 receptor expression was reduced by 50% and then cor. following treatment with EP2 and EP2/4 receptor agonists.  These findings suggest that PGE2 has an important role in acute kidney failure via the EP4 receptor, whereas in chronic kidney failure both EP2 and EP4 receptors are equally important in preserving the progression of chronic kidney failure.  Thus, agonism of EP2 and EP4 receptors may provide a basis for treating acute and chronic kidney failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow1Qeud0xZmbVg90H21EOLACvtfcHk0lgstwzuiolb4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFCls74%253D&md5=3c479ea8cf38a60c112cd480108ec2ac</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fsj.ki.5001715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ki.5001715%26sid%3Dliteratum%253Aachs%26aulast%3DVukicevic%26aufirst%3DS.%26aulast%3DSimic%26aufirst%3DP.%26aulast%3DBorovecki%26aufirst%3DF.%26aulast%3DGrgurevic%26aufirst%3DL.%26aulast%3DRogic%26aufirst%3DD.%26aulast%3DOrlic%26aufirst%3DI.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26atitle%3DRole%2520of%2520EP2%2520and%2520EP4%2520receptor-selective%2520agonists%2520of%2520prostaglandin%2520E%25282%2529%2520in%2520acute%2520and%2520chronic%2520kidney%2520failure%26jtitle%3DKidney%2520Int.%26date%3D2006%26volume%3D70%26spage%3D1099%26epage%3D1106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Houchen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturmoski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenson, W. F.</span><span> </span><span class="NLM_article-title">Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine</span> <span class="citation_source-journal">Am. J. Physiol.: Gastrointest. Liver Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">G490</span><span class="NLM_x">–</span> <span class="NLM_lpage">G498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=G490-G498&author=C.+W.+Houchenauthor=M.+A.+Sturmoskiauthor=S.+Anantauthor=R.+M.+Breyerauthor=W.+F.+Stenson&title=Prosurvival+and+antiapoptotic+effects+of+PGE2+in+radiation+injury+are+mediated+by+EP2+receptor+in+intestine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHouchen%26aufirst%3DC.%2BW.%26aulast%3DSturmoski%26aufirst%3DM.%2BA.%26aulast%3DAnant%26aufirst%3DS.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DStenson%26aufirst%3DW.%2BF.%26atitle%3DProsurvival%2520and%2520antiapoptotic%2520effects%2520of%2520PGE2%2520in%2520radiation%2520injury%2520are%2520mediated%2520by%2520EP2%2520receptor%2520in%2520intestine%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2003%26volume%3D284%26spage%3DG490%26epage%3DG498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Sheibanie, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadmori, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassiliou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganea, D.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1318</span><span class="NLM_x">–</span> <span class="NLM_lpage">1320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1318-1320&author=A.+F.+Sheibanieauthor=I.+Tadmoriauthor=H.+Jingauthor=E.+Vassiliouauthor=D.+Ganea&title=Prostaglandin+E2+induces+IL-23+production+in+bone+marrow-derived+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheibanie%26aufirst%3DA.%2BF.%26aulast%3DTadmori%26aufirst%3DI.%26aulast%3DJing%26aufirst%3DH.%26aulast%3DVassiliou%26aufirst%3DE.%26aulast%3DGanea%26aufirst%3DD.%26atitle%3DProstaglandin%2520E2%2520induces%2520IL-23%2520production%2520in%2520bone%2520marrow-derived%2520dendritic%2520cells%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1318%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segi-Nishida, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyachi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=325-335&author=T.+Hondaauthor=E.+Segi-Nishidaauthor=Y.+Miyachiauthor=S.+Narumiya&title=Prostacyclin-IP+signaling+and+prostaglandin+E2-EP2%2FEP4+signaling+both+mediate+joint+inflammation+in+mouse+collagen-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DSegi-Nishida%26aufirst%3DE.%26aulast%3DMiyachi%26aufirst%3DY.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstacyclin-IP%2520signaling%2520and%2520prostaglandin%2520E2-EP2%252FEP4%2520signaling%2520both%2520mediate%2520joint%2520inflammation%2520in%2520mouse%2520collagen-induced%2520arthritis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D325%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Kabashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagamachi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishigori, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyachi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2007&pages=49-55&author=K.+Kabashimaauthor=M.+Nagamachiauthor=T.+Hondaauthor=C.+Nishigoriauthor=Y.+Miyachiauthor=Y.+Tokuraauthor=S.+Narumiya&title=Prostaglandin+E2+is+required+for+ultraviolet+B-induced+skin+inflammation+via+EP2+and+EP4+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKabashima%26aufirst%3DK.%26aulast%3DNagamachi%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DNishigori%26aufirst%3DC.%26aulast%3DMiyachi%26aufirst%3DY.%26aulast%3DTokura%26aufirst%3DY.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstaglandin%2520E2%2520is%2520required%2520for%2520ultraviolet%2520B-induced%2520skin%2520inflammation%2520via%2520EP2%2520and%2520EP4%2520receptors%26jtitle%3DLab.%2520Invest.%26date%3D2007%26volume%3D87%26spage%3D49%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Donnini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzuoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morbidelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrignani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziche, M.</span><span> </span><span class="NLM_article-title">EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2418</span><span class="NLM_x">–</span> <span class="NLM_lpage">2430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2418-2430&author=S.+Donniniauthor=F.+Finettiauthor=R.+Solitoauthor=E.+Terzuoliauthor=A.+Sacchettiauthor=L.+Morbidelliauthor=P.+Patrignaniauthor=M.+Ziche&title=EP2+prostanoid+receptor+promotes+squamous+cell+carcinoma+growth+through+epidermal+growth+factor+receptor+transactivation+and+iNOS+and+ERK1%2F2+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonnini%26aufirst%3DS.%26aulast%3DFinetti%26aufirst%3DF.%26aulast%3DSolito%26aufirst%3DR.%26aulast%3DTerzuoli%26aufirst%3DE.%26aulast%3DSacchetti%26aufirst%3DA.%26aulast%3DMorbidelli%26aufirst%3DL.%26aulast%3DPatrignani%26aufirst%3DP.%26aulast%3DZiche%26aufirst%3DM.%26atitle%3DEP2%2520prostanoid%2520receptor%2520promotes%2520squamous%2520cell%2520carcinoma%2520growth%2520through%2520epidermal%2520growth%2520factor%2520receptor%2520transactivation%2520and%2520iNOS%2520and%2520ERK1%252F2%2520pathways%26jtitle%3DFASEB%2520J.%26date%3D2007%26volume%3D21%26spage%3D2418%26epage%3D2430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Kamiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBusk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. C.</span><span> </span><span class="NLM_article-title">EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7019</span><span class="NLM_x">–</span> <span class="NLM_lpage">7028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=7019-7028&author=M.+Kamiyamaauthor=A.+Pozziauthor=L.+Yangauthor=L.+M.+DeBuskauthor=R.+M.+Breyerauthor=P.+C.+Lin&title=EP2%2C+a+receptor+for+PGE2%2C+regulates+tumor+angiogenesis+through+direct+effects+on+endothelial+cell+motility+and+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamiyama%26aufirst%3DM.%26aulast%3DPozzi%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDeBusk%26aufirst%3DL.%2BM.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DLin%26aufirst%3DP.%2BC.%26atitle%3DEP2%252C%2520a%2520receptor%2520for%2520PGE2%252C%2520regulates%2520tumor%2520angiogenesis%2520through%2520direct%2520effects%2520on%2520endothelial%2520cell%2520motility%2520and%2520survival%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D7019%26epage%3D7028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Brouxhon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konger, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanBuskirk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheu, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almudevar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentland, A. P.</span><span> </span><span class="NLM_article-title">Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2007&pages=439-446&author=S.+Brouxhonauthor=R.+L.+Kongerauthor=J.+VanBuskirkauthor=T.+J.+Sheuauthor=J.+Ryanauthor=B.+Erdleauthor=A.+Almudevarauthor=R.+M.+Breyerauthor=G.+Scottauthor=A.+P.+Pentland&title=Deletion+of+prostaglandin+E2+EP2+receptor+protects+against+ultraviolet-induced+carcinogenesis%2C+but+increases+tumor+aggressiveness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrouxhon%26aufirst%3DS.%26aulast%3DKonger%26aufirst%3DR.%2BL.%26aulast%3DVanBuskirk%26aufirst%3DJ.%26aulast%3DSheu%26aufirst%3DT.%2BJ.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DErdle%26aufirst%3DB.%26aulast%3DAlmudevar%26aufirst%3DA.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DScott%26aufirst%3DG.%26aulast%3DPentland%26aufirst%3DA.%2BP.%26atitle%3DDeletion%2520of%2520prostaglandin%2520E2%2520EP2%2520receptor%2520protects%2520against%2520ultraviolet-induced%2520carcinogenesis%252C%2520but%2520increases%2520tumor%2520aggressiveness%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2007%26volume%3D127%26spage%3D439%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">O’Collins, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macleod, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horky, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Worp, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howells, D. W.</span><span> </span><span class="NLM_article-title">1,026 experimental treatments in acute stroke</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2Fana.20741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=16453316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtV2lsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2006&pages=467-477&author=V.+E.+O%E2%80%99Collinsauthor=M.+R.+Macleodauthor=G.+A.+Donnanauthor=L.+L.+Horkyauthor=B.+H.+van+der+Worpauthor=D.+W.+Howells&title=1%2C026+experimental+treatments+in+acute+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">1,026 Experimental treatments in acute stroke</span></div><div class="casAuthors">O'Collins, Victoria E.; Macleod, Malcolm R.; Donnan, Geoffrey A.; Horky, Laura L.; van der Worp, Bart H.; Howells, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">467-477</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: Preclin. evaluation of neuroprotectants fostered high expectations of clin. efficacy.  When not matched, the question arises whether expts. are poor indicators of clin. outcome or whether the best drugs were not taken forward to clin. trial.  Therefore, we endeavored to contrast exptl. efficacy and scope of testing of drugs used clin. and those tested only exptl.  Methods: We identified neuroprotectants and reports of exptl. efficacy via a systematic search.  Controlled in vivo and in vitro expts. using functional or histol. end points were selected for anal.  Relationships between outcome, drug mechanism, scope of testing, and clin. trial status were assessed statistically.  Results: There was no evidence that drugs used clin. (114 drugs) were more effective exptl. than those tested only in animal models (912 drugs), for example, improvement in focal models averaged 31.3±16.7% vs. 24.4±32.9%, p > 0.05, resp.  Scope of testing using Stroke Therapy Academic Industry Roundtable (STAIR) criteria was highly variable, and no relationship was found between mechanism and efficacy.  Interpretation: The results question whether the most efficacious drugs are being selected for stroke clin. trials.  This may partially explain the slow progress in developing treatments.  Greater rigor in the conduct, reporting, and anal. of animal data will improve the transition of scientific advances from bench to bedside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN7GktDgpOvLVg90H21EOLACvtfcHk0lgeUHRjODlh4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtV2lsbc%253D&md5=2d8c1160718bc20d152f7ca03eb1680b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fana.20741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20741%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Collins%26aufirst%3DV.%2BE.%26aulast%3DMacleod%26aufirst%3DM.%2BR.%26aulast%3DDonnan%26aufirst%3DG.%2BA.%26aulast%3DHorky%26aufirst%3DL.%2BL.%26aulast%3Dvan%2Bder%2BWorp%26aufirst%3DB.%2BH.%26aulast%3DHowells%26aufirst%3DD.%2BW.%26atitle%3D1%252C026%2520experimental%2520treatments%2520in%2520acute%2520stroke%26jtitle%3DAnn.%2520Neurol.%26date%3D2006%26volume%3D59%26spage%3D467%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2Fana.20461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=15852374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=758-761&author=D.+Liuauthor=L.+Wuauthor=R.+Breyerauthor=M.+P.+Mattsonauthor=K.+Andreasson&title=Neuroprotection+by+the+PGE2+EP2+receptor+in+permanent+focal+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia</span></div><div class="casAuthors">Liu, Dong; Wu, Liejun; Breyer, Richard; Mattson, Mark P.; Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">758-761</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Recent studies suggest a neuroprotective function of the PGE2 EP2 receptor in excitotoxic neuronal injury.  The function of the EP2 receptor was examd. at time points after excitotoxicity in an organotypic hippocampal model of N-methyl-D-aspartate (NMDA) challenge and in a permanent model of focal forebrain ischemia.  Activation of EP2 led to significant neuroprotection in hippocampal slices up to 3 h after a toxic NMDA stimulus.  Genetic deletion of EP2 resulted in a marked increase in stroke vol. in the permanent middle cerebral artery occlusion model.  These findings support further investigation into therapeutic strategies targeting the EP2 receptor in stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKGL6k6wt8bLVg90H21EOLACvtfcHk0lgeUHRjODlh4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFykt7c%253D&md5=d594ba060dc7701de82b460887d13d76</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fana.20461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20461%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DBreyer%26aufirst%3DR.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DNeuroprotection%2520by%2520the%2520PGE2%2520EP2%2520receptor%2520in%2520permanent%2520focal%2520cerebral%2520ischemia%26jtitle%3DAnn.%2520Neurol.%26date%3D2005%26volume%3D57%26spage%3D758%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Ahmad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, S.</span><span> </span><span class="NLM_article-title">The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke</span> <span class="citation_source-journal">Exp. Transl. Stroke Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1186%2F2040-7378-2-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=20615245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3cjht1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=12&author=M.+Ahmadauthor=S.+Saleemauthor=Z.+Shahauthor=T.+Maruyamaauthor=S.+Narumiyaauthor=S.+Dore&title=The+PGE2+EP2+receptor+and+its+selective+activation+are+beneficial+against+ischemic+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke</span></div><div class="casAuthors">Ahmad Muzamil; Saleem Sofiyan; Shah Zahoor; Dore Sylvain; Maruyama Takayuki; Narumiya Shuh; Dore Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & translational stroke medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The prostaglandin E2 EP2 receptor has been shown to be important in dictating outcomes in various neuroinflammatory disorders.  Here, we investigated the importance of the EP2 receptor in short- and long-term ischemic outcomes by subjecting wildtype (WT) and EP2 knockout (EP2-/-) mice to two distinct and complementary stroke models [transient and permanent middle cerebral artery occlusion (tMCAO and pMCAO)] and by using the EP2 receptor agonist ONO-AE1-259-01.  METHODS:  First, WT and EP2-/- mice were subjected to 90-min tMCAO with a monofilament followed by 4-day reperfusion.  Second, WT mice were infused intracerebroventricularly with vehicle or ONO-AE1-259-01 45-50 min before being subjected to tMCAO.  Finally, WT and EP2-/- mice were subjected to pMCAO and allowed to survive for an extended period of 7 days.  RESULTS:  Infarct volumes in EP2-/- mice were 55.0 +/- 9.1% larger after tMCAO and 33.3 +/- 8.6% larger after pMCAO than those in WT mice.  Neurobehavioral deficits also were significantly greater in the EP2-/- mice.  These results suggest that EP2 is beneficial and that activation is sustained for days after the stroke.  We also found that pharmacologic activation of EP2 with 1.0- and 2.0-nmol doses of ONO-AE1-259-01 was sufficient to significantly reduce the infarct volume in WT mice compared with that in vehicle-treated controls (20.1 +/- 3.9% vs. 37.1 +/- 4.6%).  This reduction correlated with improved neurologic scores.  No significant effect on physiologic parameters was observed.  CONCLUSION:  Together, our results reveal that pharmacologic stimulation of the EP2 receptor has an important beneficial role in cerebral ischemia and might be considered as an adjunct therapy for ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbF-gw_YCjbd0Q2ypr7jHkfW6udTcc2eZiMNMlyTYNubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjht1ehug%253D%253D&md5=bcc5ef44b697b99fd37b9ac94cd0a812</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1186%2F2040-7378-2-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2040-7378-2-12%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DM.%26aulast%3DSaleem%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DZ.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DNarumiya%26aufirst%3DS.%26aulast%3DDore%26aufirst%3DS.%26atitle%3DThe%2520PGE2%2520EP2%2520receptor%2520and%2520its%2520selective%2520activation%2520are%2520beneficial%2520against%2520ischemic%2520stroke%26jtitle%3DExp.%2520Transl.%2520Stroke%2520Med.%26date%3D2010%26volume%3D2%26spage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Serrano, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelutiu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makinson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FitzGerald, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">14850</span><span class="NLM_x">–</span> <span class="NLM_lpage">14860</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1523%2FJNEUROSCI.3922-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=22016518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSjurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=14850-14860&author=G.+E.+Serranoauthor=N.+Lelutiuauthor=A.+Rojasauthor=S.+Cochiauthor=R.+Shawauthor=C.+D.+Makinsonauthor=D.+Wangauthor=G.+A.+FitzGeraldauthor=R.+Dingledine&title=Ablation+of+cyclooxygenase-2+in+forebrain+neurons+is+neuroprotective+and+dampens+brain+inflammation+after+status+epilepticus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus</span></div><div class="casAuthors">Serrano, G. E.; Lelutiu, N.; Rojas, A.; Cochi, S.; Shaw, R.; Makinson, C. D.; Wang, D.; FitzGerald, G. A.; Dingledine, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14850-14860</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Cyclooxygenase-2 (COX-2), a source of inflammatory mediators and a multifunctional neuronal modulator, is rapidly induced in select populations of cortical neurons after status epilepticus.  The consequences of rapid activity-triggered induction of COX-2 in neurons were the subject of much study and speculation.  To address this issue directly, the authors created a mouse in which COX-2 is conditionally ablated in selected forebrain neurons.  Results following pilocarpine-induced status epilepticus indicate that neuronal COX-2 promotes early neuroprotection and then delayed neurodegeneration of CA1 pyramidal neurons, promotes neurodegeneration of nearby somatostatin interneurons in the CA1 stratum oriens and dentate hilus (which themselves do not express COX-2), intensifies a broad inflammatory reaction involving numerous cytokines and other inflammatory mediators in the hippocampus, and is essential for development of a leaky blood-brain barrier after seizures.  These findings point to a profound role of seizure-induced neuronal COX-2 expression in neuropathologies that accompany epileptogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFmygqaE45J7Vg90H21EOLACvtfcHk0lgeUHRjODlh4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSjurvP&md5=4af8906db3d911f843b16f0e85d0337c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3922-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3922-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano%26aufirst%3DG.%2BE.%26aulast%3DLelutiu%26aufirst%3DN.%26aulast%3DRojas%26aufirst%3DA.%26aulast%3DCochi%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DR.%26aulast%3DMakinson%26aufirst%3DC.%2BD.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DAblation%2520of%2520cyclooxygenase-2%2520in%2520forebrain%2520neurons%2520is%2520neuroprotective%2520and%2520dampens%2520brain%2520inflammation%2520after%2520status%2520epilepticus%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D14850%26epage%3D14860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Tani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egashira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a highly selective EP2-receptor agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2025</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=2025-2028&author=K.+Taniauthor=A.+Naganawaauthor=A.+Ishidaauthor=H.+Egashiraauthor=K.+Sagawaauthor=H.+Haradaauthor=M.+Ogawaauthor=T.+Maruyamaauthor=S.+Ohuchidaauthor=H.+Nakaiauthor=K.+Kondoauthor=M.+Toda&title=Design+and+synthesis+of+a+highly+selective+EP2-receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTani%26aufirst%3DK.%26aulast%3DNaganawa%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DA.%26aulast%3DEgashira%26aufirst%3DH.%26aulast%3DSagawa%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520highly%2520selective%2520EP2-receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D2025%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Lohse, M. J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of membrane receptor desensitization</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">1179</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1179&publication_year=1993&pages=171-188&author=M.+J.+Lohse&title=Molecular+mechanisms+of+membrane+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26atitle%3DMolecular%2520mechanisms%2520of%2520membrane%2520receptor%2520desensitization%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1993%26volume%3D1179%26spage%3D171%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Nishigaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, A.</span><span> </span><span class="NLM_article-title">Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=1031-1037&author=N.+Nishigakiauthor=M.+Negishiauthor=A.+Ichikawa&title=Two+Gs-coupled+prostaglandin+E+receptor+subtypes%2C+EP2+and+EP4%2C+differ+in+desensitization+and+sensitivity+to+the+metabolic+inactivation+of+the+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNishigaki%26aufirst%3DN.%26aulast%3DNegishi%26aufirst%3DM.%26aulast%3DIchikawa%26aufirst%3DA.%26atitle%3DTwo%2520Gs-coupled%2520prostaglandin%2520E%2520receptor%2520subtypes%252C%2520EP2%2520and%2520EP4%252C%2520differ%2520in%2520desensitization%2520and%2520sensitivity%2520to%2520the%2520metabolic%2520inactivation%2520of%2520the%2520agonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D1996%26volume%3D50%26spage%3D1031%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Su, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, J. P.</span><span> </span><span class="NLM_article-title">Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">7410</span><span class="NLM_x">–</span> <span class="NLM_lpage">7419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=7410-7419&author=Y.+F.+Suauthor=T.+K.+Hardenauthor=J.+P.+Perkins&title=Catecholamine-specific+desensitization+of+adenylate+cyclase.+Evidence+for+a+multistep+process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DY.%2BF.%26aulast%3DHarden%26aufirst%3DT.%2BK.%26aulast%3DPerkins%26aufirst%3DJ.%2BP.%26atitle%3DCatecholamine-specific%2520desensitization%2520of%2520adenylate%2520cyclase.%2520Evidence%2520for%2520a%2520multistep%2520process%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D7410%26epage%3D7419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Desai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">April, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nwaneshiudu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, B.</span><span> </span><span class="NLM_article-title">Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1279-1286&author=S.+Desaiauthor=H.+Aprilauthor=C.+Nwaneshiuduauthor=B.+Ashby&title=Comparison+of+agonist-induced+internalization+of+the+human+EP2+and+EP4+prostaglandin+receptors%3A+role+of+the+carboxyl+terminus+in+EP4+receptor+sequestration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DApril%26aufirst%3DH.%26aulast%3DNwaneshiudu%26aufirst%3DC.%26aulast%3DAshby%26aufirst%3DB.%26atitle%3DComparison%2520of%2520agonist-induced%2520internalization%2520of%2520the%2520human%2520EP2%2520and%2520EP4%2520prostaglandin%2520receptors%253A%2520role%2520of%2520the%2520carboxyl%2520terminus%2520in%2520EP4%2520receptor%2520sequestration%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1279%26epage%3D1286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Schwenn, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. J.</span><span> </span><span class="NLM_article-title">Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study</span> <span class="citation_source-journal">BMC Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1186%2F1471-2415-10-21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3cfkvFartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=21&author=O.+Schwennauthor=B.+Heckmannauthor=C.+Guzyauthor=P.+J.+Miller&title=Long-term+effect+of+latanoprost%2Ftimolol+fixed+combination+in+patients+with+glaucoma+or+ocular+hypertension%3A+a+prospective%2C+observational%2C+noninterventional+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study</span></div><div class="casAuthors">Schwenn Oliver; Heckmann Barbara; Guzy Claudia; Miller Paul J</div><div class="citationInfo"><span class="NLM_cas:title">BMC ophthalmology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Prospective, observational studies that enroll large numbers of patients with few exclusion criteria may better reflect actual ongoing clinical experience than randomized clinical trials.  Our purpose was to obtain efficacy and safety information from a cohort of subjects exposed to latanoprost/timolol fixed combination (FC) for ≥18 months using a prospective, observational design.  METHODS:  In all, 577 office-based ophthalmologists in Germany switched 2339 patients with glaucoma or ocular hypertension to latanoprost/timolol FC for medical reasons.  Follow-up visits were scheduled for every 6 months over 24 months; physicians followed usual care routines.  Intraocular pressure (IOP), visual field status, optic nerve head findings, and adverse events were recorded.  Efficacy parameters were evaluated for the per protocol (PP) population; the safety population included subjects receiving ≥1 drop of FC.  Physicians rated efficacy, tolerability, and subject compliance at month 24.  RESULTS:  Of the 2339 subjects switched to latanoprost/timolol FC (safety population), the primary reasons for switching were inadequate IOP reduction (78.2%) and desire to simplify treatment with once-daily dosing (29.4%; multiple reasons possible).  In all, 1317 (56.3%) subjects completed the study, and 1028 (44.0%) were included in the PP population.  Most discontinuations were due to loss to follow-up.  Change in mean IOP from baseline to month 6 was -4.0 ± 4.31 mmHg, a reduction that was maintained throughout (P < 0.05 for change at all time points).  By investigator assessments, optic disc parameters and visual field were stable over 24 months, and there was no relationship between IOP reduction over 24 months and development of a visual field defect.  More than 90% of physicians rated latanoprost/timolol FC as "very good" or "good" for efficacy (PP population), tolerability, and compliance.  The FC was safe and well tolerated.  No change in iris color was reported by most subjects (83.1%) at month 24.  CONCLUSIONS:  Over 24 months, latanoprost/timolol FC effectively lowers IOP levels and is well tolerated in patients with glaucoma or ocular hypertension who change from their previous ocular hypotensive therapy for medical reasons.  Investigator assessments found optic disc parameters and visual field to be stable throughout 24 months of follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQC23SCD_Mi60Gy1nwu7K2mfW6udTcc2ebvjf_ctX_-Crntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfkvFartw%253D%253D&md5=a2eaa27cc0a1ba93df41aacfaa00ca5d</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1186%2F1471-2415-10-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2415-10-21%26sid%3Dliteratum%253Aachs%26aulast%3DSchwenn%26aufirst%3DO.%26aulast%3DHeckmann%26aufirst%3DB.%26aulast%3DGuzy%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DP.%2BJ.%26atitle%3DLong-term%2520effect%2520of%2520latanoprost%252Ftimolol%2520fixed%2520combination%2520in%2520patients%2520with%2520glaucoma%2520or%2520ocular%2520hypertension%253A%2520a%2520prospective%252C%2520observational%252C%2520noninterventional%2520study%26jtitle%3DBMC%2520Ophthalmol.%26date%3D2010%26volume%3D10%26spage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Susanna, R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giampani, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vessani, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordao, M. L.</span><span> </span><span class="NLM_article-title">A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension</span> <span class="citation_source-journal">Ophthalmology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=259-263&author=R.+Susannaauthor=J.+Giampaniauthor=A.+S.+Borgesauthor=R.+M.+Vessaniauthor=M.+L.+Jordao&title=A+double-masked%2C+randomized+clinical+trial+comparing+latanoprost+with+unoprostone+in+patients+with+open-angle+glaucoma+or+ocular+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSusanna%26aufirst%3DR.%26aulast%3DGiampani%26aufirst%3DJ.%26aulast%3DBorges%26aufirst%3DA.%2BS.%26aulast%3DVessani%26aufirst%3DR.%2BM.%26aulast%3DJordao%26aufirst%3DM.%2BL.%26atitle%3DA%2520double-masked%252C%2520randomized%2520clinical%2520trial%2520comparing%2520latanoprost%2520with%2520unoprostone%2520in%2520patients%2520with%2520open-angle%2520glaucoma%2520or%2520ocular%2520hypertension%26jtitle%3DOphthalmology%26date%3D2001%26volume%3D108%26spage%3D259%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Prasanna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gukasyan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartnurak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almaden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafontaine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, A.</span><span> </span><span class="NLM_article-title">Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.exer.2011.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21376717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2hurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=256-264&author=G.+Prasannaauthor=S.+Carreiroauthor=S.+Andersonauthor=H.+Gukasyanauthor=S.+Sartnurakauthor=H.+Younisauthor=D.+Galeauthor=C.+Xiangauthor=P.+Wellsauthor=D.+Dinhauthor=C.+Almadenauthor=J.+Fortnerauthor=C.+Torisauthor=M.+Niesmanauthor=J.+Lafontaineauthor=A.+Krauss&title=Effect+of+PF-04217329+a+prodrug+of+a+selective+prostaglandin+EP%282%29+agonist+on+intraocular+pressure+in+preclinical+models+of+glaucoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of PF-04217329 a prodrug of a selective prostaglandin EP2 agonist on intraocular pressure in preclinical models of glaucoma</span></div><div class="casAuthors">Prasanna, Ganesh; Carreiro, Samantha; Anderson, Scott; Gukasyan, Hovhannes; Sartnurak, Soisurin; Younis, Husam; Gale, David; Xiang, Cathie; Wells, Peter; Dinh, Dac; Almaden, Chau; Fortner, Jay; Toris, Carol; Niesman, Michael; Lafontaine, Jennifer; Krauss, Achim</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">256-264</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Better control of intraocular pressure (IOP) is the most effective way to preserve visual field function in glaucomatous patients.  While prostaglandin FP analogs are leading the therapeutic intervention for glaucoma, new target classes also are being identified with new lead compds. being developed for IOP redn.  One target class currently being investigated includes the prostaglandin EP receptor agonists.  Recently PF-04217329 (Taprenepag isopropyl), a prodrug of CP-544326 (active acid metabolite), a potent and selective EP2 receptor agonist, was successfully evaluated for its ocular hypotensive activity in a clin. study involving patients with primary open angle glaucoma.  In the current manuscript, the preclin. attributes of CP-544326 and PF-0421329 have been described.  CP-544326 was found to be a potent and selective EP2 agonist (IC50 = 10 nM; EC50 = 2.8 nM) whose corneal permeability and ocular bioavailability were significantly increased when the compd. was dosed as the iso-Pr ester prodrug, PF-04217329.  Topical ocular dosing of PF-04217329 was well tolerated in preclin. species and caused an elevation of cAMP in aq. humor/iris-ciliary body indicative of in vivo EP2 target receptor activation.  Topical ocular dosing of PF-04217329 resulted in ocular exposure of CP-544326 at levels greater than the EC50 for the EP2 receptor.  PF-04217329 when dosed once daily caused between 30 and 50% IOP redn. in single day studies in normotensive Dutch-belted rabbits, normotensive dogs, and laser-induced ocular hypertensive cynomolgus monkeys and 20-40% IOP redn. in multiple day studies compared to vehicle-dosed eyes.  IOP redn. was sustained from 6 h through 24 h following a single topical dose.  In conclusion, preclin. data generated thus far appear to support the clin. development of PF-04217329 as a novel compd. for the treatment of glaucoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnGiw3YxQVbVg90H21EOLACvtfcHk0lgfzCL8qLK_8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2hurrN&md5=bd2bcd1b2a850c3d57a103f986958cfe</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2011.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2011.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DPrasanna%26aufirst%3DG.%26aulast%3DCarreiro%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DGukasyan%26aufirst%3DH.%26aulast%3DSartnurak%26aufirst%3DS.%26aulast%3DYounis%26aufirst%3DH.%26aulast%3DGale%26aufirst%3DD.%26aulast%3DXiang%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DFortner%26aufirst%3DJ.%26aulast%3DToris%26aufirst%3DC.%26aulast%3DNiesman%26aufirst%3DM.%26aulast%3DLafontaine%26aufirst%3DJ.%26aulast%3DKrauss%26aufirst%3DA.%26atitle%3DEffect%2520of%2520PF-04217329%2520a%2520prodrug%2520of%2520a%2520selective%2520prostaglandin%2520EP%25282%2529%2520agonist%2520on%2520intraocular%2520pressure%2520in%2520preclinical%2520models%2520of%2520glaucoma%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2011%26volume%3D93%26spage%3D256%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Schachar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span> </span><span class="NLM_article-title">A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension</span> <span class="citation_source-journal">Curr. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">817</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.3109%2F02713683.2011.593725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVCqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=809-817&author=R.+A.+Schacharauthor=S.+Raberauthor=R.+Courtneyauthor=M.+Zhang&title=A+phase+2%2C+randomized%2C+dose-response+trial+of+taprenepag+isopropyl+%28PF-04217329%29+versus+latanoprost+0.005%25+in+open-angle+glaucoma+and+ocular+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension</span></div><div class="casAuthors">Schachar, Ronald A.; Raber, Susan; Courtney, Rachel; Zhang, Min</div><div class="citationInfo"><span class="NLM_cas:title">Current Eye Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">809-817</span>CODEN:
                <span class="NLM_cas:coden">CEYRDM</span>;
        ISSN:<span class="NLM_cas:issn">0271-3683</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Purpose: To evaluate the safety of escalating doses of taprenepag iso-Pr (PF-04217329), a selective EP2 receptor agonist administered as a topical ophthalmic soln., vs. its vehicle (Stage I), and dose-response of taprenepag iso-Pr alone and in unfixed combination with latanoprost ophthalmic soln. 0.005% vs. latanoprost alone (Stage II).  Subjects and Methods: Randomized, vehicle- and active-controlled, double-masked, two-stage, dose-finding trial in primary open-angle glaucoma (POAG) or ocular hypertension; first taprenepag iso-Pr study in patients (NCT00572455).  Study eye: 26 mmHg ≤ intraocular pressure (IOP) <36 mmHg at 8 am and 22 mmHg ≤ IOP <36 mmHg at 10 am, 1 pm, 4 pm.  Stage I: 3 cohorts (total n = 67) received 1 drop of taprenepag iso-Pr unit dose formulation qPM/eye for 14 days: low dose: 0.0025%, 0.005%, vehicle; middle dose: 0.01%, 0.015%, vehicle; high dose: 0.02%, 0.03%, vehicle.  Stage II: 7 groups (total n = 250) received 1 drop of taprenepag iso-Pr multidose formulation qPM/eye for 28 days: 0.005%, 0.01%, 0.015% monotherapy; each in unfixed combination with latanoprost 0.005%, or latanoprost monotherapy.  Main outcomes: mean change in diurnal IOP, baseline to last visit; adverse events.  Results: Stage I at Day 14: statistically significantly greater IOP redns. were obsd. at all taprenepag iso-Pr doses vs. vehicle.  Stage II at Day 28: statistically significantly greater IOP redns. were obsd. at all doses of the unfixed combination vs. latanoprost monotherapy.  At least 1 treatment-emergent adverse event reported for 29/67 (43.3%) subjects in Stage I and 158/250 (63.2%) in Stage II.  Conclusions: Taprenepag iso-Pr significantly reduces IOP in POAG and ocular hypertension.  Taprenepag iso-Pr monotherapy is comparable to latanoprost 0.005% in reducing IOP.  As demonstrated in this report, the activity of taprenepag iso-Pr is additive to that of latanoprost 0.005%.  Further studies are required to det. whether it shows similar additivity when administered with other ocular antihypertensive medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_8ZfLz9vtebVg90H21EOLACvtfcHk0lgfzCL8qLK_8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVCqsL%252FO&md5=7e017ad68ed97d4dfd12223c39ca2691</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3109%2F02713683.2011.593725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F02713683.2011.593725%26sid%3Dliteratum%253Aachs%26aulast%3DSchachar%26aufirst%3DR.%2BA.%26aulast%3DRaber%26aufirst%3DS.%26aulast%3DCourtney%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DA%2520phase%25202%252C%2520randomized%252C%2520dose-response%2520trial%2520of%2520taprenepag%2520isopropyl%2520%2528PF-04217329%2529%2520versus%2520latanoprost%25200.005%2525%2520in%2520open-angle%2520glaucoma%2520and%2520ocular%2520hypertension%26jtitle%3DCurr.%2520Eye%2520Res.%26date%3D2011%26volume%3D36%26spage%3D809%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Schachar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczotka-Flynn, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lass, J. H.</span><span> </span><span class="NLM_article-title">Subclinical increased anterior stromal reflectivity with topical taprenepag isopropyl</span> <span class="citation_source-journal">Cornea</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=306-312&author=R.+A.+Schacharauthor=S.+Raberauthor=K.+V.+Thomasauthor=B.+A.+Benetzauthor=L.+B.+Szczotka-Flynnauthor=M.+Zhangauthor=S.+J.+Howellauthor=J.+H.+Lass&title=Subclinical+increased+anterior+stromal+reflectivity+with+topical+taprenepag+isopropyl"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchachar%26aufirst%3DR.%2BA.%26aulast%3DRaber%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DK.%2BV.%26aulast%3DBenetz%26aufirst%3DB.%2BA.%26aulast%3DSzczotka-Flynn%26aufirst%3DL.%2BB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHowell%26aufirst%3DS.%2BJ.%26aulast%3DLass%26aufirst%3DJ.%2BH.%26atitle%3DSubclinical%2520increased%2520anterior%2520stromal%2520reflectivity%2520with%2520topical%2520taprenepag%2520isopropyl%26jtitle%3DCornea%26date%3D2013%26volume%3D32%26spage%3D306%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speigel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelutiu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">3149</span><span class="NLM_x">–</span> <span class="NLM_lpage">3154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1073%2Fpnas.1120195109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=22323596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=3149-3154&author=J.+Jiangauthor=T.+Ganeshauthor=Y.+Duauthor=Y.+Quanauthor=G.+Serranoauthor=M.+Quiauthor=I.+Speigelauthor=A.+Rojasauthor=N.+Lelutiuauthor=R.+Dingledine&title=Small+molecule+antagonist+reveals+seizure-induced+mediation+of+neuronal+injury+by+prostaglandin+E2+receptor+subtype+EP2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2</span></div><div class="casAuthors">Jiang, Lianxiong; Ganesh, Thota; Du, Yuhong; Quan, Yi; Serrano, Geidy; Qui, Min; Speigel, Iris; Rojas, Asheebo; Lelutiu, Nadia; Dingledine, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3149-3154, S3149/1-S3149/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">With interest waning in the use of cyclooxygenase-2 (COX-2) inhibitors for inflammatory disease, prostaglandin receptors provide alternative targets for the treatment of COX-2-mediated pathol. conditions in both the periphery and the central nervous system.  Activation of prostaglandin E2 receptor (PGE2) subtype EP2 promotes inflammation and is just beginning to be explored as a therapeutic target.  To better understand physiol. and pathol. functions of the prostaglandin EP2 receptor, we developed a suite of small mols. with a 3-aryl-acrylamide scaffold as selective EP2 antagonists.  The 12 most potent compds. displayed competitive antagonism of the human EP2 receptor with KB 2-20 nM in Schild regression anal. and 268- to 4,730-fold selectivity over the prostaglandin EP4 receptor.  A brain-permeant compd. completely suppressed the up-regulation of COX-2 mRNA in rat cultured microglia by EP'2 activation and significantly reduced neuronal injury in hippocampus when administered in mice beginning 1 h after termination of pilocarpine-induced status epilepticus.  The salutary actions of this novel group of antagonists raise the possibility that selective block of EP2 signaling via small mols. can be an innovative therapeutic strategy for inflammation-related brain injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouf-jrW_yv2bVg90H21EOLACvtfcHk0lgfzCL8qLK_8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wmtbg%253D&md5=183b6780de14d538ef97ffb038807b0d</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1120195109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1120195109%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DQuan%26aufirst%3DY.%26aulast%3DSerrano%26aufirst%3DG.%26aulast%3DQui%26aufirst%3DM.%26aulast%3DSpeigel%26aufirst%3DI.%26aulast%3DRojas%26aufirst%3DA.%26aulast%3DLelutiu%26aufirst%3DN.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DSmall%2520molecule%2520antagonist%2520reveals%2520seizure-induced%2520mediation%2520of%2520neuronal%2520injury%2520by%2520prostaglandin%2520E2%2520receptor%2520subtype%2520EP2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D3149%26epage%3D3154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouliot, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">3591</span><span class="NLM_x">–</span> <span class="NLM_lpage">3596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1073%2Fpnas.1218498110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23401547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFynt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=3591-3596&author=J.+Jiangauthor=Y.+Quanauthor=T.+Ganeshauthor=W.+A.+Pouliotauthor=F.+E.+Dudekauthor=R.+Dingledine&title=Inhibition+of+the+prostaglandin+receptor+EP2+following+status+epilepticus+reduces+delayed+mortality+and+brain+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation</span></div><div class="casAuthors">Jiang, Jianxiong; Quan, Yi; Ganesh, Thota; Pouliot, Wendy A.; Dudek, F. Edward; Dingledine, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3591-3596, S3591/1-S3591/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostaglandin E2 is now widely recognized to play crit. roles in brain inflammation and injury, although the responsible prostaglandin receptors have not been fully identified.  We developed a potent and selective antagonist for the prostaglandin E2 receptor subtype EP2, TG6-10-1, with a sufficient pharmacokinetic profile to be used in vivo.  We found that in the mouse pilocarpine model of status epilepticus (SE), systemic administration of TG6-10-1 completely recapitulates the effects of conditional ablation of cyclooxygenase-2 from principal forebrain neurons, namely reduced delayed mortality, accelerated recovery from wt. loss, reduced brain inflammation, prevention of blood-brain barrier opening, and neuroprotection in the hippocampus, without modifying seizures acutely.  Prolonged SE in humans causes high mortality and morbidity that are assocd. with brain inflammation and injury, but currently the only effective treatment is to stop the seizures quickly enough with anticonvulsants to prevent brain damage.  Our results suggest that the prostaglandin receptor EP2 is critically involved in neuro-inflammation and neurodegeneration, and point to EP2 receptor antagonism as an adjunctive therapeutic strategy to treat SE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKncI8WoxYk7Vg90H21EOLACvtfcHk0liGe2FBQBMS-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFynt7g%253D&md5=258eb9d19f66a24a2237dcc61389e3a4</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1218498110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1218498110%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DQuan%26aufirst%3DY.%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DPouliot%26aufirst%3DW.%2BA.%26aulast%3DDudek%26aufirst%3DF.%2BE.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520the%2520prostaglandin%2520receptor%2520EP2%2520following%2520status%2520epilepticus%2520reduces%2520delayed%2520mortality%2520and%2520brain%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D3591%26epage%3D3596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Savonenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnikova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkwood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.expneurol.2009.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19416671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslKjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2009&pages=63-73&author=A.+Savonenkoauthor=P.+Munozauthor=T.+Melnikovaauthor=Q.+Wangauthor=X.+Liangauthor=R.+M.+Breyerauthor=T.+J.+Montineauthor=A.+Kirkwoodauthor=K.+Andreasson&title=Impaired+cognition%2C+sensorimotor+gating%2C+and+hippocampal+long-term+depression+in+mice+lacking+the+prostaglandin+E2+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor</span></div><div class="casAuthors">Savonenko, A.; Munoz, P.; Melnikova, T.; Wang, Q.; Liang, X.; Breyer, R. M.; Montine, T. J.; Kirkwood, A.; Andreasson, K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-73</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclooxygenase-2 (COX-2) is a neuronal immediate early gene that is regulated by N-Me aspartate (NMDA) receptor activity.  COX-2 enzymic activity catalyzes the first committed step in prostaglandin synthesis.  Recent studies demonstrate an emerging role for the downstream PGE2 EP2 receptor in diverse models of activity-dependent synaptic plasticity and a significant function in models of neurol. disease including cerebral ischemia, Familial Alzheimer's disease, and Familial amyotrophic lateral sclerosis.  Little is known, however, about the normal function of the EP2 receptor in behavior and cognition.  Here we report that deletion of the EP2 receptor leads to significant cognitive deficits in std. tests of fear and social memory.  EP2-/- mice also demonstrated impaired prepulse inhibition (PPI) and heightened anxiety, but normal startle reactivity, exploratory behavior, and spatial ref. memory.  This complex behavioral phenotype of EP2-/- mice was assocd. with a deficit in long-term depression (LTD) in hippocampus.  Our findings suggest that PGE2 signaling via the EP2 receptors plays an important role in cognitive and emotional behaviors that recapitulate some aspects of human psychopathol. related to schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqtMJ63OH0QLVg90H21EOLACvtfcHk0liGe2FBQBMS-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslKjt70%253D&md5=3ddfa6bf0988625f5ac290732ff76695</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2009.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2009.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DSavonenko%26aufirst%3DA.%26aulast%3DMunoz%26aufirst%3DP.%26aulast%3DMelnikova%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DKirkwood%26aufirst%3DA.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DImpaired%2520cognition%252C%2520sensorimotor%2520gating%252C%2520and%2520hippocampal%2520long-term%2520depression%2520in%2520mice%2520lacking%2520the%2520prostaglandin%2520E2%2520EP2%2520receptor%26jtitle%3DExp.%2520Neurol.%26date%3D2009%26volume%3D217%26spage%3D63%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1471-4159.2008.05766.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19012750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1ajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2009&pages=295-304&author=H.+Yangauthor=J.+Zhangauthor=R.+M.+Breyerauthor=C.+Chen&title=Altered+hippocampal+long-term+synaptic+plasticity+in+mice+deficient+in+the+PGE2+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor</span></div><div class="casAuthors">Yang, Hongwei; Zhang, Jian; Breyer, Richard M.; Chen, Chu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">295-304</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Our lab. demonstrated previously that PGE2-induced modulation of hippocampal synaptic transmission is via a presynaptic PGE2 EP2 receptor.  However, little is known about whether the EP2 receptor is involved in hippocampal long-term synaptic plasticity and cognitive function.  Here we show that long-term potentiation at the hippocampal perforant path synapses was impaired in mice deficient in the EP2 (KO), while membrane excitability and passive properties in granule neurons were normal.  Importantly, escape latency in the water maze in EP2 KO was longer than that in age-matched EP2 wild-type littermates (WT).  We also obsd. that long-term potentiation was potentiated in EP2 WT animals that received lipopolysaccharide (LPS, i.p.), but not in EP2 KO.  Bath application of PGE2 or butaprost, an EP2 receptor agonist, increased synaptic transmission and decreased paired-pulses ratio in EP2 WT mice, but failed to induce the changes in EP2 KO mice.  Meanwhile, synaptic transmission was elevated by application of forskolin, an adenylyl cyclase activator, both in EP2 KO and WT animals.  In addn., the PGE2-enhanced synaptic transmission was significantly attenuated by application of PKA, IP3 or MAPK inhibitors in EP2 WT animals.  Our results show that hippocampal long-term synaptic plasticity is impaired in mice deficient in the EP2, suggesting that PGE2-EP2 signaling is important for hippocampal long-term synaptic plasticity and cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqreFnreLDg7Vg90H21EOLACvtfcHk0liGe2FBQBMS-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1ajsQ%253D%253D&md5=e8a7346f6ffef53dfc5d9084ae9cffa5</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05766.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05766.x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DAltered%2520hippocampal%2520long-term%2520synaptic%2520plasticity%2520in%2520mice%2520deficient%2520in%2520the%2520PGE2%2520EP2%2520receptor%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D108%26spage%3D295%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Hizaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushikubi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, A.</span><span> </span><span class="NLM_article-title">Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">10501</span><span class="NLM_x">–</span> <span class="NLM_lpage">10506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=10501-10506&author=H.+Hizakiauthor=E.+Segiauthor=Y.+Sugimotoauthor=M.+Hiroseauthor=T.+Sajiauthor=F.+Ushikubiauthor=T.+Matsuokaauthor=Y.+Nodaauthor=T.+Tanakaauthor=N.+Yoshidaauthor=S.+Narumiyaauthor=A.+Ichikawa&title=Abortive+expansion+of+the+cumulus+and+impaired+fertility+in+mice+lacking+the+prostaglandin+E+receptor+subtype+EP%282%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHizaki%26aufirst%3DH.%26aulast%3DSegi%26aufirst%3DE.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DT.%26aulast%3DUshikubi%26aufirst%3DF.%26aulast%3DMatsuoka%26aufirst%3DT.%26aulast%3DNoda%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DNarumiya%26aufirst%3DS.%26aulast%3DIchikawa%26aufirst%3DA.%26atitle%3DAbortive%2520expansion%2520of%2520the%2520cumulus%2520and%2520impaired%2520fertility%2520in%2520mice%2520lacking%2520the%2520prostaglandin%2520E%2520receptor%2520subtype%2520EP%25282%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D10501%26epage%3D10506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Kennedy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span> </span><span class="NLM_article-title">Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=217-220&author=C.+R.+Kennedyauthor=Y.+Zhangauthor=S.+Brandonauthor=Y.+Guanauthor=K.+Coffeeauthor=C.+D.+Funkauthor=M.+A.+Magnusonauthor=J.+A.+Oatesauthor=M.+D.+Breyerauthor=R.+M.+Breyer&title=Salt-sensitive+hypertension+and+reduced+fertility+in+mice+lacking+the+prostaglandin+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DC.%2BR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBrandon%26aufirst%3DS.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DCoffee%26aufirst%3DK.%26aulast%3DFunk%26aufirst%3DC.%2BD.%26aulast%3DMagnuson%26aufirst%3DM.%2BA.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DBreyer%26aufirst%3DM.%2BD.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26atitle%3DSalt-sensitive%2520hypertension%2520and%2520reduced%2520fertility%2520in%2520mice%2520lacking%2520the%2520prostaglandin%2520EP2%2520receptor%26jtitle%3DNature%2520Med.%26date%3D1999%26volume%3D5%26spage%3D217%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Chun, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trempus, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langenbach, R.</span><span> </span><span class="NLM_article-title">The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1620</span><span class="NLM_x">–</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1620-1627&author=K.+S.+Chunauthor=H.+C.+Laoauthor=C.+S.+Trempusauthor=M.+Okadaauthor=R.+Langenbach&title=The+prostaglandin+receptor+EP2+activates+multiple+signaling+pathways+and+beta-arrestin1+complex+formation+during+mouse+skin+papilloma+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DK.%2BS.%26aulast%3DLao%26aufirst%3DH.%2BC.%26aulast%3DTrempus%26aufirst%3DC.%2BS.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DLangenbach%26aufirst%3DR.%26atitle%3DThe%2520prostaglandin%2520receptor%2520EP2%2520activates%2520multiple%2520signaling%2520pathways%2520and%2520beta-arrestin1%2520complex%2520formation%2520during%2520mouse%2520skin%2520papilloma%2520development%26jtitle%3DCarcinogenesis%26date%3D2009%26volume%3D30%26spage%3D1620%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Fujino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J. W.</span><span> </span><span class="NLM_article-title">Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=335-340&author=H.+Fujinoauthor=J.+W.+Regan&title=Prostanoid+receptors+and+phosphatidylinositol+3-kinase%3A+a+pathway+to+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DH.%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3DProstanoid%2520receptors%2520and%2520phosphatidylinositol%25203-kinase%253A%2520a%2520pathway%2520to%2520cancer%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2003%26volume%3D24%26spage%3D335%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Fujino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J. W.</span><span> </span><span class="NLM_article-title">Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=251-259&author=H.+Fujinoauthor=S.+Salviauthor=J.+W.+Regan&title=Differential+regulation+of+phosphorylation+of+the+cAMP+response+element-binding+protein+after+activation+of+EP2+and+EP4+prostanoid+receptors+by+prostaglandin+E2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DH.%26aulast%3DSalvi%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3DDifferential%2520regulation%2520of%2520phosphorylation%2520of%2520the%2520cAMP%2520response%2520element-binding%2520protein%2520after%2520activation%2520of%2520EP2%2520and%2520EP4%2520prostanoid%2520receptors%2520by%2520prostaglandin%2520E2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection</span> <span class="citation_source-journal">Trends. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.tips.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23796953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSlsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=413-423&author=J.+Jiangauthor=R.+Dingledine&title=Prostaglandin+receptor+EP2+in+the+crosshairs+of+anti-inflammation%2C+anti-cancer%2C+and+neuroprotection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection</span></div><div class="casAuthors">Jiang, Jianxiong; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">413-423</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Modulation of a specific prostanoid synthase or receptor provides therapeutic alternatives to nonsteroidal anti-inflammatory drugs (NSAIDs) for treating pathol. conditions governed by cyclooxygenase-2 (COX-2 or PTGS2).  Among the COX-2 downstream signaling pathways, the prostaglandin E2 (PGE2) receptor EP2 subtype (PTGER2) is emerging as a crucial mediator of many physiol. and pathol. events.  Genetic ablation strategies and recent advances in chem. biol. provide tools for a better understanding of EP2 signaling.  In the brain, the EP2 receptor modulates some beneficial effects, including neuroprotection, in acute models of excitotoxicity, neuroplasticity, and spatial learning via cAMP-PKA signaling.  Conversely, EP2 activation accentuates chronic inflammation mainly through the cAMP-Epac pathway, likely contributing to delayed neurotoxicity.  EP2 receptor activation also engages β-arrestin in a G-protein-independent pathway that promotes tumor cell growth and migration.  Understanding the conditions under which multiple EP2 signaling pathways are engaged might suggest novel therapeutic strategies to target this key inflammatory prostaglandin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZPJrPfUjLrLVg90H21EOLACvtfcHk0liTfPOBnvd8YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSlsbvO&md5=2833b47caa17255ef2635300d7c13575</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DProstaglandin%2520receptor%2520EP2%2520in%2520the%2520crosshairs%2520of%2520anti-inflammation%252C%2520anti-cancer%252C%2520and%2520neuroprotection%26jtitle%3DTrends.%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D413%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Regan, J. W.</span><span> </span><span class="NLM_article-title">EP2 and EP4 prostanoid receptor signaling</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=143-153&author=J.+W.+Regan&title=EP2+and+EP4+prostanoid+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3DEP2%2520and%2520EP4%2520prostanoid%2520receptor%2520signaling%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D74%26spage%3D143%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Bos, J. L.</span><span> </span><span class="NLM_article-title">Epac: a new cAMP target and new avenues in cAMP research</span> <span class="citation_source-journal">Nature Rev. Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnrm1197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=14506476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsVKqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=733-738&author=J.+L.+Bos&title=Epac%3A+a+new+cAMP+target+and+new+avenues+in+cAMP+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: Epac: a new cAMP target and new avenues in cAMP research</span></div><div class="casAuthors">Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">733-738</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Five years ago, Epac - a guanine nucleotide exchange factor for the Ras-like small GTPases Rap1 and Rap2 - was found to be a new target of cAMP, which opened up new avenues for cAMP research.  Structural anal. of the cAMP-binding domains of Epac2 has identified a unifying mechanism for how cAMP activates proteins, and the design and synthesis of an Epac-specific cAMP analog has paved the way for future discoveries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMTh0k8Iy-8LVg90H21EOLACvtfcHk0lj30ks-xLUSSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsVKqsLw%253D&md5=14be0f1922a69532b14fe2b4d3b079c5</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1038%2Fnrm1197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1197%26sid%3Dliteratum%253Aachs%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DEpac%253A%2520a%2520new%2520cAMP%2520target%2520and%2520new%2520avenues%2520in%2520cAMP%2520research%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D733%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">de Rooij, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwartkruis, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cool, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nijman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittinghofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. L.</span><span> </span><span class="NLM_article-title">Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2F24884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=9853756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaK1cXotVSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=1998&pages=474-477&author=J.+de+Rooijauthor=F.+J.+Zwartkruisauthor=M.+H.+Verheijenauthor=R.+H.+Coolauthor=S.+M.+Nijmanauthor=A.+Wittinghoferauthor=J.+L.+Bos&title=Epac+is+a+Rap1+guanine-nucleotide-exchange+factor+directly+activated+by+cyclic+AMP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP</span></div><div class="casAuthors">De Rooij, Johan; Zwartkruis, Fried J. T.; Verhaijen, Mark H. G.; Cool, Robbert H.; Nijman, Sebastian M. B.; Wittinghofer, Alfred; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">6710</span>),
    <span class="NLM_cas:pages">474-477</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Rap1 is a small, Ras-like GTPase that was first identified as a protein that could suppress the oncogenic transformation of cells by Ras.  Rap1 is activated by several extracellular stimuli and may be involved in cellular processes such as cell proliferation, cell differentiation, T-cell anergy and platelet activation.  At least three different second messengers, namely diacylglycerol, calcium and cAMP, are able to activate Rap1 by promoting its release of the guanine nucleotide GDP and its binding to GTP.  Here we report that activation of Rap1 by forskolin and cAMP occurs independently of protein kinase A (also known as cAMP-activated protein kinase).  We have cloned the gene encoding a guanine-nucleotide-exchange factor (GEF) which we have named Epac (exchange protein directly activated by cAMP).  This protein contains a cAMP-binding site and a domain that is homologous to domains of known GEFs for Ras and Rap1.  Epac binds cAMP in vitro and exhibits in vivo and in vitro GEF activity towards Rap1.  CAMP strongly induces the GEF activity of Epac towards Rap1 both in vivo and in vitro.  We conclude that Epac is a GEF for Rap1 that is regulated directly by cAMP and that Epac is a new target protein for cAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ96rDUUrIc7Vg90H21EOLACvtfcHk0lj30ks-xLUSSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVSitbs%253D&md5=8f4a50b23d8bfc344c0c9947175b89a5</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2F24884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F24884%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BRooij%26aufirst%3DJ.%26aulast%3DZwartkruis%26aufirst%3DF.%2BJ.%26aulast%3DVerheijen%26aufirst%3DM.%2BH.%26aulast%3DCool%26aufirst%3DR.%2BH.%26aulast%3DNijman%26aufirst%3DS.%2BM.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DEpac%2520is%2520a%2520Rap1%2520guanine-nucleotide-exchange%2520factor%2520directly%2520activated%2520by%2520cyclic%2520AMP%26jtitle%3DNature%26date%3D1998%26volume%3D396%26spage%3D474%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Duman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Sa, C.</span><span> </span><span class="NLM_article-title">Neuronal plasticity and survival in mood disorders</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2FS0006-3223%2800%2900935-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BD3crht1SitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=732-739&author=R.+S.+Dumanauthor=J.+Malbergauthor=S.+Nakagawaauthor=C.+D%E2%80%99Sa&title=Neuronal+plasticity+and+survival+in+mood+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal plasticity and survival in mood disorders</span></div><div class="casAuthors">Duman R S; Malberg J; Nakagawa S; D'Sa C</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">732-9</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">Studies at the basic and clinical levels demonstrate that neuronal atrophy and cell death occur in response to stress and in the brains of depressed patients.  Although the mechanisms have yet to be fully elucidated, progress has been made in characterizing the signal transduction cascades that control neuronal atrophy and programmed cell death and that may be involved in the action of antidepressant treatment.  These pathways include the cyclic adenosine monophosphate and neurotrophic factor signal transduction cascades.  It is notable that these same pathways have been demonstrated to play a pivotal role in cellular models of neural plasticity.  This overlap of plasticity and cell survival pathways, together with studies demonstrating that neuronal activity enhances cell survival, suggests that neuronal atrophy and death could result from a disruption of the mechanisms underlying neural plasticity.  The role of these pathways and failure of neuronal plasticity in stress-related mood disorders are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3Y5uxyHs5dJ6KlWarZTAzfW6udTcc2eYWgsmoTt1Bsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3crht1SitQ%253D%253D&md5=4d24a4b4d781dfff57d365c1a8f43327</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2800%2900935-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252800%252900935-5%26sid%3Dliteratum%253Aachs%26aulast%3DDuman%26aufirst%3DR.%2BS.%26aulast%3DMalberg%26aufirst%3DJ.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Sa%26aufirst%3DC.%26atitle%3DNeuronal%2520plasticity%2520and%2520survival%2520in%2520mood%2520disorders%26jtitle%3DBiol.%2520Psychiatry%26date%3D2000%26volume%3D48%26spage%3D732%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Herold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagasia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassmer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lie, D. C.</span><span> </span><span class="NLM_article-title">CREB signalling regulates early survival, neuronal gene expression and morphological development in adult subventricular zone neurogenesis</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.mcn.2010.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktF2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=79-88&author=S.+Heroldauthor=R.+Jagasiaauthor=K.+Merzauthor=K.+Wassmerauthor=D.+C.+Lie&title=CREB+signalling+regulates+early+survival%2C+neuronal+gene+expression+and+morphological+development+in+adult+subventricular+zone+neurogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">CREB signalling regulates early survival, neuronal gene expression and morphological development in adult subventricular zone neurogenesis</span></div><div class="casAuthors">Herold, S.; Jagasia, R.; Merz, K.; Wassmer, K.; Lie, D. C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neural stem cells in the subventricular zone (SVZ) of the lateral ventricles give rise to new interneurons of the olfactory bulb (OB) throughout life.  SVZ/OB neurogenesis is influenced by olfactory network activity, which modulates the survival of new neurons during their integration into the OB network.  Previous work suggested that such activity-dependent survival is regulated via the CREB signalling pathway.  Curiously, CREB signalling is already active during the early developmental stages of adult SVZ/OB neurogenesis.  To investigate the role of cell autonomous CREB signalling during early stages of adult SVZ/OB neurogenesis, we ablated CREB-pathway activity in the SVZ/OB neurogenic lineage using a retroviral strategy.  Surprisingly, loss of CREB signalling resulted in increased cell death and loss of expression of the neurogenic transcription factor Pax 6, and of a subset of neuronal proteins in migrating neurons of the RMS.  Moreover, post-migratory neurons in the OB displayed impaired dendritic development.  These results demonstrate an essential role for CREB signalling in maturation of newborn neurons in the OB and uncover a novel role for CREB signalling in the survival and maintenance of neuronal gene expression during the early stages of SVZ/OB neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBUCTVArK-67Vg90H21EOLACvtfcHk0lj30ks-xLUSSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktF2rtg%253D%253D&md5=22b76041f80e02ed91ccb216d04caee3</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2010.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2010.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DHerold%26aufirst%3DS.%26aulast%3DJagasia%26aufirst%3DR.%26aulast%3DMerz%26aufirst%3DK.%26aulast%3DWassmer%26aufirst%3DK.%26aulast%3DLie%26aufirst%3DD.%2BC.%26atitle%3DCREB%2520signalling%2520regulates%2520early%2520survival%252C%2520neuronal%2520gene%2520expression%2520and%2520morphological%2520development%2520in%2520adult%2520subventricular%2520zone%2520neurogenesis%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2011%26volume%3D46%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Ouyang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwede, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. A.</span><span> </span><span class="NLM_article-title">Epac signaling is required for hippocampus-dependent memory retrieval</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">11993</span><span class="NLM_x">–</span> <span class="NLM_lpage">11997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=11993-11997&author=M.+Ouyangauthor=L.+Zhangauthor=J.+J.+Zhuauthor=F.+Schwedeauthor=S.+A.+Thomas&title=Epac+signaling+is+required+for+hippocampus-dependent+memory+retrieval"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOuyang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%2BJ.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DS.%2BA.%26atitle%3DEpac%2520signaling%2520is%2520required%2520for%2520hippocampus-dependent%2520memory%2520retrieval%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D11993%26epage%3D11997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Shi, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, D. A.</span><span> </span><span class="NLM_article-title">A novel cyclic AMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">9136</span><span class="NLM_x">–</span> <span class="NLM_lpage">9147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1128%2FMCB.00332-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yqsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9136-9147&author=G.+X.+Shiauthor=H.+Rehmannauthor=D.+A.+Andres&title=A+novel+cyclic+AMP-dependent+Epac-Rit+signaling+pathway+contributes+to+PACAP38-mediated+neuronal+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cyclic AMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation</span></div><div class="casAuthors">Shi, Geng-Xian; Rehmann, Holger; Andres, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9136-9147</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pituitary adenylate cyclase-activating polypeptide (PACAP38) stimulation results in the activation of Gsα protein-coupled receptors to regulate neuronal differentiation in a cAMP-dependent manner.  These pathways involve protein kinase A (PKA)-dependent processes, but a growing body of evidence indicates that cAMP also regulates cellular functions through PKA-independent signaling cascades.  Here we show that the Rit small GTPase is regulated by PACAP38 in a cAMP-dependent but PKA-independent fashion.  Rit activation results from stimulation of the cAMP-activated guanine nucleotide exchange factor Epac but does not appear to rely upon the activation of Rap GTPases, the accepted cellular Epac substrates.  Although RNA interference studies demonstrated that Epac is required for PACAP38-mediated Rit activation, neither Epac1 nor Epac2 activates Rit directly, indicating that Epac signals to Rit through a novel mechanism in which Rap signaling is not essential.  Loss-of-function anal. demonstrated that Rit makes an important contribution to PACAP38-mediated neuronal differentiation.  Surprisingly, although Rit is required for sustained extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase signaling following nerve growth factor stimulation of pheochromocytoma 6 (PC6) cells, Rit silencing selectively suppressed PACAP38-elicited activation of p38, without obvious effects on ERK signaling in the same cells.  Moreover, the ability of PACAP38 to stimulate CREB-dependent transcription and to promote neurite outgrowth was inhibited by Rit knockdown.  Together, these studies identify an unsuspected connection between cAMP and Rit signaling pathways and imply that Rit can function downstream of Gsα/cAMP/Epac in a novel signal transduction pathway necessary for PACAP38-mediated neuronal differentiation and CREB signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhn7YNBTSyBLVg90H21EOLACvtfcHk0ljyzvNpszxnuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yqsb7M&md5=a46640af507f65ff525df747a96c70af</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1128%2FMCB.00332-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00332-06%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DG.%2BX.%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DAndres%26aufirst%3DD.%2BA.%26atitle%3DA%2520novel%2520cyclic%2520AMP-dependent%2520Epac-Rit%2520signaling%2520pathway%2520contributes%2520to%2520PACAP38-mediated%2520neuronal%2520differentiation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D9136%26epage%3D9147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petralia, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span> </span><span class="NLM_article-title">EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.neuron.2012.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=22365550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2ktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2012&pages=774-788&author=Y.+Yangauthor=X.+Shuauthor=D.+Liuauthor=Y.+Shangauthor=Y.+Wuauthor=L.+Peiauthor=X.+Xuauthor=Q.+Tianauthor=J.+Zhangauthor=K.+Qianauthor=Y.+X.+Wangauthor=R.+S.+Petraliaauthor=W.+Tuauthor=L.+Q.+Zhuauthor=J.+Z.+Wangauthor=Y.+Lu&title=EPAC+null+mutation+impairs+learning+and+social+interactions+via+aberrant+regulation+of+miR-124+and+Zif268+translation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation</span></div><div class="casAuthors">Yang, Ying; Shu, Xiaogang; Liu, Dan; Shang, You; Wu, Yan; Pei, Lei; Xu, Xin; Tian, Qing; Zhang, Jian; Qian, Kun; Wang, Ya-Xian; Petralia, Ronald S.; Tu, Weihong; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">774-788</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">EPAC proteins are the guanine nucleotide exchange factors that act as the intracellular receptors for cAMP.  Two variants of EPAC genes including EPAC1 and EPAC2 are cloned and are widely expressed throughout the brain.  But, their functions in the brain remain unknown.  Here, we genetically delete EPAC1 (EPAC1-/-), EPAC2 (EPAC2-/-), or both EPAC1 and EPAC2 genes (EPAC-/-) in the forebrain of mice.  We show that EPAC null mutation impairs long-term potentiation (LTP) and that this impairment is paralleled with the severe deficits in spatial learning and social interactions and is mediated in a direct manner by miR-124 transcription and Zif268 translation.  Knockdown of miR-124 restores Zif268 and hence reverses all aspects of the EPAC-/- phenotypes, whereas expression of miR-124 or knockdown of Zif268 reproduces the effects of EPAC null mutation.  Thus, EPAC proteins control miR-124 transcription in the brain for processing spatial learning and social interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS3xT7TZPA37Vg90H21EOLACvtfcHk0ljyzvNpszxnuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2ktLw%253D&md5=03fd3bd2a6401a5f3c6e36916d9b3a4b</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DShang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%2BX.%26aulast%3DPetralia%26aufirst%3DR.%2BS.%26aulast%3DTu%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DL.%2BQ.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DLu%26aufirst%3DY.%26atitle%3DEPAC%2520null%2520mutation%2520impairs%2520learning%2520and%2520social%2520interactions%2520via%2520aberrant%2520regulation%2520of%2520miR-124%2520and%2520Zif268%2520translation%26jtitle%3DNeuron%26date%3D2012%26volume%3D73%26spage%3D774%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostaglandin E receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">11613</span><span class="NLM_x">–</span> <span class="NLM_lpage">11617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1074%2Fjbc.R600038200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=17329241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFemtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=11613-11617&author=Y.+Sugimotoauthor=S.+Narumiya&title=Prostaglandin+E+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E Receptors</span></div><div class="casAuthors">Sugimoto, Yukihiko; Narumiya, Shuh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">11613-11617</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Prostaglandin (PG) E2 exerts its actions by acting on a group of G-protein-coupled receptors (GPCRs).  There are four GPCRs responding to PGE2 designated subtypes EP1, EP2, EP3, and EP4 and multiple splicing isoforms of the subtype EP3.  The EP subtypes exhibit differences in signal transduction, tissue localization, and regulation of expression.  This mol. and biochem. heterogeneity of PGE receptors leads to PGE2 being the most versatile prostanoid.  Studies on knock-out mice deficient in each EP subtype have defined PGE2 actions mediated by each subtype and identified the role each EP subtype plays in various physiol. and pathophysiol. responses.  Here we review recent advances in PGE receptor research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolU7s4EWb1LLVg90H21EOLACvtfcHk0ljrCwJpSfHEeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFemtbs%253D&md5=d63dd3c6865110eddf690a3da48990a8</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R600038200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R600038200%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstaglandin%2520E%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D11613%26epage%3D11617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carriere, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufresne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gareau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juteau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouimet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span> </span><span class="NLM_article-title">The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1483</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1483&publication_year=2000&pages=285-293&author=M.+Abramovitzauthor=M.+Adamauthor=Y.+Boieauthor=M.+Carriereauthor=D.+Denisauthor=C.+Godboutauthor=S.+Lamontagneauthor=C.+Rochetteauthor=N.+Sawyerauthor=N.+M.+Tremblayauthor=M.+Belleyauthor=M.+Gallantauthor=C.+Dufresneauthor=Y.+Gareauauthor=R.+Ruelauthor=H.+Juteauauthor=M.+Labelleauthor=N.+Ouimetauthor=K.+M.+Metters&title=The+utilization+of+recombinant+prostanoid+receptors+to+determine+the+affinities+and+selectivities+of+prostaglandins+and+related+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DAdam%26aufirst%3DM.%26aulast%3DBoie%26aufirst%3DY.%26aulast%3DCarriere%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DD.%26aulast%3DGodbout%26aufirst%3DC.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DRochette%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DTremblay%26aufirst%3DN.%2BM.%26aulast%3DBelley%26aufirst%3DM.%26aulast%3DGallant%26aufirst%3DM.%26aulast%3DDufresne%26aufirst%3DC.%26aulast%3DGareau%26aufirst%3DY.%26aulast%3DRuel%26aufirst%3DR.%26aulast%3DJuteau%26aufirst%3DH.%26aulast%3DLabelle%26aufirst%3DM.%26aulast%3DOuimet%26aufirst%3DN.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26atitle%3DThe%2520utilization%2520of%2520recombinant%2520prostanoid%2520receptors%2520to%2520determine%2520the%2520affinities%2520and%2520selectivities%2520of%2520prostaglandins%2520and%2520related%2520analogs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2000%26volume%3D1483%26spage%3D285%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Nials, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardey, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denyer, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparrow, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. A.</span><span> </span><span class="NLM_article-title">Ah13205, a Selective Prostanoid Ep2-Receptor Agonist</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1993&pages=165-179&author=A.+T.+Nialsauthor=C.+J.+Vardeyauthor=L.+H.+Denyerauthor=M.+Thomasauthor=S.+J.+Sparrowauthor=G.+D.+Shepherdauthor=R.+A.+Coleman&title=Ah13205%2C+a+Selective+Prostanoid+Ep2-Receptor+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNials%26aufirst%3DA.%2BT.%26aulast%3DVardey%26aufirst%3DC.%2BJ.%26aulast%3DDenyer%26aufirst%3DL.%2BH.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DSparrow%26aufirst%3DS.%2BJ.%26aulast%3DShepherd%26aufirst%3DG.%2BD.%26aulast%3DColeman%26aufirst%3DR.%2BA.%26atitle%3DAh13205%252C%2520a%2520Selective%2520Prostanoid%2520Ep2-Receptor%2520Agonist%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D1993%26volume%3D11%26spage%3D165%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Woodward, D. F.</span><span> </span><span class="NLM_article-title">EP2-Receptor agonists as agents for lowering intraocular pressure</span>. US 5462968, <span class="NLM_day">31</span><span class="NLM_month">October</span><span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=D.+F.+Woodward&title=EP2-Receptor+agonists+as+agents+for+lowering+intraocular+pressure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DD.%2BF.%26atitle%3DEP2-Receptor%2520agonists%2520as%2520agents%2520for%2520lowering%2520intraocular%2520pressure%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Woodward, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepperl, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkey, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J. W.</span><span> </span><span class="NLM_article-title">6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1731</span><span class="NLM_x">–</span> <span class="NLM_lpage">1733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=1731-1733&author=D.+F.+Woodwardauthor=D.+J.+Pepperlauthor=T.+H.+Burkeyauthor=J.+W.+Regan&title=6-Isopropoxy-9-oxoxanthene-2-carboxylic+acid+%28AH+6809%29%2C+a+human+EP2+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DD.%2BF.%26aulast%3DPepperl%26aufirst%3DD.%2BJ.%26aulast%3DBurkey%26aufirst%3DT.%2BH.%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3D6-Isopropoxy-9-oxoxanthene-2-carboxylic%2520acid%2520%2528AH%25206809%2529%252C%2520a%2520human%2520EP2%2520receptor%2520antagonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26spage%3D1731%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">af Forselles, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aughton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, N.</span><span> </span><span class="NLM_article-title">In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP(2) receptor antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1847</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1476-5381.2011.01495.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21595651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=1847-1856&author=K.+J.+af+Forsellesauthor=J.+Rootauthor=T.+Clarkeauthor=D.+Daveyauthor=K.+Aughtonauthor=K.+Dackauthor=N.+Pullen&title=In+vitro+and+in+vivo+characterization+of+PF-04418948%2C+a+novel%2C+potent+and+selective+prostaglandin+EP%282%29+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist</span></div><div class="casAuthors">af Forselles, K. J.; Root, J.; Clarke, T.; Davey, D.; Aughton, K.; Dack, K.; Pullen, N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1847-1856</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Studies of the role of the prostaglandin EP2 receptor) have been limited by the availability of potent and selective antagonist tools.  Here we describe the in vitro/in vivo pharmacol. characterization of a novel EP2 receptor antagonist, PF-04418948 (1-(4-fluorobenzoyl)-3-{[(6-methoxy-2-naphthyl)oxy]methyl} azetidine-3-carboxylic acid).  Exptl. Approach Functional antagonist potency was assessed in cell-based systems expressing human EP2 receptors and native tissue prepns. from human, dog and mouse.  The selectivity of PF-04418948 was assessed against related receptors and a panel of GPCRs, ion channels and enzymes.  The ability of PF-04418948 to pharmacol. block EP2 receptor function in vivo was tested in rats.  Key Results PF-04418948 inhibited prostaglandin E2 (PGE2)-induced increase in cAMP in cells expressing EP2 receptors with a functional KB value of 1.8 nM.  In human myometrium, PF-04418948 produced a parallel, rightward shift of the butaprost-induced inhibition of the contractions induced by elec. field stimulation with an apparent KB of 5.4 nM.  In dog bronchiole and mouse trachea, PF-04418948 produced parallel rightward shifts of the PGE2-induced relaxation curve with a KB of 2.5 nM and an apparent KB of 1.3 nM resp.  Reversal of the PGE2-induced relaxation in the mouse trachea by PF-04418948 produced an IC50 value of 2.7 nM.  Given orally, PF-04418948 attenuated the butaprost-induced cutaneous blood flow response in rats.  PF-04418948 was selective for EP2 receptors over homologous and unrelated receptors, enzymes and channels.  Conclusions and Implications PF-04418948 is an orally active, potent and selective surmountable EP2 receptor antagonist that should aid further elaboration of EP2 receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroU6orcpdIurVg90H21EOLACvtfcHk0lgmfiOXuu_BLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLzJ&md5=0239cd8c555c6ddf06336c46019454c9</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01495.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01495.x%26sid%3Dliteratum%253Aachs%26aulast%3Daf%2BForselles%26aufirst%3DK.%2BJ.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DT.%26aulast%3DDavey%26aufirst%3DD.%26aulast%3DAughton%26aufirst%3DK.%26aulast%3DDack%26aufirst%3DK.%26aulast%3DPullen%26aufirst%3DN.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterization%2520of%2520PF-04418948%252C%2520a%2520novel%252C%2520potent%2520and%2520selective%2520prostaglandin%2520EP%25282%2529%2520receptor%2520antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D1847%26epage%3D1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1124%2Fjpet.112.200444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23192657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=360-367&author=J.+Jiangauthor=R.+Dingledine&title=Role+of+prostaglandin+receptor+EP2+in+the+regulations+of+cancer+cell+proliferation%2C+invasion%2C+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation</span></div><div class="casAuthors">Jiang, Jianxiong; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">360-367</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Population studies, preclin., and clin. trials suggest a role for cyclooxygenase-2 (COX-2, PTGS2) in tumor formation and progression.  The downstream prostanoid receptor signaling pathways involved in tumorigenesis are poorly understood, although prostaglandin E2 (PGE2), a major COX-2 metabolite which is usually upregulated in the involved tissues, presumably plays important roles in tumor biol.  Taking advantage of our recently identified novel selective antagonist for the EP2 (PTGER2) subtype of PGE2 receptor, we demonstrated that EP2 receptor activation could promote prostate cancer cell growth and invasion in vitro, accompanied by upregulation of the tumor-promoting inflammatory cytokines, such as IL-1β and IL-6.  Our results suggest the involvement of prostaglandin receptor EP2 in cancer cell proliferation and invasion possibly via its inflammatory actions, and indicate that selective blockade of the PGE2-EP2 signaling pathway via small mol. antagonists might represent a novel therapy for tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrocrmBwMbECLVg90H21EOLACvtfcHk0lgmfiOXuu_BLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKiurY%253D&md5=fc2ef21083d4ea747aeffc95e0beb84e</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.200444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.200444%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DRole%2520of%2520prostaglandin%2520receptor%2520EP2%2520in%2520the%2520regulations%2520of%2520cancer%2520cell%2520proliferation%252C%2520invasion%252C%2520and%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D360%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Ganesh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shashidharamurthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Discovery and characterization of carbamothioylacrylamides as EP selective antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400112h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=616-621&author=T.+Ganeshauthor=J.+Jiangauthor=R.+Shashidharamurthyauthor=R.+Dingledine&title=Discovery+and+characterization+of+carbamothioylacrylamides+as+EP+selective+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fml400112h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400112h%26sid%3Dliteratum%253Aachs%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DShashidharamurthy%26aufirst%3DR.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520carbamothioylacrylamides%2520as%2520EP%2520selective%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D616%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Dack, K. N.; Skerratt, S. E.; Yeap, S. K.</span><span> </span><span class="NLM_article-title">Azetidine derivatives and their use as prostaglandin E2 antagonists</span>. WO 2008/139287 A1, <span class="NLM_day">20</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=K.+N.+Dack&author=S.+E.+Skerratt&author=S.+K.+Yeap&title=Azetidine+derivatives+and+their+use+as+prostaglandin+E2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDack%26aufirst%3DK.%2BN.%26atitle%3DAzetidine%2520derivatives%2520and%2520their%2520use%2520as%2520prostaglandin%2520E2%2520antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Buchmann, B.; Braeuer, N.; Koppitz, M.; Peters, O.; Ter Laak, A.; Lindenthal, B.; Langer, G.; Wintermantel, T.</span><span> </span><span class="NLM_article-title">Thienopyrimidylamines as modulators of the EP2 receptor</span>. WO 2009007422 A1, <span class="NLM_day">15</span><span class="NLM_month">January</span><span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Buchmann&author=N.+Braeuer&author=M.+Koppitz&author=O.+Peters&author=A.+Ter+Laak&author=B.+Lindenthal&author=G.+Langer&author=T.+Wintermantel&title=Thienopyrimidylamines+as+modulators+of+the+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DThienopyrimidylamines%2520as%2520modulators%2520of%2520the%2520EP2%2520receptor%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Braeuer, N.; Buchmann, B.; Koppitz, M.; Langer, G.; Lindenthal, B.; Peters, O.; Ter Laak, A.; Wintermantel, T.</span><span> </span><span class="NLM_article-title"><i>N</i>-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulators</span>. WO2008028689 A1, <span class="NLM_day">13</span><span class="NLM_month">March</span><span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=N.+Braeuer&author=B.+Buchmann&author=M.+Koppitz&author=G.+Langer&author=B.+Lindenthal&author=O.+Peters&author=A.+Ter+Laak&author=T.+Wintermantel&title=N-%281-Phthalazin-1-ylpiperidin-4-yl%29amides+as+EP2+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBraeuer%26aufirst%3DN.%26atitle%3DN-%25281-Phthalazin-1-ylpiperidin-4-yl%2529amides%2520as%2520EP2%2520receptor%2520modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Buchmann, B.; Brauer, N.; Koppititz, M.; Peters, O.; Ter Laak, A.; Lindenthal, B.; Langer, G.</span><span> </span><span class="NLM_article-title">Diaminopyrimidines as modulators of the EP2 receptor</span>. WO 2008/152093 A3, <span class="NLM_day">18</span><span class="NLM_month">December</span><span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Buchmann&author=N.+Brauer&author=M.+Koppititz&author=O.+Peters&author=A.+Ter+Laak&author=B.+Lindenthal&author=G.+Langer&title=Diaminopyrimidines+as+modulators+of+the+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DDiaminopyrimidines%2520as%2520modulators%2520of%2520the%2520EP2%2520receptor%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Koppitz, M.; Lindenthal, B.; Antonious Ter, L.; Wintermantel, T.; Peters, O.; Langer, G.; Bräuer, N.; Buchmann, B.</span><span> </span><span class="NLM_article-title">Dérivés de <i>n</i>-(indol-3-ylalkyl)-(hétéro)arylamide comme modulateurs du récepteur</span> WO2010012397 A1, <span class="NLM_day">4</span><span class="NLM_month">February</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Koppitz&author=B.+Lindenthal&author=L.+Antonious+Ter&author=T.+Wintermantel&author=O.+Peters&author=G.+Langer&author=N.+Br%C3%A4uer&author=B.+Buchmann&title=D%C3%A9riv%C3%A9s+de+n-%28indol-3-ylalkyl%29-%28h%C3%A9t%C3%A9ro%29arylamide+comme+modulateurs+du+r%C3%A9cepteur"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKoppitz%26aufirst%3DM.%26atitle%3DD%25C3%25A9riv%25C3%25A9s%2520de%2520n-%2528indol-3-ylalkyl%2529-%2528h%25C3%25A9t%25C3%25A9ro%2529arylamide%2520comme%2520modulateurs%2520du%2520r%25C3%25A9cepteur%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Jiang, J.; Ganesh, T.; Du, Y.; Thepchatri, P.; Quan, Y.; Dingledine, R. J.</span><span> </span><span class="NLM_article-title">Preparation of indole and benzimidazole derivatives as prostaglandin receptor EP2 antagonists</span>. WO 2012177618 A1, <span class="NLM_day">27</span><span class="NLM_month">December</span><span class="NLM_x"> </span><span class="NLM_year">2012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Jiang&author=T.+Ganesh&author=Y.+Du&author=P.+Thepchatri&author=Y.+Quan&author=R.+J.+Dingledine&title=Preparation+of+indole+and+benzimidazole+derivatives+as+prostaglandin+receptor+EP2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26atitle%3DPreparation%2520of%2520indole%2520and%2520benzimidazole%2520derivatives%2520as%2520prostaglandin%2520receptor%2520EP2%2520antagonists%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Recognizing and exploiting differences between RNAi and small-molecule inhibitors</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnchembio1207-739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=18007642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWqurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=739-744&author=W.+A.+Weissauthor=S.+S.+Taylorauthor=K.+M.+Shokat&title=Recognizing+and+exploiting+differences+between+RNAi+and+small-molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Recognizing and exploiting differences between RNAi and small-molecule inhibitors</span></div><div class="casAuthors">Weiss, William A.; Taylor, Stephen S.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The biol. of RNA interference has greatly facilitated anal. of loss-of-function phenotypes, but correlating these phenotypes with small-mol. inhibition profiles is not always straightforward.  The authors examine the rationale of comparing RNA interference to pharmacol. intervention in chem. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JPzqVyshS7Vg90H21EOLACvtfcHk0lgP9tF-Ui4Y9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWqurjO&md5=9a26c990b358a6b2c717d1e361cac2da</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fnchembio1207-739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio1207-739%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DRecognizing%2520and%2520exploiting%2520differences%2520between%2520RNAi%2520and%2520small-molecule%2520inhibitors%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D739%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Iyer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastidar, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Prostaglandin E(2) synthase inhibition as a therapeutic target</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1517%2F14728220903018932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1ynsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=849-865&author=J.+P.+Iyerauthor=P.+K.+Srivastavaauthor=R.+Devauthor=S.+G.+Dastidarauthor=A.+Ray&title=Prostaglandin+E%282%29+synthase+inhibition+as+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E2 synthase inhibition as a therapeutic target</span></div><div class="casAuthors">Iyer, Jitesh P.; Srivastava, Punit K.; Dev, Rishabh; Dastidar, Sunanda G.; Ray, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">849-865</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Most NSAIDs function by inhibiting biosynthesis of PGE2 by inhibition of COX-1 and/or COX-2.  Since COX-1 has a protective function in the gastro-intestinal tract (GIT), non-selective inhibition of both cycloxygenases leads to moderate to severe gastro-intestinal intolerance.  Attempts to identify selective inhibitors of COX-2, led to the identification of celecoxib and rofecoxib.  However, long-term use of these drugs has serious adverse effects of sudden myocardial infarction and thrombosis.  Drug-mediated imbalance in the levels of prostaglandin I2 (PGI2) and thromboxane A2 (TXA2) with a bias towards TXA2 may be the primary reason for these events.  This resulted in the drugs being withdrawn from the market, leaving a need for an effective and safe anti-inflammatory drug.  Methods: Recently, the focus of research has shifted to enzymes downstream of COX in the prostaglandin biosynthetic pathway such as prostaglandin E2 synthases.  Microsomal prostaglandin E2 synthase-1 (mPGES-1) specifically isomerizes PGH2 to PGE2, under inflammatory conditions.  In this review, we examine the biol. of mPGES-1 and its role in disease.  Progress in designing mols. that can selectively inhibit mPGES-1 is reviewed.  Conclusion: mPGES-1 has the potential to be a target for anti-inflammatory therapy, devoid of adverse GIT and cardiac effects and warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9uMQHk0EPKbVg90H21EOLACvtfcHk0lgP9tF-Ui4Y9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1ynsbw%253D&md5=8001d075a55afef68c0b41e7846212ec</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1517%2F14728220903018932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220903018932%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DJ.%2BP.%26aulast%3DSrivastava%26aufirst%3DP.%2BK.%26aulast%3DDev%26aufirst%3DR.%26aulast%3DDastidar%26aufirst%3DS.%2BG.%26aulast%3DRay%26aufirst%3DA.%26atitle%3DProstaglandin%2520E%25282%2529%2520synthase%2520inhibition%2520as%2520a%2520therapeutic%2520target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D849%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Okumura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murase, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nii, A.</span><span> </span><span class="NLM_article-title">Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1211%2Fjpp.60.6.0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1SmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=723-730&author=T.+Okumuraauthor=Y.+Murataauthor=K.+Taniguchiauthor=A.+Muraseauthor=A.+Nii&title=Effects+of+the+selective+EP4+antagonist%2C+CJ-023%2C423+on+chronic+inflammation+and+bone+destruction+in+rat+adjuvant-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis</span></div><div class="casAuthors">Okumura, Takako; Murata, Yoko; Taniguchi, Kana; Murase, Akio; Nii, Aisuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Prostaglandin E2 (PGE2) produced by cyclooxygenase (COX) is a potent pro-inflammatory mediator.  We have recently discovered CJ-023,423, a highly selective antagonist of EP4 receptors, one of the PGE2 receptors.  This agent is suitable for exploring the effects of blocking EP4 receptors following oral administration in rats.  In this study, CJ-023,423 was used in rats with adjuvant-induced arthritis (AIA) to investigate the role of the EP4 receptor in chronic inflammation and bone destruction.  These effects were compared with those of rofecoxib, a selective COX-2 inhibitor.  CJ-023,423 had significant inhibitory effects on paw swelling, inflammatory biomarkers, synovial inflammation and bone destruction in AIA rats.  In particular, the inhibitory effect on paw swelling in AIA rats was comparable to that of rofecoxib.  These results suggest that PGE2 acting via the EP4 receptor is involved in the development of chronic inflammation and bone destruction, particularly with respect to edema in AIA rats.  This is the first study to confirm the in-vivo effects of EP4 receptor blockade on inflammation and bone destruction in AIA rats with a small-mol. compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFuS15liJ4JrVg90H21EOLACvtfcHk0lgP9tF-Ui4Y9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1SmsLc%253D&md5=c210aa0e8ecba42aac9675a1072214a7</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1211%2Fjpp.60.6.0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.60.6.0007%26sid%3Dliteratum%253Aachs%26aulast%3DOkumura%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DMurase%26aufirst%3DA.%26aulast%3DNii%26aufirst%3DA.%26atitle%3DEffects%2520of%2520the%2520selective%2520EP4%2520antagonist%252C%2520CJ-023%252C423%2520on%2520chronic%2520inflammation%2520and%2520bone%2520destruction%2520in%2520rat%2520adjuvant-induced%2520arthritis%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2008%26volume%3D60%26spage%3D723%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chekler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span> </span><span class="NLM_article-title">Target validation using chemical probes</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnchembio.1197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23508172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFagsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=195-199&author=M.+E.+Bunnageauthor=E.+L.+Cheklerauthor=L.+H.+Jones&title=Target+validation+using+chemical+probes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Target validation using chemical probes</span></div><div class="casAuthors">Bunnage, Mark E.; Chekler, Eugene L. Piatnitski; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">195-199</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review on the fully profiled chem. probes essential to support the unbiased interpretation of biol. expts. necessary for rigorous preclin. target validation.  We believe that by developing a 'chem. probe tool kit', and a framework for its use, chem. biol. can have a more central role in identifying targets of potential relevance to disease, avoiding many of the biases that complicate target validation as practiced currently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLwRTT4pXGxbVg90H21EOLACvtfcHk0lh5GKF9VJP2dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFagsr4%253D&md5=af0c362882191de96a8e8698ff2c9ce8</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1197%26sid%3Dliteratum%253Aachs%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DChekler%26aufirst%3DE.%2BL.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DTarget%2520validation%2520using%2520chemical%2520probes%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D195%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Simon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Determining target engagement in living systems</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">2055</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnchembio.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23508173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=200-2055&author=G.+M.+Simonauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Determining+target+engagement+in+living+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Determining target engagement in living systems</span></div><div class="casAuthors">Simon, Gabriel M.; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. probes are crit. tools for elucidating the biol. functions of proteins and can lead to new medicines for treating disease.  The pharmacol. validation of protein function requires verification that chem. probes engage their intended targets in vivo.  Here we discuss technologies, both established and emergent, for measuring target engagement in living systems and propose that detg. this parameter should become std. practice for chem. probe and drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5eudh3YJSOLVg90H21EOLACvtfcHk0lh5GKF9VJP2dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D&md5=48a97d0d8ff7a7de4f9de0e9c54a1c5c</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1211%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDetermining%2520target%2520engagement%2520in%2520living%2520systems%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D200%26epage%3D2055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Iwamura, R.; Tanaka, M.; Katsube, T.; Shibakawa, N.; Shigetomi, M.; Okanari, E.; Kanda, T.; Tokunaga, Y.; Fujiwara, H.</span><span> </span><span class="NLM_article-title">Aminopyridine compound</span>. EP 2520570 A1, <span class="NLM_day">7</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Iwamura&author=M.+Tanaka&author=T.+Katsube&author=N.+Shibakawa&author=M.+Shigetomi&author=E.+Okanari&author=T.+Kanda&author=Y.+Tokunaga&author=H.+Fujiwara&title=Aminopyridine+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIwamura%26aufirst%3DR.%26atitle%3DAminopyridine%2520compound%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Hoffmeyer, A.; Boer, R.; Hessmann, M.; Pahl, A.; Dunkern, T.; Hartung, S.; Zitt, C.; Volz, J.; Prachter, C.; Makhija, M.; Jain, H.; Gavade, S.; Prabhu, A.; Tiwari, M.; Keche, A.; Patel, S.</span><span> </span><span class="NLM_article-title">Novel ep2 receptor agonists</span>. WO2013164326 A1, <span class="NLM_day">7</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+Hoffmeyer&author=R.+Boer&author=M.+Hessmann&author=A.+Pahl&author=T.+Dunkern&author=S.+Hartung&author=C.+Zitt&author=J.+Volz&author=C.+Prachter&author=M.+Makhija&author=H.+Jain&author=S.+Gavade&author=A.+Prabhu&author=M.+Tiwari&author=A.+Keche&author=S.+Patel&title=Novel+ep2+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmeyer%26aufirst%3DA.%26atitle%3DNovel%2520ep2%2520receptor%2520agonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Old, D. W.; Dinh, D. T.</span><span> </span><span class="NLM_article-title">Substituted gama lactams as therapeutic agents</span>. US 2009/0286787, <span class="NLM_day">19</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+W.+Old&author=D.+T.+Dinh&title=Substituted+gama+lactams+as+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOld%26aufirst%3DD.%2BW.%26atitle%3DSubstituted%2520gama%2520lactams%2520as%2520therapeutic%2520agents%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Prassanna, G.; Bosworth, C. F.; Lafontaine, J. A.</span><span> </span><span class="NLM_article-title">EP2 agonist</span>. US 2008/00455 A1, <span class="NLM_day">21</span><span class="NLM_month">February</span><span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Prassanna&author=C.+F.+Bosworth&author=J.+A.+Lafontaine&title=EP2+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPrassanna%26aufirst%3DG.%26atitle%3DEP2%2520agonist%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kuei-Ju Cheng, Chien-Ming Hsieh, Kunal Nepali, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Ping Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10533-10593. <a href="https://doi.org/10.1021/acs.jmedchem.9b01033" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOcular%252BDisease%252BTherapeutics%25253A%252BDesign%252Band%252BDelivery%252Bof%252BDrugs%252Bfor%252BDiseases%252Bof%252Bthe%252BEye%26aulast%3DCheng%26aufirst%3DKuei-Ju%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D28062019%26date%3D02062020%26volume%3D63%26issue%3D19%26spage%3D10533%26epage%3D10593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radhika Amaradhi, Avijit Banik, Shabber Mohammed, Vidyavathi Patro, Asheebo Rojas, Wenyi Wang, Damoder Reddy Motati, Ray Dingledine, <span class="NLM_string-name hlFld-ContribAuthor">Thota Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 1032-1050. <a href="https://doi.org/10.1021/acs.jmedchem.9b01218" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01218%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252BWater%252BSoluble%25252C%252BBrain-Permeable%252BEP2%252BReceptor%252BAntagonist%252Bfor%252BUse%252Bin%252BCentral%252BNervous%252BSystem%252BDisease%252BModels%26aulast%3DAmaradhi%26aufirst%3DRadhika%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D14082019%26date%3D16012020%26date%3D06012020%26volume%3D63%26issue%3D3%26spage%3D1032%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thota Ganesh, Avijit Banik, Ray Dingledine, Wenyi Wang, <span class="NLM_string-name hlFld-ContribAuthor">Radhika Amaradhi</span>. </span><span class="cited-content_cbyCitation_article-title">Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (12)
                                     , 5809-5817. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00764" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00764</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00764%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DPeripherally%252BRestricted%25252C%252BHighly%252BPotent%25252C%252BSelective%25252C%252BAqueous-Soluble%252BEP2%252BAntagonist%252Bwith%252BAnti-Inflammatory%252BProperties%26aulast%3DGanesh%26aufirst%3DThota%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18072018%26date%3D06112018%26date%3D01112018%26date%3D15112018%26date%3D06112018%26volume%3D15%26issue%3D12%26spage%3D5809%26epage%3D5817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Wenzhong Yan, John D. McCorvy, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9841-9878. <a href="https://doi.org/10.1021/acs.jmedchem.8b00435" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiased%252BLigands%252Bof%252BG%252BProtein-Coupled%252BReceptors%252B%252528GPCRs%252529%25253A%252BStructure%2525E2%252580%252593Functional%252BSelectivity%252BRelationships%252B%252528SFSRs%252529%252Band%252BTherapeutic%252BPotential%26aulast%3DTan%26aufirst%3DLiang%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19032018%26date%3D10072018%26date%3D25062018%26volume%3D61%26issue%3D22%26spage%3D9841%26epage%3D9878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ryo Iwamura, Masayuki Tanaka, Eiji Okanari, Tomoko Kirihara, Noriko Odani-Kawabata, Naveed Shams, <span class="NLM_string-name hlFld-ContribAuthor">Kenji Yoneda</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6869-6891. <a href="https://doi.org/10.1021/acs.jmedchem.8b00808" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00808</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00808%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BSelective%25252C%252BNon-Prostanoid%252BEP2%252BReceptor%252BAgonist%252Bfor%252Bthe%252BTreatment%252Bof%252BGlaucoma%25253A%252BOmidenepag%252Band%252Bits%252BProdrug%252BOmidenepag%252BIsopropyl%26aulast%3DIwamura%26aufirst%3DRyo%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21052018%26date%3D30072018%26date%3D11072018%26volume%3D61%26issue%3D15%26spage%3D6869%26epage%3D6891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Koeberle</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, and <span class="hlFld-ContribAuthor ">Oliver  Werz</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 5970-5986. <a href="https://doi.org/10.1021/acs.jmedchem.5b01750" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01750%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BDevelopment%252Bof%252BMicrosomal%252BProstaglandin%252BE2%252BSynthase-1%252BInhibitors%25253A%252BChallenges%252Band%252BFuture%252BDirections%26aulast%3DKoeberle%26aufirst%3DAndreas%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D09112015%26date%3D24022016%26date%3D14072016%26date%3D20012016%26volume%3D59%26issue%3D13%26spage%3D5970%26epage%3D5986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian M.  Fox</span>, <span class="hlFld-ContribAuthor ">Hilary P.  Beck</span>, <span class="hlFld-ContribAuthor ">Philip M.  Roveto</span>, <span class="hlFld-ContribAuthor ">Frank  Kayser</span>, <span class="hlFld-ContribAuthor ">Qingwen  Cheng</span>, <span class="hlFld-ContribAuthor ">Hannah  Dou</span>, <span class="hlFld-ContribAuthor ">Toni  Williamson</span>, <span class="hlFld-ContribAuthor ">James  Treanor</span>, <span class="hlFld-ContribAuthor ">Hantao  Liu</span>, <span class="hlFld-ContribAuthor ">Lixia  Jin</span>, <span class="hlFld-ContribAuthor ">Guifen  Xu</span>, <span class="hlFld-ContribAuthor ">Ji  Ma</span>, <span class="hlFld-ContribAuthor ">Songli  Wang</span>, and <span class="hlFld-ContribAuthor ">Steven H.  Olson</span>  . </span><span class="cited-content_cbyCitation_article-title">A Selective Prostaglandin E2 Receptor Subtype 2 (EP2) Antagonist Increases the Macrophage-Mediated Clearance of Amyloid-Beta Plaques. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (13)
                                     , 5256-5273. <a href="https://doi.org/10.1021/acs.jmedchem.5b00567" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00567%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BSelective%252BProstaglandin%252BE2%252BReceptor%252BSubtype%252B2%252B%252528EP2%252529%252BAntagonist%252BIncreases%252Bthe%252BMacrophage-Mediated%252BClearance%252Bof%252BAmyloid-Beta%252BPlaques%26aulast%3DFox%26aufirst%3DBrian%2BM.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10042015%26date%3D24062015%26date%3D09072015%26date%3D10062015%26volume%3D58%26issue%3D13%26spage%3D5256%26epage%3D5273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thota  Ganesh</span>, <span class="hlFld-ContribAuthor ">Jianxiong  Jiang</span>, <span class="hlFld-ContribAuthor ">Myung-Soon  Yang</span>, and <span class="hlFld-ContribAuthor ">Ray  Dingledine</span>  . </span><span class="cited-content_cbyCitation_article-title">Lead Optimization Studies of Cinnamic Amide EP2 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (10)
                                     , 4173-4184. <a href="https://doi.org/10.1021/jm5000672" title="DOI URL">https://doi.org/10.1021/jm5000672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5000672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5000672%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252BStudies%252Bof%252BCinnamic%252BAmide%252BEP2%252BAntagonists%26aulast%3DGanesh%26aufirst%3DThota%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13012014%26date%3D05052014%26date%3D22052014%26date%3D28042014%26volume%3D57%26issue%3D10%26spage%3D4173%26epage%3D4184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger G.  Biringer</span>. </span><span class="cited-content_cbyCitation_article-title">A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Communication and Signaling</span><span> <strong>2021,</strong> <em>15 </em>
                                    (2)
                                     , 155-184. <a href="https://doi.org/10.1007/s12079-020-00585-0" title="DOI URL">https://doi.org/10.1007/s12079-020-00585-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12079-020-00585-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12079-020-00585-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Communication%2520and%2520Signaling%26atitle%3DA%252BReview%252Bof%252BProstanoid%252BReceptors%25253A%252BExpression%25252C%252BCharacterization%25252C%252BRegulation%25252C%252Band%252BMechanism%252Bof%252BAction%26aulast%3DBiringer%26aufirst%3DRoger%2BG.%26date%3D2021%26date%3D2020%26volume%3D15%26issue%3D2%26spage%3D155%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamie  Golden</span>, <span class="hlFld-ContribAuthor ">Laura  Illingworth</span>, <span class="hlFld-ContribAuthor ">Patil  Kavarian</span>, <span class="hlFld-ContribAuthor ">Oswaldo  Escobar</span>, <span class="hlFld-ContribAuthor ">Patrick  Delaplain</span>, <span class="hlFld-ContribAuthor ">Mubina  Isani</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Joanna  Lim</span>, <span class="hlFld-ContribAuthor ">Jordan  Bowling</span>, <span class="hlFld-ContribAuthor ">Brandon  Bell</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Gayer</span>, <span class="hlFld-ContribAuthor ">Anatoly  Grishin</span>, <span class="hlFld-ContribAuthor ">Henri R.  Ford</span>. </span><span class="cited-content_cbyCitation_article-title">EP2 Receptor Blockade Attenuates COX-2 Upregulation During Intestinal Inflammation. </span><span class="cited-content_cbyCitation_journal-name">Shock</span><span> <strong>2020,</strong> <em>54 </em>
                                    (3)
                                     , 394-401. <a href="https://doi.org/10.1097/SHK.0000000000001444" title="DOI URL">https://doi.org/10.1097/SHK.0000000000001444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/SHK.0000000000001444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FSHK.0000000000001444%26sid%3Dliteratum%253Aachs%26jtitle%3DShock%26atitle%3DEP2%252BReceptor%252BBlockade%252BAttenuates%252BCOX-2%252BUpregulation%252BDuring%252BIntestinal%252BInflammation%26aulast%3DGolden%26aufirst%3DJamie%26date%3D2020%26date%3D2019%26volume%3D54%26issue%3D3%26spage%3D394%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clifford L.  Eastman</span>, <span class="hlFld-ContribAuthor ">Raimondo  D'Ambrosio</span>, <span class="hlFld-ContribAuthor ">Thota  Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>172 </em>, 107907. <a href="https://doi.org/10.1016/j.neuropharm.2019.107907" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.107907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.107907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.107907%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DModulating%252Bneuroinflammation%252Band%252Boxidative%252Bstress%252Bto%252Bprevent%252Bepilepsy%252Band%252Bimprove%252Boutcomes%252Bafter%252Btraumatic%252Bbrain%252Binjury%26aulast%3DEastman%26aufirst%3DClifford%2BL.%26date%3D2020%26volume%3D172%26spage%3D107907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nethrajeith  Srinivasalu</span>, <span class="hlFld-ContribAuthor ">Sen  Zhang</span>, <span class="hlFld-ContribAuthor ">Renchang  Xu</span>, <span class="hlFld-ContribAuthor ">Peter Sol  Reinach</span>, <span class="hlFld-ContribAuthor ">Yongchao  Su</span>, <span class="hlFld-ContribAuthor ">Yun  Zhu</span>, <span class="hlFld-ContribAuthor ">Jia  Qu</span>, <span class="hlFld-ContribAuthor ">Xiangtian  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Crosstalk between EP2 and PPARα Modulates Hypoxic Signaling and Myopia Development in Guinea Pigs. </span><span class="cited-content_cbyCitation_journal-name">Investigative Opthalmology & Visual Science</span><span> <strong>2020,</strong> <em>61 </em>
                                    (8)
                                     , 44. <a href="https://doi.org/10.1167/iovs.61.8.44" title="DOI URL">https://doi.org/10.1167/iovs.61.8.44</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1167/iovs.61.8.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1167%2Fiovs.61.8.44%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigative%2520Opthalmology%2520%2526%2520Visual%2520Science%26atitle%3DCrosstalk%252Bbetween%252BEP2%252Band%252BPPAR%2525CE%2525B1%252BModulates%252BHypoxic%252BSignaling%252Band%252BMyopia%252BDevelopment%252Bin%252BGuinea%252BPigs%26aulast%3DSrinivasalu%26aufirst%3DNethrajeith%26date%3D2020%26volume%3D61%26issue%3D8%26spage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Porta</span>, <span class="hlFld-ContribAuthor ">Francesca Maria  Consonni</span>, <span class="hlFld-ContribAuthor ">Sara  Morlacchi</span>, <span class="hlFld-ContribAuthor ">Sabina  Sangaletti</span>, <span class="hlFld-ContribAuthor ">Augusto  Bleve</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Totaro</span>, <span class="hlFld-ContribAuthor ">Paola  Larghi</span>, <span class="hlFld-ContribAuthor ">Monica  Rimoldi</span>, <span class="hlFld-ContribAuthor ">Claudio  Tripodo</span>, <span class="hlFld-ContribAuthor ">Laura  Strauss</span>, <span class="hlFld-ContribAuthor ">Stefania  Banfi</span>, <span class="hlFld-ContribAuthor ">Mariangela  Storto</span>, <span class="hlFld-ContribAuthor ">Tiziana  Pressiani</span>, <span class="hlFld-ContribAuthor ">Lorenza  Rimassa</span>, <span class="hlFld-ContribAuthor ">Silvia  Tartari</span>, <span class="hlFld-ContribAuthor ">Alessandro  Ippolito</span>, <span class="hlFld-ContribAuthor ">Andrea  Doni</span>, <span class="hlFld-ContribAuthor ">Giulia  Soldà</span>, <span class="hlFld-ContribAuthor ">Stefano  Duga</span>, <span class="hlFld-ContribAuthor ">Viviana  Piccolo</span>, <span class="hlFld-ContribAuthor ">Renato  Ostuni</span>, <span class="hlFld-ContribAuthor ">Gioacchino  Natoli</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Bronte</span>, <span class="hlFld-ContribAuthor ">Fiorella  Balzac</span>, <span class="hlFld-ContribAuthor ">Emilia  Turco</span>, <span class="hlFld-ContribAuthor ">Emilio  Hirsch</span>, <span class="hlFld-ContribAuthor ">Mario P.  Colombo</span>, <span class="hlFld-ContribAuthor ">Antonio  Sica</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2020,</strong> <em>80 </em>
                                    (13)
                                     , 2874-2888. <a href="https://doi.org/10.1158/0008-5472.CAN-19-2843" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-19-2843</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-19-2843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-19-2843%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DTumor-Derived%252BProstaglandin%252BE2%252BPromotes%252Bp50%252BNF-%2525CE%2525BAB-Dependent%252BDifferentiation%252Bof%252BMonocytic%252BMDSCs%26aulast%3DPorta%26aufirst%3DChiara%26date%3D2020%26date%3D2020%26volume%3D80%26issue%3D13%26spage%3D2874%26epage%3D2888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Yue</span>, <span class="hlFld-ContribAuthor ">Ming  Hu</span>, <span class="hlFld-ContribAuthor ">Xingyi  He</span>, <span class="hlFld-ContribAuthor ">Shuang  Wu</span>, <span class="hlFld-ContribAuthor ">Jin-Heng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A radical-mediated 1,3,4-trifunctionalization cascade of 1,3-enynes with sulfinates and
              tert
              -butyl nitrite: facile access to sulfonyl isoxazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (46)
                                     , 6253-6256. <a href="https://doi.org/10.1039/D0CC01659D" title="DOI URL">https://doi.org/10.1039/D0CC01659D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC01659D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC01659D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bradical-mediated%252B1%25252C3%25252C4-trifunctionalization%252Bcascade%252Bof%252B1%25252C3-enynes%252Bwith%252Bsulfinates%252Band%252Btert%252B-butyl%252Bnitrite%25253A%252Bfacile%252Baccess%252Bto%252Bsulfonyl%252Bisoxazoles%26aulast%3DYue%26aufirst%3DXin%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D46%26spage%3D6253%26epage%3D6256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Lan  Ling</span>, <span class="hlFld-ContribAuthor ">Hironari  Akasaka</span>, <span class="hlFld-ContribAuthor ">Chang  Chen</span>, <span class="hlFld-ContribAuthor ">Colin N  Haile</span>, <span class="hlFld-ContribAuthor ">Kevin  Winoske</span>, <span class="hlFld-ContribAuthor ">Ke-He  Ruan</span>. </span><span class="cited-content_cbyCitation_article-title">The Protective Effects of Up-Regulating Prostacyclin Biosynthesis on Neuron Survival in Hippocampus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroimmune Pharmacology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (2)
                                     , 292-308. <a href="https://doi.org/10.1007/s11481-019-09896-5" title="DOI URL">https://doi.org/10.1007/s11481-019-09896-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11481-019-09896-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11481-019-09896-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroimmune%2520Pharmacology%26atitle%3DThe%252BProtective%252BEffects%252Bof%252BUp-Regulating%252BProstacyclin%252BBiosynthesis%252Bon%252BNeuron%252BSurvival%252Bin%252BHippocampus%26aulast%3DLing%26aufirst%3DQing-Lan%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D2%26spage%3D292%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francisco J.  Nunez</span>, <span class="hlFld-ContribAuthor ">Nancy A.  Schulte</span>, <span class="hlFld-ContribAuthor ">David M.  Fogel</span>, <span class="hlFld-ContribAuthor ">Joel  Michalski</span>, <span class="hlFld-ContribAuthor ">Stephen I.  Rennard</span>, <span class="hlFld-ContribAuthor ">Raymond B.  Penn</span>, <span class="hlFld-ContribAuthor ">Myron L.  Toews</span>, <span class="hlFld-ContribAuthor ">Rennolds S  Ostrom</span>. </span><span class="cited-content_cbyCitation_article-title">Agonist-specific desensitization of PGE2-stimulated cAMP signaling due to upregulated phosphodiesterase expression in human lung fibroblasts. </span><span class="cited-content_cbyCitation_journal-name">Naunyn-Schmiedeberg's Archives of Pharmacology</span><span> <strong>2020,</strong> <em>393 </em>
                                    (5)
                                     , 843-856. <a href="https://doi.org/10.1007/s00210-019-01800-5" title="DOI URL">https://doi.org/10.1007/s00210-019-01800-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00210-019-01800-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00210-019-01800-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Archives%2520of%2520Pharmacology%26atitle%3DAgonist-specific%252Bdesensitization%252Bof%252BPGE2-stimulated%252BcAMP%252Bsignaling%252Bdue%252Bto%252Bupregulated%252Bphosphodiesterase%252Bexpression%252Bin%252Bhuman%252Blung%252Bfibroblasts%26aulast%3DNunez%26aufirst%3DFrancisco%2BJ.%26date%3D2020%26date%3D2019%26volume%3D393%26issue%3D5%26spage%3D843%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rebecca  Rothe</span>, <span class="hlFld-ContribAuthor ">Sabine  Schulze</span>, <span class="hlFld-ContribAuthor ">Christin  Neuber</span>, <span class="hlFld-ContribAuthor ">Sandra  Hauser</span>, <span class="hlFld-ContribAuthor ">Stefan  Rammelt</span>, <span class="hlFld-ContribAuthor ">Jens  Pietzsch</span>, , . </span><span class="cited-content_cbyCitation_article-title">Adjuvant drug-assisted bone healing: Part I – Modulation of inflammation. </span><span class="cited-content_cbyCitation_journal-name">Clinical Hemorheology and Microcirculation</span><span> <strong>2020,</strong> <em>73 </em>
                                    (3)
                                     , 381-408. <a href="https://doi.org/10.3233/CH-199102" title="DOI URL">https://doi.org/10.3233/CH-199102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/CH-199102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FCH-199102%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Hemorheology%2520and%2520Microcirculation%26atitle%3DAdjuvant%252Bdrug-assisted%252Bbone%252Bhealing%25253A%252BPart%252BI%252B%2525E2%252580%252593%252BModulation%252Bof%252Binflammation%26aulast%3DRothe%26aufirst%3DRebecca%26date%3D2020%26volume%3D73%26issue%3D3%26spage%3D381%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shilpa  Choudhary</span>, <span class="hlFld-ContribAuthor ">Carol  Pilbeam</span>. </span><span class="cited-content_cbyCitation_article-title">Prostaglandins and bone metabolism. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1247-1269. <a href="https://doi.org/10.1016/B978-0-12-814841-9.00051-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-814841-9.00051-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-814841-9.00051-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-814841-9.00051-8%26sid%3Dliteratum%253Aachs%26atitle%3DProstaglandins%252Band%252Bbone%252Bmetabolism%26aulast%3DChoudhary%26aufirst%3DShilpa%26date%3D2020%26spage%3D1247%26epage%3D1269%26pub%3DElsevier%26atitle%3DPrinciples%252Bof%252BBone%252BBiology%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chitra  Rawat</span>, <span class="hlFld-ContribAuthor ">Samiksha  Kukal</span>, <span class="hlFld-ContribAuthor ">Ujjwal Ranjan  Dahiya</span>, <span class="hlFld-ContribAuthor ">Ritushree  Kukreti</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2019,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-019-1592-3" title="DOI URL">https://doi.org/10.1186/s12974-019-1592-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-019-1592-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-019-1592-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DCyclooxygenase-2%252B%252528COX-2%252529%252Binhibitors%25253A%252Bfuture%252Btherapeutic%252Bstrategies%252Bfor%252Bepilepsy%252Bmanagement%26aulast%3DRawat%26aufirst%3DChitra%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nobuaki  Tanaka</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Nariyasu  Mano</span>. </span><span class="cited-content_cbyCitation_article-title">Involvement of H+-gradient dependent transporter in PGE2 release from A549 cells. </span><span class="cited-content_cbyCitation_journal-name">Prostaglandins, Leukotrienes and Essential Fatty Acids</span><span> <strong>2019,</strong> <em>149 </em>, 30-36. <a href="https://doi.org/10.1016/j.plefa.2019.08.003" title="DOI URL">https://doi.org/10.1016/j.plefa.2019.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.plefa.2019.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.plefa.2019.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520and%2520Essential%2520Fatty%2520Acids%26atitle%3DInvolvement%252Bof%252BH%25252B-gradient%252Bdependent%252Btransporter%252Bin%252BPGE2%252Brelease%252Bfrom%252BA549%252Bcells%26aulast%3DTanaka%26aufirst%3DNobuaki%26date%3D2019%26volume%3D149%26spage%3D30%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel  Hofbauer</span>, <span class="hlFld-ContribAuthor ">Ashkan  Salamatipour</span>, <span class="hlFld-ContribAuthor ">Ian A.  Blair</span>, <span class="hlFld-ContribAuthor ">Clementina  Mesaros</span>. </span><span class="cited-content_cbyCitation_article-title">Sample Preparation for LC‐MS Bioanalysis of Lipids. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 275-283. <a href="https://doi.org/10.1002/9781119274315.ch22" title="DOI URL">https://doi.org/10.1002/9781119274315.ch22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119274315.ch22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119274315.ch22%26sid%3Dliteratum%253Aachs%26atitle%3DSample%252BPreparation%252Bfor%252BLC%2525E2%252580%252590MS%252BBioanalysis%252Bof%252BLipids%26aulast%3DHofbauer%26aufirst%3DSamuel%26date%3D2019%26date%3D2019%26spage%3D275%26epage%3D283%26pub%3DWiley%26atitle%3DSample%252BPreparation%252Bin%252BLC%2525E2%252580%252590MS%252BBioanalysis%26aulast%3DLi%26aufirst%3DWenkui%26date%3D2019%26date%3D2019%26volume%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asheebo  Rojas</span>, <span class="hlFld-ContribAuthor ">Di  Chen</span>, <span class="hlFld-ContribAuthor ">Thota  Ganesh</span>, <span class="hlFld-ContribAuthor ">Nicholas H.  Varvel</span>, <span class="hlFld-ContribAuthor ">Raymond  Dingledine</span>. </span><span class="cited-content_cbyCitation_article-title">The COX-2/prostanoid signaling cascades in seizure disorders. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2019,</strong> <em>23 </em>
                                    (1)
                                     , 1-13. <a href="https://doi.org/10.1080/14728222.2019.1554056" title="DOI URL">https://doi.org/10.1080/14728222.2019.1554056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2019.1554056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2019.1554056%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DThe%252BCOX-2%25252Fprostanoid%252Bsignaling%252Bcascades%252Bin%252Bseizure%252Bdisorders%26aulast%3DRojas%26aufirst%3DAsheebo%26date%3D2019%26date%3D2018%26volume%3D23%26issue%3D1%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Artemis  Matsou</span>, <span class="hlFld-ContribAuthor ">Eleftherios  Anastasopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2018,</strong> <em>27 </em>
                                    (10)
                                     , 777-785. <a href="https://doi.org/10.1080/13543784.2018.1526279" title="DOI URL">https://doi.org/10.1080/13543784.2018.1526279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2018.1526279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2018.1526279%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bdrugs%252Btargeting%252Bprostaglandin%252Breceptors%252Bfor%252Bthe%252Btreatment%252Bof%252Bglaucoma%26aulast%3DMatsou%26aufirst%3DArtemis%26date%3D2018%26date%3D2018%26volume%3D27%26issue%3D10%26spage%3D777%26epage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarak  Srivastava</span>, <span class="hlFld-ContribAuthor ">Sundaram  Hariharan</span>, <span class="hlFld-ContribAuthor ">Uri S.  Alon</span>, <span class="hlFld-ContribAuthor ">Ellen T.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Ram  Sharma</span>, <span class="hlFld-ContribAuthor ">Ashraf  El-Meanawy</span>, <span class="hlFld-ContribAuthor ">Virginia J.  Savin</span>, <span class="hlFld-ContribAuthor ">Mukut  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor. </span><span class="cited-content_cbyCitation_journal-name">Transplantation</span><span> <strong>2018,</strong> <em>102 </em>
                                    (10)
                                     , 1624-1635. <a href="https://doi.org/10.1097/TP.0000000000002304" title="DOI URL">https://doi.org/10.1097/TP.0000000000002304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/TP.0000000000002304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FTP.0000000000002304%26sid%3Dliteratum%253Aachs%26jtitle%3DTransplantation%26atitle%3DHyperfiltration-mediated%252BInjury%252Bin%252Bthe%252BRemaining%252BKidney%252Bof%252Ba%252BTransplant%252BDonor%26aulast%3DSrivastava%26aufirst%3DTarak%26date%3D2018%26volume%3D102%26issue%3D10%26spage%3D1624%26epage%3D1635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing-Yu  Xiao</span>, <span class="hlFld-ContribAuthor ">Bing-Rui  Xiong</span>, <span class="hlFld-ContribAuthor ">Wen  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen-Chang  Zhou</span>, <span class="hlFld-ContribAuthor ">Hui  Yang</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>, <span class="hlFld-ContribAuthor ">Hong-Bing  Xiang</span>, <span class="hlFld-ContribAuthor ">Anne  Manyande</span>, <span class="hlFld-ContribAuthor ">Xue-Bi  Tian</span>, <span class="hlFld-ContribAuthor ">Yu-Ke  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">PGE2-EP3 signaling exacerbates hippocampus-dependent cognitive impairment after laparotomy by reducing expression levels of hippocampal synaptic plasticity-related proteins in aged mice. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2018,</strong> <em>24 </em>
                                    (10)
                                     , 917-929. <a href="https://doi.org/10.1111/cns.12832" title="DOI URL">https://doi.org/10.1111/cns.12832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cns.12832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcns.12832%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3DPGE2-EP3%252Bsignaling%252Bexacerbates%252Bhippocampus-dependent%252Bcognitive%252Bimpairment%252Bafter%252Blaparotomy%252Bby%252Breducing%252Bexpression%252Blevels%252Bof%252Bhippocampal%252Bsynaptic%252Bplasticity-related%252Bproteins%252Bin%252Baged%252Bmice%26aulast%3DXiao%26aufirst%3DJing-Yu%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D10%26spage%3D917%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoting  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review). </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Medicine</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/ijmm.2018.3744" title="DOI URL">https://doi.org/10.3892/ijmm.2018.3744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijmm.2018.3744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijmm.2018.3744%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Medicine%26atitle%3DProstaglandin%252BEP2%252Breceptor%25253A%252BNovel%252Btherapeutic%252Btarget%252Bfor%252Bhuman%252Bcancers%252B%252528Review%252529%26aulast%3DSun%26aufirst%3DXiaoting%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena I.  Fedoros</span>, <span class="hlFld-ContribAuthor ">Alexey A.  Orlov</span>, <span class="hlFld-ContribAuthor ">Alexander  Zherebker</span>, <span class="hlFld-ContribAuthor ">Ekaterina A.  Gubareva</span>, <span class="hlFld-ContribAuthor ">Mikhail A.  Maydin</span>, <span class="hlFld-ContribAuthor ">Andrey I.  Konstantinov</span>, <span class="hlFld-ContribAuthor ">Konstantin A.  Krasnov</span>, <span class="hlFld-ContribAuthor ">Ruben N.  Karapetian</span>, <span class="hlFld-ContribAuthor ">Ekaterina I.  Izotova</span>, <span class="hlFld-ContribAuthor ">Sergey E.  Pigarev</span>, <span class="hlFld-ContribAuthor ">Andrey V.  Panchenko</span>, <span class="hlFld-ContribAuthor ">Margarita L.  Tyndyk</span>, <span class="hlFld-ContribAuthor ">Dmitry I.  Osolodkin</span>, <span class="hlFld-ContribAuthor ">Evgeny N.  Nikolaev</span>, <span class="hlFld-ContribAuthor ">Irina V.  Perminova</span>, <span class="hlFld-ContribAuthor ">Vladimir N.  Anisimov</span>. </span><span class="cited-content_cbyCitation_article-title">Novel water-soluble lignin derivative BP-Cx-1: identification of components and screening of potential targets
              in silico
              and
              in vitro. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (26)
                                     , 18578-18593. <a href="https://doi.org/10.18632/oncotarget.24990" title="DOI URL">https://doi.org/10.18632/oncotarget.24990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.24990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.24990%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DNovel%252Bwater-soluble%252Blignin%252Bderivative%252BBP-Cx-1%25253A%252Bidentification%252Bof%252Bcomponents%252Band%252Bscreening%252Bof%252Bpotential%252Btargets%252Bin%252Bsilico%252Band%252Bin%252Bvitro%26aulast%3DFedoros%26aufirst%3DElena%2BI.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D26%26spage%3D18578%26epage%3D18593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonard F.  Lebender</span>, <span class="hlFld-ContribAuthor ">Laura  Prünte</span>, <span class="hlFld-ContribAuthor ">Nowshin N.  Rumzhum</span>, <span class="hlFld-ContribAuthor ">Alaina J.  Ammit</span>. </span><span class="cited-content_cbyCitation_article-title">Selectively targeting prostanoid E (EP) receptor-mediated cell signalling pathways: Implications for lung health and disease. </span><span class="cited-content_cbyCitation_journal-name">Pulmonary Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>49 </em>, 75-87. <a href="https://doi.org/10.1016/j.pupt.2018.01.008" title="DOI URL">https://doi.org/10.1016/j.pupt.2018.01.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pupt.2018.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pupt.2018.01.008%26sid%3Dliteratum%253Aachs%26jtitle%3DPulmonary%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DSelectively%252Btargeting%252Bprostanoid%252BE%252B%252528EP%252529%252Breceptor-mediated%252Bcell%252Bsignalling%252Bpathways%25253A%252BImplications%252Bfor%252Blung%252Bhealth%252Band%252Bdisease%26aulast%3DLebender%26aufirst%3DLeonard%2BF.%26date%3D2018%26volume%3D49%26spage%3D75%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khurshed  Bozorov</span>, <span class="hlFld-ContribAuthor ">Li Fei  Nie</span>, <span class="hlFld-ContribAuthor ">Jiangyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Haji A.  Aisa</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminothiophene scaffolds: Diverse biological and pharmacological attributes in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>140 </em>, 465-493. <a href="https://doi.org/10.1016/j.ejmech.2017.09.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminothiophene%252Bscaffolds%25253A%252BDiverse%252Bbiological%252Band%252Bpharmacological%252Battributes%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DBozorov%26aufirst%3DKhurshed%26date%3D2017%26volume%3D140%26spage%3D465%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Alexanian</span>, <span class="hlFld-ContribAuthor ">Andrey  Sorokin</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclooxygenase 2: protein-protein interactions and posttranslational modifications. </span><span class="cited-content_cbyCitation_journal-name">Physiological Genomics</span><span> <strong>2017,</strong> <em>49 </em>
                                    (11)
                                     , 667-681. <a href="https://doi.org/10.1152/physiolgenomics.00086.2017" title="DOI URL">https://doi.org/10.1152/physiolgenomics.00086.2017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/physiolgenomics.00086.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fphysiolgenomics.00086.2017%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Genomics%26atitle%3DCyclooxygenase%252B2%25253A%252Bprotein-protein%252Binteractions%252Band%252Bposttranslational%252Bmodifications%26aulast%3DAlexanian%26aufirst%3DAnna%26date%3D2017%26volume%3D49%26issue%3D11%26spage%3D667%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aline Carré  Santos</span>, <span class="hlFld-ContribAuthor ">Fernanda Rossatto  Temp</span>, <span class="hlFld-ContribAuthor ">Joseane Righes  Marafiga</span>, <span class="hlFld-ContribAuthor ">Micheli Mainardi  Pillat</span>, <span class="hlFld-ContribAuthor ">Amanda Titzel  Hessel</span>, <span class="hlFld-ContribAuthor ">Leandro Rodrigo  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Lígia Gomes  Miyazato</span>, <span class="hlFld-ContribAuthor ">Mauro Schneider  Oliveira</span>, <span class="hlFld-ContribAuthor ">Carlos Fernando  Mello</span>. </span><span class="cited-content_cbyCitation_article-title">EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Epilepsy & Behavior</span><span> <strong>2017,</strong> <em>73 </em>, 180-188. <a href="https://doi.org/10.1016/j.yebeh.2017.03.033" title="DOI URL">https://doi.org/10.1016/j.yebeh.2017.03.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yebeh.2017.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yebeh.2017.03.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEpilepsy%2520%2526%2520Behavior%26atitle%3DEP2%252Breceptor%252Bagonist%252BONO-AE1-259-01%252Battenuates%252Bpentylenetetrazole-%252Band%252Bpilocarpine-induced%252Bseizures%252Bbut%252Bcauses%252Bhippocampal%252Bneurotoxicity%26aulast%3DSantos%26aufirst%3DAline%2BCarr%25C3%25A9%26date%3D2017%26volume%3D73%26spage%3D180%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Cooper</span>, <span class="hlFld-ContribAuthor ">Sameek  Singh</span>, <span class="hlFld-ContribAuthor ">Sarah  Hook</span>, <span class="hlFld-ContribAuthor ">Joel D. A.  Tyndall</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Vernall</span>, . </span><span class="cited-content_cbyCitation_article-title">Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2017,</strong> <em>69 </em>
                                    (3)
                                     , 316-353. <a href="https://doi.org/10.1124/pr.116.013243" title="DOI URL">https://doi.org/10.1124/pr.116.013243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.116.013243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.116.013243%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DChemical%252BTools%252Bfor%252BStudying%252BLipid-Binding%252BClass%252BA%252BG%252BProtein%2525E2%252580%252593Coupled%252BReceptors%26aulast%3DCooper%26aufirst%3DAnna%26date%3D2017%26date%3D2017%26volume%3D69%26issue%3D3%26spage%3D316%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji-Young  An</span>, <span class="hlFld-ContribAuthor ">Hwi-Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Ji-Sun  Shin</span>, <span class="hlFld-ContribAuthor ">Hyung-Seok  Yoo</span>, <span class="hlFld-ContribAuthor ">Jong Seon  Park</span>, <span class="hlFld-ContribAuthor ">Seung Hwan  Son</span>, <span class="hlFld-ContribAuthor ">Sang Won  Kim</span>, <span class="hlFld-ContribAuthor ">Jihyun  Yu</span>, <span class="hlFld-ContribAuthor ">Jun  Lee</span>, <span class="hlFld-ContribAuthor ">Kyung-Tae  Lee</span>, <span class="hlFld-ContribAuthor ">Nam-Jung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and structure activity relationship of novel flavone derivatives that inhibit the production of nitric oxide and PGE 2 in LPS-induced RAW 264.7 cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2613-2616. <a href="https://doi.org/10.1016/j.bmcl.2017.03.057" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.057%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Band%252Bstructure%252Bactivity%252Brelationship%252Bof%252Bnovel%252Bflavone%252Bderivatives%252Bthat%252Binhibit%252Bthe%252Bproduction%252Bof%252Bnitric%252Boxide%252Band%252BPGE%252B2%252Bin%252BLPS-induced%252BRAW%252B264.7%252Bcells%26aulast%3DAn%26aufirst%3DJi-Young%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2613%26epage%3D2616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Zhen  Xu</span>, <span class="hlFld-ContribAuthor ">Ai  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Prostaglandin E2 EP4 Receptor Activation Attenuates Neuroinflammation and Early Brain Injury Induced by Subarachnoid Hemorrhage in Rats. </span><span class="cited-content_cbyCitation_journal-name">Neurochemical Research</span><span> <strong>2017,</strong> <em>42 </em>
                                    (4)
                                     , 1267-1278. <a href="https://doi.org/10.1007/s11064-016-2168-6" title="DOI URL">https://doi.org/10.1007/s11064-016-2168-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11064-016-2168-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11064-016-2168-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemical%2520Research%26atitle%3DProstaglandin%252BE2%252BEP4%252BReceptor%252BActivation%252BAttenuates%252BNeuroinflammation%252Band%252BEarly%252BBrain%252BInjury%252BInduced%252Bby%252BSubarachnoid%252BHemorrhage%252Bin%252BRats%26aulast%3DXu%26aufirst%3DJie%26date%3D2017%26date%3D2017%26volume%3D42%26issue%3D4%26spage%3D1267%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adarsh S  Gandhi</span>, <span class="hlFld-ContribAuthor ">David  Budac</span>, <span class="hlFld-ContribAuthor ">Tanzilya  Khayrullina</span>, <span class="hlFld-ContribAuthor ">Roland  Staal</span>, <span class="hlFld-ContribAuthor ">Gamini  Chandrasena</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative analysis of lipids: a higher-throughput LC–MS/MS-based method and its comparison to ELISA. </span><span class="cited-content_cbyCitation_journal-name">Future Science OA</span><span> <strong>2017,</strong> <em>3 </em>
                                    (1)
                                     , FSO157. <a href="https://doi.org/10.4155/fsoa-2016-0067" title="DOI URL">https://doi.org/10.4155/fsoa-2016-0067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fsoa-2016-0067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffsoa-2016-0067%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Science%2520OA%26atitle%3DQuantitative%252Banalysis%252Bof%252Blipids%25253A%252Ba%252Bhigher-throughput%252BLC%2525E2%252580%252593MS%25252FMS-based%252Bmethod%252Band%252Bits%252Bcomparison%252Bto%252BELISA%26aulast%3DGandhi%26aufirst%3DAdarsh%2BS%26date%3D2017%26volume%3D3%26issue%3D1%26spage%3DFSO157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Etheresia  Pretorius</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of Hypercoagulation and Aberrant Clot Lyses in Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 377-393. <a href="https://doi.org/10.1007/978-3-319-60324-7_17" title="DOI URL">https://doi.org/10.1007/978-3-319-60324-7_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-60324-7_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-60324-7_17%26sid%3Dliteratum%253Aachs%26atitle%3DMechanisms%252Bof%252BHypercoagulation%252Band%252BAberrant%252BClot%252BLyses%252Bin%252BType%252B2%252BDiabetes%26aulast%3DPretorius%26aufirst%3DEtheresia%26date%3D2017%26date%3D2017%26spage%3D377%26epage%3D393%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMechanisms%252Bof%252BVascular%252BDefects%252Bin%252BDiabetes%252BMellitus%26aulast%3DKartha%26aufirst%3DC.C.%26date%3D2017%26volume%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.L.  Adams</span>, <span class="hlFld-ContribAuthor ">K.J.  Duffy</span>, <span class="hlFld-ContribAuthor ">M.L.  Moore</span>, <span class="hlFld-ContribAuthor ">J.  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer Immunotherapy—An Emerging Field That Bridges Oncology and Immunology Research. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 357-394. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12400-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12400-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12400-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12400-X%26sid%3Dliteratum%253Aachs%26atitle%3DCancer%252BImmunotherapy%2525E2%252580%252594An%252BEmerging%252BField%252BThat%252BBridges%252BOncology%252Band%2525C2%2525A0Immunology%252BResearch%26aulast%3DAdams%26aufirst%3DJ.L.%26date%3D2017%26spage%3D357%26epage%3D394%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tijana  Markovič</span>, <span class="hlFld-ContribAuthor ">Žiga  Jakopin</span>, <span class="hlFld-ContribAuthor ">Marija Sollner  Dolenc</span>, <span class="hlFld-ContribAuthor ">Irena  Mlinarič-Raščan</span>. </span><span class="cited-content_cbyCitation_article-title">Structural features of subtype-selective EP receptor modulators. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (1)
                                     , 57-71. <a href="https://doi.org/10.1016/j.drudis.2016.08.003" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DStructural%252Bfeatures%252Bof%252Bsubtype-selective%252BEP%252Breceptor%252Bmodulators%26aulast%3DMarkovi%25C4%258D%26aufirst%3DTijana%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D57%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annika Gustafsson  Asting</span>, <span class="hlFld-ContribAuthor ">Britt-Marie  Iresjö</span>, <span class="hlFld-ContribAuthor ">Camilla  Nilsberth</span>, <span class="hlFld-ContribAuthor ">Ulrika  Smedh</span>, <span class="hlFld-ContribAuthor ">Kent  Lundholm</span>. </span><span class="cited-content_cbyCitation_article-title">Host knockout of E-prostanoid 2 receptors reduces tumor growth and causes major alterations of gene expression in prostaglandin E2-producing tumors. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2017,</strong> <em>13 </em>
                                    (1)
                                     , 476-482. <a href="https://doi.org/10.3892/ol.2016.5448" title="DOI URL">https://doi.org/10.3892/ol.2016.5448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2016.5448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2016.5448%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DHost%252Bknockout%252Bof%252BE-prostanoid%252B2%252Breceptors%252Breduces%252Btumor%252Bgrowth%252Band%252Bcauses%252Bmajor%252Balterations%252Bof%252Bgene%252Bexpression%252Bin%252Bprostaglandin%252BE2-producing%252Btumors%26aulast%3DAsting%26aufirst%3DAnnika%2BGustafsson%26date%3D2017%26date%3D2016%26volume%3D13%26issue%3D1%26spage%3D476%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Consalvi</span>, <span class="hlFld-ContribAuthor ">Mariangela  Biava</span>, <span class="hlFld-ContribAuthor ">Giovanna  Poce</span>. </span><span class="cited-content_cbyCitation_article-title">COX inhibitors: a patent review (2011 – 2014). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (12)
                                     , 1357-1371. <a href="https://doi.org/10.1517/13543776.2015.1090973" title="DOI URL">https://doi.org/10.1517/13543776.2015.1090973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1090973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1090973%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCOX%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282011%252B%2525E2%252580%252593%252B2014%252529%26aulast%3DConsalvi%26aufirst%3DSara%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D12%26spage%3D1357%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thota  Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E
              2
              receptor EP2. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 837-844. <a href="https://doi.org/10.1517/13543776.2015.1025752" title="DOI URL">https://doi.org/10.1517/13543776.2015.1025752</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1025752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1025752%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEvaluation%252Bof%252BWO%252B2012%25252F177618%252BA1%252Band%252BUS-2014%25252F0179750%252BA1%25253A%252Bnovel%252Bsmall%252Bmolecule%252Bantagonists%252Bof%252Bprostaglandin-E%252B2%252Breceptor%252BEP2%26aulast%3DGanesh%26aufirst%3DThota%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D837%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Christina S.  Verdam</span>, <span class="hlFld-ContribAuthor ">Fernanda  Guilhon-Simplicio</span>, <span class="hlFld-ContribAuthor ">Gleyce S.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Alcineide L.  Magalhães</span>, <span class="hlFld-ContribAuthor ">Cinthya I.F.B.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Patrícia D.O.  Almeida</span>, <span class="hlFld-ContribAuthor ">Tallita M.  Machado</span>, <span class="hlFld-ContribAuthor ">Marne C.  Vasconcellos</span>, <span class="hlFld-ContribAuthor ">Emerson S.  Lima</span>, <span class="hlFld-ContribAuthor ">Débora T.  Ohana</span>, <span class="hlFld-ContribAuthor ">Maria M.  Pereira</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-inflammatory action of Justicia acuminatissima leaves. </span><span class="cited-content_cbyCitation_journal-name">Revista Brasileira de Farmacognosia</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 264-268. <a href="https://doi.org/10.1016/j.bjp.2015.05.002" title="DOI URL">https://doi.org/10.1016/j.bjp.2015.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bjp.2015.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bjp.2015.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DRevista%2520Brasileira%2520de%2520Farmacognosia%26atitle%3DAnti-inflammatory%252Baction%252Bof%252BJusticia%252Bacuminatissima%252Bleaves%26aulast%3DVerdam%26aufirst%3DMaria%2BChristina%2BS.%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D264%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhanjun  Jia</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Guixia  Ding</span>, <span class="hlFld-ContribAuthor ">Kristina Marie  Heiney</span>, <span class="hlFld-ContribAuthor ">Songming  Huang</span>, <span class="hlFld-ContribAuthor ">Aihua  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Role of COX-2/mPGES-1/Prostaglandin E2 Cascade in Kidney Injury. </span><span class="cited-content_cbyCitation_journal-name">Mediators of Inflammation</span><span> <strong>2015,</strong> <em>2015 </em>, 1-8. <a href="https://doi.org/10.1155/2015/147894" title="DOI URL">https://doi.org/10.1155/2015/147894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/147894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F147894%26sid%3Dliteratum%253Aachs%26jtitle%3DMediators%2520of%2520Inflammation%26atitle%3DRole%252Bof%252BCOX-2%25252FmPGES-1%25252FProstaglandin%252BE2%252BCascade%252Bin%252BKidney%252BInjury%26aulast%3DJia%26aufirst%3DZhanjun%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thota  Ganesh</span>, <span class="hlFld-ContribAuthor ">Jianxiong  Jiang</span>, <span class="hlFld-ContribAuthor ">Ray  Dingledine</span>. </span><span class="cited-content_cbyCitation_article-title">Development of second generation EP2 antagonists with high selectivity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>82 </em>, 521-535. <a href="https://doi.org/10.1016/j.ejmech.2014.05.076" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.05.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.05.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.05.076%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bsecond%252Bgeneration%252BEP2%252Bantagonists%252Bwith%252Bhigh%252Bselectivity%26aulast%3DGanesh%26aufirst%3DThota%26date%3D2014%26volume%3D82%26spage%3D521%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0008.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. COX/prostaglandin signaling cascade. Arachidonic acid is converted to PGG<sub>2</sub> and then to PGH<sub>2</sub> by both COX-1 and COX-2 enzymes. Cell specific synthases convert the intermediate PGH<sub>2</sub> into prostaglandin ligands, which activate one or more G coupled-prostanoid receptors. There are four receptors, DP1, EP2, EP4, and IP, which promote cAMP production. cAMP then activates PKA- and Epac-signaling. COX-2 inhibitor (red) would block every prostanoid receptor type, but an EP2 antagonist (blue) could block only one out of 11 prostanoid receptors and may avoid COX-2 inhibition mediated side effects.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PGE<sub>2</sub> via EP2 receptor stimulates the differentiation of Th0 to Th17, which exacerbates the disease progression and severity in peripheral diseases such as arthritis and IBD. Additional EP2 signaling is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. EP2 receptors are involved in a variety of CNS and peripheral diseases. EP2 receptors shown to play a protective role in models of stroke, bone fracture, and glaucoma, but mouse models of cancer, endometriosis, AD, PD, ALS, arthritis, and IBD suggest EP2 promotes inflammatory cascade or exacerbates disease pathology. Thus EP2 may be targeted for discovery of therapeutics for these diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of EP2 agonists, EP2 allosteric potentiator, and EP2 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. EP2 mediates both beneficial and deleterious effects by G protein-coupled and G protein-independent downstream mechanisms. Upon PGE<sub>2</sub> binding, EP2 activates and dissociates Gas protein. Then Gas regulates activities of various effectors. Abbreviations used: PKA = protein kinase A, CREB = cAMP responsive binding element protein, PI3K = phosphatidylinositol-3-kinase, ERK = extracellular signal regulated kinase, JNK = c-Jun N-terminal kinase, EGFR = epidermal growth factor receptor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. General structural scaffolds of EP2 antagonists reported in the patent literature. EP2 inhibition activity range from nanomolar to micromolar among the members in each class is shown here for comparison purposes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/medium/jm-2013-01431x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Two potential therapeutic strategies that may be useful for EP2 receptor mediated effects in the brain for neuroprotection and for blocking the neurodegeneration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm401431x/production/images/large/jm-2013-01431x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401431x&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 125 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lucas, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothwell, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R. M.</span><span> </span><span class="NLM_article-title">The role of inflammation in CNS injury and disease</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S232</span><span class="NLM_x">–</span> <span class="NLM_lpage">S240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S232-S240&issue=Suppl+1&author=S.+M.+Lucasauthor=N.+J.+Rothwellauthor=R.+M.+Gibson&title=The+role+of+inflammation+in+CNS+injury+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DS.%2BM.%26aulast%3DRothwell%26aufirst%3DN.%2BJ.%26aulast%3DGibson%26aufirst%3DR.%2BM.%26atitle%3DThe%2520role%2520of%2520inflammation%2520in%2520CNS%2520injury%2520and%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26issue%3DSuppl%25201%26spage%3DS232%26epage%3DS240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Minghetti, L.</span><span> </span><span class="NLM_article-title">Role of inflammation in neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1097%2F01.wco.0000169752.54191.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=15891419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslWht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=315-321&author=L.+Minghetti&title=Role+of+inflammation+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Role of inflammation in neurodegenerative diseases</span></div><div class="casAuthors">Minghetti, Luisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Although significant advances have been made in the knowledge of degenerative diseases, there remains controversy regarding whether neuroinflammation and microglial activation are beneficial or detrimental.  Strategies aimed at both preventing and boosting microglial activation are presently under investigation, and these studies might reveal new potentially effective treatments for these neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFq64evVEgCLVg90H21EOLACvtfcHk0lipkUwEAfSUQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslWht7Y%253D&md5=6cbc4795a09f1014e26eb0b0f8ad2100</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2F01.wco.0000169752.54191.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wco.0000169752.54191.97%26sid%3Dliteratum%253Aachs%26aulast%3DMinghetti%26aufirst%3DL.%26atitle%3DRole%2520of%2520inflammation%2520in%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2005%26volume%3D18%26spage%3D315%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Baumgart, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carding, S. R.</span><span> </span><span class="NLM_article-title">Gastroenterology 1—Inflammatory bowel disease: cause and immunobiology</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=1627-1640&author=D.+C.+Baumgartauthor=S.+R.+Carding&title=Gastroenterology+1%E2%80%94Inflammatory+bowel+disease%3A+cause+and+immunobiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgart%26aufirst%3DD.%2BC.%26aulast%3DCarding%26aufirst%3DS.%2BR.%26atitle%3DGastroenterology%25201%25E2%2580%2594Inflammatory%2520bowel%2520disease%253A%2520cause%2520and%2520immunobiology%26jtitle%3DLancet%26date%3D2007%26volume%3D369%26spage%3D1627%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schett, G.</span><span> </span><span class="NLM_article-title">The pathogenesis of rheumatoid arthritis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">2205</span><span class="NLM_x">–</span> <span class="NLM_lpage">2219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1056%2FNEJMra1004965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=22150039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ajsrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=2205-2219&author=I.+B.+McInnesauthor=G.+Schett&title=The+pathogenesis+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The pathogenesis of rheumatoid arthritis</span></div><div class="casAuthors">McInnes, Lain B.; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2205-2219</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review discusses key pathogenic advances in rheumatoid arthritis, genetics, environmental factors, immunol. processes, inflammation, and structural damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJslDVaG7MxbVg90H21EOLACvtfcHk0lipkUwEAfSUQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ajsrrM&md5=31a79ccb05bca03f207b15f934b2d52d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1004965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1004965%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DThe%2520pathogenesis%2520of%2520rheumatoid%2520arthritis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D2205%26epage%3D2219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sethi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahler, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yawn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S.</span><span> </span><span class="NLM_article-title">Inflammation in COPD: implications for management</span> <span class="citation_source-journal">Am. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.amjmed.2012.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3s7ks1aruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2012&pages=1162-1170&author=S.+Sethiauthor=D.+A.+Mahlerauthor=P.+Marcusauthor=C.+A.+Owenauthor=B.+Yawnauthor=S.+Rennard&title=Inflammation+in+COPD%3A+implications+for+management"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation in COPD: implications for management</span></div><div class="casAuthors">Sethi Sanjay; Mahler Donald A; Marcus Philip; Owen Caroline A; Yawn Barbara; Rennard Stephen</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1162-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) is recognized by the Global Initiative for Chronic Obstructive Lung Disease guidelines as an inflammatory disease state, and treatment rationales are provided accordingly.  However, not all physicians follow or are even aware of these guidelines.  Research has shown that COPD inflammation involves multiple inflammatory cells and mediators and the underlying pathology differs from asthma inflammation.  For these reasons, therapeutic agents that are effective in asthma patients may not be optimal in COPD patients.  COPD exacerbations are intensified inflammatory events compared with stable COPD.  The clinical and systemic consequences believed to result from the chronic inflammation observed in COPD suggest that inflammation intensity is a key factor in COPD and exacerbation severity and frequency.  Although inhaled corticosteroids are commonly used and are essential in asthma management, their efficacy in COPD is limited, with only a modest effect at reducing exacerbations.  The importance of inflammation in COPD needs to be better understood by clinicians, and the differences in inflammation in COPD versus asthma should be considered carefully to optimize the use of anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzQskOX44WUjEwO064Z95rfW6udTcc2ebUD356ABKjQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7ks1aruw%253D%253D&md5=3cc2174d2b8a69585346c756f3ca3d39</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.amjmed.2012.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjmed.2012.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DSethi%26aufirst%3DS.%26aulast%3DMahler%26aufirst%3DD.%2BA.%26aulast%3DMarcus%26aufirst%3DP.%26aulast%3DOwen%26aufirst%3DC.%2BA.%26aulast%3DYawn%26aufirst%3DB.%26aulast%3DRennard%26aufirst%3DS.%26atitle%3DInflammation%2520in%2520COPD%253A%2520implications%2520for%2520management%26jtitle%3DAm.%2520J.%2520Med.%26date%3D2012%26volume%3D125%26spage%3D1162%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Tabas, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, C. K.</span><span> </span><span class="NLM_article-title">Anti-inflammatory therapy in chronic disease: challenges and opportunities</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1126%2Fscience.1230720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23307734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=166-172&author=I.+Tabasauthor=C.+K.+Glass&title=Anti-inflammatory+therapy+in+chronic+disease%3A+challenges+and+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities</span></div><div class="casAuthors">Tabas, Ira; Glass, Christopher K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6116</span>),
    <span class="NLM_cas:pages">166-172</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  A no. of widespread and devastating chronic diseases, including atherosclerosis, type 2 diabetes, and Alzheimer's disease, have a pathophysiol. important inflammatory component.  In these diseases, the precise identity of the inflammatory stimulus is often unknown and, if known, is difficult to remove.  Thus, there is interest in therapeutically targeting the inflammatory response.  Although there has been success with anti-inflammatory therapy in chronic diseases triggered by primary inflammation dysregulation or autoimmunity, there are considerable limitations.  In particular, the inflammatory response is crit. for survival.  As a result, redundancy, compensatory pathways, and necessity narrow the risk:benefit ratio of anti-inflammatory drugs.  However, new advances in understanding inflammatory signaling and its links to resoln. pathways, together with new drug development, offer promise in this area of translational biomedical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru6vCXZUnqN7Vg90H21EOLACvtfcHk0lgusvVdXtEASA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVCnuw%253D%253D&md5=7f05ebe4e34eb363f11bdc891350e7f2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1230720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1230720%26sid%3Dliteratum%253Aachs%26aulast%3DTabas%26aufirst%3DI.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26atitle%3DAnti-inflammatory%2520therapy%2520in%2520chronic%2520disease%253A%2520challenges%2520and%2520opportunities%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D166%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Akiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, N. R.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Inflammation and Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2FS0197-4580%2800%2900124-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=10858586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVSmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=383-421&author=H.+Akiyamaauthor=S.+Bargerauthor=S.+Barnumauthor=B.+Bradtauthor=J.+Bauerauthor=G.+M.+Coleauthor=N.+R.+Cooper&title=Inflammation+and+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and Alzheimer's disease</span></div><div class="casAuthors">Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G. M.; Cooper, N. R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B. L.; Finch, C. E.; Frautschy, S.; Griffin, W. S. T.; Hampel, H.; Hull, M.; Landreth, G.; Lue, L.-F.; Mrak, R.; Mackenzie, I. R.; McGeer, P. L.; O'Banion, M. K.; Pachter, J.; Pasinetti, G.; Plata-Salaman, C.; Rogers, J.; Rydel, R.; Shen, Y.; Streit, W.; Strohmeyer, R.; Tooyoma, I.; Van Muiswinkel, F. L.; Veerhuis, R.; Walker, D.; Webster, S.; Wegrzyniak, B.; Wenk, G.; Wyss-Coray, T.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">383-421</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 636 refs.  Inflammation clearly occurs in pathol. vulnerable regions of the Alzheimer's disease (AD) brain, and it does so with the full complexity of local peripheral inflammatory responses.  In the periphery, degenerating tissue and the deposition of highly insol. abnormal materials are classical stimulants of inflammation.  Likewise, in the AD brain damaged neurons and neurites and highly insol. amyloid β peptide deposits and neurofibrillary tangles provide obvious stimuli for inflammation.  Because these stimuli are discrete, microlocalized, and present from early preclin. to terminal stages of AD, local upregulation of complement, cytokines, acute-phase reactants, and other inflammatory mediators is also discrete, microlocalized, and chronic.  Cumulated over many years, direct and bystander damage from AD inflammatory mechanisms is likely to exacerbate the very pathogenic processes that gave rise to it.  Thus, animal models and clin. studies, although still in their infancy, strongly suggest that AD inflammation contributes to AD pathogenesis.  By better understanding AD inflammatory and immunoregulatory processes, it should be possible to develop anti-inflammatory approaches that may not cure AD but will likely help slow the progression or delay the onset of this devastating disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr72c3W8HExubVg90H21EOLACvtfcHk0lgusvVdXtEASA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVSmt74%253D&md5=409a0ca2920ef2cba12474cb7d05f4aa</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2800%2900124-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252800%252900124-X%26sid%3Dliteratum%253Aachs%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DBarger%26aufirst%3DS.%26aulast%3DBarnum%26aufirst%3DS.%26aulast%3DBradt%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DJ.%26aulast%3DCole%26aufirst%3DG.%2BM.%26aulast%3DCooper%26aufirst%3DN.%2BR.%26atitle%3DInflammation%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2000%26volume%3D21%26spage%3D383%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Heneka, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Banion, M. K.</span><span> </span><span class="NLM_article-title">Inflammatory processes in Alzheimer’s disease</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.jneuroim.2006.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=17222916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXislejtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2007&pages=69-91&author=M.+T.+Henekaauthor=M.+K.+O%E2%80%99Banion&title=Inflammatory+processes+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory processes in Alzheimer's disease</span></div><div class="casAuthors">Heneka, Michael T.; O'Banion, M. Kerry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">69-91</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Generation and deposition of amyloid beta peptides and neurofibrillary tangle formation are key mechanisms involved in AD pathogenesis.  Recent evidence suggests that inflammatory mechanisms represent a third component which, once initiated by degeneration, may significantly contribute to disease progression and chronicity.  Various neuroinflammatory mediators including complement activators and inhibitors, chemokines, cytokines, radical oxygen species and inflammatory enzymes are generated and released by microglia, astrocytes and neurons.  Degeneration of aminergic brain stem nuclei such as the locus ceruleus and the nucleus baslis of Meynert may facilitate the occurrence of inflammation in their resp. projection areas given the antiinflammatory and neuroprotective action of their key products norepinephrine and acetylcholine.  While inflammation has been thought to arise secondary to degeneration, recent expts. demonstrated that inflammatory mediators may stimulate APP processing by upregulation of beta secretase 1 and therefore are able to establish a vicious cycle.  Despite the fact that some aspects of inflammation may even exert protective effects to bystander neurons, antiinflammatory treatment strategies should therefore be considered.  Non-steroidal antiinflammatory drugs have been shown to reduce the risk and delay the onset to develop AD.  However, the precise mol. mechanism underlying this effect is still being debated.  Several mechanisms including inhibition of cyclooxygenase 2, gamma secretase or activation of the peroxisome proliferator activated receptor gamma may alone or, more likely, in concert account for the epidemiol. obsd. protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUnTmvRLIgtrVg90H21EOLACvtfcHk0lgusvVdXtEASA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXislejtLo%253D&md5=d06c7d14ee09331a8a1432d0f3740264</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2006.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2006.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DO%25E2%2580%2599Banion%26aufirst%3DM.%2BK.%26atitle%3DInflammatory%2520processes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2007%26volume%3D184%26spage%3D69%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ferrari, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarelli, R.</span><span> </span><span class="NLM_article-title">Parkinson’s disease and systemic inflammation</span> <span class="citation_source-journal">Parkinsons Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">436813</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><div class="note"><p class="first last">9 pp.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436813&publication_year=2011&pages=9&author=C.+C.+Ferrariauthor=R.+Tarelli&title=Parkinson%E2%80%99s+disease+and+systemic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DC.%2BC.%26aulast%3DTarelli%26aufirst%3DR.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520and%2520systemic%2520inflammation%26jtitle%3DParkinsons%2520Dis.%26date%3D2011%26volume%3D436813%26spage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Inflammation and Parkinson’s disease pathogenesis</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S55</span><span class="NLM_x">–</span> <span class="NLM_lpage">S57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=S55-S57&issue=Suppl+1&author=S.+Przedborski&title=Inflammation+and+Parkinson%E2%80%99s+disease+pathogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DInflammation%2520and%2520Parkinson%25E2%2580%2599s%2520disease%2520pathogenesis%26jtitle%3DMov.%2520Disord.%26date%3D2010%26volume%3D25%26issue%3DSuppl%25201%26spage%3DS55%26epage%3DS57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Vezzani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronica, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazarati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittman, Q. J.</span><span> </span><span class="NLM_article-title">Epilepsy and brain inflammation</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.expneurol.2011.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21985866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntV2gu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2013&pages=11-21&author=A.+Vezzaniauthor=E.+Aronicaauthor=A.+Mazaratiauthor=Q.+J.+Pittman&title=Epilepsy+and+brain+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Epilepsy and brain inflammation</span></div><div class="casAuthors">Vezzani, Annamaria; Aronica, Eleonora; Mazarati, Andrey; Pittman, Quentin J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-21</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  During the last decade, exptl. research has demonstrated a prominent role of glial cells, activated in brain by various injuries, in the mechanisms of seizure pptn. and recurrence.  In particular, alterations in the phenotype and function of activated astrocytes and microglial cells have been described in exptl. and human epileptic tissue, including modifications in potassium and water channels, alterations of glutamine/glutamate cycle, changes in glutamate receptor expression and transporters, release of neuromodulatory mols. (e.g. gliotransmitters, neurotrophic factors), and induction of mols. involved in inflammatory processes (e.g. cytokines, chemokines, prostaglandins, complement factors, cell adhesion mols.) (Seifert et al., 2006; Vezzani et al., 2011; Wetherington et al., 2008).  In particular, brain injury or proconvulsant events can activate microglia and astrocytes to release a no. of proinflammatory mediators, thus initiating a cascade of inflammatory processes in brain tissue.  Proinflammatory mols. can alter neuronal excitability and affect the physiol. functions of glia by paracrine or autocrine actions, thus perturbing the glioneuronal communications.  In exptl. models, these changes contribute to decreasing the threshold to seizures and may compromise neuronal survival (Riazi et al., 2010; Vezzani et al., 2008).  In this context, understanding which are the sol. mediators and the mol. mechanisms crucially involved in glio-neuronal interactions is instrumental to shed light on how brain inflammation may contribute to neuronal hyperexcitability in epilepsy.  This review will report the clin. observations in drug-resistant human epilepsies and the exptl. findings in adult and immature rodents linking brain inflammation to the epileptic process in a causal and reciprocal manner.  By confronting the clin. evidence with the exptl. findings, we will discuss the role of specific sol. inflammatory mediators in the etiopathogenesis of seizures, reporting evidence for both their acute and long term effects on seizure threshold.  The possible contribution of these mediators to co-morbidities often described in epilepsy patients will be also discussed.  Finally, we will report on the anti-inflammatory treatments with anticonvulsant actions in exptl. models highlighting possible therapeutic options for treating drug-resistant seizures and for prevention of epileptogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3phEZ4D9TULVg90H21EOLACvtfcHk0lg-7yk2cMp9hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntV2gu7g%253D&md5=21506046fc3ff021e246cdb511b4e358</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2011.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2011.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DVezzani%26aufirst%3DA.%26aulast%3DAronica%26aufirst%3DE.%26aulast%3DMazarati%26aufirst%3DA.%26aulast%3DPittman%26aufirst%3DQ.%2BJ.%26atitle%3DEpilepsy%2520and%2520brain%2520inflammation%26jtitle%3DExp.%2520Neurol.%26date%3D2013%26volume%3D244%26spage%3D11%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Vezzani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balosso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravizza, T.</span><span> </span><span class="NLM_article-title">Inflammation and epilepsy</span> <span class="citation_source-journal">Handb. Clin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2FB978-0-444-52898-8.00010-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC38bjsFelsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=163-175&author=A.+Vezzaniauthor=S.+Balossoauthor=T.+Ravizza&title=Inflammation+and+epilepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and epilepsy</span></div><div class="casAuthors">Vezzani Annamaria; Balosso Silvia; Ravizza Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of clinical neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">163-75</span>
        ISSN:<span class="NLM_cas:issn">0072-9752</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQox4gD7Gi_p5dYoSR9eyvsfW6udTcc2eb4BHln6rULArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bjsFelsw%253D%253D&md5=807caa42771e3af01b8acc6a3d67bb68</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-52898-8.00010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-52898-8.00010-0%26sid%3Dliteratum%253Aachs%26aulast%3DVezzani%26aufirst%3DA.%26aulast%3DBalosso%26aufirst%3DS.%26aulast%3DRavizza%26aufirst%3DT.%26atitle%3DInflammation%2520and%2520epilepsy%26jtitle%3DHandb.%2520Clin.%2520Neurol.%26date%3D2012%26volume%3D107%26spage%3D163%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Vezzani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartfai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baram, T. Z.</span><span> </span><span class="NLM_article-title">The role of inflammation in epilepsy</span> <span class="citation_source-journal">Nature Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnrneurol.2010.178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1OmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=31-40&author=A.+Vezzaniauthor=J.+Frenchauthor=T.+Bartfaiauthor=T.+Z.+Baram&title=The+role+of+inflammation+in+epilepsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The role of inflammation in epilepsy</span></div><div class="casAuthors">Vezzani, Annamaria; French, Jacqueline; Bartfai, Tamas; Baram, Tallie Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Relatively little is known about the mechanisms and processes that lead to the generation of seizures in patients with epilepsy, and this lack of knowledge hampers the development of treatments and cures.  In this article, Vezzani et al. provide an overview of the involvement of inflammatory mediators in epileptic seizures.  Gaining insights into the role of inflammation should yield new mol. targets for the design of antiepileptic drugs.  Epilepsy is the third most common chronic brain disorder, and is characterized by an enduring predisposition to generate seizures.  Despite progress in pharmacol. and surgical treatments of epilepsy, relatively little is known about the processes leading to the generation of individual seizures, and about the mechanisms whereby a healthy brain is rendered epileptic.  These gaps in our knowledge hamper the development of better preventive treatments and cures for the ≈30% of epilepsy cases that prove resistant to current therapies.  Here, we focus on the rapidly growing body of evidence that supports the involvement of inflammatory mediators-released by brain cells and peripheral immune cells-in both the origin of individual seizures and the epileptogenic process.  We first describe aspects of brain inflammation and immunity, before exploring the evidence from clin. and exptl. studies for a relationship between inflammation and epilepsy.  Subsequently, we discuss how seizures cause inflammation, and whether such inflammation, in turn, influences the occurrence and severity of seizures, and seizure-related neuronal death.  Further insight into the complex role of inflammation in the generation and exacerbation of epilepsy should yield new mol. targets for the design of antiepileptic drugs, which might not only inhibit the symptoms of this disorder, but also prevent or abrogate disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZXR_EQsILxbVg90H21EOLACvtfcHk0lg-7yk2cMp9hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1OmtA%253D%253D&md5=08b7773b0139313e77d4a233c55167fc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2010.178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2010.178%26sid%3Dliteratum%253Aachs%26aulast%3DVezzani%26aufirst%3DA.%26aulast%3DFrench%26aufirst%3DJ.%26aulast%3DBartfai%26aufirst%3DT.%26aulast%3DBaram%26aufirst%3DT.%2BZ.%26atitle%3DThe%2520role%2520of%2520inflammation%2520in%2520epilepsy%26jtitle%3DNature%2520Rev.%2520Neurol.%26date%3D2011%26volume%3D7%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Vezzani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R. J.</span><span> </span><span class="NLM_article-title">The role of inflammation in epileptogenesis</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=16-24&author=A.+Vezzaniauthor=A.+Friedmanauthor=R.+J.+Dingledine&title=The+role+of+inflammation+in+epileptogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVezzani%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DA.%26aulast%3DDingledine%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520role%2520of%2520inflammation%2520in%2520epileptogenesis%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D69%26spage%3D16%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">McGeer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeer, E. G.</span><span> </span><span class="NLM_article-title">Inflammatory processes in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Muscle Nerve</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2002&pages=459-470&author=P.+L.+McGeerauthor=E.+G.+McGeer&title=Inflammatory+processes+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGeer%26aufirst%3DP.%2BL.%26aulast%3DMcGeer%26aufirst%3DE.%2BG.%26atitle%3DInflammatory%2520processes%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DMuscle%2520Nerve%26date%3D2002%26volume%3D26%26spage%3D459%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Nagamoto-Combs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeal, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morecraft, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, C. K.</span><span> </span><span class="NLM_article-title">Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury</span> <span class="citation_source-journal">J. Neurotrauma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1742</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1089%2Fneu.2007.0377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=18001202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BD2snnslKksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2007&pages=1719-1742&author=K.+Nagamoto-Combsauthor=D.+W.+McNealauthor=R.+J.+Morecraftauthor=C.+K.+Combs&title=Prolonged+microgliosis+in+the+rhesus+monkey+central+nervous+system+after+traumatic+brain+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury</span></div><div class="casAuthors">Nagamoto-Combs Kumi; McNeal David W; Morecraft Robert J; Combs Colin K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1719-42</span>
        ISSN:<span class="NLM_cas:issn">0897-7151</span>.
    </div><div class="casAbstract">Impaired fine motor functions after traumatic brain injury (TBI) in humans and non-human primates often continue to improve months after injury.  To initiate a series of studies in the primate model designed to investigate possible involvement of microglia/macrophage in the long-term recovery processes, changes in these cells were studied in the rhesus monkey central nervous system at 1, 6, and 12 months after a combined unilateral lesion of the arm area of the primary motor cortex and arm area of the lateral premotor cortex.  Immunohistological studies showed profound CD68 immunoreactivity in the lesion area and the contralateral lateral corticospinal tract in the spinal cord at all time points, demonstrating that microglia/macrophage remain reactive at the sites of injury and axonal degeneration/survival for at least 12 months.  We also observed marked increases in brain-derived neurotrophic factor (BDNF) and its receptor subtypes, TrkB[gp145] and TrkB[TK-], around the cortical lesion site after 6-month survival.  Similar increases were also observed in the spinal cord, although it was less apparent for TrkB[gp145].  Double-labeling revealed that a subpopulation of CD68-immunoreacitve microglia/macrophage co-expressed BDNF in the cortex and spinal cord, and also TrkB[gp145] or TrkB[TK-] in the spinal cord.  In contrast, cytokine expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interleukin-6 (IL-6) at these time intervals was less prominent, suggesting that immediate inflammatory responses had subsided.  These results demonstrate that microglia/macrophage undergo prolonged activation after TBI in the non-human primate brain and express BDNF and its receptors, suggesting their tropic/trophic roles in the long-term recovery processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpwL6y37wYDBgd2Wuil24tfW6udTcc2eY9OBGzfiwAEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snnslKksQ%253D%253D&md5=15bc8f12575575f81c0271daf090478c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1089%2Fneu.2007.0377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2007.0377%26sid%3Dliteratum%253Aachs%26aulast%3DNagamoto-Combs%26aufirst%3DK.%26aulast%3DMcNeal%26aufirst%3DD.%2BW.%26aulast%3DMorecraft%26aufirst%3DR.%2BJ.%26aulast%3DCombs%26aufirst%3DC.%2BK.%26atitle%3DProlonged%2520microgliosis%2520in%2520the%2520rhesus%2520monkey%2520central%2520nervous%2520system%2520after%2520traumatic%2520brain%2520injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2007%26volume%3D24%26spage%3D1719%26epage%3D1742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ramlackhansingh, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwood, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkheimer, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnunen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentleman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckemann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunanayagam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, D. J.</span><span> </span><span class="NLM_article-title">Inflammation after trauma: microglial activation and traumatic brain injury</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2Fana.22455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21710619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3MfitFCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=374-383&author=A.+F.+Ramlackhansinghauthor=D.+J.+Brooksauthor=R.+J.+Greenwoodauthor=S.+K.+Boseauthor=F.+E.+Turkheimerauthor=K.+M.+Kinnunenauthor=S.+Gentlemanauthor=R.+A.+Heckemannauthor=K.+Gunanayagamauthor=G.+Gelosaauthor=D.+J.+Sharp&title=Inflammation+after+trauma%3A+microglial+activation+and+traumatic+brain+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation after trauma: microglial activation and traumatic brain injury</span></div><div class="casAuthors">Ramlackhansingh Anil F; Brooks David J; Greenwood Richard J; Bose Subrata K; Turkheimer Federico E; Kinnunen Kirsi M; Gentleman Steve; Heckemann Rolf A; Gunanayagam Karen; Gelosa Giorgio; Sharp David J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">374-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Patient outcome after traumatic brain injury (TBI) is highly variable.  The underlying pathophysiology of this is poorly understood, but inflammation is potentially an important factor.  Microglia orchestrate many aspects of this response.  Their activation can be studied in vivo using the positron emission tomography (PET) ligand [11C](R)PK11195 (PK).  In this study, we investigate whether an inflammatory response to TBI persists, and whether this response relates to structural brain abnormalities and cognitive function.  METHODS:  Ten patients, studied at least 11 months after moderate to severe TBI, underwent PK PET and structural magnetic resonance imaging (including diffusion tensor imaging).  PK binding potentials were calculated in and around the site of focal brain damage, and in selected distant and subcortical brain regions.  Standardized neuropsychological tests were administered.  RESULTS:  PK binding was significantly raised in the thalami, putamen, occipital cortices, and posterior limb of the internal capsules after TBI.  There was no increase in PK binding at the original site of focal brain injury.  High PK binding in the thalamus was associated with more severe cognitive impairment, although binding was not correlated with either the time since the injury or the extent of structural brain damage.  INTERPRETATION:  We demonstrate that increased microglial activation can be present up to 17 years after TBI.  This suggests that TBI triggers a chronic inflammatory response particularly in subcortical regions.  This highlights the importance of considering the response to TBI as evolving over time and suggests interventions may be beneficial for longer intervals after trauma than previously assumed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuaFbXMB7kxJagfuraLLzSfW6udTcc2eY9OBGzfiwAEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MfitFCnuw%253D%253D&md5=6471bbc334c28ee0f03d4e39d4d70192</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fana.22455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22455%26sid%3Dliteratum%253Aachs%26aulast%3DRamlackhansingh%26aufirst%3DA.%2BF.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DGreenwood%26aufirst%3DR.%2BJ.%26aulast%3DBose%26aufirst%3DS.%2BK.%26aulast%3DTurkheimer%26aufirst%3DF.%2BE.%26aulast%3DKinnunen%26aufirst%3DK.%2BM.%26aulast%3DGentleman%26aufirst%3DS.%26aulast%3DHeckemann%26aufirst%3DR.%2BA.%26aulast%3DGunanayagam%26aufirst%3DK.%26aulast%3DGelosa%26aufirst%3DG.%26aulast%3DSharp%26aufirst%3DD.%2BJ.%26atitle%3DInflammation%2520after%2520trauma%253A%2520microglial%2520activation%2520and%2520traumatic%2520brain%2520injury%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D70%26spage%3D374%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Turini, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, R. N.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2: a therapeutic target</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2002&pages=35-57&author=M.+E.+Turiniauthor=R.+N.+DuBois&title=Cyclooxygenase-2%3A+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurini%26aufirst%3DM.%2BE.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26atitle%3DCyclooxygenase-2%253A%2520a%2520therapeutic%2520target%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2002%26volume%3D53%26spage%3D35%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Davies, N. M.</span><span> </span><span class="NLM_article-title">Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine</span> <span class="citation_source-journal">Dis. Colon Rectum</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1007%2FBF02049158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=7497845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADyaK287gtFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1311-1121&author=N.+M.+Davies&title=Toxicity+of+nonsteroidal+anti-inflammatory+drugs+in+the+large+intestine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine</span></div><div class="casAuthors">Davies N M</div><div class="citationInfo"><span class="NLM_cas:title">Diseases of the colon and rectum</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1311-21</span>
        ISSN:<span class="NLM_cas:issn">0012-3706</span>.
    </div><div class="casAbstract">PURPOSE:  Adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDS) on the upper gastrointestinal (GI) tract and small intestine are well described.  Evidence is also accumulating that implicate NSAIDS in inducing and exacerbating damage in the distal GI tract.  The purpose of this review is to identify possible adverse effects of NSAIDS on the large intestine and increase the clinical awareness of these toxicologic effects.  METHODS:  A literature review identified the diversity of toxicologic effects induced by NSAIDS in the large intestine.  The epidemiology, pathogenesis, and clinical implications of these adverse effects are described.  RESULTS:  NSAID use has been associated with colonic bleeding, iron deficiency anemia, strictures, ulcerations, perforations, diarrhea, and death.  In addition, NSAIDS can exacerbate inflammatory bowel disease and ulcerative colitis.  The prevalence of NSAID-induced large intestinal damage is unknown.  Diagnosis can be made by colonoscopy and barium scans.  Although the clinical presentation of NSAID-induced gastropathy and enteropathy, bleeding or perforation, may be more dramatic than colonopathy, the overall clinical significance of these adverse effects of NSAIDS on the large intestine has not been fully characterized.  CONCLUSIONS:  This review illustrates that NSAID-induced large bowel toxicity can cause significant morbidity in some patients, ranging from profuse diarrhea, chronic blood loss, and iron deficiency anemia to fatality.  The pathogenesis is likely multifactorial and is thought to be related to inhibition of prostaglandin synthesis.  Because NSAIDS are widely prescribed and some are available without a prescription, heightened awareness of these toxicologic manifestations throughout the GI tract may reduce morbidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4iCgcs9PWFxfKb6ELK8t0fW6udTcc2eY9OBGzfiwAEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287gtFGlsQ%253D%253D&md5=dad5beb858de832f17cc3cf09868bb38</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2FBF02049158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02049158%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DN.%2BM.%26atitle%3DToxicity%2520of%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520in%2520the%2520large%2520intestine%26jtitle%3DDis.%2520Colon%2520Rectum%26date%3D1995%26volume%3D38%26spage%3D1311%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Murray, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brater, D. C.</span><span> </span><span class="NLM_article-title">Renal toxicity of the nonsteroidal anti-inflammatory drugs</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1993&pages=435-465&author=M.+D.+Murrayauthor=D.+C.+Brater&title=Renal+toxicity+of+the+nonsteroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DM.%2BD.%26aulast%3DBrater%26aufirst%3DD.%2BC.%26atitle%3DRenal%2520toxicity%2520of%2520the%2520nonsteroidal%2520anti-inflammatory%2520drugs%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1993%26volume%3D33%26spage%3D435%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Knights, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangoni, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miners, J. O.</span><span> </span><span class="NLM_article-title">Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity</span> <span class="citation_source-journal">Expert Rev. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1586%2Fecp.10.120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVCjsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=769-776&author=K.+M.+Knightsauthor=A.+A.+Mangoniauthor=J.+O.+Miners&title=Defining+the+COX+inhibitor+selectivity+of+NSAIDs%3A+implications+for+understanding+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity</span></div><div class="casAuthors">Knights, Kathleen M.; Mangoni, Arduino A.; Miners, John O.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">769-776</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The hypothesis that the anti-inflammatory activity of NSAIDs derives from COX inhibition is well established.  It also underpins the accepted mechanism of the gastrointestinal and renal toxicity of NSAIDs.  However, in terms of NSAID-induced cardiovascular toxicity, is COX inhibition then guilty by assocn. Multiple exptl. models of COX-1/COX-2 inhibition have enabled ranking of the relative inhibitory activity of NSAIDs.  Inhibition is expressed as an IC50 value and the index of COX selectivity as the ratio of the IC50 value for COX-2 and COX-1.  These data informed the imbalance hypothesis' that the cardiovascular risk of NSAIDs results from an imbalance in the detrimental actions of COX-1-derived thromboxane A2 and the beneficial actions of COX-2-derived prostacyclin (PGI2).  Data derived from in vitro models used to generate NSAID IC50 values are discussed in the context of the difficulties in defining COX selectivity and hence understanding the toxicity of NSAIDs in current clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzdgl8xodkfrVg90H21EOLACvtfcHk0ljZzz1_iDHH_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVCjsbnN&md5=e7af1b58553876d622732e19403fc5ca</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1586%2Fecp.10.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fecp.10.120%26sid%3Dliteratum%253Aachs%26aulast%3DKnights%26aufirst%3DK.%2BM.%26aulast%3DMangoni%26aufirst%3DA.%2BA.%26aulast%3DMiners%26aufirst%3DJ.%2BO.%26atitle%3DDefining%2520the%2520COX%2520inhibitor%2520selectivity%2520of%2520NSAIDs%253A%2520implications%2520for%2520understanding%2520toxicity%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D3%26spage%3D769%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Anderson, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGarity, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremer, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, S. A.</span><span> </span><span class="NLM_article-title">Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2672</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1996&pages=2672-2679&author=G.+D.+Andersonauthor=S.+D.+Hauserauthor=K.+L.+McGarityauthor=M.+E.+Bremerauthor=P.+C.+Isaksonauthor=S.+A.+Gregory&title=Selective+inhibition+of+cyclooxygenase+%28COX%29-2+reverses+inflammation+and+expression+of+COX-2+and+interleukin+6+in+rat+adjuvant+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DG.%2BD.%26aulast%3DHauser%26aufirst%3DS.%2BD.%26aulast%3DMcGarity%26aufirst%3DK.%2BL.%26aulast%3DBremer%26aufirst%3DM.%2BE.%26aulast%3DIsakson%26aufirst%3DP.%2BC.%26aulast%3DGregory%26aufirst%3DS.%2BA.%26atitle%3DSelective%2520inhibition%2520of%2520cyclooxygenase%2520%2528COX%2529-2%2520reverses%2520inflammation%2520and%2520expression%2520of%2520COX-2%2520and%2520interleukin%25206%2520in%2520rat%2520adjuvant%2520arthritis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1996%26volume%3D97%26spage%3D2672%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kang, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freire-Moar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigal, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. Q.</span><span> </span><span class="NLM_article-title">Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis</span> <span class="citation_source-journal">Br. J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1093%2Frheumatology%2F35.8.711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=8761181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaK28XmsFWlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=711-718&author=R.+Y.+Kangauthor=J.+Freire-Moarauthor=E.+Sigalauthor=C.+Q.+Chu&title=Expression+of+cyclooxygenase-2+in+human+and+an+animal+model+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis</span></div><div class="casAuthors">Kang, R. Y.; Freire-Moar, J.; Sigal, E.; Chu, C. -Q.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Rheumatology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-718</span>CODEN:
                <span class="NLM_cas:coden">BJRHDF</span>;
        ISSN:<span class="NLM_cas:issn">0263-7103</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">An inducible form of cyclooxygenase-2 (COX-2) has been shown to be upregulated in vitro by various pro-inflammatory agents, such as lipopolysaccharide, IL-1 and TNF.  COX-2 appears to be responsible for the increase in prostaglandin synthesis at the site of inflammation.  To examine the involvement of COX-2 in inflammation, we analyzed the expression of this gene in human rheumatoid arthritis (RA) and in rat adjuvant-induced arthritis.  Immunocytochem. studies of synovial membrane biopsies from human RA, osteoarthritic (OA) and normal joints using a COX-2 specific antibody showed pos. staining in RA, but not in normal synovial membranes.  Specifically, expression of COX-2 was detected in synovial lining cells, lymphoid aggregates and endothelial cells of blood vessels.  Although some pos. staining was obsd. in the OA joints, the no. of stained cells was dramatically lower and the staining of the cells was less intense than in the rheumatoid tissue.  By reverse transcription and polymerase chain reaction anal., COX-2 mRNA was detected in the rat adjuvant arthritic limb, whereas no COX-2 mRNA was detectable in the normal limb.  These observations indicate that COX-2 expression is upregulated in inflammatory joint disease and that COX-2 is a potential therapeutic target for specific inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCj8czAXbB9LVg90H21EOLACvtfcHk0ljZzz1_iDHH_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsFWlu7o%253D&md5=8f0e3915319601eb98d9b36b603b1964</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2F35.8.711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252F35.8.711%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DR.%2BY.%26aulast%3DFreire-Moar%26aufirst%3DJ.%26aulast%3DSigal%26aufirst%3DE.%26aulast%3DChu%26aufirst%3DC.%2BQ.%26atitle%3DExpression%2520of%2520cyclooxygenase-2%2520in%2520human%2520and%2520an%2520animal%2520model%2520of%2520rheumatoid%2520arthritis%26jtitle%3DBr.%2520J.%2520Rheumatol.%26date%3D1996%26volume%3D35%26spage%3D711%26epage%3D718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">DeWitt, D. L.</span><span> </span><span class="NLM_article-title">Cox-2-selective inhibitors: the new super aspirins</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">631</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=10101019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaK1MXisVCgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=625-631&author=D.+L.+DeWitt&title=Cox-2-selective+inhibitors%3A+the+new+super+aspirins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cox-2-selective inhibitors: the new super aspirins</span></div><div class="casAuthors">DeWitt, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">625-631</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review, with 35 refs. describing a new family of cyclooxygenase-2 isoenzyme inhibitors.  The author discusses the rationale for Cox-2-selective drugs, development of Cox-2-selective inhibitors, and mechanism of nonsteroidal anti-inflammatory drug inhibition of Cox-1 and Cox-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cLRNAKHt4rVg90H21EOLACvtfcHk0ljZzz1_iDHH_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisVCgs70%253D&md5=afbe2a13a17d8f9a3793535e344daf58</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeWitt%26aufirst%3DD.%2BL.%26atitle%3DCox-2-selective%2520inhibitors%253A%2520the%2520new%2520super%2520aspirins%26jtitle%3DMol.%2520Pharmacol.%26date%3D1999%26volume%3D55%26spage%3D625%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Tacconelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capone, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciulli, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricciotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrignani, P.</span><span> </span><span class="NLM_article-title">The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1185%2F030079902125001335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=12564662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Wku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=503-511&author=S.+Tacconelliauthor=M.+L.+Caponeauthor=M.+G.+Sciulliauthor=E.+Ricciottiauthor=P.+Patrignani&title=The+biochemical+selectivity+of+novel+COX-2+inhibitors+in+whole+blood+assays+of+COX-isozyme+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity</span></div><div class="casAuthors">Tacconelli, Stefania; Capone, Marta L.; Sciulli, Maria G.; Ricciotti, Emanuela; Patrignani, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">503-511</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">We have evaluated the biochem. selectivity of novel cyclo-oxygenase (COX)-2 inhibitors, etoricoxib, valdecoxib/, DFU and DFP, vs. rofecoxib and celecoxib, using the human whole blood assays of COX-isoenzyme activity, in vitro.  Compds. were incubated with human whole blood samples, allowed to clot for 1 h at 37°, or stimulated with lipopolysaccharide (10 μg/mL) for 24 h at 37°.  Serum thromboxane (TX) B2 and plasma prostaglandin (PG) E2 levels were measured by specific RIAs as indexes of platelet COX-1 and monocyte COX-2 activity, resp.  Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, resp.  The ref. compds., celecoxib and rofecoxib had corresponding values of 29.6 and 272.  In conclusion, a second wave of COX-2 inhibitors with higher biochem. selectivity than the existing coxibs has been developed.  Whether their administration will be assocd. with improved clin. efficacy and/or safety visa-vis celecoxib and rofecoxib remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXp52P5XevwrVg90H21EOLACvtfcHk0ljNS1hjHuguTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Wku7c%253D&md5=6adbff0cb04b5f79618387d63efef8d5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1185%2F030079902125001335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079902125001335%26sid%3Dliteratum%253Aachs%26aulast%3DTacconelli%26aufirst%3DS.%26aulast%3DCapone%26aufirst%3DM.%2BL.%26aulast%3DSciulli%26aufirst%3DM.%2BG.%26aulast%3DRicciotti%26aufirst%3DE.%26aulast%3DPatrignani%26aufirst%3DP.%26atitle%3DThe%2520biochemical%2520selectivity%2520of%2520novel%2520COX-2%2520inhibitors%2520in%2520whole%2520blood%2520assays%2520of%2520COX-isozyme%2520activity%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2002%26volume%3D18%26spage%3D503%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Cannon, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidenberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, B.</span><span> </span><span class="NLM_article-title">Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">978</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2F1529-0131%28200005%2943%3A5%3C978%3A%3AAID-ANR4%3E3.0.CO%3B2-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=10817549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvVeitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=978-987&author=G.+W.+Cannonauthor=J.+R.+Caldwellauthor=P.+Holtauthor=B.+McLeanauthor=B.+Seidenbergauthor=J.+Bologneseauthor=E.+Ehrichauthor=S.+Mukhopadhyayauthor=B.+Daniels&title=Rofecoxib%2C+a+specific+inhibitor+of+cyclooxygenase+2%2C+with+clinical+efficacy+comparable+with+that+of+diclofenac+sodium%3A+results+of+a+one-year%2C+randomized%2C+clinical+trial+in+patients+with+osteoarthritis+of+the+knee+and+hip.+Rofecoxib+Phase+III+Protocol+035+Study+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip</span></div><div class="casAuthors">Cannon, Grant W.; Caldwell, Jacques R.; Holt, Peter; McLean, Barry; Seidenberg, Beth; Bolognese, James; Ehrich, Elliot; Mukhopadhyay, Suarabh; Daniels, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">978-987</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective. To compare the clin. efficacy of rofecoxib, a specific inhibitor of cyclooxygenase 2 (COX-2), with that of diclofenac in patients with osteoarthritis (OA) and to evaluate the safety and tolerability of rofecoxib.  Methods. We performed a randomized, double-blind, active comparator-controlled trial in 784 adults with OA of the knee or hip.  Patients were randomized to 1 of 3 treatment groups: 12.5 mg of rofecoxib once daily, 25 mg of rofecoxib once daily, and 50 mg of diclofenac 3 times daily.  Clin. efficacy and safety were evaluated over a 1-yr continuous treatment period.  Results. Rofecoxib at dosages of 12.5 and 25 mg demonstrated efficacy that was clin. comparable to that of diclofenac, as assessed by all 3 primary end points according to predefined comparability criteria.  Results from secondary end points were consistent with those of the primary end points.  There were small statistical differences favoring diclofenac for 2 of the end points.  All treatments were well tolerated.  Conclusion. Rofecoxib was well tolerated and provided efficacy that was clin. comparable, according to predefined statistical criteria, to that of 150 mg of diclofenac per day in this 1-yr study.  Specific inhibition of COX-2 provided therapeutic efficacy in OA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6_K36-J_gVLVg90H21EOLACvtfcHk0ljNS1hjHuguTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvVeitbs%253D&md5=432390eacb31d325bfa052443bd5bf34</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28200005%2943%3A5%3C978%3A%3AAID-ANR4%3E3.0.CO%3B2-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528200005%252943%253A5%253C978%253A%253AAID-ANR4%253E3.0.CO%253B2-0%26sid%3Dliteratum%253Aachs%26aulast%3DCannon%26aufirst%3DG.%2BW.%26aulast%3DCaldwell%26aufirst%3DJ.%2BR.%26aulast%3DHolt%26aufirst%3DP.%26aulast%3DMcLean%26aufirst%3DB.%26aulast%3DSeidenberg%26aufirst%3DB.%26aulast%3DBolognese%26aufirst%3DJ.%26aulast%3DEhrich%26aufirst%3DE.%26aulast%3DMukhopadhyay%26aufirst%3DS.%26aulast%3DDaniels%26aufirst%3DB.%26atitle%3DRofecoxib%252C%2520a%2520specific%2520inhibitor%2520of%2520cyclooxygenase%25202%252C%2520with%2520clinical%2520efficacy%2520comparable%2520with%2520that%2520of%2520diclofenac%2520sodium%253A%2520results%2520of%2520a%2520one-year%252C%2520randomized%252C%2520clinical%2520trial%2520in%2520patients%2520with%2520osteoarthritis%2520of%2520the%2520knee%2520and%2520hip.%2520Rofecoxib%2520Phase%2520III%2520Protocol%2520035%2520Study%2520Group%26jtitle%3DArthritis%2520Rheum.%26date%3D2000%26volume%3D43%26spage%3D978%26epage%3D987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Clemett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goa, K. L.</span><span> </span><span class="NLM_article-title">Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">980</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2000&pages=957-980&author=D.+Clemettauthor=K.+L.+Goa&title=Celecoxib%3A+a+review+of+its+use+in+osteoarthritis%2C+rheumatoid+arthritis+and+acute+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClemett%26aufirst%3DD.%26aulast%3DGoa%26aufirst%3DK.%2BL.%26atitle%3DCelecoxib%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520osteoarthritis%252C%2520rheumatoid%2520arthritis%2520and%2520acute%2520pain%26jtitle%3DDrugs%26date%3D2000%26volume%3D59%26spage%3D957%26epage%3D980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pasinetti, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer’s disease brain</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1998&pages=319-324&author=G.+M.+Pasinettiauthor=P.+S.+Aisen&title=Cyclooxygenase-2+expression+is+increased+in+frontal+cortex+of+Alzheimer%E2%80%99s+disease+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26atitle%3DCyclooxygenase-2%2520expression%2520is%2520increased%2520in%2520frontal%2520cortex%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%26jtitle%3DNeuroscience%26date%3D1998%26volume%3D87%26spage%3D319%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span> </span><span class="NLM_article-title">Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">2819</span><span class="NLM_x">–</span> <span class="NLM_lpage">2826</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2003&pages=2819-2826&author=P.+S.+Aisenauthor=K.+A.+Schaferauthor=M.+Grundmanauthor=E.+Pfeifferauthor=M.+Sanoauthor=K.+L.+Davisauthor=M.+R.+Farlowauthor=S.+Jinauthor=R.+G.+Thomasauthor=L.+J.+Thal&title=Effects+of+rofecoxib+or+naproxen+vs+placebo+on+Alzheimer+disease+progression%3A+a+randomized+controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSchafer%26aufirst%3DK.%2BA.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DPfeiffer%26aufirst%3DE.%26aulast%3DSano%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DK.%2BL.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26atitle%3DEffects%2520of%2520rofecoxib%2520or%2520naproxen%2520vs%2520placebo%2520on%2520Alzheimer%2520disease%2520progression%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2003%26volume%3D289%26spage%3D2819%26epage%3D2826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Breitner, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meinert, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyketsos, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashe, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismail, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P. N.</span><span> </span><span class="NLM_article-title">Extended results of the Alzheimer’s disease anti-inflammatory prevention trial</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">402</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.jalz.2010.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21784351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3MjgslemtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=402-411&author=J.+C.+Breitnerauthor=L.+D.+Bakerauthor=T.+J.+Montineauthor=C.+L.+Meinertauthor=C.+G.+Lyketsosauthor=K.+H.+Asheauthor=J.+Brandtauthor=S.+Craftauthor=D.+E.+Evansauthor=R.+C.+Greenauthor=M.+S.+Ismailauthor=B.+K.+Martinauthor=M.+J.+Mullanauthor=M.+Sabbaghauthor=P.+N.+Tariot&title=Extended+results+of+the+Alzheimer%E2%80%99s+disease+anti-inflammatory+prevention+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Extended results of the Alzheimer's disease anti-inflammatory prevention trial</span></div><div class="casAuthors">Breitner John C; Baker Laura D; Montine Thomas J; Meinert Curtis L; Lyketsos Constantine G; Ashe Karen H; Brandt Jason; Craft Suzanne; Evans Denis E; Green Robert C; Ismail M Saleem; Martin Barbara K; Mullan Michael J; Sabbagh Marwan; Tariot Pierre N</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">402-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Epidemiologic evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) delay onset of Alzheimer's dementia (AD), but randomized trials show no benefit from NSAIDs in patients with symptomatic AD.  The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) randomized 2,528 elderly persons to naproxen or celecoxib versus placebo for 2 years (standard deviation = 11 months) before treatments were terminated.  During the treatment interval, 32 cases of AD revealed increased rates in both NSAID-assigned groups.  METHODS:  We continued the double-masked ADAPT protocol for 2 additional years to investigate incidence of AD (primary outcome).  We then collected cerebrospinal fluid (CSF) from 117 volunteer participants to assess their ratio of CSF tau to Aβ(1-42.)  RESULTS:  Including 40 new events observed during follow-up of 2,071 randomized individuals (92% of participants at treatment cessation), there were 72 AD cases.  Overall, NSAID-related harm was no longer evident, but secondary analyses showed that increased risk remained notable in the first 2.5 years of observations, especially in 54 persons enrolled with cognitive impairment--no dementia (CIND).  These same analyses showed later reduction in AD incidence among asymptomatic enrollees who were given naproxen.  CSF biomarker assays suggested that the latter result reflected reduced Alzheimer-type neurodegeneration.  CONCLUSIONS:  These data suggest a revision of the original ADAPT hypothesis that NSAIDs reduce AD risk, as follows: NSAIDs have an adverse effect in later stages of AD pathogenesis, whereas asymptomatic individuals treated with conventional NSAIDs such as naproxen experience reduced AD incidence, but only after 2 to 3 years.  Thus, treatment effects differ at various stages of disease.  This hypothesis is consistent with data from both trials and epidemiological studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRp1vb8yEF2ZtenUz0lpNqnfW6udTcc2ebpuUYZDz8fC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjgslemtQ%253D%253D&md5=72baff395a1e0c2ead0e181d7d82a0f8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2010.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2010.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DBreitner%26aufirst%3DJ.%2BC.%26aulast%3DBaker%26aufirst%3DL.%2BD.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMeinert%26aufirst%3DC.%2BL.%26aulast%3DLyketsos%26aufirst%3DC.%2BG.%26aulast%3DAshe%26aufirst%3DK.%2BH.%26aulast%3DBrandt%26aufirst%3DJ.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DD.%2BE.%26aulast%3DGreen%26aufirst%3DR.%2BC.%26aulast%3DIsmail%26aufirst%3DM.%2BS.%26aulast%3DMartin%26aufirst%3DB.%2BK.%26aulast%3DMullan%26aufirst%3DM.%2BJ.%26aulast%3DSabbagh%26aufirst%3DM.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26atitle%3DExtended%2520results%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520anti-inflammatory%2520prevention%2520trial%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D402%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Grosser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, G. A.</span><span> </span><span class="NLM_article-title">Emotion recollected in tranquility: lessons learned from the COX-2 saga</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1146%2Fannurev-med-011209-153129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=20059330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFyls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2010&pages=17-33&author=T.+Grosserauthor=Y.+Yuauthor=G.+A.+Fitzgerald&title=Emotion+recollected+in+tranquility%3A+lessons+learned+from+the+COX-2+saga"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Emotion recollected in tranquility: lessons learned from the COX-2 saga</span></div><div class="casAuthors">Grosser, Tilo; Yu, Ying; FitzGerald, Garret A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-33</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">Nonsteroidal antinflammatory drugs (NSAIDs) inhibit prostaglandin formation by cyclooxygenases (COX) 1 and 2.  NSAIDs selective for inhibition of COX-2 are less likely than traditional drugs to cause serious gastrointestinal adverse effects, but predispose to adverse cardiovascular events, such as heart failure, myocardial infarction, and stroke.  Evidence from human pharmacol. and genetics, genetically manipulated rodents, and other animal models and randomized trials indicates that this is consequent to suppression of COX-2-dependent cardioprotective prostagladins, particularly prostacyclin.  Lessons drawn from how this saga unfolded are relevant to how we approach drug surveillance and regulation, integrate diversifed forms of information and might pursue a more personalized approach to drug efficacy and risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7InShCVYT_bVg90H21EOLACvtfcHk0lgAxSlyQJHGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFyls7s%253D&md5=4706ede28ada88f53acde7c31b1189ef</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-011209-153129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-011209-153129%26sid%3Dliteratum%253Aachs%26aulast%3DGrosser%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DFitzgerald%26aufirst%3DG.%2BA.%26atitle%3DEmotion%2520recollected%2520in%2520tranquility%253A%2520lessons%2520learned%2520from%2520the%2520COX-2%2520saga%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2010%26volume%3D61%26spage%3D17%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Egan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rader, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyth, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FitzGerald, G. A.</span><span> </span><span class="NLM_article-title">COX-2-derived prostacyclin confers atheroprotection on female mice</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">1954</span><span class="NLM_x">–</span> <span class="NLM_lpage">1957</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2004&pages=1954-1957&author=K.+M.+Eganauthor=J.+A.+Lawsonauthor=S.+Friesauthor=B.+Kollerauthor=D.+J.+Raderauthor=E.+M.+Smythauthor=G.+A.+FitzGerald&title=COX-2-derived+prostacyclin+confers+atheroprotection+on+female+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgan%26aufirst%3DK.%2BM.%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26aulast%3DFries%26aufirst%3DS.%26aulast%3DKoller%26aufirst%3DB.%26aulast%3DRader%26aufirst%3DD.%2BJ.%26aulast%3DSmyth%26aufirst%3DE.%2BM.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26atitle%3DCOX-2-derived%2520prostacyclin%2520confers%2520atheroprotection%2520on%2520female%2520mice%26jtitle%3DScience%26date%3D2004%26volume%3D306%26spage%3D1954%26epage%3D1957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Grosser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FitzGerald, G. A.</span><span> </span><span class="NLM_article-title">Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=4-15&author=T.+Grosserauthor=S.+Friesauthor=G.+A.+FitzGerald&title=Biological+basis+for+the+cardiovascular+consequences+of+COX-2+inhibition%3A+therapeutic+challenges+and+opportunities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrosser%26aufirst%3DT.%26aulast%3DFries%26aufirst%3DS.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26atitle%3DBiological%2520basis%2520for%2520the%2520cardiovascular%2520consequences%2520of%2520COX-2%2520inhibition%253A%2520therapeutic%2520challenges%2520and%2520opportunities%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D4%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hirata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostanoid receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">6209</span><span class="NLM_x">–</span> <span class="NLM_lpage">6230</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr200010h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVWltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6209-6230&author=T.+Hirataauthor=S.+Narumiya&title=Prostanoid+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Prostanoid Receptors</span></div><div class="casAuthors">Hirata, Takako; Narumiya, Shuh</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6209-6230</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, on prostanoid receptors features and role as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGfWgwLJd47Vg90H21EOLACvtfcHk0lgAxSlyQJHGFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWltro%253D&md5=6132b351c7983ef2618149991c0166b6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcr200010h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr200010h%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DT.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstanoid%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6209%26epage%3D6230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Narumiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushikubi, F.</span><span> </span><span class="NLM_article-title">Prostanoid receptors: structures, properties, and functions</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1152%2Fphysrev.1999.79.4.1193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=10508233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVymtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1999&pages=1193-1226&author=S.+Narumiyaauthor=Y.+Sugimotoauthor=F.+Ushikubi&title=Prostanoid+receptors%3A+structures%2C+properties%2C+and+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Prostanoid receptors: structures, properties, and functions</span></div><div class="casAuthors">Narumiya, Shuh; Sugimoto, Yukihiko; Ushikubi, Fumitaka</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1193-1226</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 254 refs.  Prostanoids are the cyclooxygenase metabolites of arachidonic acid and include prostaglandin (PG) D2, PGE2, PGF2α, PGI2, and thromboxane A2.  They are synthesized and released upon cell stimulation and act on cells in the vicinity of their synthesis to exert their actions.  Receptors mediating the actions of prostanoids were recently identified and cloned.  They are G protein-coupled receptors with seven transmembrane domains.  There are eight types and subtypes of prostanoid receptors that are encoded by different genes but as a whole constitute a subfamily in the superfamily of the rhodopsin-type receptors.  Each of the receptors was expressed in cultured cells, and its ligand-binding properties and signal transduction pathways were characterized.  Moreover, domains and amino acid residues conferring the specificities of ligand binding and signal transduction are being clarified.  Information also is accumulating as to the distribution of these receptors in the body.  It is also becoming clear for some types of receptors how expression of their genes is regulated.  Furthermore, the gene for each of the eight types of prostanoid receptor has been disrupted, and mice deficient in each type of receptor are being examd. to identify and assess the roles played by each receptor under various physiol. and pathophysiol. conditions.  In this article, we summarize these findings and attempt to give an overview of the current status of research on the prostanoid receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryyKYnqFDGUbVg90H21EOLACvtfcHk0liJypBpT_C8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVymtL0%253D&md5=868b556bb0e6b8628efbc5bdc630025d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1999.79.4.1193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1999.79.4.1193%26sid%3Dliteratum%253Aachs%26aulast%3DNarumiya%26aufirst%3DS.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DUshikubi%26aufirst%3DF.%26atitle%3DProstanoid%2520receptors%253A%2520structures%252C%2520properties%252C%2520and%2520functions%26jtitle%3DPhysiol.%2520Rev.%26date%3D1999%26volume%3D79%26spage%3D1193%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Emerging roles of PGE2 receptors in models of neurological disease</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.prostaglandins.2009.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19808012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=104-112&author=K.+Andreasson&title=Emerging+roles+of+PGE2+receptors+in+models+of+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of PGE2 receptors in models of neurological disease</span></div><div class="casAuthors">Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">104-112</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This review presents an overview of the emerging field of prostaglandin signaling in neurol. diseases, focusing on PGE2 signaling through its four E-prostanoid (EP) receptors.  A large no. of studies have demonstrated a neurotoxic function of the inducible cyclooxygenase COX-2 in a broad spectrum of neurol. disease models in the central nervous system (CNS), from models of cerebral ischemia to models of neurodegeneration and inflammation.  Since COX-1 and COX-2 catalyze the first committed step in prostaglandin synthesis, an effort is underway to identify the downstream prostaglandin signaling pathways that mediate the toxic effect of COX-2.  Recent epidemiol. studies demonstrate that chronic COX-2 inhibition can produce adverse cerebrovascular and cardiovascular effects, indicating that some prostaglandin signaling pathways are beneficial.  Consistent with this concept, recent studies demonstrate that in the CNS, specific prostaglandin receptor signaling pathways mediate toxic effects in brain but a larger no. appear to mediate paradoxically protective effects.  Further complexity is emerging, as exemplified by the PGE2 EP2 receptor, where cerebroprotective or toxic effects of a particular prostaglandin signaling pathway can differ depending on the context of cerebral injury, for example, in excitotoxicity/hypoxia paradigms vs. inflammatory-mediated secondary neurotoxicity.  The divergent effects of prostaglandin receptor signaling will likely depend on distinct patterns and dynamics of receptor expression in neurons, endothelial cells, and glia and the specific ways in which these cell types participate in particular models of neurol. injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3_8vqPcrborVg90H21EOLACvtfcHk0liJypBpT_C8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu78%253D&md5=a4c75c03cd679c5316d515ff72515567</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DEmerging%2520roles%2520of%2520PGE2%2520receptors%2520in%2520models%2520of%2520neurological%2520disease%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26spage%3D104%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hata, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span> </span><span class="NLM_article-title">Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.pharmthera.2004.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=15369681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFSqtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=147-166&author=A.+N.+Hataauthor=R.+M.+Breyer&title=Pharmacology+and+signaling+of+prostaglandin+receptors%3A+multiple+roles+in+inflammation+and+immune+modulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation</span></div><div class="casAuthors">Hata, Aaron N.; Breyer, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">147-166</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Prostaglandins are lipid-derived autacoids that modulate many physiol. systems including the CNS, cardiovascular, gastrointestinal, genitourinary, endocrine, respiratory, and immune systems.  In addn., prostaglandins were implicated in a broad array of diseases including cancer, inflammation, cardiovascular disease, and hypertension.  Prostaglandins exert their effects by activating rhodopsin-like 7 transmembrane spanning G protein-coupled receptors (GPCRs).  The prostanoid receptor subfamily is comprised of 8 members (DP, EP1-4, FP, IP, and TP), and recently, a ninth prostaglandin receptor was identified-the chemoattractant receptor homologous mol. expressed on Th2 cells (CRTH2).  The precise roles prostaglandin receptors play in physiol. and pathol. settings are detd. by multiple factors including cellular context, receptor expression profile, ligand affinity, and differential coupling to signal transduction pathways.  This complexity is highlighted by the diverse and often opposing effects of prostaglandins within the immune system.  In certain settings, prostaglandins function as pro-inflammatory mediators, but in others, they appear to have anti-inflammatory properties.  In this review, the authors will discuss the pharmacol. and signaling of the 9 known prostaglandin GPCRs and highlight the specific roles that these receptors play in inflammation and immune modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUuiw0S9UeQ7Vg90H21EOLACvtfcHk0liJypBpT_C8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFSqtL8%253D&md5=98c2a06cdfcc3c2e02d7b856a052201c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DHata%26aufirst%3DA.%2BN.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26atitle%3DPharmacology%2520and%2520signaling%2520of%2520prostaglandin%2520receptors%253A%2520multiple%2520roles%2520in%2520inflammation%2520and%2520immune%2520modulation%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D103%26spage%3D147%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Jones, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giembycz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, D. F.</span><span> </span><span class="NLM_article-title">Prostanoid receptor antagonists: development strategies and therapeutic applications</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1476-5381.2009.00317.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19624532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKmu7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=104-145&author=R.+L.+Jonesauthor=M.+A.+Giembyczauthor=D.+F.+Woodward&title=Prostanoid+receptor+antagonists%3A+development+strategies+and+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Prostanoid Receptor Antagonists: Development Strategies and Therapeutic Applications</span></div><div class="casAuthors">Jones, R. L.; Giembycz, M. A.; Woodward, D. F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-145</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Identification of the primary products of cyclo-oxygenase (COX)/prostaglandin synthase(s), which occurred between 1958 and 1976, was followed by a classification system for prostanoid receptors (DP, EP1, EP2...) based mainly on the pharmacol. actions of natural and synthetic agonists and a few antagonists.  The design of potent selective antagonists was rapid for certain prostanoid receptors (EP1, TP), slow for others (FP, IP) and has yet to be achieved in certain cases (EP2).  While some antagonists are structurally related to the natural agonist, most recent compds. are 'non-prostanoid' (often acyl-sulfonamides) and have emerged from high-throughput screening of compd. libraries, made possible by the development of (functional) assays involving single recombinant prostanoid receptors.  Selective antagonists have been crucial to defining the roles of PGD2 (acting on DP1 and DP2 receptors) and PGE2 (on EP1 and EP4 receptors) in various inflammatory conditions; there are clear opportunities for therapeutic intervention.  The vast endeavour on TP (thromboxane) antagonists is considered in relation to their limited pharmaceutical success in the cardiovascular area.  Correspondingly, the clin. utility of IP (prostacyclin) antagonists is assessed in relation to the cloud hanging over the long-term safety of selective COX-2 inhibitors.  Aspirin apart, COX inhibitors broadly suppress all prostanoid pathways, while high selectivity has been a major goal in receptor antagonist development; more targeted therapy may require an intermediate position with defined antagonist selectivity profiles.  This review is intended to provide overviews of each antagonist class (including prostamide antagonists), covering major development strategies and current and potential clin. usage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyqQqvML3herVg90H21EOLACvtfcHk0liJypBpT_C8uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKmu7bJ&md5=cc9dda6d0296b60531ba6484fb8d318a</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00317.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00317.x%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BL.%26aulast%3DGiembycz%26aufirst%3DM.%2BA.%26aulast%3DWoodward%26aufirst%3DD.%2BF.%26atitle%3DProstanoid%2520receptor%2520antagonists%253A%2520development%2520strategies%2520and%2520therapeutic%2520applications%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D104%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Dong, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, N. H.</span><span> </span><span class="NLM_article-title">Prostaglandin-E Receptor Subtypes in Smooth-Muscle-Agonist Activities of Stable Prostacyclin Analogs</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1476-5381.1986.tb10161.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=2420404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaL28XhtVeis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1986&pages=97-107&author=Y.+J.+Dongauthor=R.+L.+Jonesauthor=N.+H.+Wilson&title=Prostaglandin-E+Receptor+Subtypes+in+Smooth-Muscle-Agonist+Activities+of+Stable+Prostacyclin+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E receptor subtypes in smooth muscle:  agonist activities of stable prostacyclin analogs</span></div><div class="casAuthors">Dong, Y. J.; Jones, R. L.; Wilson, N. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-107</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">The agonist activities of a range of prostaglandin (PG) analogs on smooth muscle prepns. sensitive to PGE2  [363-24-6] were investigated.  When necessary, thromboxane-like activity was eliminated by using the thromboxane receptor antagonists EP 045 and EP 092.  On the bullock iris sphincter, rat stomach fundus, and guinea pig trachea, (±)-ω-tetranor-16-p-chlorophenoxy PGE2  [75024-02-1] and 16,16-dimethyl PGE2  [39746-25-3] were more active contractile agents than PGE2; for relaxant activity on the cat trachea, guinea pig trachea, and dog hind limb arterial vessels in vivo, the order of potency was reversed.  11-Deoxy PGE1  [37786-00-8] exhibited greater relaxant than contractile activity when compared with PGE2.  Iloprost  [78919-13-8] and 6a-carba-Δ6,6a-PGI1  [88911-35-7] (potent mimetics of PGI2) showed high contractile activity on the PGE-sensitive prepns.  PGI2  [35121-78-9] was less active, and another potent PGI2 mimetic, ZK96480  [94079-80-8], showed only very weak activity.  When tested, the dibenzoxazepines SC 19220 and SC 25191 blocked the contractile actions of iloprost and 6a-carba-Δ6,6a-PGI1 and those of PGE2 and 16,16-dimethyl PGE2 to similar extents.  Each of the PGI2 analogs showed weak activity on the relaxant systems.  On the proximal portion of the ascending colon of the rat, PGI2, iloprost, 6a-carba-Δ6,6a-PGI1 and ZK 96480 always inhibited spontaneous activity at nanomolar concns.  PGE2 and PGE1 showed weak contractile activity.  The distal portion of the ascending colon was more responsive to the contractile action of PGE analogs: both iloprost and 6a-carba-Δ6,6a-PGI1 showed evidence of contractile activity, whereas PGI2 and ZK 96480 always inhibited spontaneous activity.  Evidence was obtained that the rat stomach fundus also contains a PGF receptor; (±)-ω-tetranor-16-m-trifluoromethylphenoxy PGF2α (ICI 81008)  [55028-71-2] acted as a specific agonist.  PGF2α  [551-11-1] and ω-tetranor-16-p-fluorophenoxy PGF2α  [96443-56-0] produced a higher max. response than ICI 81008, probably due to their addnl. agonist action at the PGE receptor.  Apparently, there are 2 subtypes of the PGE receptor.  ZK 96480 has minimal activity on both receptor subtypes and appears to be a highly specific PGI2 mimetic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc0SPuJS3XkrVg90H21EOLACvtfcHk0lgc9PlmGEaTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XhtVeis7c%253D&md5=4d745e0cb7ff1337a3658f5ad0ba5cfd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1986.tb10161.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1986.tb10161.x%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BL.%26aulast%3DWilson%26aufirst%3DN.%2BH.%26atitle%3DProstaglandin-E%2520Receptor%2520Subtypes%2520in%2520Smooth-Muscle-Agonist%2520Activities%2520of%2520Stable%2520Prostacyclin%2520Analogs%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1986%26volume%3D87%26spage%3D97%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Bastien, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygorczyk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, M.</span><span> </span><span class="NLM_article-title">Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">11873</span><span class="NLM_x">–</span> <span class="NLM_lpage">11877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=11873-11877&author=L.+Bastienauthor=N.+Sawyerauthor=R.+Grygorczykauthor=K.+M.+Mettersauthor=M.+Adam&title=Cloning%2C+functional+expression%2C+and+characterization+of+the+human+prostaglandin+E2+receptor+EP2+subtype"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBastien%26aufirst%3DL.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DGrygorczyk%26aufirst%3DR.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26aulast%3DAdam%26aufirst%3DM.%26atitle%3DCloning%252C%2520functional%2520expression%252C%2520and%2520characterization%2520of%2520the%2520human%2520prostaglandin%2520E2%2520receptor%2520EP2%2520subtype%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D11873%26epage%3D11877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lokteva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2Fana.21437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=18825663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yisr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=304-314&author=X.+Liangauthor=Q.+Wangauthor=J.+Shiauthor=L.+Loktevaauthor=R.+M.+Breyerauthor=T.+J.+Montineauthor=K.+Andreasson&title=The+prostaglandin+E2+EP2+receptor+accelerates+disease+progression+and+inflammation+in+a+model+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Liang, Xibin; Wang, Qian; Shi, Ju; Lokteva, Ludmila; Breyer, Richard M.; Montine, Thomas J.; Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-314</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Inflammation has emerged as an important factor in disease progression in human and transgenic models of amyotrophic lateral sclerosis (ALS).  Recent studies demonstrate that the prostaglandin E2 EP2 receptor is a major regulator of inflammatory oxidative injury in innate immunity.  We tested whether EP2 signaling participated in disease pathogenesis in the G93A superoxide dismutase (SOD) model of familial ALS.  We examd. the phenotype of G93A SOD mice lacking the EP2 receptor and performed immunocytochem., quant. reverse transcriptase polymerase chain reaction, and Western analyses to det. the mechanism of EP2 toxicity in this model.  EP2 receptor is significantly induced in G93A SOD mice in astrocytes and microglia in parallel with increases in expression of proinflammatory enzymes and lipid peroxidn.  In human ALS, EP2 receptor immunoreactivity was upregulated in astrocytes in ventral spinal cord.  In aging G93A SOD mice, genetic deletion of the prostaglandin E2 EP2 receptor improved motor strength and extended survival.  Deletion of the EP2 receptor in G93A SOD mice resulted in significant redns. in levels of proinflammatory effectors, including cyclooxygenase-1, cyclooxygenase-2, inducible nitric oxide synthase, and components of the NADPH oxidase complex.  In alternate models of inflammation, including the lipopolysaccharide model of innate immunity and the APPSwe-PS1ΔE9 model of amyloidosis, deletion of EP2 also reduced expression of proinflammatory genes.  These data suggest that prostaglandin E2 signaling via the EP2 receptor functions in the mutant SOD model and more broadly in inflammatory neurodegeneration to regulate expression of a cassette of proinflammatory genes.  Inhibition of EP2 signaling may represent a novel strategy to downregulate the inflammatory response in neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruLggt1bC9dbVg90H21EOLACvtfcHk0lgc9PlmGEaTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yisr3O&md5=fe6acc1bb4b3be25e4d9d7474a5b2b3a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fana.21437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21437%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLokteva%26aufirst%3DL.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DThe%2520prostaglandin%2520E2%2520EP2%2520receptor%2520accelerates%2520disease%2520progression%2520and%2520inflammation%2520in%2520a%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D2008%26volume%3D64%26spage%3D304%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">McCullough, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haughey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1523%2FJNEUROSCI.4485-03.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=14715958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotF2ltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=257-268&author=L.+McCulloughauthor=L.+Wuauthor=N.+Haugheyauthor=X.+Liangauthor=T.+Handauthor=Q.+Wangauthor=R.+M.+Breyerauthor=K.+Andreasson&title=Neuroprotective+function+of+the+PGE2+EP2+receptor+in+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia</span></div><div class="casAuthors">McCullough, Louise; Wu, Liejun; Haughey, Norman; Liang, Xibin; Hand, Tracey; Wang, Qian; Breyer, Richard M.; Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">257-268</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The cyclooxygenases COX-1 and COX-2 catalyze the first committed step of prostaglandin synthesis from arachidonic acid.  Previous studies in rodent stroke models have shown that the inducible COX-2 isoform promotes neuronal injury, and the administration of COX-2 inhibitors reduces infarct vol.  We investigated the function of PGE2, a principal prostaglandin product of COX-2 enzymic activity, in neuronal survival in cerebral ischemia.  PGE2 exerts its downstream effects by signaling through a class of four distinct G-protein-coupled EP receptors (for E-prostanoid: EP1, EP2, EP3, and EP4) that have divergent effects on cAMP and phosphoinositol turnover and different anatomical distributions in brain.  The EP2 receptor subtype is abundantly expressed in cerebral cortex, striatum, and hippocampus, and is pos. coupled to cAMP prodn.  In vitro studies of dispersed neurons and organotypic hippocampal cultures demonstrated that activation of the EP2 receptor was neuroprotective in paradigms of NMDA toxicity and oxygen glucose deprivation.  Pharmacol. blockade of EP2 signaling by inhibition of protein kinase A activation reversed this protective effect, suggesting that EP2-mediated neuroprotection is dependent on cAMP signaling.  In the middle cerebral artery occlusion-reperfusion model of transient forebrain ischemia, genetic deletion of the EP2 receptor significantly increased cerebral infarction in cerebral cortex and subcortical structures.  These studies indicate that activation of the PGE2 EP2 receptor can protect against excitotoxic and anoxic injury in a cAMP-dependent manner.  Taken together, these data suggest a novel mechanism of neuroprotection mediated by a dominant PGE2 receptor subtype in brain that may provide a target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjazLQgIyS47Vg90H21EOLACvtfcHk0lgc9PlmGEaTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotF2ltQ%253D%253D&md5=73a862c6c9372fccb711bfacd07ff6d6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4485-03.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4485-03.2004%26sid%3Dliteratum%253Aachs%26aulast%3DMcCullough%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DHaughey%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DHand%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DNeuroprotective%2520function%2520of%2520the%2520PGE2%2520EP2%2520receptor%2520in%2520cerebral%2520ischemia%26jtitle%3DJ.%2520Neurosci.%26date%3D2004%26volume%3D24%26spage%3D257%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Gardiner, P. J.</span><span> </span><span class="NLM_article-title">Characterization of Prostanoid Relaxant Inhibitory Receptors (Psi) Using a Highly Selective Agonist, TR4979</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1476-5381.1986.tb10155.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaL28Xht1ektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1986&pages=45-56&author=P.+J.+Gardiner&title=Characterization+of+Prostanoid+Relaxant+Inhibitory+Receptors+%28Psi%29+Using+a+Highly+Selective+Agonist%2C+TR4979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979</span></div><div class="casAuthors">Gardiner, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-56</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">TR 4979 (I) [69648-38-0], an analog of PGE1 [745-65-3], was evaluated on respiratory and nonrespiratory isolated tissues known to contain heterogeneous or homogeneous populations of the 2 classes of prostanoid (prostaglandins and thromboxanes) receptors.  These receptors are classified as χ the contractant/stimulant receptor with χ1,2,3 being 3 subdivisions and ψ the relaxant/inhibitory receptor(s).  On a respiratory tissue (cat trachea) contg. predominantly ψ receptors, I was 26 times less potent than PGE1 or PGE2 [363-24-6].  On other respiratory tissues known to contain mixts. of the χ1,2,3- and ψ-receptors (guinea-pig trachea and lung strip, cat lung strip, and human bronchial muscle), I consistently acted as a potent relaxant whereas PGE2 and to a lesser extent PGE1 had contractant activities.  Human pregnant uterus, guinea-pig and rat pseudopregnant uteri, rat colon and fundic strips, and chick ileum are known to contain 1 or more of the 3 subclasses of the χ-receptor.  I (10-9-10-5 M) was inactive on all these tissues whereas all of the ref. prostanoids were contractants of varying potencies.  PGE1 and histamine [51-45-6]-induced contractions of the guinea-pig isolated ileum were both noncompetitively antagonized by increasing concns. of I suggesting that ψ-receptors also exist on this tissue.  I is a highly selective agonist of prostanoid ψ (relaxant/inhibitory)-receptors which exist mainly in the lung.  This prostaglandin analog is a useful new selective pharmacol. tool for revealing as yet unidentified prostanoid ψ-receptors and actions in a wide range of nonrespiratory tissues/organs such as the guinea-pige ileum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcKdpcICdVLVg90H21EOLACvtfcHk0lgZaSq689hL2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28Xht1ektb4%253D&md5=13cd55eed4f220c8cf2739a5fc539aad</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1986.tb10155.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1986.tb10155.x%26sid%3Dliteratum%253Aachs%26aulast%3DGardiner%26aufirst%3DP.%2BJ.%26atitle%3DCharacterization%2520of%2520Prostanoid%2520Relaxant%2520Inhibitory%2520Receptors%2520%2528Psi%2529%2520Using%2520a%2520Highly%2520Selective%2520Agonist%252C%2520TR4979%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1986%26volume%3D87%26spage%3D45%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Ahmad, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echeverria, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, S.</span><span> </span><span class="NLM_article-title">Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity</span> <span class="citation_source-journal">J. Neurotrauma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1895</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1089%2Fneu.2006.23.1895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BD28jkslagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=1895-1903&author=A.+S.+Ahmadauthor=H.+A.+Zhuangauthor=V.+Echeverriaauthor=S.+Dore&title=Stimulation+of+prostaglandin+EP2+receptors+prevents+NMDA-induced+excitotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity</span></div><div class="casAuthors">Ahmad Abdullah Shafique; Zhuang Hean; Echeverria Valentina; Dore Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1895-903</span>
        ISSN:<span class="NLM_cas:issn">0897-7151</span>.
    </div><div class="casAbstract">Prostaglandin E(2) (PGE(2)) plays an important role in inflammation and neurologic disorders.  The neuromodulatory effects of PGE(2) are mediated through regulation of four G-protein-coupled receptors known as EP1, EP2, EP3, and EP4.  The goal of the current study was to determine whether EP2 receptor activation protects neurons from acute NMDA-mediated excitotoxicity.  To examine the effects of EP2 activation, mice were given an injection of the EP2 receptor-selective agonist butaprost (K (i) = 110 nM for EP2 receptor; K (i) > 10,000 for other prostaglandin receptors) in the cerebral ventricle and then an injection of NMDA in the right striatum.  After 48 h, a significant reduction in NMDA-induced lesion volume was observed in groups pretreated with butaprost (1-300 nmol/L), with maximal protection at 100 nmol/L (p < 0.001).  To determine if EP2-activated protection was specific to neurons, mouse neuronal cultures were treated with butaprost, and cell viability was analyzed after 24 h of NMDA excitotoxicity.  The results showed that butaprost significantly increased neuron survival in a dose-dependent fashion.  Furthermore, treatment of primary neurons with butaprost significantly increased cAMP levels (p < 0.001).  Together, these data reveal that EP2 receptor stimulation mediates neuroprotection against NMDA excitotoxicity both in vivo and in vitro and that butaprost can limit acute brain damage.  Development and testing of specific PGE(2) receptor mimetics could lead to a decrease in side effects associated with anti-inflammatory drugs and could help to fight acute and/or chronic neurologic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0CGBldOxMXt-cVm4E2RlLfW6udTcc2eYCMo38XjbfPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jkslagsA%253D%253D&md5=bec86d4155fa57c6af14ca0c4ccd7b6f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1089%2Fneu.2006.23.1895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2006.23.1895%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DA.%2BS.%26aulast%3DZhuang%26aufirst%3DH.%2BA.%26aulast%3DEcheverria%26aufirst%3DV.%26aulast%3DDore%26aufirst%3DS.%26atitle%3DStimulation%2520of%2520prostaglandin%2520EP2%2520receptors%2520prevents%2520NMDA-induced%2520excitotoxicity%26jtitle%3DJ.%2520Neurotrauma%26date%3D2006%26volume%3D23%26spage%3D1895%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Carrasco, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casper, D.</span><span> </span><span class="NLM_article-title">Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2008&pages=44-49&author=E.+Carrascoauthor=P.+Wernerauthor=D.+Casper&title=Prostaglandin+receptor+EP2+protects+dopaminergic+neurons+against+6-OHDA-mediated+low+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarrasco%26aufirst%3DE.%26aulast%3DWerner%26aufirst%3DP.%26aulast%3DCasper%26aufirst%3DD.%26atitle%3DProstaglandin%2520receptor%2520EP2%2520protects%2520dopaminergic%2520neurons%2520against%25206-OHDA-mediated%2520low%2520oxidative%2520stress%26jtitle%3DNeurosci.%2520Lett.%26date%3D2008%26volume%3D441%26spage%3D44%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thepchatri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtkaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">2307</span><span class="NLM_x">–</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1073%2Fpnas.0909310107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=20080612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFChsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2307-2312&author=J.+Jiangauthor=T.+Ganeshauthor=Y.+Duauthor=P.+Thepchatriauthor=A.+Rojasauthor=I.+Lewisauthor=S.+Kurtkayaauthor=L.+Liauthor=M.+Quiauthor=G.+Serranoauthor=R.+Shawauthor=A.+Sunauthor=R.+Dingledine&title=Neuroprotection+by+selective+allosteric+potentiators+of+the+EP2+prostaglandin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor</span></div><div class="casAuthors">Jiang, Jianxiong; Ganesh, Thota; Du, Yuhong; Thepchatri, Pahk; Rojas, Asheebo; Lewis, Lestyn; Kurtkaya, Serdar; Li, Lian; Qui, Min; Serrano, Geidy; Shaw, Renee; Sun, Aiming; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2307-2312, S2307/1-S2307/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Activation of the Gαs-coupled EP2 receptor for prostaglandin E2 (PGE2) promotes cell survival in several models of tissue damage.  To advance understanding of EP2 functions, we designed expts. to develop allosteric potentiators of this key prostaglandin receptor.  Screens of 292,000 compds. identified 93 that at 20 μM (i) potentiated the cAMP response to a low concn. of PGE2 by >50%; (ii) had no effect on EP4 or β2 adrenergic receptors, the cAMP assay itself, or the parent cell line; and (iii) increased the potency of PGE2 on EP2 receptors at least 3-fold.  In aq. soln., the active compds. are largely present as nanoparticles that appear to serve as active reservoirs for bioactive monomer.  From 94 compds. synthesized or purchased, based on the modification of one hit compd., the most active increased the potency of PGE2 on EP2 receptors 4- to 5-fold at 10 to 20 μM and showed substantial neuroprotection in an excitotoxicity model.  These small mols. represent previously undescribed allosteric modulators of a PGE2 receptor.  Our results strongly reinforce the notion that activation of EP2 receptors by endogenous PGE2 released in a cell-injury setting is neuroprotective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreVs-Pts4UO7Vg90H21EOLACvtfcHk0lgZaSq689hL2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFChsrw%253D&md5=46aabca1d636956d252e2b9114650b69</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0909310107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0909310107%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DThepchatri%26aufirst%3DP.%26aulast%3DRojas%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DI.%26aulast%3DKurtkaya%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DQui%26aufirst%3DM.%26aulast%3DSerrano%26aufirst%3DG.%26aulast%3DShaw%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DA.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DNeuroprotection%2520by%2520selective%2520allosteric%2520potentiators%2520of%2520the%2520EP2%2520prostaglandin%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26spage%3D2307%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10180</span><span class="NLM_x">–</span> <span class="NLM_lpage">10187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1523%2FJNEUROSCI.3591-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=16267225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wqt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10180-10187&author=X.+Liangauthor=Q.+Wangauthor=T.+Handauthor=L.+Wuauthor=R.+M.+Breyerauthor=T.+J.+Montineauthor=K.+Andreasson&title=Deletion+of+the+prostaglandin+E2+EP2+receptor+reduces+oxidative+damage+and+amyloid+burden+in+a+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease</span></div><div class="casAuthors">Liang, Xibin; Wang, Qian; Hand, Tracey; Wu, Liejun; Breyer, Richard M.; Montine, Thomas J.; Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">10180-10187</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Epidemiol. studies demonstrate that chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) in normal aging populations reduces the risk of developing Alzheimer's disease (AD).  NSAIDs inhibit the enzymic activity of cyclooxygenase-1 (COX-1) and inducible COX-2, which catalyze the first committed step in the synthesis of prostaglandins.  These studies implicate COX-mediated inflammation as an early and potentially reversible preclin. event; however, the mechanism by which COX activity promotes development of AD has not been detd.  Recent studies implicate the prostaglandin E2 (PGE2) E prostanoid subtype 2 (EP2) receptor in the development of the innate immune response in brain.  Here, we report that deletion of the PGE2 EP2 receptor in the APPSwe-PS1ΔE9 model of familial AD results in marked redns. in lipid peroxidn. in aging mice.  This redn. in oxidative stress is assocd. with significant decreases in levels of amyloid-β (Aβ) 40 and 42 peptides and amyloid deposition.  Aged APPSwe-PS1ΔE9 mice lacking the EP2 receptor harbor lower levels of β C-terminal fragments, the product of β-site APP cleaving enzyme (BACE1) processing of amyloid precursor protein.  Increases in BACE1 processing have been demonstrated in models of aging and AD and after oxidative stress.  Our results indicate that PGE2 signaling via the EP2 receptor promotes age-dependent oxidative damage and increased Aβ peptide burden in this model of AD, possibly via effects on BACE1 activity.  Our findings identify EP2 receptor signaling as a novel proinflammatory and proamyloidogenic pathway in this model of AD, and suggest a rationale for development of therapeutics targeting the EP2 receptor in neuroinflammatory diseases such as AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvQcRSqBUHdrVg90H21EOLACvtfcHk0li6F5lONbYhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wqt77I&md5=fadd58f101e78d983b0be1832c5bbb10</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3591-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3591-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHand%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DDeletion%2520of%2520the%2520prostaglandin%2520E2%2520EP2%2520receptor%2520reduces%2520oxidative%2520damage%2520and%2520amyloid%2520burden%2520in%2520a%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10180%26epage%3D10187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shie, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schantz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1186%2F1742-2094-4-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=17204153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FhvFOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=2&author=J.+Jinauthor=F.+S.+Shieauthor=J.+Liuauthor=Y.+Wangauthor=J.+Davisauthor=A.+M.+Schantzauthor=K.+S.+Montineauthor=T.+J.+Montineauthor=J.+Zhang&title=Prostaglandin+E2+receptor+subtype+2+%28EP2%29+regulates+microglial+activation+and+associated+neurotoxicity+induced+by+aggregated+alpha-synuclein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein</span></div><div class="casAuthors">Jin Jinghua; Shie Feng-Shiun; Liu Jun; Wang Yan; Davis Jeanne; Schantz Aimee M; Montine Kathleen S; Montine Thomas J; Zhang Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The pathogenesis of idiopathic Parkinson's disease (PD) remains elusive, although evidence has suggested that neuroinflammation characterized by activation of resident microglia in the brain may contribute significantly to neurodegeneration in PD.  It has been demonstrated that aggregated alpha-synuclein potently activates microglia and causes neurotoxicity.  However, the mechanisms by which aggregated alpha-synuclein activates microglia are not understood fully.  METHODS:  We investigated the role of prostaglandin E2 receptor subtype 2 (EP2) in alpha-synuclein aggregation-induced microglial activation using ex vivo, in vivo and in vitro experimental systems.  RESULTS:  Results demonstrated that ablation of EP2(EP2-/-) significantly enhanced microglia-mediated ex vivo clearance of alpha-synuclein aggregates (from mesocortex of Lewy body disease patients) while significantly attenuating neurotoxicity and extent of alpha-synuclein aggregation in mice treated with a parkinsonian toxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.  Furthermore, we report that reduced neurotoxicity by EP2-/- microglia could be attributed to suppressed translocation of a critical cytoplasmic subunit (p47-phox) of NADPH oxidase (PHOX) to the membranous compartment after exposure to aggregated alpha-synuclein.  CONCLUSION:  Thus, it appears that microglial EP2 plays a critical role in alpha-synuclein-mediated neurotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRG7pnC3ErmPJdYoSR9eyvsfW6udTcc2eYevzVMsSSwO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FhvFOisQ%253D%253D&md5=e37cc154dc6e92d9a1e3ccc9ebcfcfcd</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-4-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-4-2%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DShie%26aufirst%3DF.%2BS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DSchantz%26aufirst%3DA.%2BM.%26aulast%3DMontine%26aufirst%3DK.%2BS.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DProstaglandin%2520E2%2520receptor%2520subtype%25202%2520%2528EP2%2529%2520regulates%2520microglial%2520activation%2520and%2520associated%2520neurotoxicity%2520induced%2520by%2520aggregated%2520alpha-synuclein%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2007%26volume%3D4%26spage%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milatovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valyi-Nagy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span> </span><span class="NLM_article-title">Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent</span> <span class="citation_source-journal">J. Neurochem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1046%2Fj.1471-4159.2002.01157.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=12423256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFylur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2002&pages=463-70&author=T.+J.+Montineauthor=D.+Milatovicauthor=R.+C.+Guptaauthor=T.+Valyi-Nagyauthor=J.+D.+Morrowauthor=R.+M.+Breyer&title=Neuronal+oxidative+damage+from+activated+innate+immunity+is+EP2+receptor-dependent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent</span></div><div class="casAuthors">Montine, Thomas J.; Milatovic, Dejan; Gupta, Ramesh C.; Valyi-Nagy, Tibor; Morrow, Jason D.; Breyer, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">463-470</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Increase in prostaglandin (PG) E2 levels and oxidative damage are assocd. with diseases of brain that involve activation of innate immunity.  We tested the hypothesis that cerebral oxidative damage resulting from activation of innate immunity with intracerebroventricular (icv) lipopolysaccharide (LPS) is dependent on PGE2-mediated signaling.  We measured two quant. in vivo biomarkers of lipid peroxidn.: F2-isoprostanes (IsoPs) that derive from arachidonic acid (AA) that is uniformly distributed in all cell types in brain, and F4-neuroprostanes (NeuroPs) that derive from docosahexaenoic acid (DHA) that is highly concd. in neuronal membranes.  LPS stimulated delayed elevations in cerebral F2-IsoPs and F4-NeuroPs that were completely suppressed by indomethacin or ibuprofen pre-treatment.  LPS-induced cerebral oxidative damage was abolished by disruption of subtype 2 receptor for PGE2 (EP2).  In contrast, initial oxidative damage from icv kainic acid (KA) was more rapid than with LPS also was completely suppressed by indomethacin or ibuprofen pre-treatment but was independent of EP2 receptor activation.  The protective effect of deleting the EP2 receptor was not assocd. with changes in cerebral eicosaniod prodn., but was partially related to reduced induction of nitric oxide synthase (NOS) activity.  These results suggest the EP2 receptor as a therapeutic target to limit oxidative damage from activation of innate immunity in cerebrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxTvNydACwmrVg90H21EOLACvtfcHk0li6F5lONbYhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFylur0%253D&md5=95f5b6706a9fc10c2410cadf8cd471d4</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01157.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01157.x%26sid%3Dliteratum%253Aachs%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMilatovic%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DR.%2BC.%26aulast%3DValyi-Nagy%26aufirst%3DT.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26atitle%3DNeuronal%2520oxidative%2520damage%2520from%2520activated%2520innate%2520immunity%2520is%2520EP2%2520receptor-dependent%26jtitle%3DJ.%2520Neurochem%26date%3D2002%26volume%3D83%26spage%3D463%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Shie, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span> </span><span class="NLM_article-title">Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=70-77&author=F.+S.+Shieauthor=K.+S.+Montineauthor=R.+M.+Breyerauthor=T.+J.+Montine&title=Microglial+EP2+is+critical+to+neurotoxicity+from+activated+cerebral+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShie%26aufirst%3DF.%2BS.%26aulast%3DMontine%26aufirst%3DK.%2BS.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26atitle%3DMicroglial%2520EP2%2520is%2520critical%2520to%2520neurotoxicity%2520from%2520activated%2520cerebral%2520innate%2520immunity%26jtitle%3DGlia%26date%3D2005%26volume%3D52%26spage%3D70%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Shie, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span> </span><span class="NLM_article-title">Microglia lacking E prostanoid receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2FS0002-9440%2810%2962336-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=15793296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFaksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2005&pages=1163-1172&author=F.+S.+Shieauthor=R.+M.+Breyerauthor=T.+J.+Montine&title=Microglia+lacking+E+prostanoid+receptor+subtype+2+have+enhanced+Abeta+phagocytosis+yet+lack+Abeta-activated+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia lacking E prostanoid receptor subtype 2 have enhanced Aβ phagocytosis yet lack Aβ-activated neurotoxicity</span></div><div class="casAuthors">Shie, Feng-Shiun; Breyer, Richard M.; Montine, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1163-1172</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Exptl. therapies for Alzheimer's disease (AD) are focused on enhanced clearance of neurotoxic Aβ peptides from brain.  Microglia can be neuroprotective by phagocytosing Aβ; however, this comes at the cost of activated innate immunity that causes paracrine damage to neurons.  Here, we show that ablation of E prostanoid receptor subtype 2 (EP2) significantly increased microglial-mediated clearance of Aβ peptides from AD brain sections-and enhanced microglial Aβ phagocytosis in cell culture.  The enhanced phagocytosis was PKC-dependent and was assocd. with elevated microglial secretion of the chemoattractant chemokines, macrophage inflammatory protein-1α and macrophage chemoattractant protein-1.  This suggested that microglial activation is neg. regulated by EP2 signaling through suppression of prophagocytic cytokine secretion.  However, despite this enhancement of Aβ phagocytosis, lack of EP2 completely suppressed Aβ-activated microglia-mediated paracrine neurotoxicity.  These data demonstrate that blockade of microglial EP2 is a highly desirable mechanism for AD therapy that can maximize neuroprotective actions while minimizing bystander damage to neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL7BtF6wH0_LVg90H21EOLACvtfcHk0lgqi-CI8RmdAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFaksLc%253D&md5=2724ce1927452f9b018cb2ba78bfd4da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2962336-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252962336-X%26sid%3Dliteratum%253Aachs%26aulast%3DShie%26aufirst%3DF.%2BS.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26atitle%3DMicroglia%2520lacking%2520E%2520prostanoid%2520receptor%2520subtype%25202%2520have%2520enhanced%2520Abeta%2520phagocytosis%2520yet%2520lack%2520Abeta-activated%2520neurotoxicity%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2005%26volume%3D166%26spage%3D1163%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Hoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizushima, T.</span><span> </span><span class="NLM_article-title">Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">32676</span><span class="NLM_x">–</span> <span class="NLM_lpage">32688</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=32676-32688&author=T.+Hoshinoauthor=T.+Nakayaauthor=T.+Homanauthor=K.+Tanakaauthor=Y.+Sugimotoauthor=W.+Arakiauthor=M.+Naritaauthor=S.+Narumiyaauthor=T.+Suzukiauthor=T.+Mizushima&title=Involvement+of+prostaglandin+E2+in+production+of+amyloid-beta+peptides+both+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoshino%26aufirst%3DT.%26aulast%3DNakaya%26aufirst%3DT.%26aulast%3DHoman%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DAraki%26aufirst%3DW.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DNarumiya%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMizushima%26aufirst%3DT.%26atitle%3DInvolvement%2520of%2520prostaglandin%2520E2%2520in%2520production%2520of%2520amyloid-beta%2520peptides%2520both%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D32676%26epage%3D32688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Hsiao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, S. F.</span><span> </span><span class="NLM_article-title">TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=214-223&author=H.+Y.+Hsiaoauthor=O.+T.+Makauthor=C.+S.+Yangauthor=Y.+P.+Liuauthor=K.+M.+Fangauthor=S.+F.+Tzeng&title=TNF-alpha%2FIFN-gamma-induced+iNOS+expression+increased+by+prostaglandin+E2+in+rat+primary+astrocytes+via+EP2-evoked+cAMP%2FPKA+and+intracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DH.%2BY.%26aulast%3DMak%26aufirst%3DO.%2BT.%26aulast%3DYang%26aufirst%3DC.%2BS.%26aulast%3DLiu%26aufirst%3DY.%2BP.%26aulast%3DFang%26aufirst%3DK.%2BM.%26aulast%3DTzeng%26aufirst%3DS.%2BF.%26atitle%3DTNF-alpha%252FIFN-gamma-induced%2520iNOS%2520expression%2520increased%2520by%2520prostaglandin%2520E2%2520in%2520rat%2520primary%2520astrocytes%2520via%2520EP2-evoked%2520cAMP%252FPKA%2520and%2520intracellular%2520calcium%2520signaling%26jtitle%3DGlia%26date%3D2007%26volume%3D55%26spage%3D214%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Banu, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speights, V. O.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starzinski-Powitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arosh, J. A.</span><span> </span><span class="NLM_article-title">Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1291</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1210%2Fme.2009-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19407222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFOnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1291-1305&author=S.+K.+Banuauthor=J.+Leeauthor=V.+O.+Speightsauthor=A.+Starzinski-Powitzauthor=J.+A.+Arosh&title=Selective+inhibition+of+prostaglandin+E2+receptors+EP2+and+EP4+induces+apoptosis+of+human+endometriotic+cells+through+suppression+of+ERK1%2F2%2C+AKT%2C+NFkappaB%2C+and+beta-catenin+pathways+and+activation+of+intrinsic+apoptotic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFκB, and β-catenin pathways and activation of intrinsic apoptotic mechanisms</span></div><div class="casAuthors">Banu, Sakhila K.; Lee, Je Hoon; Speights, V. O., Jr.; Starzinski-Powitz, Anna; Arosh, Joe A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1291-1305</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Endometriosis is a benign chronic gynecol. disease of reproductive-age women characterized by the presence of functional endometrial tissues outside the uterine cavity.  It is an estrogen-dependent disease.  Current treatment modalities to inhibit biosynthesis and actions of estrogen compromise menstruation, pregnancy, and the reproductive health of women and fail to prevent reoccurrence of disease.  There is a crit. need to identify new specific signaling modules for non-estrogen-targeted therapies for endometriosis.  In our previous study, we reported that selective inhibition of cyclooxygenase-2 prevented survival, migration, and invasion of human endometriotic epithelial and stromal cells, which was due to decreased prostaglandin E2 (PGE2) prodn.  In this study, we detd. mechanisms through which PGE2 promoted survival of human endometriotic cells.  Results of the present study indicate that (1) PGE2 promotes survival of human endometriotic cells through EP2 and EP4 receptors by activating ERK1/2, AKT, nuclear factor-κB, and β-catenin signaling pathways; (2) selective inhibition of EP2 and EP4 suppresses these cell survival pathways and augments interactions between proapoptotic proteins (Bax and Bad) and antiapoptotic proteins (Bcl-2/Bcl-XL), facilitates the release of cytochrome c, and thus activates caspase-3/poly (ADP-ribose) polymerase-mediated intrinsic apoptotic pathways; and (3) these PGE2 signaling components are more abundantly expressed in ectopic endometriosis tissues compared with eutopic endometrial tissues during the menstrual cycle in women.  These novel findings may provide an important mol. framework for further evaluation of selective inhibition of EP2 and EP4 as potential therapy, including nonestrogen target, to expand the spectrum of currently available treatment options for endometriosis in women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT-eMJGdcvIbVg90H21EOLACvtfcHk0lgqi-CI8RmdAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFOnurk%253D&md5=a94631d71a249410f9be5b5612ed8ed1</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0017%26sid%3Dliteratum%253Aachs%26aulast%3DBanu%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSpeights%26aufirst%3DV.%2BO.%26aulast%3DStarzinski-Powitz%26aufirst%3DA.%26aulast%3DArosh%26aufirst%3DJ.%2BA.%26atitle%3DSelective%2520inhibition%2520of%2520prostaglandin%2520E2%2520receptors%2520EP2%2520and%2520EP4%2520induces%2520apoptosis%2520of%2520human%2520endometriotic%2520cells%2520through%2520suppression%2520of%2520ERK1%252F2%252C%2520AKT%252C%2520NFkappaB%252C%2520and%2520beta-catenin%2520pathways%2520and%2520activation%2520of%2520intrinsic%2520apoptotic%2520mechanisms%26jtitle%3DMol.%2520Endocrinol.%26date%3D2009%26volume%3D23%26spage%3D1291%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Sheibanie, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khayrullina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emig, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganea, D.</span><span> </span><span class="NLM_article-title">The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">8138</span><span class="NLM_x">–</span> <span class="NLM_lpage">8147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=8138-8147&author=A.+F.+Sheibanieauthor=J.+H.+Yenauthor=T.+Khayrullinaauthor=F.+Emigauthor=M.+Zhangauthor=R.+Tumaauthor=D.+Ganea&title=The+proinflammatory+effect+of+prostaglandin+E2+in+experimental+inflammatory+bowel+disease+is+mediated+through+the+IL-23%E2%86%92IL-17+axis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheibanie%26aufirst%3DA.%2BF.%26aulast%3DYen%26aufirst%3DJ.%2BH.%26aulast%3DKhayrullina%26aufirst%3DT.%26aulast%3DEmig%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DTuma%26aufirst%3DR.%26aulast%3DGanea%26aufirst%3DD.%26atitle%3DThe%2520proinflammatory%2520effect%2520of%2520prostaglandin%2520E2%2520in%2520experimental%2520inflammatory%2520bowel%2520disease%2520is%2520mediated%2520through%2520the%2520IL-23%25E2%2586%2592IL-17%2520axis%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D8138%26epage%3D8147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Sung, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, S. M.</span><span> </span><span class="NLM_article-title">Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5507</span><span class="NLM_x">–</span> <span class="NLM_lpage">5516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=5507-5516&author=Y.+M.+Sungauthor=G.+Heauthor=D.+H.+Hwangauthor=S.+M.+Fischer&title=Overexpression+of+the+prostaglandin+E2+receptor+EP2+results+in+enhanced+skin+tumor+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSung%26aufirst%3DY.%2BM.%26aulast%3DHe%26aufirst%3DG.%26aulast%3DHwang%26aufirst%3DD.%2BH.%26aulast%3DFischer%26aufirst%3DS.%2BM.%26atitle%3DOverexpression%2520of%2520the%2520prostaglandin%2520E2%2520receptor%2520EP2%2520results%2520in%2520enhanced%2520skin%2520tumor%2520development%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D5507%26epage%3D5516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Tani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egashira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Development of a highly selective EP2-receptor agonist. Part 2: Identification of 16-hydroxy-17,17-trimethylene 9beta-chloro PGF derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=1107-1114&author=K.+Taniauthor=A.+Naganawaauthor=A.+Ishidaauthor=H.+Egashiraauthor=K.+Sagawaauthor=H.+Haradaauthor=M.+Ogawaauthor=T.+Maruyamaauthor=S.+Ohuchidaauthor=H.+Nakaiauthor=K.+Kondoauthor=M.+Toda&title=Development+of+a+highly+selective+EP2-receptor+agonist.+Part+2%3A+Identification+of+16-hydroxy-17%2C17-trimethylene+9beta-chloro+PGF+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTani%26aufirst%3DK.%26aulast%3DNaganawa%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DA.%26aulast%3DEgashira%26aufirst%3DH.%26aulast%3DSagawa%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520highly%2520selective%2520EP2-receptor%2520agonist.%2520Part%25202%253A%2520Identification%2520of%252016-hydroxy-17%252C17-trimethylene%25209beta-chloro%2520PGF%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D1107%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">The prostanoid EP(2) receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">616</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.ejphar.2009.04.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlant70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=616&publication_year=2009&pages=64-67&author=A.+Moriauthor=T.+Ishiiauthor=T.+Kurokiauthor=N.+Shigetaauthor=K.+Sakamotoauthor=T.+Nakaharaauthor=K.+Ishii&title=The+prostanoid+EP%282%29+receptor+agonist+ONO-AE1-259-01+protects+against+glutamate-induced+neurotoxicity+in+rat+retina"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The prostanoid EP2 receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina</span></div><div class="casAuthors">Mori, Asami; Ishii, Takayuki; Kuroki, Taiyo; Shigeta, Naoki; Sakamoto, Kenji; Nakahara, Tsutomu; Ishii, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">616</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">64-67</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Prostaglandin E2 (PGE2) plays an important role in promoting inflammation and neurol. disorders.  The actions of PGE2 are mediated by four different G-protein-coupled receptors (EP1, EP2, EP3, and EP4).  The purpose of this study was to det. whether stimulation of prostanoid EP2 receptors has the potential to prevent the excitotoxic injuries in the retina.  For this purpose, we examd. the effect of 11,15-O-dimethyl prostaglandin E2 (ONO-AE1-259-01), a selective prostanoid EP2 receptor agonist, on N-methyl-D-aspartate (NMDA)-induced neurotoxicity in the rat retina.  ONO-AE1-259-01 (2 or 20 nmol) together with NMDA (200 nmol) was given intravitreally, and histol. evaluation was performed at 1 wk after the injection.  ONO-AE1-259-01 concn.-dependently prevented NMDA-induced cell loss in ganglion cell layer and redn. in thickness of inner plexiform layer.  These results indicate that ONO-AE1-259-01 protects the excitotoxic injuries in the rat retina, and that the prostanoid EP2 receptor may be a target for neuroprotective intervention in the retinal diseases assocd. with glutamate-induced excitotoxicity, such as glaucoma and diabetic retinopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAIBBrBH0PZLVg90H21EOLACvtfcHk0ljlJvVOj-8O8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlant70%253D&md5=565912dd747bc8504e0c7ec0b6db7996</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.04.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.04.051%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DA.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DKuroki%26aufirst%3DT.%26aulast%3DShigeta%26aufirst%3DN.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNakahara%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DThe%2520prostanoid%2520EP%25282%2529%2520receptor%2520agonist%2520ONO-AE1-259-01%2520protects%2520against%2520glutamate-induced%2520neurotoxicity%2520in%2520rat%2520retina%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D616%26spage%3D64%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">570</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.ejphar.2007.05.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Sjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2007&pages=135-141&author=A.+Moriauthor=M.+Saitoauthor=K.+Sakamotoauthor=M.+Naritaauthor=T.+Nakaharaauthor=K.+Ishii&title=Stimulation+of+prostanoid+IP+and+EP%282%29+receptors+dilates+retinal+arterioles+and+increases+retinal+and+choroidal+blood+flow+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of prostanoid IP and EP2 receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats</span></div><div class="casAuthors">Mori, Asami; Saito, Maki; Sakamoto, Kenji; Narita, Masami; Nakahara, Tsutomu; Ishii, Kunio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">135-141</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the effects of vasodilatory prostaglandins (prostacyclin and prostaglandin E2) and selective agonists for prostanoid EP2 and EP4 receptor on the diams. of retinal blood vessels and fundus (retinal/choroidal) blood flow in rats.  Male Wistar rats (8- to 10-wk-old) were treated with tetrodotoxin (50 μg/kg, i.v.) to eliminate any nerve activity and prevent movement of the eye and infused with a mixt. soln. of norepinephrine and epinephrine (1:9) to maintain adequate systemic circulation under artificial ventilation.  Fundus images were captured with a digital camera that was equipped with the special objective lens for small animals, and the diams. of retinal arterioles and venules were measured on a personal computer.  Fundus blood flow was estd. using a laser Doppler flowmetry.  I.v. infusions of prostacyclin and prostaglandin E2 dilated retinal blood vessels, increased fundus blood flow and decreased systemic blood pressure in a dose-dependent manner.  The effects of vasodilatory prostaglandins on retinal arterioles were greater than those on retinal venules.  Similarly, a prostanoid EP2 receptor agonist (ONO-AE1-259-01) dilated retinal blood vessels, and increased fundus blood flow and decreased systemic blood pressure.  However, a prostanoid EP4 receptor agonist (ONO-AE1-329) failed to increase fundus blood flow, despite its comparable depressor response with those to vasodilatory prostaglandins and the prostanoid EP2 receptor agonist.  The responses to forskolin, an activator of adenylyl cyclase, were very similar to those to prostacyclin and the prostanoid EP2 receptor agonist.  These results suggest that prostacyclin and prostaglandin E2 act as vasodilators in retinal and choroidal circulation, and prostanoid IP and EP2 receptors play an important role in the regulation of ocular hemodynamics in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3ecv4TYhZj7Vg90H21EOLACvtfcHk0ljlJvVOj-8O8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Sjsbs%253D&md5=597f83e4cdb74b38f7232ce8363294ba</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.05.052%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DA.%26aulast%3DSaito%26aufirst%3DM.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DNarita%26aufirst%3DM.%26aulast%3DNakahara%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DStimulation%2520of%2520prostanoid%2520IP%2520and%2520EP%25282%2529%2520receptors%2520dilates%2520retinal%2520arterioles%2520and%2520increases%2520retinal%2520and%2520choroidal%2520blood%2520flow%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D570%26spage%3D135%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borovecki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowchalk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vukicevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">An EP2 receptor-selective prostaglandin E2 agonist induces bone healing</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">6736</span><span class="NLM_x">–</span> <span class="NLM_lpage">6740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=6736-6740&author=V.+M.+Paralkarauthor=F.+Boroveckiauthor=H.+Z.+Keauthor=K.+O.+Cameronauthor=B.+Lefkerauthor=W.+A.+Grasserauthor=T.+A.+Owenauthor=M.+Liauthor=P.+DaSilva-Jardineauthor=M.+Zhouauthor=R.+L.+Dunnauthor=F.+Dumontauthor=R.+Korsmeyerauthor=P.+Krasneyauthor=T.+A.+Brownauthor=D.+Plowchalkauthor=S.+Vukicevicauthor=D.+D.+Thompson&title=An+EP2+receptor-selective+prostaglandin+E2+agonist+induces+bone+healing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DBorovecki%26aufirst%3DF.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DR.%2BL.%26aulast%3DDumont%26aufirst%3DF.%26aulast%3DKorsmeyer%26aufirst%3DR.%26aulast%3DKrasney%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DPlowchalk%26aufirst%3DD.%26aulast%3DVukicevic%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DAn%2520EP2%2520receptor-selective%2520prostaglandin%2520E2%2520agonist%2520induces%2520bone%2520healing%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D6736%26epage%3D6740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawistoski, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjoa, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2075</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2075-2078&author=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=H.+Z.+Keauthor=M.+Liauthor=M.+P.+Zawistoskiauthor=C.+M.+Tjoaauthor=A.+S.+Wrightauthor=S.+L.+DeNinnoauthor=V.+M.+Paralkarauthor=T.+A.+Owenauthor=L.+Yuauthor=D.+D.+Thompson&title=Discovery+of+CP-533536%3A+an+EP2+receptor+selective+prostaglandin+E2+%28PGE2%29+agonist+that+induces+local+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DTjoa%26aufirst%3DC.%2BM.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520of%2520CP-533536%253A%2520an%2520EP2%2520receptor%2520selective%2520prostaglandin%2520E2%2520%2528PGE2%2529%2520agonist%2520that%2520induces%2520local%2520bone%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2075%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing</span> <span class="citation_source-journal">J. Bone. Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1359%2Fjbmr.2003.18.11.2033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=14606517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVyiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=2033-2042&author=M.+Liauthor=H.+Z.+Keauthor=H.+Qiauthor=D.+R.+Healyauthor=Y.+Liauthor=D.+T.+Crawfordauthor=V.+M.+Paralkarauthor=T.+A.+Owenauthor=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=T.+A.+Brownauthor=D.+D.+Thompson&title=A+novel%2C+non-prostanoid+EP2+receptor-selective+prostaglandin+E2+agonist+stimulates+local+bone+formation+and+enhances+fracture+healing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing</span></div><div class="casAuthors">Li, Mei; Ke, Hua Zhu; Qi, Hong; Healy, David R.; Li, Yan; Crawford, D. Todd; Paralkar, Vishwas M.; Owen, Thomas A.; Cameron, Kimberly O.; Lefker, Bruce A.; Brown, Thomas A.; Thompson, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2033-2042</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">CP-533,536, a newly discovered, non-prostanoid EP2 receptor-selective PGE2 agonist, stimulates local bone formation and enhances fracture healing in rat models.  There is a significant medical need for agents that can stimulate local bone formation and enhance fracture healing.  The authors tested the effects of CP-533,536, a newly discovered, non-prostanoid EP2 receptor-selective PGE2 agonist, in stimulating local bone formation and enhancing fracture healing in rat models.  In the first model, a single injection of CP-533,536 at doses of 0.3, 1, or 3 mg/kg to the proximal tibial metaphysis of 6-wk-old male rats was given on day 1, and the local bone anabolic effect was detd. on day 7.  The authors then tested the effects of this compd. in inducing bone formation on rat periosteum of the femur.  A single dose of 0.3 mg of CP-533,536 incorporated in a poly-(DL-lactide-co-glycolide) (PLGH) matrix was injected onto the periosteum of the femur in 3-wk-old male rats, and local bone formation was detd. on day 14.  Finally, the ability of CP-533,536 in PLGH matrix in enhancing fracture healing was tested using the rat femoral fracture model.  CP-533,536 in PLGH matrix at doses of 0.05, 0.5, or 5 mg was delivered to the local fracture site on the same day of fracture, and its efficacy was evaluated on day 21.  A single injection of CP-533,536 at doses of 0.3, 1, or 3 mg/kg to the proximal tibial metaphysis dose-dependently stimulated local lamellar bone formation on trabecular, endocortical, and periosteal surfaces, and thus increased bone mineral content and bone strength at the injected site.  Similarly, a single injection of 0.3 mg of CP-533,536 incorporated in PLGH matrix onto the periosteum of the femur induced significantly local bone formation.  In the rat femoral fracture model, CP-533,536 in PLGH matrix at doses of 0.05, 0.5, and 5 mg dose-dependently increased callus size, d., and strength compared with PLGH matrix alone.  These results show that CP-533,536 stimulates new bone formation on trabecular, endocortical, and periosteal surfaces and enhances fracture healing.  These data reveal that EP2 receptor-selective agonists provide therapeutic potential for local bone augmentation, bone repair, and bone healing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eB8GOoJsErVg90H21EOLACvtfcHk0lgAs34iWtS66g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVyiu7o%253D&md5=96d5d5fca5c87a121edda85af9cdbb9b</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.11.2033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.11.2033%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DHealy%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DA%2520novel%252C%2520non-prostanoid%2520EP2%2520receptor-selective%2520prostaglandin%2520E2%2520agonist%2520stimulates%2520local%2520bone%2520formation%2520and%2520enhances%2520fracture%2520healing%26jtitle%3DJ.%2520Bone.%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26spage%3D2033%26epage%3D2042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Vukicevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simic, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borovecki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grgurevic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span> </span><span class="NLM_article-title">Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1099</span><span class="NLM_x">–</span> <span class="NLM_lpage">1106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fsj.ki.5001715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFCls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1099-1106&author=S.+Vukicevicauthor=P.+Simicauthor=F.+Boroveckiauthor=L.+Grgurevicauthor=D.+Rogicauthor=I.+Orlicauthor=W.+A.+Grasserauthor=D.+D.+Thompsonauthor=V.+M.+Paralkar&title=Role+of+EP2+and+EP4+receptor-selective+agonists+of+prostaglandin+E%282%29+in+acute+and+chronic+kidney+failure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Role of EP2 and EP4 receptor-selective agonists of prostaglandin E2 in acute and chronic kidney failure</span></div><div class="casAuthors">Vukicevic, S.; Simic, P.; Borovecki, F.; Grgurevic, L.; Rogic, D.; Orlic, I.; Grasser, W. A.; Thompson, D. D.; Paralkar, V. M.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1099-1106</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the efficacy of three selective agonists of prostaglandin E2 (PGE2) receptor, EP2 (CP-536,745-01), EP2/4 (CP-043,305-02), and EP4 (CP-044,519-02), in two models of acute and chronic kidney failure.  In the nephrotoxic mercury chloride (HgCl2) rat model of acute kidney failure systemically administered EP4 agonist reduced the serum creatinine values and increased the survival rate.  Although the EP2 or the EP2/4 agonist did not change the serum creatinine values, the EP2 receptor agonist increased the survival rate.  Histol. evaluation of kidneys from EP4-treated rats indicated less proximal tubular necrosis and less apoptotic cells.  In a rat model of chronic renal failure, the three receptor agonists decreased the serum creatinine and increased the glomerular filtration rate at 9 wk following therapy.  Kidneys treated with the EP4 agonist had less glomerular sclerosis, better preservation of proximal and distal tubules and blood vessels, increased convoluted epithelium proliferation and less apoptotic cells.  Nephrectomy had no influence on the expression of the EP4 receptor, whereas EP2 receptor expression was reduced by 50% and then cor. following treatment with EP2 and EP2/4 receptor agonists.  These findings suggest that PGE2 has an important role in acute kidney failure via the EP4 receptor, whereas in chronic kidney failure both EP2 and EP4 receptors are equally important in preserving the progression of chronic kidney failure.  Thus, agonism of EP2 and EP4 receptors may provide a basis for treating acute and chronic kidney failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow1Qeud0xZmbVg90H21EOLACvtfcHk0lgAs34iWtS66g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFCls74%253D&md5=3c479ea8cf38a60c112cd480108ec2ac</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fsj.ki.5001715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ki.5001715%26sid%3Dliteratum%253Aachs%26aulast%3DVukicevic%26aufirst%3DS.%26aulast%3DSimic%26aufirst%3DP.%26aulast%3DBorovecki%26aufirst%3DF.%26aulast%3DGrgurevic%26aufirst%3DL.%26aulast%3DRogic%26aufirst%3DD.%26aulast%3DOrlic%26aufirst%3DI.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26atitle%3DRole%2520of%2520EP2%2520and%2520EP4%2520receptor-selective%2520agonists%2520of%2520prostaglandin%2520E%25282%2529%2520in%2520acute%2520and%2520chronic%2520kidney%2520failure%26jtitle%3DKidney%2520Int.%26date%3D2006%26volume%3D70%26spage%3D1099%26epage%3D1106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Houchen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturmoski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenson, W. F.</span><span> </span><span class="NLM_article-title">Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine</span> <span class="citation_source-journal">Am. J. Physiol.: Gastrointest. Liver Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">G490</span><span class="NLM_x">–</span> <span class="NLM_lpage">G498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=G490-G498&author=C.+W.+Houchenauthor=M.+A.+Sturmoskiauthor=S.+Anantauthor=R.+M.+Breyerauthor=W.+F.+Stenson&title=Prosurvival+and+antiapoptotic+effects+of+PGE2+in+radiation+injury+are+mediated+by+EP2+receptor+in+intestine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHouchen%26aufirst%3DC.%2BW.%26aulast%3DSturmoski%26aufirst%3DM.%2BA.%26aulast%3DAnant%26aufirst%3DS.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DStenson%26aufirst%3DW.%2BF.%26atitle%3DProsurvival%2520and%2520antiapoptotic%2520effects%2520of%2520PGE2%2520in%2520radiation%2520injury%2520are%2520mediated%2520by%2520EP2%2520receptor%2520in%2520intestine%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2003%26volume%3D284%26spage%3DG490%26epage%3DG498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Sheibanie, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadmori, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassiliou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganea, D.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1318</span><span class="NLM_x">–</span> <span class="NLM_lpage">1320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1318-1320&author=A.+F.+Sheibanieauthor=I.+Tadmoriauthor=H.+Jingauthor=E.+Vassiliouauthor=D.+Ganea&title=Prostaglandin+E2+induces+IL-23+production+in+bone+marrow-derived+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheibanie%26aufirst%3DA.%2BF.%26aulast%3DTadmori%26aufirst%3DI.%26aulast%3DJing%26aufirst%3DH.%26aulast%3DVassiliou%26aufirst%3DE.%26aulast%3DGanea%26aufirst%3DD.%26atitle%3DProstaglandin%2520E2%2520induces%2520IL-23%2520production%2520in%2520bone%2520marrow-derived%2520dendritic%2520cells%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1318%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segi-Nishida, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyachi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=325-335&author=T.+Hondaauthor=E.+Segi-Nishidaauthor=Y.+Miyachiauthor=S.+Narumiya&title=Prostacyclin-IP+signaling+and+prostaglandin+E2-EP2%2FEP4+signaling+both+mediate+joint+inflammation+in+mouse+collagen-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DSegi-Nishida%26aufirst%3DE.%26aulast%3DMiyachi%26aufirst%3DY.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstacyclin-IP%2520signaling%2520and%2520prostaglandin%2520E2-EP2%252FEP4%2520signaling%2520both%2520mediate%2520joint%2520inflammation%2520in%2520mouse%2520collagen-induced%2520arthritis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D325%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Kabashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagamachi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishigori, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyachi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2007&pages=49-55&author=K.+Kabashimaauthor=M.+Nagamachiauthor=T.+Hondaauthor=C.+Nishigoriauthor=Y.+Miyachiauthor=Y.+Tokuraauthor=S.+Narumiya&title=Prostaglandin+E2+is+required+for+ultraviolet+B-induced+skin+inflammation+via+EP2+and+EP4+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKabashima%26aufirst%3DK.%26aulast%3DNagamachi%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DNishigori%26aufirst%3DC.%26aulast%3DMiyachi%26aufirst%3DY.%26aulast%3DTokura%26aufirst%3DY.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstaglandin%2520E2%2520is%2520required%2520for%2520ultraviolet%2520B-induced%2520skin%2520inflammation%2520via%2520EP2%2520and%2520EP4%2520receptors%26jtitle%3DLab.%2520Invest.%26date%3D2007%26volume%3D87%26spage%3D49%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Donnini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terzuoli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morbidelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrignani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziche, M.</span><span> </span><span class="NLM_article-title">EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2418</span><span class="NLM_x">–</span> <span class="NLM_lpage">2430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=2418-2430&author=S.+Donniniauthor=F.+Finettiauthor=R.+Solitoauthor=E.+Terzuoliauthor=A.+Sacchettiauthor=L.+Morbidelliauthor=P.+Patrignaniauthor=M.+Ziche&title=EP2+prostanoid+receptor+promotes+squamous+cell+carcinoma+growth+through+epidermal+growth+factor+receptor+transactivation+and+iNOS+and+ERK1%2F2+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonnini%26aufirst%3DS.%26aulast%3DFinetti%26aufirst%3DF.%26aulast%3DSolito%26aufirst%3DR.%26aulast%3DTerzuoli%26aufirst%3DE.%26aulast%3DSacchetti%26aufirst%3DA.%26aulast%3DMorbidelli%26aufirst%3DL.%26aulast%3DPatrignani%26aufirst%3DP.%26aulast%3DZiche%26aufirst%3DM.%26atitle%3DEP2%2520prostanoid%2520receptor%2520promotes%2520squamous%2520cell%2520carcinoma%2520growth%2520through%2520epidermal%2520growth%2520factor%2520receptor%2520transactivation%2520and%2520iNOS%2520and%2520ERK1%252F2%2520pathways%26jtitle%3DFASEB%2520J.%26date%3D2007%26volume%3D21%26spage%3D2418%26epage%3D2430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Kamiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBusk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P. C.</span><span> </span><span class="NLM_article-title">EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7019</span><span class="NLM_x">–</span> <span class="NLM_lpage">7028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=7019-7028&author=M.+Kamiyamaauthor=A.+Pozziauthor=L.+Yangauthor=L.+M.+DeBuskauthor=R.+M.+Breyerauthor=P.+C.+Lin&title=EP2%2C+a+receptor+for+PGE2%2C+regulates+tumor+angiogenesis+through+direct+effects+on+endothelial+cell+motility+and+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKamiyama%26aufirst%3DM.%26aulast%3DPozzi%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDeBusk%26aufirst%3DL.%2BM.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DLin%26aufirst%3DP.%2BC.%26atitle%3DEP2%252C%2520a%2520receptor%2520for%2520PGE2%252C%2520regulates%2520tumor%2520angiogenesis%2520through%2520direct%2520effects%2520on%2520endothelial%2520cell%2520motility%2520and%2520survival%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D7019%26epage%3D7028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Brouxhon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konger, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanBuskirk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheu, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almudevar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pentland, A. P.</span><span> </span><span class="NLM_article-title">Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2007&pages=439-446&author=S.+Brouxhonauthor=R.+L.+Kongerauthor=J.+VanBuskirkauthor=T.+J.+Sheuauthor=J.+Ryanauthor=B.+Erdleauthor=A.+Almudevarauthor=R.+M.+Breyerauthor=G.+Scottauthor=A.+P.+Pentland&title=Deletion+of+prostaglandin+E2+EP2+receptor+protects+against+ultraviolet-induced+carcinogenesis%2C+but+increases+tumor+aggressiveness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrouxhon%26aufirst%3DS.%26aulast%3DKonger%26aufirst%3DR.%2BL.%26aulast%3DVanBuskirk%26aufirst%3DJ.%26aulast%3DSheu%26aufirst%3DT.%2BJ.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DErdle%26aufirst%3DB.%26aulast%3DAlmudevar%26aufirst%3DA.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DScott%26aufirst%3DG.%26aulast%3DPentland%26aufirst%3DA.%2BP.%26atitle%3DDeletion%2520of%2520prostaglandin%2520E2%2520EP2%2520receptor%2520protects%2520against%2520ultraviolet-induced%2520carcinogenesis%252C%2520but%2520increases%2520tumor%2520aggressiveness%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2007%26volume%3D127%26spage%3D439%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">O’Collins, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macleod, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horky, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Worp, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howells, D. W.</span><span> </span><span class="NLM_article-title">1,026 experimental treatments in acute stroke</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2Fana.20741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=16453316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtV2lsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2006&pages=467-477&author=V.+E.+O%E2%80%99Collinsauthor=M.+R.+Macleodauthor=G.+A.+Donnanauthor=L.+L.+Horkyauthor=B.+H.+van+der+Worpauthor=D.+W.+Howells&title=1%2C026+experimental+treatments+in+acute+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">1,026 Experimental treatments in acute stroke</span></div><div class="casAuthors">O'Collins, Victoria E.; Macleod, Malcolm R.; Donnan, Geoffrey A.; Horky, Laura L.; van der Worp, Bart H.; Howells, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">467-477</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: Preclin. evaluation of neuroprotectants fostered high expectations of clin. efficacy.  When not matched, the question arises whether expts. are poor indicators of clin. outcome or whether the best drugs were not taken forward to clin. trial.  Therefore, we endeavored to contrast exptl. efficacy and scope of testing of drugs used clin. and those tested only exptl.  Methods: We identified neuroprotectants and reports of exptl. efficacy via a systematic search.  Controlled in vivo and in vitro expts. using functional or histol. end points were selected for anal.  Relationships between outcome, drug mechanism, scope of testing, and clin. trial status were assessed statistically.  Results: There was no evidence that drugs used clin. (114 drugs) were more effective exptl. than those tested only in animal models (912 drugs), for example, improvement in focal models averaged 31.3±16.7% vs. 24.4±32.9%, p > 0.05, resp.  Scope of testing using Stroke Therapy Academic Industry Roundtable (STAIR) criteria was highly variable, and no relationship was found between mechanism and efficacy.  Interpretation: The results question whether the most efficacious drugs are being selected for stroke clin. trials.  This may partially explain the slow progress in developing treatments.  Greater rigor in the conduct, reporting, and anal. of animal data will improve the transition of scientific advances from bench to bedside.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN7GktDgpOvLVg90H21EOLACvtfcHk0lhDeZR3XE3grQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtV2lsbc%253D&md5=2d8c1160718bc20d152f7ca03eb1680b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fana.20741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20741%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Collins%26aufirst%3DV.%2BE.%26aulast%3DMacleod%26aufirst%3DM.%2BR.%26aulast%3DDonnan%26aufirst%3DG.%2BA.%26aulast%3DHorky%26aufirst%3DL.%2BL.%26aulast%3Dvan%2Bder%2BWorp%26aufirst%3DB.%2BH.%26aulast%3DHowells%26aufirst%3DD.%2BW.%26atitle%3D1%252C026%2520experimental%2520treatments%2520in%2520acute%2520stroke%26jtitle%3DAnn.%2520Neurol.%26date%3D2006%26volume%3D59%26spage%3D467%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1002%2Fana.20461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=15852374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvFykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=758-761&author=D.+Liuauthor=L.+Wuauthor=R.+Breyerauthor=M.+P.+Mattsonauthor=K.+Andreasson&title=Neuroprotection+by+the+PGE2+EP2+receptor+in+permanent+focal+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia</span></div><div class="casAuthors">Liu, Dong; Wu, Liejun; Breyer, Richard; Mattson, Mark P.; Andreasson, Katrin</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">758-761</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Recent studies suggest a neuroprotective function of the PGE2 EP2 receptor in excitotoxic neuronal injury.  The function of the EP2 receptor was examd. at time points after excitotoxicity in an organotypic hippocampal model of N-methyl-D-aspartate (NMDA) challenge and in a permanent model of focal forebrain ischemia.  Activation of EP2 led to significant neuroprotection in hippocampal slices up to 3 h after a toxic NMDA stimulus.  Genetic deletion of EP2 resulted in a marked increase in stroke vol. in the permanent middle cerebral artery occlusion model.  These findings support further investigation into therapeutic strategies targeting the EP2 receptor in stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKGL6k6wt8bLVg90H21EOLACvtfcHk0lhPOYDxdizp1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvFykt7c%253D&md5=d594ba060dc7701de82b460887d13d76</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Fana.20461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20461%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DBreyer%26aufirst%3DR.%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DNeuroprotection%2520by%2520the%2520PGE2%2520EP2%2520receptor%2520in%2520permanent%2520focal%2520cerebral%2520ischemia%26jtitle%3DAnn.%2520Neurol.%26date%3D2005%26volume%3D57%26spage%3D758%26epage%3D761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Ahmad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saleem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, S.</span><span> </span><span class="NLM_article-title">The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke</span> <span class="citation_source-journal">Exp. Transl. Stroke Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1186%2F2040-7378-2-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=20615245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3cjht1ehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=12&author=M.+Ahmadauthor=S.+Saleemauthor=Z.+Shahauthor=T.+Maruyamaauthor=S.+Narumiyaauthor=S.+Dore&title=The+PGE2+EP2+receptor+and+its+selective+activation+are+beneficial+against+ischemic+stroke"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke</span></div><div class="casAuthors">Ahmad Muzamil; Saleem Sofiyan; Shah Zahoor; Dore Sylvain; Maruyama Takayuki; Narumiya Shuh; Dore Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Experimental & translational stroke medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The prostaglandin E2 EP2 receptor has been shown to be important in dictating outcomes in various neuroinflammatory disorders.  Here, we investigated the importance of the EP2 receptor in short- and long-term ischemic outcomes by subjecting wildtype (WT) and EP2 knockout (EP2-/-) mice to two distinct and complementary stroke models [transient and permanent middle cerebral artery occlusion (tMCAO and pMCAO)] and by using the EP2 receptor agonist ONO-AE1-259-01.  METHODS:  First, WT and EP2-/- mice were subjected to 90-min tMCAO with a monofilament followed by 4-day reperfusion.  Second, WT mice were infused intracerebroventricularly with vehicle or ONO-AE1-259-01 45-50 min before being subjected to tMCAO.  Finally, WT and EP2-/- mice were subjected to pMCAO and allowed to survive for an extended period of 7 days.  RESULTS:  Infarct volumes in EP2-/- mice were 55.0 +/- 9.1% larger after tMCAO and 33.3 +/- 8.6% larger after pMCAO than those in WT mice.  Neurobehavioral deficits also were significantly greater in the EP2-/- mice.  These results suggest that EP2 is beneficial and that activation is sustained for days after the stroke.  We also found that pharmacologic activation of EP2 with 1.0- and 2.0-nmol doses of ONO-AE1-259-01 was sufficient to significantly reduce the infarct volume in WT mice compared with that in vehicle-treated controls (20.1 +/- 3.9% vs. 37.1 +/- 4.6%).  This reduction correlated with improved neurologic scores.  No significant effect on physiologic parameters was observed.  CONCLUSION:  Together, our results reveal that pharmacologic stimulation of the EP2 receptor has an important beneficial role in cerebral ischemia and might be considered as an adjunct therapy for ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbF-gw_YCjbd0Q2ypr7jHkfW6udTcc2eacL-Kbll-Nwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjht1ehug%253D%253D&md5=bcc5ef44b697b99fd37b9ac94cd0a812</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1186%2F2040-7378-2-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2040-7378-2-12%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DM.%26aulast%3DSaleem%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DZ.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DNarumiya%26aufirst%3DS.%26aulast%3DDore%26aufirst%3DS.%26atitle%3DThe%2520PGE2%2520EP2%2520receptor%2520and%2520its%2520selective%2520activation%2520are%2520beneficial%2520against%2520ischemic%2520stroke%26jtitle%3DExp.%2520Transl.%2520Stroke%2520Med.%26date%3D2010%26volume%3D2%26spage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Serrano, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelutiu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makinson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FitzGerald, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">14850</span><span class="NLM_x">–</span> <span class="NLM_lpage">14860</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1523%2FJNEUROSCI.3922-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=22016518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSjurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=14850-14860&author=G.+E.+Serranoauthor=N.+Lelutiuauthor=A.+Rojasauthor=S.+Cochiauthor=R.+Shawauthor=C.+D.+Makinsonauthor=D.+Wangauthor=G.+A.+FitzGeraldauthor=R.+Dingledine&title=Ablation+of+cyclooxygenase-2+in+forebrain+neurons+is+neuroprotective+and+dampens+brain+inflammation+after+status+epilepticus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus</span></div><div class="casAuthors">Serrano, G. E.; Lelutiu, N.; Rojas, A.; Cochi, S.; Shaw, R.; Makinson, C. D.; Wang, D.; FitzGerald, G. A.; Dingledine, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">14850-14860</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Cyclooxygenase-2 (COX-2), a source of inflammatory mediators and a multifunctional neuronal modulator, is rapidly induced in select populations of cortical neurons after status epilepticus.  The consequences of rapid activity-triggered induction of COX-2 in neurons were the subject of much study and speculation.  To address this issue directly, the authors created a mouse in which COX-2 is conditionally ablated in selected forebrain neurons.  Results following pilocarpine-induced status epilepticus indicate that neuronal COX-2 promotes early neuroprotection and then delayed neurodegeneration of CA1 pyramidal neurons, promotes neurodegeneration of nearby somatostatin interneurons in the CA1 stratum oriens and dentate hilus (which themselves do not express COX-2), intensifies a broad inflammatory reaction involving numerous cytokines and other inflammatory mediators in the hippocampus, and is essential for development of a leaky blood-brain barrier after seizures.  These findings point to a profound role of seizure-induced neuronal COX-2 expression in neuropathologies that accompany epileptogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFmygqaE45J7Vg90H21EOLACvtfcHk0lhPOYDxdizp1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSjurvP&md5=4af8906db3d911f843b16f0e85d0337c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3922-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3922-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano%26aufirst%3DG.%2BE.%26aulast%3DLelutiu%26aufirst%3DN.%26aulast%3DRojas%26aufirst%3DA.%26aulast%3DCochi%26aufirst%3DS.%26aulast%3DShaw%26aufirst%3DR.%26aulast%3DMakinson%26aufirst%3DC.%2BD.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DAblation%2520of%2520cyclooxygenase-2%2520in%2520forebrain%2520neurons%2520is%2520neuroprotective%2520and%2520dampens%2520brain%2520inflammation%2520after%2520status%2520epilepticus%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D14850%26epage%3D14860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Tani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egashira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a highly selective EP2-receptor agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2025</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=2025-2028&author=K.+Taniauthor=A.+Naganawaauthor=A.+Ishidaauthor=H.+Egashiraauthor=K.+Sagawaauthor=H.+Haradaauthor=M.+Ogawaauthor=T.+Maruyamaauthor=S.+Ohuchidaauthor=H.+Nakaiauthor=K.+Kondoauthor=M.+Toda&title=Design+and+synthesis+of+a+highly+selective+EP2-receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTani%26aufirst%3DK.%26aulast%3DNaganawa%26aufirst%3DA.%26aulast%3DIshida%26aufirst%3DA.%26aulast%3DEgashira%26aufirst%3DH.%26aulast%3DSagawa%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520highly%2520selective%2520EP2-receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D2025%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Lohse, M. J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of membrane receptor desensitization</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">1179</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1179&publication_year=1993&pages=171-188&author=M.+J.+Lohse&title=Molecular+mechanisms+of+membrane+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26atitle%3DMolecular%2520mechanisms%2520of%2520membrane%2520receptor%2520desensitization%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1993%26volume%3D1179%26spage%3D171%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Nishigaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Negishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, A.</span><span> </span><span class="NLM_article-title">Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=1031-1037&author=N.+Nishigakiauthor=M.+Negishiauthor=A.+Ichikawa&title=Two+Gs-coupled+prostaglandin+E+receptor+subtypes%2C+EP2+and+EP4%2C+differ+in+desensitization+and+sensitivity+to+the+metabolic+inactivation+of+the+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNishigaki%26aufirst%3DN.%26aulast%3DNegishi%26aufirst%3DM.%26aulast%3DIchikawa%26aufirst%3DA.%26atitle%3DTwo%2520Gs-coupled%2520prostaglandin%2520E%2520receptor%2520subtypes%252C%2520EP2%2520and%2520EP4%252C%2520differ%2520in%2520desensitization%2520and%2520sensitivity%2520to%2520the%2520metabolic%2520inactivation%2520of%2520the%2520agonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D1996%26volume%3D50%26spage%3D1031%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Su, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harden, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, J. P.</span><span> </span><span class="NLM_article-title">Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">7410</span><span class="NLM_x">–</span> <span class="NLM_lpage">7419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=7410-7419&author=Y.+F.+Suauthor=T.+K.+Hardenauthor=J.+P.+Perkins&title=Catecholamine-specific+desensitization+of+adenylate+cyclase.+Evidence+for+a+multistep+process"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DY.%2BF.%26aulast%3DHarden%26aufirst%3DT.%2BK.%26aulast%3DPerkins%26aufirst%3DJ.%2BP.%26atitle%3DCatecholamine-specific%2520desensitization%2520of%2520adenylate%2520cyclase.%2520Evidence%2520for%2520a%2520multistep%2520process%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D7410%26epage%3D7419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Desai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">April, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nwaneshiudu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashby, B.</span><span> </span><span class="NLM_article-title">Comparison of agonist-induced internalization of the human EP2 and EP4 prostaglandin receptors: role of the carboxyl terminus in EP4 receptor sequestration</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1279</span><span class="NLM_x">–</span> <span class="NLM_lpage">1286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1279-1286&author=S.+Desaiauthor=H.+Aprilauthor=C.+Nwaneshiuduauthor=B.+Ashby&title=Comparison+of+agonist-induced+internalization+of+the+human+EP2+and+EP4+prostaglandin+receptors%3A+role+of+the+carboxyl+terminus+in+EP4+receptor+sequestration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DApril%26aufirst%3DH.%26aulast%3DNwaneshiudu%26aufirst%3DC.%26aulast%3DAshby%26aufirst%3DB.%26atitle%3DComparison%2520of%2520agonist-induced%2520internalization%2520of%2520the%2520human%2520EP2%2520and%2520EP4%2520prostaglandin%2520receptors%253A%2520role%2520of%2520the%2520carboxyl%2520terminus%2520in%2520EP4%2520receptor%2520sequestration%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1279%26epage%3D1286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Schwenn, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. J.</span><span> </span><span class="NLM_article-title">Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study</span> <span class="citation_source-journal">BMC Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1186%2F1471-2415-10-21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BC3cfkvFartw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=21&author=O.+Schwennauthor=B.+Heckmannauthor=C.+Guzyauthor=P.+J.+Miller&title=Long-term+effect+of+latanoprost%2Ftimolol+fixed+combination+in+patients+with+glaucoma+or+ocular+hypertension%3A+a+prospective%2C+observational%2C+noninterventional+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study</span></div><div class="casAuthors">Schwenn Oliver; Heckmann Barbara; Guzy Claudia; Miller Paul J</div><div class="citationInfo"><span class="NLM_cas:title">BMC ophthalmology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Prospective, observational studies that enroll large numbers of patients with few exclusion criteria may better reflect actual ongoing clinical experience than randomized clinical trials.  Our purpose was to obtain efficacy and safety information from a cohort of subjects exposed to latanoprost/timolol fixed combination (FC) for ≥18 months using a prospective, observational design.  METHODS:  In all, 577 office-based ophthalmologists in Germany switched 2339 patients with glaucoma or ocular hypertension to latanoprost/timolol FC for medical reasons.  Follow-up visits were scheduled for every 6 months over 24 months; physicians followed usual care routines.  Intraocular pressure (IOP), visual field status, optic nerve head findings, and adverse events were recorded.  Efficacy parameters were evaluated for the per protocol (PP) population; the safety population included subjects receiving ≥1 drop of FC.  Physicians rated efficacy, tolerability, and subject compliance at month 24.  RESULTS:  Of the 2339 subjects switched to latanoprost/timolol FC (safety population), the primary reasons for switching were inadequate IOP reduction (78.2%) and desire to simplify treatment with once-daily dosing (29.4%; multiple reasons possible).  In all, 1317 (56.3%) subjects completed the study, and 1028 (44.0%) were included in the PP population.  Most discontinuations were due to loss to follow-up.  Change in mean IOP from baseline to month 6 was -4.0 ± 4.31 mmHg, a reduction that was maintained throughout (P < 0.05 for change at all time points).  By investigator assessments, optic disc parameters and visual field were stable over 24 months, and there was no relationship between IOP reduction over 24 months and development of a visual field defect.  More than 90% of physicians rated latanoprost/timolol FC as "very good" or "good" for efficacy (PP population), tolerability, and compliance.  The FC was safe and well tolerated.  No change in iris color was reported by most subjects (83.1%) at month 24.  CONCLUSIONS:  Over 24 months, latanoprost/timolol FC effectively lowers IOP levels and is well tolerated in patients with glaucoma or ocular hypertension who change from their previous ocular hypotensive therapy for medical reasons.  Investigator assessments found optic disc parameters and visual field to be stable throughout 24 months of follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQC23SCD_Mi60Gy1nwu7K2mfW6udTcc2eYS8gbKxuD4Ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfkvFartw%253D%253D&md5=a2eaa27cc0a1ba93df41aacfaa00ca5d</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1186%2F1471-2415-10-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2415-10-21%26sid%3Dliteratum%253Aachs%26aulast%3DSchwenn%26aufirst%3DO.%26aulast%3DHeckmann%26aufirst%3DB.%26aulast%3DGuzy%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DP.%2BJ.%26atitle%3DLong-term%2520effect%2520of%2520latanoprost%252Ftimolol%2520fixed%2520combination%2520in%2520patients%2520with%2520glaucoma%2520or%2520ocular%2520hypertension%253A%2520a%2520prospective%252C%2520observational%252C%2520noninterventional%2520study%26jtitle%3DBMC%2520Ophthalmol.%26date%3D2010%26volume%3D10%26spage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Susanna, R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giampani, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vessani, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordao, M. L.</span><span> </span><span class="NLM_article-title">A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension</span> <span class="citation_source-journal">Ophthalmology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2001&pages=259-263&author=R.+Susannaauthor=J.+Giampaniauthor=A.+S.+Borgesauthor=R.+M.+Vessaniauthor=M.+L.+Jordao&title=A+double-masked%2C+randomized+clinical+trial+comparing+latanoprost+with+unoprostone+in+patients+with+open-angle+glaucoma+or+ocular+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSusanna%26aufirst%3DR.%26aulast%3DGiampani%26aufirst%3DJ.%26aulast%3DBorges%26aufirst%3DA.%2BS.%26aulast%3DVessani%26aufirst%3DR.%2BM.%26aulast%3DJordao%26aufirst%3DM.%2BL.%26atitle%3DA%2520double-masked%252C%2520randomized%2520clinical%2520trial%2520comparing%2520latanoprost%2520with%2520unoprostone%2520in%2520patients%2520with%2520open-angle%2520glaucoma%2520or%2520ocular%2520hypertension%26jtitle%3DOphthalmology%26date%3D2001%26volume%3D108%26spage%3D259%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Prasanna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gukasyan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartnurak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almaden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafontaine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, A.</span><span> </span><span class="NLM_article-title">Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.exer.2011.02.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21376717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2hurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=256-264&author=G.+Prasannaauthor=S.+Carreiroauthor=S.+Andersonauthor=H.+Gukasyanauthor=S.+Sartnurakauthor=H.+Younisauthor=D.+Galeauthor=C.+Xiangauthor=P.+Wellsauthor=D.+Dinhauthor=C.+Almadenauthor=J.+Fortnerauthor=C.+Torisauthor=M.+Niesmanauthor=J.+Lafontaineauthor=A.+Krauss&title=Effect+of+PF-04217329+a+prodrug+of+a+selective+prostaglandin+EP%282%29+agonist+on+intraocular+pressure+in+preclinical+models+of+glaucoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of PF-04217329 a prodrug of a selective prostaglandin EP2 agonist on intraocular pressure in preclinical models of glaucoma</span></div><div class="casAuthors">Prasanna, Ganesh; Carreiro, Samantha; Anderson, Scott; Gukasyan, Hovhannes; Sartnurak, Soisurin; Younis, Husam; Gale, David; Xiang, Cathie; Wells, Peter; Dinh, Dac; Almaden, Chau; Fortner, Jay; Toris, Carol; Niesman, Michael; Lafontaine, Jennifer; Krauss, Achim</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">256-264</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Better control of intraocular pressure (IOP) is the most effective way to preserve visual field function in glaucomatous patients.  While prostaglandin FP analogs are leading the therapeutic intervention for glaucoma, new target classes also are being identified with new lead compds. being developed for IOP redn.  One target class currently being investigated includes the prostaglandin EP receptor agonists.  Recently PF-04217329 (Taprenepag isopropyl), a prodrug of CP-544326 (active acid metabolite), a potent and selective EP2 receptor agonist, was successfully evaluated for its ocular hypotensive activity in a clin. study involving patients with primary open angle glaucoma.  In the current manuscript, the preclin. attributes of CP-544326 and PF-0421329 have been described.  CP-544326 was found to be a potent and selective EP2 agonist (IC50 = 10 nM; EC50 = 2.8 nM) whose corneal permeability and ocular bioavailability were significantly increased when the compd. was dosed as the iso-Pr ester prodrug, PF-04217329.  Topical ocular dosing of PF-04217329 was well tolerated in preclin. species and caused an elevation of cAMP in aq. humor/iris-ciliary body indicative of in vivo EP2 target receptor activation.  Topical ocular dosing of PF-04217329 resulted in ocular exposure of CP-544326 at levels greater than the EC50 for the EP2 receptor.  PF-04217329 when dosed once daily caused between 30 and 50% IOP redn. in single day studies in normotensive Dutch-belted rabbits, normotensive dogs, and laser-induced ocular hypertensive cynomolgus monkeys and 20-40% IOP redn. in multiple day studies compared to vehicle-dosed eyes.  IOP redn. was sustained from 6 h through 24 h following a single topical dose.  In conclusion, preclin. data generated thus far appear to support the clin. development of PF-04217329 as a novel compd. for the treatment of glaucoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnGiw3YxQVbVg90H21EOLACvtfcHk0lh2sOFS5h885g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2hurrN&md5=bd2bcd1b2a850c3d57a103f986958cfe</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2011.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2011.02.015%26sid%3Dliteratum%253Aachs%26aulast%3DPrasanna%26aufirst%3DG.%26aulast%3DCarreiro%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DS.%26aulast%3DGukasyan%26aufirst%3DH.%26aulast%3DSartnurak%26aufirst%3DS.%26aulast%3DYounis%26aufirst%3DH.%26aulast%3DGale%26aufirst%3DD.%26aulast%3DXiang%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DFortner%26aufirst%3DJ.%26aulast%3DToris%26aufirst%3DC.%26aulast%3DNiesman%26aufirst%3DM.%26aulast%3DLafontaine%26aufirst%3DJ.%26aulast%3DKrauss%26aufirst%3DA.%26atitle%3DEffect%2520of%2520PF-04217329%2520a%2520prodrug%2520of%2520a%2520selective%2520prostaglandin%2520EP%25282%2529%2520agonist%2520on%2520intraocular%2520pressure%2520in%2520preclinical%2520models%2520of%2520glaucoma%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2011%26volume%3D93%26spage%3D256%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Schachar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span> </span><span class="NLM_article-title">A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension</span> <span class="citation_source-journal">Curr. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">817</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.3109%2F02713683.2011.593725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVCqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=809-817&author=R.+A.+Schacharauthor=S.+Raberauthor=R.+Courtneyauthor=M.+Zhang&title=A+phase+2%2C+randomized%2C+dose-response+trial+of+taprenepag+isopropyl+%28PF-04217329%29+versus+latanoprost+0.005%25+in+open-angle+glaucoma+and+ocular+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension</span></div><div class="casAuthors">Schachar, Ronald A.; Raber, Susan; Courtney, Rachel; Zhang, Min</div><div class="citationInfo"><span class="NLM_cas:title">Current Eye Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">809-817</span>CODEN:
                <span class="NLM_cas:coden">CEYRDM</span>;
        ISSN:<span class="NLM_cas:issn">0271-3683</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Purpose: To evaluate the safety of escalating doses of taprenepag iso-Pr (PF-04217329), a selective EP2 receptor agonist administered as a topical ophthalmic soln., vs. its vehicle (Stage I), and dose-response of taprenepag iso-Pr alone and in unfixed combination with latanoprost ophthalmic soln. 0.005% vs. latanoprost alone (Stage II).  Subjects and Methods: Randomized, vehicle- and active-controlled, double-masked, two-stage, dose-finding trial in primary open-angle glaucoma (POAG) or ocular hypertension; first taprenepag iso-Pr study in patients (NCT00572455).  Study eye: 26 mmHg ≤ intraocular pressure (IOP) <36 mmHg at 8 am and 22 mmHg ≤ IOP <36 mmHg at 10 am, 1 pm, 4 pm.  Stage I: 3 cohorts (total n = 67) received 1 drop of taprenepag iso-Pr unit dose formulation qPM/eye for 14 days: low dose: 0.0025%, 0.005%, vehicle; middle dose: 0.01%, 0.015%, vehicle; high dose: 0.02%, 0.03%, vehicle.  Stage II: 7 groups (total n = 250) received 1 drop of taprenepag iso-Pr multidose formulation qPM/eye for 28 days: 0.005%, 0.01%, 0.015% monotherapy; each in unfixed combination with latanoprost 0.005%, or latanoprost monotherapy.  Main outcomes: mean change in diurnal IOP, baseline to last visit; adverse events.  Results: Stage I at Day 14: statistically significantly greater IOP redns. were obsd. at all taprenepag iso-Pr doses vs. vehicle.  Stage II at Day 28: statistically significantly greater IOP redns. were obsd. at all doses of the unfixed combination vs. latanoprost monotherapy.  At least 1 treatment-emergent adverse event reported for 29/67 (43.3%) subjects in Stage I and 158/250 (63.2%) in Stage II.  Conclusions: Taprenepag iso-Pr significantly reduces IOP in POAG and ocular hypertension.  Taprenepag iso-Pr monotherapy is comparable to latanoprost 0.005% in reducing IOP.  As demonstrated in this report, the activity of taprenepag iso-Pr is additive to that of latanoprost 0.005%.  Further studies are required to det. whether it shows similar additivity when administered with other ocular antihypertensive medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_8ZfLz9vtebVg90H21EOLACvtfcHk0lh2sOFS5h885g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVCqsL%252FO&md5=7e017ad68ed97d4dfd12223c39ca2691</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3109%2F02713683.2011.593725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F02713683.2011.593725%26sid%3Dliteratum%253Aachs%26aulast%3DSchachar%26aufirst%3DR.%2BA.%26aulast%3DRaber%26aufirst%3DS.%26aulast%3DCourtney%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DA%2520phase%25202%252C%2520randomized%252C%2520dose-response%2520trial%2520of%2520taprenepag%2520isopropyl%2520%2528PF-04217329%2529%2520versus%2520latanoprost%25200.005%2525%2520in%2520open-angle%2520glaucoma%2520and%2520ocular%2520hypertension%26jtitle%3DCurr.%2520Eye%2520Res.%26date%3D2011%26volume%3D36%26spage%3D809%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Schachar, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczotka-Flynn, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lass, J. H.</span><span> </span><span class="NLM_article-title">Subclinical increased anterior stromal reflectivity with topical taprenepag isopropyl</span> <span class="citation_source-journal">Cornea</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=306-312&author=R.+A.+Schacharauthor=S.+Raberauthor=K.+V.+Thomasauthor=B.+A.+Benetzauthor=L.+B.+Szczotka-Flynnauthor=M.+Zhangauthor=S.+J.+Howellauthor=J.+H.+Lass&title=Subclinical+increased+anterior+stromal+reflectivity+with+topical+taprenepag+isopropyl"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchachar%26aufirst%3DR.%2BA.%26aulast%3DRaber%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DK.%2BV.%26aulast%3DBenetz%26aufirst%3DB.%2BA.%26aulast%3DSzczotka-Flynn%26aufirst%3DL.%2BB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHowell%26aufirst%3DS.%2BJ.%26aulast%3DLass%26aufirst%3DJ.%2BH.%26atitle%3DSubclinical%2520increased%2520anterior%2520stromal%2520reflectivity%2520with%2520topical%2520taprenepag%2520isopropyl%26jtitle%3DCornea%26date%3D2013%26volume%3D32%26spage%3D306%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speigel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelutiu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">3149</span><span class="NLM_x">–</span> <span class="NLM_lpage">3154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1073%2Fpnas.1120195109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=22323596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=3149-3154&author=J.+Jiangauthor=T.+Ganeshauthor=Y.+Duauthor=Y.+Quanauthor=G.+Serranoauthor=M.+Quiauthor=I.+Speigelauthor=A.+Rojasauthor=N.+Lelutiuauthor=R.+Dingledine&title=Small+molecule+antagonist+reveals+seizure-induced+mediation+of+neuronal+injury+by+prostaglandin+E2+receptor+subtype+EP2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2</span></div><div class="casAuthors">Jiang, Lianxiong; Ganesh, Thota; Du, Yuhong; Quan, Yi; Serrano, Geidy; Qui, Min; Speigel, Iris; Rojas, Asheebo; Lelutiu, Nadia; Dingledine, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3149-3154, S3149/1-S3149/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">With interest waning in the use of cyclooxygenase-2 (COX-2) inhibitors for inflammatory disease, prostaglandin receptors provide alternative targets for the treatment of COX-2-mediated pathol. conditions in both the periphery and the central nervous system.  Activation of prostaglandin E2 receptor (PGE2) subtype EP2 promotes inflammation and is just beginning to be explored as a therapeutic target.  To better understand physiol. and pathol. functions of the prostaglandin EP2 receptor, we developed a suite of small mols. with a 3-aryl-acrylamide scaffold as selective EP2 antagonists.  The 12 most potent compds. displayed competitive antagonism of the human EP2 receptor with KB 2-20 nM in Schild regression anal. and 268- to 4,730-fold selectivity over the prostaglandin EP4 receptor.  A brain-permeant compd. completely suppressed the up-regulation of COX-2 mRNA in rat cultured microglia by EP'2 activation and significantly reduced neuronal injury in hippocampus when administered in mice beginning 1 h after termination of pilocarpine-induced status epilepticus.  The salutary actions of this novel group of antagonists raise the possibility that selective block of EP2 signaling via small mols. can be an innovative therapeutic strategy for inflammation-related brain injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouf-jrW_yv2bVg90H21EOLACvtfcHk0lgvnwnG9tWF-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wmtbg%253D&md5=183b6780de14d538ef97ffb038807b0d</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1120195109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1120195109%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DQuan%26aufirst%3DY.%26aulast%3DSerrano%26aufirst%3DG.%26aulast%3DQui%26aufirst%3DM.%26aulast%3DSpeigel%26aufirst%3DI.%26aulast%3DRojas%26aufirst%3DA.%26aulast%3DLelutiu%26aufirst%3DN.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DSmall%2520molecule%2520antagonist%2520reveals%2520seizure-induced%2520mediation%2520of%2520neuronal%2520injury%2520by%2520prostaglandin%2520E2%2520receptor%2520subtype%2520EP2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D3149%26epage%3D3154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouliot, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">3591</span><span class="NLM_x">–</span> <span class="NLM_lpage">3596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1073%2Fpnas.1218498110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23401547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFynt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=3591-3596&author=J.+Jiangauthor=Y.+Quanauthor=T.+Ganeshauthor=W.+A.+Pouliotauthor=F.+E.+Dudekauthor=R.+Dingledine&title=Inhibition+of+the+prostaglandin+receptor+EP2+following+status+epilepticus+reduces+delayed+mortality+and+brain+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation</span></div><div class="casAuthors">Jiang, Jianxiong; Quan, Yi; Ganesh, Thota; Pouliot, Wendy A.; Dudek, F. Edward; Dingledine, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3591-3596, S3591/1-S3591/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Prostaglandin E2 is now widely recognized to play crit. roles in brain inflammation and injury, although the responsible prostaglandin receptors have not been fully identified.  We developed a potent and selective antagonist for the prostaglandin E2 receptor subtype EP2, TG6-10-1, with a sufficient pharmacokinetic profile to be used in vivo.  We found that in the mouse pilocarpine model of status epilepticus (SE), systemic administration of TG6-10-1 completely recapitulates the effects of conditional ablation of cyclooxygenase-2 from principal forebrain neurons, namely reduced delayed mortality, accelerated recovery from wt. loss, reduced brain inflammation, prevention of blood-brain barrier opening, and neuroprotection in the hippocampus, without modifying seizures acutely.  Prolonged SE in humans causes high mortality and morbidity that are assocd. with brain inflammation and injury, but currently the only effective treatment is to stop the seizures quickly enough with anticonvulsants to prevent brain damage.  Our results suggest that the prostaglandin receptor EP2 is critically involved in neuro-inflammation and neurodegeneration, and point to EP2 receptor antagonism as an adjunctive therapeutic strategy to treat SE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKncI8WoxYk7Vg90H21EOLACvtfcHk0lgvnwnG9tWF-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFynt7g%253D&md5=258eb9d19f66a24a2237dcc61389e3a4</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1218498110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1218498110%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DQuan%26aufirst%3DY.%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DPouliot%26aufirst%3DW.%2BA.%26aulast%3DDudek%26aufirst%3DF.%2BE.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520the%2520prostaglandin%2520receptor%2520EP2%2520following%2520status%2520epilepticus%2520reduces%2520delayed%2520mortality%2520and%2520brain%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D3591%26epage%3D3596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Savonenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnikova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkwood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasson, K.</span><span> </span><span class="NLM_article-title">Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.expneurol.2009.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19416671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslKjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2009&pages=63-73&author=A.+Savonenkoauthor=P.+Munozauthor=T.+Melnikovaauthor=Q.+Wangauthor=X.+Liangauthor=R.+M.+Breyerauthor=T.+J.+Montineauthor=A.+Kirkwoodauthor=K.+Andreasson&title=Impaired+cognition%2C+sensorimotor+gating%2C+and+hippocampal+long-term+depression+in+mice+lacking+the+prostaglandin+E2+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor</span></div><div class="casAuthors">Savonenko, A.; Munoz, P.; Melnikova, T.; Wang, Q.; Liang, X.; Breyer, R. M.; Montine, T. J.; Kirkwood, A.; Andreasson, K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-73</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclooxygenase-2 (COX-2) is a neuronal immediate early gene that is regulated by N-Me aspartate (NMDA) receptor activity.  COX-2 enzymic activity catalyzes the first committed step in prostaglandin synthesis.  Recent studies demonstrate an emerging role for the downstream PGE2 EP2 receptor in diverse models of activity-dependent synaptic plasticity and a significant function in models of neurol. disease including cerebral ischemia, Familial Alzheimer's disease, and Familial amyotrophic lateral sclerosis.  Little is known, however, about the normal function of the EP2 receptor in behavior and cognition.  Here we report that deletion of the EP2 receptor leads to significant cognitive deficits in std. tests of fear and social memory.  EP2-/- mice also demonstrated impaired prepulse inhibition (PPI) and heightened anxiety, but normal startle reactivity, exploratory behavior, and spatial ref. memory.  This complex behavioral phenotype of EP2-/- mice was assocd. with a deficit in long-term depression (LTD) in hippocampus.  Our findings suggest that PGE2 signaling via the EP2 receptors plays an important role in cognitive and emotional behaviors that recapitulate some aspects of human psychopathol. related to schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqtMJ63OH0QLVg90H21EOLACvtfcHk0lj8SOz3p5XjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslKjt70%253D&md5=3ddfa6bf0988625f5ac290732ff76695</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2009.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2009.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DSavonenko%26aufirst%3DA.%26aulast%3DMunoz%26aufirst%3DP.%26aulast%3DMelnikova%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DKirkwood%26aufirst%3DA.%26aulast%3DAndreasson%26aufirst%3DK.%26atitle%3DImpaired%2520cognition%252C%2520sensorimotor%2520gating%252C%2520and%2520hippocampal%2520long-term%2520depression%2520in%2520mice%2520lacking%2520the%2520prostaglandin%2520E2%2520EP2%2520receptor%26jtitle%3DExp.%2520Neurol.%26date%3D2009%26volume%3D217%26spage%3D63%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1471-4159.2008.05766.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=19012750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1ajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2009&pages=295-304&author=H.+Yangauthor=J.+Zhangauthor=R.+M.+Breyerauthor=C.+Chen&title=Altered+hippocampal+long-term+synaptic+plasticity+in+mice+deficient+in+the+PGE2+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor</span></div><div class="casAuthors">Yang, Hongwei; Zhang, Jian; Breyer, Richard M.; Chen, Chu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">295-304</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Our lab. demonstrated previously that PGE2-induced modulation of hippocampal synaptic transmission is via a presynaptic PGE2 EP2 receptor.  However, little is known about whether the EP2 receptor is involved in hippocampal long-term synaptic plasticity and cognitive function.  Here we show that long-term potentiation at the hippocampal perforant path synapses was impaired in mice deficient in the EP2 (KO), while membrane excitability and passive properties in granule neurons were normal.  Importantly, escape latency in the water maze in EP2 KO was longer than that in age-matched EP2 wild-type littermates (WT).  We also obsd. that long-term potentiation was potentiated in EP2 WT animals that received lipopolysaccharide (LPS, i.p.), but not in EP2 KO.  Bath application of PGE2 or butaprost, an EP2 receptor agonist, increased synaptic transmission and decreased paired-pulses ratio in EP2 WT mice, but failed to induce the changes in EP2 KO mice.  Meanwhile, synaptic transmission was elevated by application of forskolin, an adenylyl cyclase activator, both in EP2 KO and WT animals.  In addn., the PGE2-enhanced synaptic transmission was significantly attenuated by application of PKA, IP3 or MAPK inhibitors in EP2 WT animals.  Our results show that hippocampal long-term synaptic plasticity is impaired in mice deficient in the EP2, suggesting that PGE2-EP2 signaling is important for hippocampal long-term synaptic plasticity and cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqreFnreLDg7Vg90H21EOLACvtfcHk0lj8SOz3p5XjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1ajsQ%253D%253D&md5=e8a7346f6ffef53dfc5d9084ae9cffa5</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05766.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05766.x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DAltered%2520hippocampal%2520long-term%2520synaptic%2520plasticity%2520in%2520mice%2520deficient%2520in%2520the%2520PGE2%2520EP2%2520receptor%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D108%26spage%3D295%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Hizaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushikubi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, A.</span><span> </span><span class="NLM_article-title">Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2)</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">10501</span><span class="NLM_x">–</span> <span class="NLM_lpage">10506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=10501-10506&author=H.+Hizakiauthor=E.+Segiauthor=Y.+Sugimotoauthor=M.+Hiroseauthor=T.+Sajiauthor=F.+Ushikubiauthor=T.+Matsuokaauthor=Y.+Nodaauthor=T.+Tanakaauthor=N.+Yoshidaauthor=S.+Narumiyaauthor=A.+Ichikawa&title=Abortive+expansion+of+the+cumulus+and+impaired+fertility+in+mice+lacking+the+prostaglandin+E+receptor+subtype+EP%282%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHizaki%26aufirst%3DH.%26aulast%3DSegi%26aufirst%3DE.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DHirose%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DT.%26aulast%3DUshikubi%26aufirst%3DF.%26aulast%3DMatsuoka%26aufirst%3DT.%26aulast%3DNoda%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DNarumiya%26aufirst%3DS.%26aulast%3DIchikawa%26aufirst%3DA.%26atitle%3DAbortive%2520expansion%2520of%2520the%2520cumulus%2520and%2520impaired%2520fertility%2520in%2520mice%2520lacking%2520the%2520prostaglandin%2520E%2520receptor%2520subtype%2520EP%25282%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D10501%26epage%3D10506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Kennedy, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breyer, R. M.</span><span> </span><span class="NLM_article-title">Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=217-220&author=C.+R.+Kennedyauthor=Y.+Zhangauthor=S.+Brandonauthor=Y.+Guanauthor=K.+Coffeeauthor=C.+D.+Funkauthor=M.+A.+Magnusonauthor=J.+A.+Oatesauthor=M.+D.+Breyerauthor=R.+M.+Breyer&title=Salt-sensitive+hypertension+and+reduced+fertility+in+mice+lacking+the+prostaglandin+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DC.%2BR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBrandon%26aufirst%3DS.%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DCoffee%26aufirst%3DK.%26aulast%3DFunk%26aufirst%3DC.%2BD.%26aulast%3DMagnuson%26aufirst%3DM.%2BA.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DBreyer%26aufirst%3DM.%2BD.%26aulast%3DBreyer%26aufirst%3DR.%2BM.%26atitle%3DSalt-sensitive%2520hypertension%2520and%2520reduced%2520fertility%2520in%2520mice%2520lacking%2520the%2520prostaglandin%2520EP2%2520receptor%26jtitle%3DNature%2520Med.%26date%3D1999%26volume%3D5%26spage%3D217%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Chun, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lao, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trempus, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langenbach, R.</span><span> </span><span class="NLM_article-title">The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1620</span><span class="NLM_x">–</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1620-1627&author=K.+S.+Chunauthor=H.+C.+Laoauthor=C.+S.+Trempusauthor=M.+Okadaauthor=R.+Langenbach&title=The+prostaglandin+receptor+EP2+activates+multiple+signaling+pathways+and+beta-arrestin1+complex+formation+during+mouse+skin+papilloma+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DK.%2BS.%26aulast%3DLao%26aufirst%3DH.%2BC.%26aulast%3DTrempus%26aufirst%3DC.%2BS.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DLangenbach%26aufirst%3DR.%26atitle%3DThe%2520prostaglandin%2520receptor%2520EP2%2520activates%2520multiple%2520signaling%2520pathways%2520and%2520beta-arrestin1%2520complex%2520formation%2520during%2520mouse%2520skin%2520papilloma%2520development%26jtitle%3DCarcinogenesis%26date%3D2009%26volume%3D30%26spage%3D1620%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Fujino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J. W.</span><span> </span><span class="NLM_article-title">Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=335-340&author=H.+Fujinoauthor=J.+W.+Regan&title=Prostanoid+receptors+and+phosphatidylinositol+3-kinase%3A+a+pathway+to+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DH.%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3DProstanoid%2520receptors%2520and%2520phosphatidylinositol%25203-kinase%253A%2520a%2520pathway%2520to%2520cancer%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2003%26volume%3D24%26spage%3D335%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Fujino, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J. W.</span><span> </span><span class="NLM_article-title">Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=251-259&author=H.+Fujinoauthor=S.+Salviauthor=J.+W.+Regan&title=Differential+regulation+of+phosphorylation+of+the+cAMP+response+element-binding+protein+after+activation+of+EP2+and+EP4+prostanoid+receptors+by+prostaglandin+E2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFujino%26aufirst%3DH.%26aulast%3DSalvi%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3DDifferential%2520regulation%2520of%2520phosphorylation%2520of%2520the%2520cAMP%2520response%2520element-binding%2520protein%2520after%2520activation%2520of%2520EP2%2520and%2520EP4%2520prostanoid%2520receptors%2520by%2520prostaglandin%2520E2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D68%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection</span> <span class="citation_source-journal">Trends. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.tips.2013.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23796953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSlsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=413-423&author=J.+Jiangauthor=R.+Dingledine&title=Prostaglandin+receptor+EP2+in+the+crosshairs+of+anti-inflammation%2C+anti-cancer%2C+and+neuroprotection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection</span></div><div class="casAuthors">Jiang, Jianxiong; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">413-423</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Modulation of a specific prostanoid synthase or receptor provides therapeutic alternatives to nonsteroidal anti-inflammatory drugs (NSAIDs) for treating pathol. conditions governed by cyclooxygenase-2 (COX-2 or PTGS2).  Among the COX-2 downstream signaling pathways, the prostaglandin E2 (PGE2) receptor EP2 subtype (PTGER2) is emerging as a crucial mediator of many physiol. and pathol. events.  Genetic ablation strategies and recent advances in chem. biol. provide tools for a better understanding of EP2 signaling.  In the brain, the EP2 receptor modulates some beneficial effects, including neuroprotection, in acute models of excitotoxicity, neuroplasticity, and spatial learning via cAMP-PKA signaling.  Conversely, EP2 activation accentuates chronic inflammation mainly through the cAMP-Epac pathway, likely contributing to delayed neurotoxicity.  EP2 receptor activation also engages β-arrestin in a G-protein-independent pathway that promotes tumor cell growth and migration.  Understanding the conditions under which multiple EP2 signaling pathways are engaged might suggest novel therapeutic strategies to target this key inflammatory prostaglandin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZPJrPfUjLrLVg90H21EOLACvtfcHk0lhdZ2GywZJ16w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSlsbvO&md5=2833b47caa17255ef2635300d7c13575</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DProstaglandin%2520receptor%2520EP2%2520in%2520the%2520crosshairs%2520of%2520anti-inflammation%252C%2520anti-cancer%252C%2520and%2520neuroprotection%26jtitle%3DTrends.%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D413%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Regan, J. W.</span><span> </span><span class="NLM_article-title">EP2 and EP4 prostanoid receptor signaling</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=143-153&author=J.+W.+Regan&title=EP2+and+EP4+prostanoid+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3DEP2%2520and%2520EP4%2520prostanoid%2520receptor%2520signaling%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D74%26spage%3D143%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Bos, J. L.</span><span> </span><span class="NLM_article-title">Epac: a new cAMP target and new avenues in cAMP research</span> <span class="citation_source-journal">Nature Rev. Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnrm1197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=14506476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsVKqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=733-738&author=J.+L.+Bos&title=Epac%3A+a+new+cAMP+target+and+new+avenues+in+cAMP+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Opinion: Epac: a new cAMP target and new avenues in cAMP research</span></div><div class="casAuthors">Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">733-738</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Five years ago, Epac - a guanine nucleotide exchange factor for the Ras-like small GTPases Rap1 and Rap2 - was found to be a new target of cAMP, which opened up new avenues for cAMP research.  Structural anal. of the cAMP-binding domains of Epac2 has identified a unifying mechanism for how cAMP activates proteins, and the design and synthesis of an Epac-specific cAMP analog has paved the way for future discoveries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMTh0k8Iy-8LVg90H21EOLACvtfcHk0lhdZ2GywZJ16w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsVKqsLw%253D&md5=14be0f1922a69532b14fe2b4d3b079c5</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1038%2Fnrm1197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1197%26sid%3Dliteratum%253Aachs%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DEpac%253A%2520a%2520new%2520cAMP%2520target%2520and%2520new%2520avenues%2520in%2520cAMP%2520research%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D733%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">de Rooij, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwartkruis, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cool, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nijman, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittinghofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. L.</span><span> </span><span class="NLM_article-title">Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">396</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2F24884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=9853756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADyaK1cXotVSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=396&publication_year=1998&pages=474-477&author=J.+de+Rooijauthor=F.+J.+Zwartkruisauthor=M.+H.+Verheijenauthor=R.+H.+Coolauthor=S.+M.+Nijmanauthor=A.+Wittinghoferauthor=J.+L.+Bos&title=Epac+is+a+Rap1+guanine-nucleotide-exchange+factor+directly+activated+by+cyclic+AMP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP</span></div><div class="casAuthors">De Rooij, Johan; Zwartkruis, Fried J. T.; Verhaijen, Mark H. G.; Cool, Robbert H.; Nijman, Sebastian M. B.; Wittinghofer, Alfred; Bos, Johannes L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">396</span>
        (<span class="NLM_cas:issue">6710</span>),
    <span class="NLM_cas:pages">474-477</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Rap1 is a small, Ras-like GTPase that was first identified as a protein that could suppress the oncogenic transformation of cells by Ras.  Rap1 is activated by several extracellular stimuli and may be involved in cellular processes such as cell proliferation, cell differentiation, T-cell anergy and platelet activation.  At least three different second messengers, namely diacylglycerol, calcium and cAMP, are able to activate Rap1 by promoting its release of the guanine nucleotide GDP and its binding to GTP.  Here we report that activation of Rap1 by forskolin and cAMP occurs independently of protein kinase A (also known as cAMP-activated protein kinase).  We have cloned the gene encoding a guanine-nucleotide-exchange factor (GEF) which we have named Epac (exchange protein directly activated by cAMP).  This protein contains a cAMP-binding site and a domain that is homologous to domains of known GEFs for Ras and Rap1.  Epac binds cAMP in vitro and exhibits in vivo and in vitro GEF activity towards Rap1.  CAMP strongly induces the GEF activity of Epac towards Rap1 both in vivo and in vitro.  We conclude that Epac is a GEF for Rap1 that is regulated directly by cAMP and that Epac is a new target protein for cAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ96rDUUrIc7Vg90H21EOLACvtfcHk0lh_kmJ-B1ZznQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVSitbs%253D&md5=8f4a50b23d8bfc344c0c9947175b89a5</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1038%2F24884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F24884%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BRooij%26aufirst%3DJ.%26aulast%3DZwartkruis%26aufirst%3DF.%2BJ.%26aulast%3DVerheijen%26aufirst%3DM.%2BH.%26aulast%3DCool%26aufirst%3DR.%2BH.%26aulast%3DNijman%26aufirst%3DS.%2BM.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DEpac%2520is%2520a%2520Rap1%2520guanine-nucleotide-exchange%2520factor%2520directly%2520activated%2520by%2520cyclic%2520AMP%26jtitle%3DNature%26date%3D1998%26volume%3D396%26spage%3D474%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Duman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Sa, C.</span><span> </span><span class="NLM_article-title">Neuronal plasticity and survival in mood disorders</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2FS0006-3223%2800%2900935-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A280%3ADC%252BD3crht1SitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=732-739&author=R.+S.+Dumanauthor=J.+Malbergauthor=S.+Nakagawaauthor=C.+D%E2%80%99Sa&title=Neuronal+plasticity+and+survival+in+mood+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal plasticity and survival in mood disorders</span></div><div class="casAuthors">Duman R S; Malberg J; Nakagawa S; D'Sa C</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">732-9</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">Studies at the basic and clinical levels demonstrate that neuronal atrophy and cell death occur in response to stress and in the brains of depressed patients.  Although the mechanisms have yet to be fully elucidated, progress has been made in characterizing the signal transduction cascades that control neuronal atrophy and programmed cell death and that may be involved in the action of antidepressant treatment.  These pathways include the cyclic adenosine monophosphate and neurotrophic factor signal transduction cascades.  It is notable that these same pathways have been demonstrated to play a pivotal role in cellular models of neural plasticity.  This overlap of plasticity and cell survival pathways, together with studies demonstrating that neuronal activity enhances cell survival, suggests that neuronal atrophy and death could result from a disruption of the mechanisms underlying neural plasticity.  The role of these pathways and failure of neuronal plasticity in stress-related mood disorders are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3Y5uxyHs5dJ6KlWarZTAzfW6udTcc2eaG1HfAPtMpRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3crht1SitQ%253D%253D&md5=4d24a4b4d781dfff57d365c1a8f43327</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2800%2900935-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252800%252900935-5%26sid%3Dliteratum%253Aachs%26aulast%3DDuman%26aufirst%3DR.%2BS.%26aulast%3DMalberg%26aufirst%3DJ.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DD%25E2%2580%2599Sa%26aufirst%3DC.%26atitle%3DNeuronal%2520plasticity%2520and%2520survival%2520in%2520mood%2520disorders%26jtitle%3DBiol.%2520Psychiatry%26date%3D2000%26volume%3D48%26spage%3D732%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Herold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagasia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wassmer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lie, D. C.</span><span> </span><span class="NLM_article-title">CREB signalling regulates early survival, neuronal gene expression and morphological development in adult subventricular zone neurogenesis</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.mcn.2010.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktF2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=79-88&author=S.+Heroldauthor=R.+Jagasiaauthor=K.+Merzauthor=K.+Wassmerauthor=D.+C.+Lie&title=CREB+signalling+regulates+early+survival%2C+neuronal+gene+expression+and+morphological+development+in+adult+subventricular+zone+neurogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">CREB signalling regulates early survival, neuronal gene expression and morphological development in adult subventricular zone neurogenesis</span></div><div class="casAuthors">Herold, S.; Jagasia, R.; Merz, K.; Wassmer, K.; Lie, D. C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neural stem cells in the subventricular zone (SVZ) of the lateral ventricles give rise to new interneurons of the olfactory bulb (OB) throughout life.  SVZ/OB neurogenesis is influenced by olfactory network activity, which modulates the survival of new neurons during their integration into the OB network.  Previous work suggested that such activity-dependent survival is regulated via the CREB signalling pathway.  Curiously, CREB signalling is already active during the early developmental stages of adult SVZ/OB neurogenesis.  To investigate the role of cell autonomous CREB signalling during early stages of adult SVZ/OB neurogenesis, we ablated CREB-pathway activity in the SVZ/OB neurogenic lineage using a retroviral strategy.  Surprisingly, loss of CREB signalling resulted in increased cell death and loss of expression of the neurogenic transcription factor Pax 6, and of a subset of neuronal proteins in migrating neurons of the RMS.  Moreover, post-migratory neurons in the OB displayed impaired dendritic development.  These results demonstrate an essential role for CREB signalling in maturation of newborn neurons in the OB and uncover a novel role for CREB signalling in the survival and maintenance of neuronal gene expression during the early stages of SVZ/OB neurogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBUCTVArK-67Vg90H21EOLACvtfcHk0lh_kmJ-B1ZznQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktF2rtg%253D%253D&md5=22b76041f80e02ed91ccb216d04caee3</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2010.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2010.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DHerold%26aufirst%3DS.%26aulast%3DJagasia%26aufirst%3DR.%26aulast%3DMerz%26aufirst%3DK.%26aulast%3DWassmer%26aufirst%3DK.%26aulast%3DLie%26aufirst%3DD.%2BC.%26atitle%3DCREB%2520signalling%2520regulates%2520early%2520survival%252C%2520neuronal%2520gene%2520expression%2520and%2520morphological%2520development%2520in%2520adult%2520subventricular%2520zone%2520neurogenesis%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2011%26volume%3D46%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Ouyang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwede, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S. A.</span><span> </span><span class="NLM_article-title">Epac signaling is required for hippocampus-dependent memory retrieval</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">11993</span><span class="NLM_x">–</span> <span class="NLM_lpage">11997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=11993-11997&author=M.+Ouyangauthor=L.+Zhangauthor=J.+J.+Zhuauthor=F.+Schwedeauthor=S.+A.+Thomas&title=Epac+signaling+is+required+for+hippocampus-dependent+memory+retrieval"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOuyang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%2BJ.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DS.%2BA.%26atitle%3DEpac%2520signaling%2520is%2520required%2520for%2520hippocampus-dependent%2520memory%2520retrieval%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D11993%26epage%3D11997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Shi, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, D. A.</span><span> </span><span class="NLM_article-title">A novel cyclic AMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">9136</span><span class="NLM_x">–</span> <span class="NLM_lpage">9147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1128%2FMCB.00332-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yqsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9136-9147&author=G.+X.+Shiauthor=H.+Rehmannauthor=D.+A.+Andres&title=A+novel+cyclic+AMP-dependent+Epac-Rit+signaling+pathway+contributes+to+PACAP38-mediated+neuronal+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cyclic AMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation</span></div><div class="casAuthors">Shi, Geng-Xian; Rehmann, Holger; Andres, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9136-9147</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pituitary adenylate cyclase-activating polypeptide (PACAP38) stimulation results in the activation of Gsα protein-coupled receptors to regulate neuronal differentiation in a cAMP-dependent manner.  These pathways involve protein kinase A (PKA)-dependent processes, but a growing body of evidence indicates that cAMP also regulates cellular functions through PKA-independent signaling cascades.  Here we show that the Rit small GTPase is regulated by PACAP38 in a cAMP-dependent but PKA-independent fashion.  Rit activation results from stimulation of the cAMP-activated guanine nucleotide exchange factor Epac but does not appear to rely upon the activation of Rap GTPases, the accepted cellular Epac substrates.  Although RNA interference studies demonstrated that Epac is required for PACAP38-mediated Rit activation, neither Epac1 nor Epac2 activates Rit directly, indicating that Epac signals to Rit through a novel mechanism in which Rap signaling is not essential.  Loss-of-function anal. demonstrated that Rit makes an important contribution to PACAP38-mediated neuronal differentiation.  Surprisingly, although Rit is required for sustained extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase signaling following nerve growth factor stimulation of pheochromocytoma 6 (PC6) cells, Rit silencing selectively suppressed PACAP38-elicited activation of p38, without obvious effects on ERK signaling in the same cells.  Moreover, the ability of PACAP38 to stimulate CREB-dependent transcription and to promote neurite outgrowth was inhibited by Rit knockdown.  Together, these studies identify an unsuspected connection between cAMP and Rit signaling pathways and imply that Rit can function downstream of Gsα/cAMP/Epac in a novel signal transduction pathway necessary for PACAP38-mediated neuronal differentiation and CREB signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhn7YNBTSyBLVg90H21EOLACvtfcHk0liIrhP5n2jjlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yqsb7M&md5=a46640af507f65ff525df747a96c70af</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1128%2FMCB.00332-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00332-06%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DG.%2BX.%26aulast%3DRehmann%26aufirst%3DH.%26aulast%3DAndres%26aufirst%3DD.%2BA.%26atitle%3DA%2520novel%2520cyclic%2520AMP-dependent%2520Epac-Rit%2520signaling%2520pathway%2520contributes%2520to%2520PACAP38-mediated%2520neuronal%2520differentiation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D9136%26epage%3D9147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petralia, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span> </span><span class="NLM_article-title">EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1016%2Fj.neuron.2012.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=22365550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2ktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2012&pages=774-788&author=Y.+Yangauthor=X.+Shuauthor=D.+Liuauthor=Y.+Shangauthor=Y.+Wuauthor=L.+Peiauthor=X.+Xuauthor=Q.+Tianauthor=J.+Zhangauthor=K.+Qianauthor=Y.+X.+Wangauthor=R.+S.+Petraliaauthor=W.+Tuauthor=L.+Q.+Zhuauthor=J.+Z.+Wangauthor=Y.+Lu&title=EPAC+null+mutation+impairs+learning+and+social+interactions+via+aberrant+regulation+of+miR-124+and+Zif268+translation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation</span></div><div class="casAuthors">Yang, Ying; Shu, Xiaogang; Liu, Dan; Shang, You; Wu, Yan; Pei, Lei; Xu, Xin; Tian, Qing; Zhang, Jian; Qian, Kun; Wang, Ya-Xian; Petralia, Ronald S.; Tu, Weihong; Zhu, Ling-Qiang; Wang, Jian-Zhi; Lu, Youming</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">774-788</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">EPAC proteins are the guanine nucleotide exchange factors that act as the intracellular receptors for cAMP.  Two variants of EPAC genes including EPAC1 and EPAC2 are cloned and are widely expressed throughout the brain.  But, their functions in the brain remain unknown.  Here, we genetically delete EPAC1 (EPAC1-/-), EPAC2 (EPAC2-/-), or both EPAC1 and EPAC2 genes (EPAC-/-) in the forebrain of mice.  We show that EPAC null mutation impairs long-term potentiation (LTP) and that this impairment is paralleled with the severe deficits in spatial learning and social interactions and is mediated in a direct manner by miR-124 transcription and Zif268 translation.  Knockdown of miR-124 restores Zif268 and hence reverses all aspects of the EPAC-/- phenotypes, whereas expression of miR-124 or knockdown of Zif268 reproduces the effects of EPAC null mutation.  Thus, EPAC proteins control miR-124 transcription in the brain for processing spatial learning and social interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS3xT7TZPA37Vg90H21EOLACvtfcHk0liIrhP5n2jjlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2ktLw%253D&md5=03fd3bd2a6401a5f3c6e36916d9b3a4b</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DShu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DShang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%2BX.%26aulast%3DPetralia%26aufirst%3DR.%2BS.%26aulast%3DTu%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DL.%2BQ.%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DLu%26aufirst%3DY.%26atitle%3DEPAC%2520null%2520mutation%2520impairs%2520learning%2520and%2520social%2520interactions%2520via%2520aberrant%2520regulation%2520of%2520miR-124%2520and%2520Zif268%2520translation%26jtitle%3DNeuron%26date%3D2012%26volume%3D73%26spage%3D774%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Prostaglandin E receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">11613</span><span class="NLM_x">–</span> <span class="NLM_lpage">11617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1074%2Fjbc.R600038200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=17329241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFemtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=11613-11617&author=Y.+Sugimotoauthor=S.+Narumiya&title=Prostaglandin+E+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E Receptors</span></div><div class="casAuthors">Sugimoto, Yukihiko; Narumiya, Shuh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">11613-11617</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Prostaglandin (PG) E2 exerts its actions by acting on a group of G-protein-coupled receptors (GPCRs).  There are four GPCRs responding to PGE2 designated subtypes EP1, EP2, EP3, and EP4 and multiple splicing isoforms of the subtype EP3.  The EP subtypes exhibit differences in signal transduction, tissue localization, and regulation of expression.  This mol. and biochem. heterogeneity of PGE receptors leads to PGE2 being the most versatile prostanoid.  Studies on knock-out mice deficient in each EP subtype have defined PGE2 actions mediated by each subtype and identified the role each EP subtype plays in various physiol. and pathophysiol. responses.  Here we review recent advances in PGE receptor research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolU7s4EWb1LLVg90H21EOLACvtfcHk0liIrhP5n2jjlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFemtbs%253D&md5=d63dd3c6865110eddf690a3da48990a8</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R600038200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R600038200%26sid%3Dliteratum%253Aachs%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DProstaglandin%2520E%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D11613%26epage%3D11617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Abramovitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carriere, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochette, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufresne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gareau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juteau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouimet, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metters, K. M.</span><span> </span><span class="NLM_article-title">The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1483</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1483&publication_year=2000&pages=285-293&author=M.+Abramovitzauthor=M.+Adamauthor=Y.+Boieauthor=M.+Carriereauthor=D.+Denisauthor=C.+Godboutauthor=S.+Lamontagneauthor=C.+Rochetteauthor=N.+Sawyerauthor=N.+M.+Tremblayauthor=M.+Belleyauthor=M.+Gallantauthor=C.+Dufresneauthor=Y.+Gareauauthor=R.+Ruelauthor=H.+Juteauauthor=M.+Labelleauthor=N.+Ouimetauthor=K.+M.+Metters&title=The+utilization+of+recombinant+prostanoid+receptors+to+determine+the+affinities+and+selectivities+of+prostaglandins+and+related+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbramovitz%26aufirst%3DM.%26aulast%3DAdam%26aufirst%3DM.%26aulast%3DBoie%26aufirst%3DY.%26aulast%3DCarriere%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DD.%26aulast%3DGodbout%26aufirst%3DC.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DRochette%26aufirst%3DC.%26aulast%3DSawyer%26aufirst%3DN.%26aulast%3DTremblay%26aufirst%3DN.%2BM.%26aulast%3DBelley%26aufirst%3DM.%26aulast%3DGallant%26aufirst%3DM.%26aulast%3DDufresne%26aufirst%3DC.%26aulast%3DGareau%26aufirst%3DY.%26aulast%3DRuel%26aufirst%3DR.%26aulast%3DJuteau%26aufirst%3DH.%26aulast%3DLabelle%26aufirst%3DM.%26aulast%3DOuimet%26aufirst%3DN.%26aulast%3DMetters%26aufirst%3DK.%2BM.%26atitle%3DThe%2520utilization%2520of%2520recombinant%2520prostanoid%2520receptors%2520to%2520determine%2520the%2520affinities%2520and%2520selectivities%2520of%2520prostaglandins%2520and%2520related%2520analogs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2000%26volume%3D1483%26spage%3D285%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Nials, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardey, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denyer, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparrow, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. A.</span><span> </span><span class="NLM_article-title">Ah13205, a Selective Prostanoid Ep2-Receptor Agonist</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1993&pages=165-179&author=A.+T.+Nialsauthor=C.+J.+Vardeyauthor=L.+H.+Denyerauthor=M.+Thomasauthor=S.+J.+Sparrowauthor=G.+D.+Shepherdauthor=R.+A.+Coleman&title=Ah13205%2C+a+Selective+Prostanoid+Ep2-Receptor+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNials%26aufirst%3DA.%2BT.%26aulast%3DVardey%26aufirst%3DC.%2BJ.%26aulast%3DDenyer%26aufirst%3DL.%2BH.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DSparrow%26aufirst%3DS.%2BJ.%26aulast%3DShepherd%26aufirst%3DG.%2BD.%26aulast%3DColeman%26aufirst%3DR.%2BA.%26atitle%3DAh13205%252C%2520a%2520Selective%2520Prostanoid%2520Ep2-Receptor%2520Agonist%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D1993%26volume%3D11%26spage%3D165%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Woodward, D. F.</span><span> </span><span class="NLM_article-title">EP2-Receptor agonists as agents for lowering intraocular pressure</span>. US 5462968, <span class="NLM_day">31</span><span class="NLM_month">October</span><span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=D.+F.+Woodward&title=EP2-Receptor+agonists+as+agents+for+lowering+intraocular+pressure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DD.%2BF.%26atitle%3DEP2-Receptor%2520agonists%2520as%2520agents%2520for%2520lowering%2520intraocular%2520pressure%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Woodward, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepperl, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkey, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J. W.</span><span> </span><span class="NLM_article-title">6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1731</span><span class="NLM_x">–</span> <span class="NLM_lpage">1733</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1995&pages=1731-1733&author=D.+F.+Woodwardauthor=D.+J.+Pepperlauthor=T.+H.+Burkeyauthor=J.+W.+Regan&title=6-Isopropoxy-9-oxoxanthene-2-carboxylic+acid+%28AH+6809%29%2C+a+human+EP2+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodward%26aufirst%3DD.%2BF.%26aulast%3DPepperl%26aufirst%3DD.%2BJ.%26aulast%3DBurkey%26aufirst%3DT.%2BH.%26aulast%3DRegan%26aufirst%3DJ.%2BW.%26atitle%3D6-Isopropoxy-9-oxoxanthene-2-carboxylic%2520acid%2520%2528AH%25206809%2529%252C%2520a%2520human%2520EP2%2520receptor%2520antagonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D50%26spage%3D1731%26epage%3D1733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">af Forselles, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aughton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dack, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, N.</span><span> </span><span class="NLM_article-title">In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP(2) receptor antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">1847</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1111%2Fj.1476-5381.2011.01495.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=21595651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=1847-1856&author=K.+J.+af+Forsellesauthor=J.+Rootauthor=T.+Clarkeauthor=D.+Daveyauthor=K.+Aughtonauthor=K.+Dackauthor=N.+Pullen&title=In+vitro+and+in+vivo+characterization+of+PF-04418948%2C+a+novel%2C+potent+and+selective+prostaglandin+EP%282%29+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist</span></div><div class="casAuthors">af Forselles, K. J.; Root, J.; Clarke, T.; Davey, D.; Aughton, K.; Dack, K.; Pullen, N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1847-1856</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Studies of the role of the prostaglandin EP2 receptor) have been limited by the availability of potent and selective antagonist tools.  Here we describe the in vitro/in vivo pharmacol. characterization of a novel EP2 receptor antagonist, PF-04418948 (1-(4-fluorobenzoyl)-3-{[(6-methoxy-2-naphthyl)oxy]methyl} azetidine-3-carboxylic acid).  Exptl. Approach Functional antagonist potency was assessed in cell-based systems expressing human EP2 receptors and native tissue prepns. from human, dog and mouse.  The selectivity of PF-04418948 was assessed against related receptors and a panel of GPCRs, ion channels and enzymes.  The ability of PF-04418948 to pharmacol. block EP2 receptor function in vivo was tested in rats.  Key Results PF-04418948 inhibited prostaglandin E2 (PGE2)-induced increase in cAMP in cells expressing EP2 receptors with a functional KB value of 1.8 nM.  In human myometrium, PF-04418948 produced a parallel, rightward shift of the butaprost-induced inhibition of the contractions induced by elec. field stimulation with an apparent KB of 5.4 nM.  In dog bronchiole and mouse trachea, PF-04418948 produced parallel rightward shifts of the PGE2-induced relaxation curve with a KB of 2.5 nM and an apparent KB of 1.3 nM resp.  Reversal of the PGE2-induced relaxation in the mouse trachea by PF-04418948 produced an IC50 value of 2.7 nM.  Given orally, PF-04418948 attenuated the butaprost-induced cutaneous blood flow response in rats.  PF-04418948 was selective for EP2 receptors over homologous and unrelated receptors, enzymes and channels.  Conclusions and Implications PF-04418948 is an orally active, potent and selective surmountable EP2 receptor antagonist that should aid further elaboration of EP2 receptor function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroU6orcpdIurVg90H21EOLACvtfcHk0lgDyIeC-PMBHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFyqsLzJ&md5=0239cd8c555c6ddf06336c46019454c9</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01495.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01495.x%26sid%3Dliteratum%253Aachs%26aulast%3Daf%2BForselles%26aufirst%3DK.%2BJ.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DT.%26aulast%3DDavey%26aufirst%3DD.%26aulast%3DAughton%26aufirst%3DK.%26aulast%3DDack%26aufirst%3DK.%26aulast%3DPullen%26aufirst%3DN.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterization%2520of%2520PF-04418948%252C%2520a%2520novel%252C%2520potent%2520and%2520selective%2520prostaglandin%2520EP%25282%2529%2520receptor%2520antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D1847%26epage%3D1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1124%2Fjpet.112.200444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23192657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2013&pages=360-367&author=J.+Jiangauthor=R.+Dingledine&title=Role+of+prostaglandin+receptor+EP2+in+the+regulations+of+cancer+cell+proliferation%2C+invasion%2C+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation</span></div><div class="casAuthors">Jiang, Jianxiong; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">360-367</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Population studies, preclin., and clin. trials suggest a role for cyclooxygenase-2 (COX-2, PTGS2) in tumor formation and progression.  The downstream prostanoid receptor signaling pathways involved in tumorigenesis are poorly understood, although prostaglandin E2 (PGE2), a major COX-2 metabolite which is usually upregulated in the involved tissues, presumably plays important roles in tumor biol.  Taking advantage of our recently identified novel selective antagonist for the EP2 (PTGER2) subtype of PGE2 receptor, we demonstrated that EP2 receptor activation could promote prostate cancer cell growth and invasion in vitro, accompanied by upregulation of the tumor-promoting inflammatory cytokines, such as IL-1β and IL-6.  Our results suggest the involvement of prostaglandin receptor EP2 in cancer cell proliferation and invasion possibly via its inflammatory actions, and indicate that selective blockade of the PGE2-EP2 signaling pathway via small mol. antagonists might represent a novel therapy for tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrocrmBwMbECLVg90H21EOLACvtfcHk0lh3y7DrXO3bUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKiurY%253D&md5=fc2ef21083d4ea747aeffc95e0beb84e</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.200444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.200444%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DRole%2520of%2520prostaglandin%2520receptor%2520EP2%2520in%2520the%2520regulations%2520of%2520cancer%2520cell%2520proliferation%252C%2520invasion%252C%2520and%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D344%26spage%3D360%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Ganesh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shashidharamurthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Discovery and characterization of carbamothioylacrylamides as EP selective antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400112h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=616-621&author=T.+Ganeshauthor=J.+Jiangauthor=R.+Shashidharamurthyauthor=R.+Dingledine&title=Discovery+and+characterization+of+carbamothioylacrylamides+as+EP+selective+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fml400112h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400112h%26sid%3Dliteratum%253Aachs%26aulast%3DGanesh%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DShashidharamurthy%26aufirst%3DR.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520carbamothioylacrylamides%2520as%2520EP%2520selective%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D616%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Dack, K. N.; Skerratt, S. E.; Yeap, S. K.</span><span> </span><span class="NLM_article-title">Azetidine derivatives and their use as prostaglandin E2 antagonists</span>. WO 2008/139287 A1, <span class="NLM_day">20</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=K.+N.+Dack&author=S.+E.+Skerratt&author=S.+K.+Yeap&title=Azetidine+derivatives+and+their+use+as+prostaglandin+E2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDack%26aufirst%3DK.%2BN.%26atitle%3DAzetidine%2520derivatives%2520and%2520their%2520use%2520as%2520prostaglandin%2520E2%2520antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Buchmann, B.; Braeuer, N.; Koppitz, M.; Peters, O.; Ter Laak, A.; Lindenthal, B.; Langer, G.; Wintermantel, T.</span><span> </span><span class="NLM_article-title">Thienopyrimidylamines as modulators of the EP2 receptor</span>. WO 2009007422 A1, <span class="NLM_day">15</span><span class="NLM_month">January</span><span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Buchmann&author=N.+Braeuer&author=M.+Koppitz&author=O.+Peters&author=A.+Ter+Laak&author=B.+Lindenthal&author=G.+Langer&author=T.+Wintermantel&title=Thienopyrimidylamines+as+modulators+of+the+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DThienopyrimidylamines%2520as%2520modulators%2520of%2520the%2520EP2%2520receptor%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Braeuer, N.; Buchmann, B.; Koppitz, M.; Langer, G.; Lindenthal, B.; Peters, O.; Ter Laak, A.; Wintermantel, T.</span><span> </span><span class="NLM_article-title"><i>N</i>-(1-Phthalazin-1-ylpiperidin-4-yl)amides as EP2 receptor modulators</span>. WO2008028689 A1, <span class="NLM_day">13</span><span class="NLM_month">March</span><span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=N.+Braeuer&author=B.+Buchmann&author=M.+Koppitz&author=G.+Langer&author=B.+Lindenthal&author=O.+Peters&author=A.+Ter+Laak&author=T.+Wintermantel&title=N-%281-Phthalazin-1-ylpiperidin-4-yl%29amides+as+EP2+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBraeuer%26aufirst%3DN.%26atitle%3DN-%25281-Phthalazin-1-ylpiperidin-4-yl%2529amides%2520as%2520EP2%2520receptor%2520modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Buchmann, B.; Brauer, N.; Koppititz, M.; Peters, O.; Ter Laak, A.; Lindenthal, B.; Langer, G.</span><span> </span><span class="NLM_article-title">Diaminopyrimidines as modulators of the EP2 receptor</span>. WO 2008/152093 A3, <span class="NLM_day">18</span><span class="NLM_month">December</span><span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+Buchmann&author=N.+Brauer&author=M.+Koppititz&author=O.+Peters&author=A.+Ter+Laak&author=B.+Lindenthal&author=G.+Langer&title=Diaminopyrimidines+as+modulators+of+the+EP2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBuchmann%26aufirst%3DB.%26atitle%3DDiaminopyrimidines%2520as%2520modulators%2520of%2520the%2520EP2%2520receptor%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Koppitz, M.; Lindenthal, B.; Antonious Ter, L.; Wintermantel, T.; Peters, O.; Langer, G.; Bräuer, N.; Buchmann, B.</span><span> </span><span class="NLM_article-title">Dérivés de <i>n</i>-(indol-3-ylalkyl)-(hétéro)arylamide comme modulateurs du récepteur</span> WO2010012397 A1, <span class="NLM_day">4</span><span class="NLM_month">February</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+Koppitz&author=B.+Lindenthal&author=L.+Antonious+Ter&author=T.+Wintermantel&author=O.+Peters&author=G.+Langer&author=N.+Br%C3%A4uer&author=B.+Buchmann&title=D%C3%A9riv%C3%A9s+de+n-%28indol-3-ylalkyl%29-%28h%C3%A9t%C3%A9ro%29arylamide+comme+modulateurs+du+r%C3%A9cepteur"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKoppitz%26aufirst%3DM.%26atitle%3DD%25C3%25A9riv%25C3%25A9s%2520de%2520n-%2528indol-3-ylalkyl%2529-%2528h%25C3%25A9t%25C3%25A9ro%2529arylamide%2520comme%2520modulateurs%2520du%2520r%25C3%25A9cepteur%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Jiang, J.; Ganesh, T.; Du, Y.; Thepchatri, P.; Quan, Y.; Dingledine, R. J.</span><span> </span><span class="NLM_article-title">Preparation of indole and benzimidazole derivatives as prostaglandin receptor EP2 antagonists</span>. WO 2012177618 A1, <span class="NLM_day">27</span><span class="NLM_month">December</span><span class="NLM_x"> </span><span class="NLM_year">2012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Jiang&author=T.+Ganesh&author=Y.+Du&author=P.+Thepchatri&author=Y.+Quan&author=R.+J.+Dingledine&title=Preparation+of+indole+and+benzimidazole+derivatives+as+prostaglandin+receptor+EP2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26atitle%3DPreparation%2520of%2520indole%2520and%2520benzimidazole%2520derivatives%2520as%2520prostaglandin%2520receptor%2520EP2%2520antagonists%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Recognizing and exploiting differences between RNAi and small-molecule inhibitors</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnchembio1207-739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=18007642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWqurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=739-744&author=W.+A.+Weissauthor=S.+S.+Taylorauthor=K.+M.+Shokat&title=Recognizing+and+exploiting+differences+between+RNAi+and+small-molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Recognizing and exploiting differences between RNAi and small-molecule inhibitors</span></div><div class="casAuthors">Weiss, William A.; Taylor, Stephen S.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The biol. of RNA interference has greatly facilitated anal. of loss-of-function phenotypes, but correlating these phenotypes with small-mol. inhibition profiles is not always straightforward.  The authors examine the rationale of comparing RNA interference to pharmacol. intervention in chem. biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JPzqVyshS7Vg90H21EOLACvtfcHk0lh3y7DrXO3bUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWqurjO&md5=9a26c990b358a6b2c717d1e361cac2da</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fnchembio1207-739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio1207-739%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DRecognizing%2520and%2520exploiting%2520differences%2520between%2520RNAi%2520and%2520small-molecule%2520inhibitors%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D739%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Iyer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastidar, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Prostaglandin E(2) synthase inhibition as a therapeutic target</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1517%2F14728220903018932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1ynsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=849-865&author=J.+P.+Iyerauthor=P.+K.+Srivastavaauthor=R.+Devauthor=S.+G.+Dastidarauthor=A.+Ray&title=Prostaglandin+E%282%29+synthase+inhibition+as+a+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E2 synthase inhibition as a therapeutic target</span></div><div class="casAuthors">Iyer, Jitesh P.; Srivastava, Punit K.; Dev, Rishabh; Dastidar, Sunanda G.; Ray, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">849-865</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Most NSAIDs function by inhibiting biosynthesis of PGE2 by inhibition of COX-1 and/or COX-2.  Since COX-1 has a protective function in the gastro-intestinal tract (GIT), non-selective inhibition of both cycloxygenases leads to moderate to severe gastro-intestinal intolerance.  Attempts to identify selective inhibitors of COX-2, led to the identification of celecoxib and rofecoxib.  However, long-term use of these drugs has serious adverse effects of sudden myocardial infarction and thrombosis.  Drug-mediated imbalance in the levels of prostaglandin I2 (PGI2) and thromboxane A2 (TXA2) with a bias towards TXA2 may be the primary reason for these events.  This resulted in the drugs being withdrawn from the market, leaving a need for an effective and safe anti-inflammatory drug.  Methods: Recently, the focus of research has shifted to enzymes downstream of COX in the prostaglandin biosynthetic pathway such as prostaglandin E2 synthases.  Microsomal prostaglandin E2 synthase-1 (mPGES-1) specifically isomerizes PGH2 to PGE2, under inflammatory conditions.  In this review, we examine the biol. of mPGES-1 and its role in disease.  Progress in designing mols. that can selectively inhibit mPGES-1 is reviewed.  Conclusion: mPGES-1 has the potential to be a target for anti-inflammatory therapy, devoid of adverse GIT and cardiac effects and warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9uMQHk0EPKbVg90H21EOLACvtfcHk0lgi58lITc_V1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1ynsbw%253D&md5=8001d075a55afef68c0b41e7846212ec</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1517%2F14728220903018932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728220903018932%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DJ.%2BP.%26aulast%3DSrivastava%26aufirst%3DP.%2BK.%26aulast%3DDev%26aufirst%3DR.%26aulast%3DDastidar%26aufirst%3DS.%2BG.%26aulast%3DRay%26aufirst%3DA.%26atitle%3DProstaglandin%2520E%25282%2529%2520synthase%2520inhibition%2520as%2520a%2520therapeutic%2520target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2009%26volume%3D13%26spage%3D849%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Okumura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murase, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nii, A.</span><span> </span><span class="NLM_article-title">Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1211%2Fjpp.60.6.0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1SmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=723-730&author=T.+Okumuraauthor=Y.+Murataauthor=K.+Taniguchiauthor=A.+Muraseauthor=A.+Nii&title=Effects+of+the+selective+EP4+antagonist%2C+CJ-023%2C423+on+chronic+inflammation+and+bone+destruction+in+rat+adjuvant-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis</span></div><div class="casAuthors">Okumura, Takako; Murata, Yoko; Taniguchi, Kana; Murase, Akio; Nii, Aisuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Prostaglandin E2 (PGE2) produced by cyclooxygenase (COX) is a potent pro-inflammatory mediator.  We have recently discovered CJ-023,423, a highly selective antagonist of EP4 receptors, one of the PGE2 receptors.  This agent is suitable for exploring the effects of blocking EP4 receptors following oral administration in rats.  In this study, CJ-023,423 was used in rats with adjuvant-induced arthritis (AIA) to investigate the role of the EP4 receptor in chronic inflammation and bone destruction.  These effects were compared with those of rofecoxib, a selective COX-2 inhibitor.  CJ-023,423 had significant inhibitory effects on paw swelling, inflammatory biomarkers, synovial inflammation and bone destruction in AIA rats.  In particular, the inhibitory effect on paw swelling in AIA rats was comparable to that of rofecoxib.  These results suggest that PGE2 acting via the EP4 receptor is involved in the development of chronic inflammation and bone destruction, particularly with respect to edema in AIA rats.  This is the first study to confirm the in-vivo effects of EP4 receptor blockade on inflammation and bone destruction in AIA rats with a small-mol. compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFuS15liJ4JrVg90H21EOLACvtfcHk0lgi58lITc_V1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1SmsLc%253D&md5=c210aa0e8ecba42aac9675a1072214a7</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1211%2Fjpp.60.6.0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.60.6.0007%26sid%3Dliteratum%253Aachs%26aulast%3DOkumura%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DMurase%26aufirst%3DA.%26aulast%3DNii%26aufirst%3DA.%26atitle%3DEffects%2520of%2520the%2520selective%2520EP4%2520antagonist%252C%2520CJ-023%252C423%2520on%2520chronic%2520inflammation%2520and%2520bone%2520destruction%2520in%2520rat%2520adjuvant-induced%2520arthritis%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2008%26volume%3D60%26spage%3D723%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chekler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span> </span><span class="NLM_article-title">Target validation using chemical probes</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnchembio.1197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23508172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFagsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=195-199&author=M.+E.+Bunnageauthor=E.+L.+Cheklerauthor=L.+H.+Jones&title=Target+validation+using+chemical+probes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Target validation using chemical probes</span></div><div class="casAuthors">Bunnage, Mark E.; Chekler, Eugene L. Piatnitski; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">195-199</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review on the fully profiled chem. probes essential to support the unbiased interpretation of biol. expts. necessary for rigorous preclin. target validation.  We believe that by developing a 'chem. probe tool kit', and a framework for its use, chem. biol. can have a more central role in identifying targets of potential relevance to disease, avoiding many of the biases that complicate target validation as practiced currently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLwRTT4pXGxbVg90H21EOLACvtfcHk0lgi58lITc_V1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFagsr4%253D&md5=af0c362882191de96a8e8698ff2c9ce8</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1197%26sid%3Dliteratum%253Aachs%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DChekler%26aufirst%3DE.%2BL.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DTarget%2520validation%2520using%2520chemical%2520probes%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D195%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Simon, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niphakis, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Determining target engagement in living systems</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">2055</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm401431x&amp;key=10.1038%2Fnchembio.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm401431x&amp;key=23508173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm401431x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=200-2055&author=G.+M.+Simonauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Determining+target+engagement+in+living+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Determining target engagement in living systems</span></div><div class="casAuthors">Simon, Gabriel M.; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. probes are crit. tools for elucidating the biol. functions of proteins and can lead to new medicines for treating disease.  The pharmacol. validation of protein function requires verification that chem. probes engage their intended targets in vivo.  Here we discuss technologies, both established and emergent, for measuring target engagement in living systems and propose that detg. this parameter should become std. practice for chem. probe and drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5eudh3YJSOLVg90H21EOLACvtfcHk0lgi58lITc_V1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D&md5=48a97d0d8ff7a7de4f9de0e9c54a1c5c</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1211%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDetermining%2520target%2520engagement%2520in%2520living%2520systems%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D200%26epage%3D2055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Iwamura, R.; Tanaka, M.; Katsube, T.; Shibakawa, N.; Shigetomi, M.; Okanari, E.; Kanda, T.; Tokunaga, Y.; Fujiwara, H.</span><span> </span><span class="NLM_article-title">Aminopyridine compound</span>. EP 2520570 A1, <span class="NLM_day">7</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Iwamura&author=M.+Tanaka&author=T.+Katsube&author=N.+Shibakawa&author=M.+Shigetomi&author=E.+Okanari&author=T.+Kanda&author=Y.+Tokunaga&author=H.+Fujiwara&title=Aminopyridine+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIwamura%26aufirst%3DR.%26atitle%3DAminopyridine%2520compound%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Hoffmeyer, A.; Boer, R.; Hessmann, M.; Pahl, A.; Dunkern, T.; Hartung, S.; Zitt, C.; Volz, J.; Prachter, C.; Makhija, M.; Jain, H.; Gavade, S.; Prabhu, A.; Tiwari, M.; Keche, A.; Patel, S.</span><span> </span><span class="NLM_article-title">Novel ep2 receptor agonists</span>. WO2013164326 A1, <span class="NLM_day">7</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+Hoffmeyer&author=R.+Boer&author=M.+Hessmann&author=A.+Pahl&author=T.+Dunkern&author=S.+Hartung&author=C.+Zitt&author=J.+Volz&author=C.+Prachter&author=M.+Makhija&author=H.+Jain&author=S.+Gavade&author=A.+Prabhu&author=M.+Tiwari&author=A.+Keche&author=S.+Patel&title=Novel+ep2+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmeyer%26aufirst%3DA.%26atitle%3DNovel%2520ep2%2520receptor%2520agonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Old, D. W.; Dinh, D. T.</span><span> </span><span class="NLM_article-title">Substituted gama lactams as therapeutic agents</span>. US 2009/0286787, <span class="NLM_day">19</span><span class="NLM_month">November</span><span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+W.+Old&author=D.+T.+Dinh&title=Substituted+gama+lactams+as+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOld%26aufirst%3DD.%2BW.%26atitle%3DSubstituted%2520gama%2520lactams%2520as%2520therapeutic%2520agents%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Prassanna, G.; Bosworth, C. F.; Lafontaine, J. A.</span><span> </span><span class="NLM_article-title">EP2 agonist</span>. US 2008/00455 A1, <span class="NLM_day">21</span><span class="NLM_month">February</span><span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+Prassanna&author=C.+F.+Bosworth&author=J.+A.+Lafontaine&title=EP2+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPrassanna%26aufirst%3DG.%26atitle%3DEP2%2520agonist%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401431x&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm401431x%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401431x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                995KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aa50e6d84234a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
